venlafaxine hydrochloride has been researched along with cyclohexanol in 1975 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (0.20) | 18.7374 |
| 1990's | 328 (16.61) | 18.2507 |
| 2000's | 1047 (53.01) | 29.6817 |
| 2010's | 582 (29.47) | 24.3611 |
| 2020's | 14 (0.71) | 2.80 |
| Authors | Studies |
|---|---|
| Anderer, P; Grünberger, J; Linzmayer, L; Magni, G; Saletu, B; Semlitsch, HV | 1 |
| Chiang, ST; Jusko, WJ; Klamerus, KJ; Maloney, K; Rudolph, RL; Sisenwine, SF | 1 |
| Howell, SR; Scatina, J; Sisenwine, SF; Wang, CP | 1 |
| Clary, C; Fox, I; Rickels, K; Schweizer, E; Weise, C | 1 |
| Fabre, LF; Khan, A; Rudolph, R | 1 |
| Fawcett, J; Guy, C; Zajecka, JM | 1 |
| Haskins, JT; Moyer, JA; Muth, EA; Sigg, EB | 1 |
| Clary, C; Rickels, K; Schweizer, E; Weise, C | 1 |
| Finnerty, R; Goldberg, HL | 1 |
| Haskins, JT; Husbands, GE; Moyer, JA; Muth, EA; Nielsen, ST; Sigg, EB | 1 |
| Hyllested, M; Klysner, R; Larsen, JK; Pedersen, BD; Sørensen, P | 1 |
| Perez, J; Popoli, M; Racagni, G; Smeraldi, E; Vocaturo, C | 1 |
| Derivan, A; Entsuah, AR; Kikta, D | 1 |
| Goldberg, RJ | 2 |
| Albano, D; Amchin, J | 2 |
| Guelfi, JD; Guichoux, JY; Hackett, D; Magni, G; White, C | 1 |
| Danjou, P; Hackett, D | 1 |
| Montgomery, SA | 1 |
| Lecrubier, Y | 1 |
| Mendlewicz, J | 1 |
| Burkhart, KK; Fantaskey, A | 1 |
| Morton, WA; Sonne, SC; Verga, MA | 1 |
| Preskorn, SH | 4 |
| Chiang, ST; Fruncillo, RJ; Parker, VD; Troy, SM | 1 |
| Chiang, ST; Klockowski, PM; Lucki, I; Parker, VD; Peirgies, AA; Troy, SM | 1 |
| Phillips, SD; Ringo, P | 1 |
| Geracioti, TD | 1 |
| Benfield, P; Holliday, SM | 1 |
| Keltner, NL | 1 |
| Jaffe, IA | 1 |
| Althof, SE | 1 |
| Ahmad, S | 1 |
| Gormly, LJ; Pleak, RR | 1 |
| Biederman, J; Spencer, TJ; Wilens, TE | 1 |
| Cohn, C; Crowder, J; Davidson, J; Dunner, D; Feighner, J; Kiev, A; Patrick, R; Shrivastava, RK | 1 |
| Nemeroff, CB | 2 |
| Clerc, GE; Ruimy, P; Verdeau-Pallès, J | 1 |
| Holdcroft, C | 1 |
| Ellingrod, VL; Perry, PJ | 1 |
| Cole, JO; Feighner, JP; Nierenberg, AA; Rudolph, R; Sullivan, J | 1 |
| Bradley, MM; Entsuah, AR; Littman, GS | 1 |
| Feighner, JP | 4 |
| Drevets, WC | 1 |
| Cunningham, LA | 2 |
| Blum, RA; Chiang, ST; Parker, VD; Schultz, RW; Troy, SM | 1 |
| Hicks, DR; Howell, SR; Scatina, JA; Sisenwine, SF | 1 |
| Feighner, J; Mandos, LA; Rickels, K; Schweizer, E | 1 |
| Cavanaugh, N; Hicks, DR; Kraml, M; Russell, A; Wolaniuk, D | 1 |
| Borison, RL; Carman, JS; Chouinard, G; Crowder, JE; Cunningham, LA; Diamond, BI; Fischer, DE; Hearst, E | 1 |
| Anderer, P; Binder, GA; Decker, KA; Saletu, B; Semlitsch, HV | 1 |
| Johnston, R; Mattes, J; Mendels, J; Riesenberg, R | 1 |
| Fletcher, A; Mitchell, PJ | 1 |
| Howell, SR; Husbands, GE; Scatina, JA; Sisenwine, SF | 1 |
| Ananth, J; Burgoyne, K; Smith, M; Swartz, R | 1 |
| Goodnick, PJ | 1 |
| Farah, A; Lauer, TE | 1 |
| Grossman, R; Hollander, E | 1 |
| Schulte, H; Songer, DA | 1 |
| Findling, RL; Flannery, DJ; Manos, MJ; Schwartz, MA | 1 |
| Leonard, BE | 1 |
| Rothschild, AJ | 1 |
| Neziroglu, FA; Yaryura-Tobias, JA | 1 |
| Shuster, J | 1 |
| Benkert, O; Gründer, G; Schlösser, R; Wetzel, H | 1 |
| Arnecke, B; Guidry, JR; Heisler, MA | 1 |
| Thase, ME | 9 |
| Kelsey, JE | 3 |
| Ballenger, JC | 2 |
| Ereshefsky, L | 2 |
| Derivan, AT; Rudolph, RL | 1 |
| Entsuah, AR; Hackett, D; Miska, S; Rudolph, RL | 1 |
| Russell, JL | 1 |
| Jenike, MA; O'Sullivan, RL; Rauch, SL | 1 |
| Ball, SE; Cheung, SW; Inaba, T; Otton, SV; Rudolph, RL; Sellers, EM | 1 |
| Baumel, B; Ferguson, J; Khan, A; Rudolph, R; Ryan, P; Shrivastava, R | 1 |
| Chitra, R; Entsuah, AR; Rudolph, RL | 1 |
| Markovitz, PJ; Wagner, SC | 1 |
| Hedges, D; Reimherr, FW; Rogers, A; Strong, R; Wender, PH | 1 |
| Adler, LA; Devinsky, O; Kunz, M; Resnick, S | 1 |
| Boudino, FD; Chiang, ST; Hicks, DR; Parker, VD; Troy, SM | 1 |
| Stoudemire, A | 1 |
| Dierick, M; Martin, A; Ravizza, L; Realini, R | 1 |
| Benazzi, F | 9 |
| Brubacher, JR; Hoffman, RS; Lurin, MJ | 1 |
| Jenkins, AJ; Jufer, R; Levine, B; Queen, M; Smialek, JE | 1 |
| Dierick, M | 1 |
| Rowbotham, MC; Taylor, K | 1 |
| Castañeda, R; Levy, R; Sussman, N; Westreich, LM | 1 |
| Kirsch, MA; Lannon, RA; Lewis, TB; Louie, AK | 1 |
| Entsuah, AR; Wolfe, JC; Wolfe, RA | 1 |
| Entsuah, R | 1 |
| Duan, SX; Fogelman, SM; Greenblatt, DJ; Harmatz, JS; Kudchadker, L; Schmider, J; Shader, RI; von Moltke, LL | 1 |
| Benson, B; Danielson, A; Ketter, TA; Kimbrell, TA; Little, JT; Post, RM; Willis, MW | 1 |
| Bailey, P; Danjou, PH; Guichoux, JY; Hackett, D; Luthringer, R; Macher, JP; Schaltenbrand, N; Toussaint, M | 1 |
| Maki, KM; Manfro, GG; Otto, MW; Pollack, MH; Rosenbaum, JF; Rudolph, R; Smoller, JW; Worthington, JJ | 1 |
| Gitlin, MJ | 1 |
| Hodgman, MJ; Krenzelok, EP; Martin, TG | 1 |
| Duan, SX; Fogelman, SM; Greenblatt, DJ; Harmatz, JS; Schmider, J; Shader, RI; von Moltke, LL | 1 |
| Gailey, RA; Levin, GM; Smith, T; White, CM | 1 |
| Clark, A; Livingston, MG | 1 |
| Kohn, S; Labbate, LA | 1 |
| Cavanaugh, GL; Martin, RE; Robinson, DD; Stenson, MA | 1 |
| Moro-Lopez, ML; Salin-Pascual, RJ | 1 |
| Duman, RS; Heninger, GR; Malison, RT; Nestler, EJ; Price, LH | 1 |
| Michael, A; Owen, A | 1 |
| Ravsten, DV; Smith, NB; Thatcher, GW | 1 |
| Möller, HJ; Volz, HP | 1 |
| Kolecki, P | 1 |
| Mandoki, MW; Parker, JL; Sumner, GS; Tapia, MA; Tapia, MR | 1 |
| Gartside, SE; Sharp, T; Umbers, V | 1 |
| Andrews, JM; Nemeroff, CB; Ninan, PT | 1 |
| Garber, A; Gregory, RJ | 1 |
| Smith, MN | 1 |
| de Koning, FH; Egberts, AC; Lenderink, AW; Leufkens, HG | 1 |
| Gupta, AK; Saravay, SM | 1 |
| Dagg, PK | 1 |
| Durback, LF; Scharman, EJ | 1 |
| Franzoni, S; Ranieri, P; Rozzini, R; Trabucchi, M | 1 |
| Ahern, D; Ball, SE; Kao, J; Scatina, J | 1 |
| Andersen, F; Danielsen, E; Gee, AD; Gjedde, A; Hansen, SB; Jensen, PN; Saiz, PA; Smith, DF | 1 |
| Adès, J; Lejoyeux, M | 1 |
| Haddad, P | 1 |
| Frazer, A | 1 |
| Nelson, JC | 2 |
| Hesselink, JK; Panagides, J; Pinder, R; Sambunaris, A; Stahl, SM | 1 |
| Luh, J; Olvera, RL; Pliszka, SR; Tatum, R | 1 |
| Meynaar, IA; Mulder, AH; Ottervanger, JP; Peeters, AJ | 1 |
| Adesanya, A; Varma, SL | 1 |
| Jenkins, P; Wilson, R | 1 |
| Blanchard, C; Bourin, M; Danjou, P; Hackett, D; Lecrubier, Y; Moon, CA; Schifano, F | 1 |
| Denson, D; Hord, HA; Lang, E | 1 |
| Wolfe, RM | 1 |
| Pinder, RM | 1 |
| Mitchell, S; Tracy, KA; Zajecka, J | 1 |
| Jaffe, IA; Rudikoff, D | 1 |
| Heal, DJ; Hutchins, LJ; Jackson, HC; Mazurkiewicz, SE; Needham, AM | 1 |
| Hackett, D; Mahapatra, SN | 1 |
| Richelson, E | 2 |
| Bagby, RM; Dickens, SE; Joffe, R; Kennedy, SH; Levitt, A; Minifie, CE; Schuller, DR | 1 |
| Brown, DJ; Gunn, RN; Jones, T; Malizia, AL; Melichar, JM; Nutt, DJ; Reynolds, A | 1 |
| Behar, L; DiGregorio, RV; Iyer, GR; Taft, DR | 1 |
| Agelink, MW; Klieser, E; Zitzelsberger, A | 1 |
| Hanashiro, PK; Leikin, JB; Peano, C | 1 |
| Alpert, J; Fava, M; Mulroy, R; Nierenberg, AA; Rosenbaum, JF | 1 |
| Bourgeois, JA; Walker, D; Zhalkovsky, B | 1 |
| Yonkers, KA | 1 |
| Hirschfeld, RM | 2 |
| Gorman, JM | 4 |
| Davidson, RJ; Irwin, W; Kalin, NH; Lowe, M; Mock, BJ; Orendi, JL; Sorenson, JA; Sutton, SK; Turski, PA; Warner, G | 1 |
| Mekler, G; Woggon, B | 1 |
| Albers, L; Helmeste, D; Reist, C; Vu, RL | 1 |
| Bea, C; Budech, CB; Dunner, DL; Hendrickson, HE | 1 |
| Entsuah, R; Khan, A; Leventer, SM; Rudolph, RL; Upton, GV | 1 |
| Karki, SD; Masood, GR; Patterson, WR | 1 |
| Leaf, EV | 1 |
| Entsuah, AR; Feighner, JP; McPherson, MK | 1 |
| Amsterdam, JD; Garcia-España, F; Goodman, D; Hooper, M; Hornig-Rohan, M | 1 |
| Chitra, R; Entsuah, R | 1 |
| Chiang, ST; Hicks, DR; Parker, VP; Pollack, GM; Troy, SM | 1 |
| Chiang, ST; Parker, VD; Troy, SM; Turner, MB; Unruh, M | 1 |
| Donnelly, NJ; Khouzam, HR | 1 |
| Drucker-Colín, R; Galicia-Polo, L; Salín-Pascual, RJ | 1 |
| Clement, EM; Franklin, M; Odontiadis, J | 1 |
| Derivan, AT; Entsuah, R; Fabre, LF; Feighner, JP; Rickels, K; Rudolph, RL | 1 |
| Amore, M; Ferrari, G; Perez, J; Ricci, M; Zanardi, R | 1 |
| Allain, H; Burke, J; Danjou, P; Gandon, JM; Le Coz, F; Patat, A; Trocherie, S; Troy, S | 1 |
| Stahl, SM | 3 |
| Chitra, R; Entsuah, R; Rudolph, RL | 1 |
| Bhatara, VS; Magnus, RD; Paul, KL; Preskorn, SH | 1 |
| Ansseau, M | 1 |
| Brilmyer, M; Kant, R; Zeiler, D; Zimmer, B | 1 |
| Blennerhassett, J; Parker, G | 1 |
| Nemeroff, CB; Owen, JR | 1 |
| McGrath, C; Norman, TR | 1 |
| Chiang, ST; Mayersohn, M; Rudolph, R; Troy, SM | 1 |
| Rajagopalan, M | 1 |
| Macbeth, R; Rajagopalan, M | 1 |
| Spier, SA | 1 |
| Danjou, PE; O'Hanlon, JF; Robbe, HW; van Leeuwen, C; Vermeeren, A | 1 |
| Bader, GM; Hawley, JM; Short, DD | 1 |
| Coorey, AN; Wenck, DJ | 1 |
| Machado, JF; Roxanas, MG | 1 |
| Amchin, J; Amsterdam, JD; Hooper, MB | 1 |
| Amchin, J; Coplan, JD; Gorman, JM; Martinez, JM; Papp, LA; Sinha, SS | 1 |
| Albano, D; Amchin, J; Klockowski, PM; Taylor, KP; Zarycranski, W | 4 |
| Kelsey, J; Kirk, L; Knight, B; Nemeroff, CB; Ninan, PT; Rothbaum, BO | 1 |
| Dusci, LJ; Groves, A; Hackett, LP; Ilett, KF; Kristensen, JH; Paech, M; Roberts, MJ; Yapp, P | 1 |
| Coupland, NJ; Zedkova, L | 1 |
| Dumesic, DA; Fonseca, R; Loprinzi, CL; Novotny, PJ; Perez, EA; Pisansky, TM; Quella, SK; Rummans, TA; Sloan, JA; Zahasky, KM | 1 |
| Béïque, JC; de Montigny, C; Debonnel, G; Lavoie, N | 1 |
| Kubb, R; Lyndon, B; Walter, G | 1 |
| Diamond, ML; Diamond, S; Erdemoglu, AK; Freitag, FG; Pepper, BJ; Urban, GJ | 1 |
| Dogin, JW; Findling, RL | 1 |
| Hornig, M | 1 |
| Chouinard, G; Dallal, A | 1 |
| Baker, GB; Bourin, M; Colombel, MC; Redrobe, JP | 1 |
| Boyd, IW | 2 |
| Costa e Silva, J | 1 |
| Sharma, V | 1 |
| Gillespie, DD; Manier, DH; Nalepa, I; Rossby, SP; Schmidt, DE; Sulser, F | 1 |
| Bouman, WP; Johnson, H; Lawton, J | 1 |
| Bhatia, SC; Gupta, S; Theesen, KA | 1 |
| Daniels, RJ | 1 |
| Amsterdam, J | 1 |
| Crawford, M; Emmanuel, N; Johnson, MR; Lydiard, RB; Villareal, G | 1 |
| Béïque, JC; Blier, P; de Montigny, C; Debonnel, G | 4 |
| Frueh, BC; Hamner, MB | 1 |
| Joffe, RT; Lee, DK; Marshall, AM | 1 |
| Banham, ND | 1 |
| Mitchell, PJ; Redfern, PH | 1 |
| Busch, FN; Gabbard, GO; Milrod, BL | 1 |
| al-Zaid, K; Anisman, H; Charbonneau, Y; Ravindran, AV; Wiens, A; Zaharia, MD | 1 |
| Raby, WN | 1 |
| Markowitz, JS; Patrick, KS | 1 |
| Kornischka, J | 1 |
| Agelink, MM; Klieser, E; Zeit, T | 1 |
| Archer, SL; Nelson, DP; Reeve, HL; Weir, EK | 1 |
| Batziris, HP; DeSilva, D; Jaffe, PD; McIntyre, IM; van der Hoeven, P | 1 |
| Frye, MA; Ketter, TA; Little, JT; Luckenbaugh, D; Mathé, AA; Post, RM | 1 |
| Nascimento, ED | 1 |
| Campling, G; Clement, EM; Cowen, PJ; Franklin, M | 1 |
| Dahmen, N; Hopf, HC; Marx, J; Röder, R; Tettenborn, B | 1 |
| Anand, VS; Dewan, MJ | 1 |
| Ravindran, A; Silverstone, PH | 1 |
| Kirsch, MA; Louie, AK | 1 |
| Schatzberg, AF | 1 |
| Addis, A; Einarson, TR; Iskedjian, M | 1 |
| Hale, MS; Lenderking, WR; Nackley, JF; Tennen, H; Testa, MA; Turner, RR | 1 |
| Fogelman, SM; Greenblatt, DJ; Harmatz, JS; Schmider, J; Shader, RI; Venkatakrishnan, K; von Moltke, LL | 1 |
| Hwang, W; Kim, KY; Narendran, R | 1 |
| Arikian, SR; Casciano, J; Doyle, JJ; Einarson, TR | 1 |
| Ramlatchman, L; Stoner, SC; Williams, RJ; Worrel, J | 1 |
| Maj, J; Rogóz, Z | 1 |
| Azuma, J; Fukuda, T; Nishida, Y; Ohno, M; Takada, K; Yamamoto, I; Zhou, Q | 1 |
| Ferrier, IN | 1 |
| Bakish, D | 2 |
| Horst, WD; Preskorn, SH | 1 |
| Altenburg, SP; da-Silva, VA; Lindsey, CJ; Malheiros, LR; Thomaz, TG | 1 |
| Elizur, A; Mazeh, D; Melamed, Y | 1 |
| Bitsios, P; Bradshaw, CM; Szabadi, E | 1 |
| Michelson, D | 1 |
| Akyol, A; Bolukbasi, O | 1 |
| Andersson, G; Apelqvist, G; Bengtsson, F; Bergqvist, PB; Hindfelt, B; Wikell, C | 1 |
| Birkenhäger, TK; Moleman, P | 1 |
| da Silva, AS; Delerue-Matos, C; Lima, JL; Loo, DV | 1 |
| Blythe, D; Hackett, LP | 1 |
| Dremencov, E; Gur, E; Lerer, B; Newman, ME | 1 |
| De Clercq, M; Horsmans, Y; Sempoux, C | 1 |
| Antolak, SJ; Burch, PA; Loprinzi, CL; Novotny, P; Perez, EA; Pisansky, TM; Quella, SK; Sloan, J | 1 |
| Chong, Y; Harris, R; Kim, WJ | 1 |
| Emamian, ES; Fatemi, SH; Kist, DA | 1 |
| Martin, P | 1 |
| Bourin, M | 1 |
| Boyer, P | 1 |
| Corruble, E; Guelfi, JD | 1 |
| Peretti, CS | 1 |
| Poirier, MF | 1 |
| Borgherini, G; Conforti, D; Fiorellini Bernardis, LA; Magni, G | 1 |
| Dawson, LA; Geiger, A; Nguyen, HQ | 1 |
| Arruza, A; Carvajal, A; Fernández del Busto, E; García del Pozo, J; Maroto, M; Velasco, A | 1 |
| Altamura, AC; Mannu, P; Pioli, R; Vitto, M | 1 |
| Reznik, I; Rosen, B; Rosen, Y | 1 |
| Davidson, JR; DuPont, RL; Haskins, JT; Hedges, D | 1 |
| Daleau, P; Khalifa, M; Turgeon, aJ | 1 |
| Schwartz, TL | 1 |
| Bakish, D; Blier, P; de Montigny, C; Debonnel, G; Silverstone, PH | 1 |
| Backer, MM; Pick, CG; Schreiber, S | 1 |
| Abdelmawla, AH; Bradshaw, CM; Langley, RW; Szabadi, E | 1 |
| Salzman, C | 1 |
| DeVane, CL; Pollock, BG | 1 |
| McAllister-Williams, RH; Porter, RJ; Young, AH | 1 |
| Clouse, J; Frank, RG; Goldman, HH; Griffiths, RI; Herbert, RJ; Strauss, MJ; Sullivan, EM | 2 |
| Davis, JL; Smith, RL | 1 |
| Paton, C | 1 |
| Maltese, TM | 1 |
| Brown, ES; Hong, SC | 1 |
| Connor, TJ; Kelly, JP; Leonard, BE; Nolan, Y; Shen, Y | 1 |
| Brager, N; Tham, CJ; Trew, M | 1 |
| Judge, R; Wagner, BE | 1 |
| Boyer, P; Poirier, MF | 1 |
| Alfaro, CL; Ereshefsky, L; Lam, YW; Simpson, J | 1 |
| Nierenberg, AA; Wright, EC | 1 |
| Ninan, PT | 3 |
| Sheehan, DV | 2 |
| Samuel, RZ | 1 |
| Aparicio Jabalquinto, G; Barriochoa Martínez de Pisón, C; Ortega García, A; Raigal Martín, Y; Sierra Santos, L | 1 |
| Batchelder, ST; Fedak, MJ; Hellerstein, DJ; Kreditor, D; Little, SA; Rosenthal, J | 1 |
| Atkin, SL; Nimmagadda, SR; Ryan, DH | 1 |
| Blauer, F; Fleisch, MC; Gubler, JG; Kuhn, M; Scherer, TA | 1 |
| Blanco, C; Mullen, LS; Roose, SP; Vaughan, R; Vaughan, SC | 1 |
| Avila, A; Cardona, X; Castellanos, P | 1 |
| Franchini, L; Perez, J; Serretti, A; Smeraldi, E; Zanardi, R | 1 |
| Cartwright, C; Hollander, E; Kaplan, A; Reichman, D | 1 |
| Cordova, S; Lee, R | 1 |
| Feiger, AD; Rudolph, RL | 1 |
| Levin, FR; McDowell, DM; Nunes, EV; Seracini, AM | 1 |
| Bennett, VL; Bowen, RC; Chlan-Fourney, J; Juorio, AV; Li, XM; Shrikhande, S | 1 |
| Perry, NK | 1 |
| Cabras, PL; Cellini, M; Di Bernardo, M; Mannucci, E; Paionni, A; Ricca, V; Rotella, CM | 1 |
| Behnke, K; Mehtonen, OP; Roponen, P; Søgaard, J | 1 |
| Arrufat, FJ; Baeza, I; Bernardo, M; Navarro, V; Salvà, J | 1 |
| Kent, JM | 1 |
| Benedictis, E; D'Arrigo Busnello, E; De Campos, JA; De Cassia Rodrigues, RL; Gentil, V; Juruena, MF; Kerr-Correa, F; Lafer, B; Moreno, DH; Moreno, R; Tiosso, A | 1 |
| Anisman, H; Griffiths, J; Merali, Z; Ravindran, AV; Zaharia, MD | 1 |
| Abbar, M; Blayac, JP; Giniès, E; Peyrière, H; Pinzani, V; Robert, L | 1 |
| Connor, TJ; Harkin, A; Kelliher, P; Kelly, JP; Leonard, BE; Shen, Y | 1 |
| Guze, BH; Pierre, JM | 1 |
| Haffmans, PM; Hoencamp, E; Veefkind, AH | 1 |
| Hamelin, BA; LeBlanc, J; Lessard, E; O'Hara, G; Turgeon, J; Yessine, MA | 1 |
| Hatanaka, K; Yamaguchi, T; Yatsugi, S | 2 |
| Farmer, AE; Malhi, GS | 1 |
| Gregson, J | 1 |
| Harvey, AT; Preskorn, SH; Rudolph, RL | 1 |
| Dunn, NR; Freemantle, SN; Mackay, FR; Mann, RD; Martin, RM; Pearce, GL | 1 |
| Daniels, S | 1 |
| Bacchiochi, JR; Bagby, RM; Dickens, SE; Eisfeld, BS; Kennedy, SH | 1 |
| Gómez Gómez, JM; Teixidó Perramón, C | 1 |
| Haskins, JT; Pollack, MH; Rickels, K; Sheehan, DV | 1 |
| Kiayias, JA; Lakka-Papadodima, E; Vlachou, ED | 1 |
| Guazzelli, M; Nimatoudis, I; Rizzo, F; Smeraldi, E; Tzanakaki, M; Zissis, NP | 1 |
| Ballús, C; Casais, L; De Flores, T; de la Torre, J; Gutiérrez, M; Palao, D; Quiros, G; Riesgo, Y; Rojo, L | 1 |
| Amsterdam, JD; Garcia-España, F | 1 |
| Amey, M; Baumann, P; Bertel-Laubscher, R; Eap, CB; Zullino, D | 1 |
| Dryson, E | 1 |
| Aguiar, L; Gelenberg, AJ; Haskins, JT; Lydiard, RB; Rudolph, RL; Salinas, E | 1 |
| Azuma, J; Fukuda, T; Kondo, S; Nishida, Y; Yamamoto, I; Zhou, Q | 1 |
| Béïque, J; Blier, P; de Montigny, C; Debonnel, G | 2 |
| Balant-Gorgia, AE; Fanali, S; Rudaz, S; Stella, C; Veuthey, JL | 1 |
| Blass, DM; Pearson, VE | 1 |
| Cassidy, EM; O'Kearne, V | 1 |
| Gottlieb, N | 1 |
| Elie, R; Habimana, A; Hébert, C; Reader, TA | 1 |
| Farley, NJ; Garavaglia, JC; Kunsman, CM; Kunsman, GW; Presses, CL | 1 |
| Burrows, G; Johnson, G; Mitchell, PB; Polonowita, A; Schweitzer, I | 1 |
| Kleinschmidt, R; Lucht, MJ; Maier, W; Rietschel, M | 1 |
| David, JM; Jean-Pastor, MJ; Nguyen, N; Prost, N; Rodor, F; Tichadou, L | 1 |
| MacIver, DH; Partridge, SJ; Solanki, T | 1 |
| Azuma, J; Fukuda, T; Funae, Y; Hiroi, T; Imaoka, S; Naohara, M; Nishida, Y | 1 |
| Echeverría, G; Fernández, D; Vega, D | 1 |
| Hackett, D; Samuelian, JC | 1 |
| Bjorvatn, B; Fornal, CA; Jacobs, BL; Martín, FJ; Metzler, CW | 1 |
| Riquier, F; Zullino, DF | 1 |
| Bell, S; Shipman, M | 1 |
| Calderón, E; Micó, JA; Pernia, A; Torres, LM | 1 |
| Dijken, WA; Haffmans, J; Hoencamp, E; Huijbrechts, IP | 1 |
| Holmsen, H; Lund, A; Odegaard, K; Selheim, F; Tharmapathy, P | 1 |
| Bencomo, L; Bhatia, SC; Bhatia, SK | 1 |
| Gunning, K; Magill, MK | 1 |
| Michael, A | 1 |
| Lithner, F | 2 |
| Hostetter, A; Ritchie, JC; Stowe, ZN | 1 |
| Albers, LJ; Fujimoto, K; Helmeste, D; Ozdemir, V; Poland, R; Reist, C; Tang, SW; Vu, RL | 1 |
| Deslandes, PN; Pache, DM; Sewell, RD; Subhan, F | 1 |
| Kalin, NH; Roseboom, PH | 1 |
| Dugan, D; Ereshefsky, L | 1 |
| Golden, RN; Nicholas, L | 1 |
| Kienke, AS; Rosenbaum, JF | 1 |
| Friedman, ES; Howland, RH; Thase, ME | 1 |
| Evans, DL; Staab, JP | 1 |
| Davis, GP; Weller, EB; Weller, RA | 1 |
| Woods, SW | 1 |
| Sheridan, MJ; Wise, TN | 1 |
| Levine, BS; Pestaner, JP; Ripple, MG; Smialek, JE | 1 |
| Sarko, J | 1 |
| Hackett, D | 1 |
| Drewe, J; Eggenberger, C; Klink, MH; Schlienger, RG | 1 |
| Barlow, DH | 1 |
| Barton, DL; Christensen, BJ; Dakhil, SR; Kugler, JW; LaVasseur, BI; Loprinzi, CL; Mailliard, JA; Novotny, PJ; Rodger, K; Rummans, TA; Sloan, JA | 1 |
| Caputo, RM; Stern, S; Votolato, NA | 1 |
| Fitzgerald, F; Glod, CA; Lynch, A | 1 |
| Combes, A; Peytavin, G; Théron, D | 1 |
| Nathan, PJ; Sali, A; Silberstein, RB; Sitaram, G; Stough, C | 1 |
| Brady, KT; Malcolm, R; Sethuraman, G; Sonne, SC; Upadhyaya, HP | 1 |
| Behar, D; Schaller, JL | 1 |
| Gorman, JM; Nierenberg, AA; Stahl, SM | 1 |
| Blier, P | 2 |
| Entsuah, AR; Rudolph, RL; Thase, ME | 1 |
| Devarajan, S; Dursun, SM | 2 |
| Cherkaoui, S; Rudaz, S; Veuthey, JL | 1 |
| Aturki, Z; Desiderio, C; Fanali, S | 1 |
| Gauvin, C; Hamelin, BA; Labbé, L; LeBlanc, J; Lessard, E; O'Hara, G; Turgeon, J; Yessine, MA | 1 |
| Burrows, G; Flynn, P; George, T; Mitchell, P; Polonowita, A; Schweitzer, I; Theodoros, M; Tuckwell, V | 1 |
| Bosmans, E; Kenis, G; Kubera, M; Lin, AH; Maes, M; van Bockstaele, D | 1 |
| Nayudu, S; Scheftner, WA; Shulman, RB | 1 |
| Baumann, P; Preisig, M; Zullino, D | 1 |
| Haida, A; Malizia, AL; Melichar, JK; Nutt, DJ; Reynolds, AH; Rhodes, C | 1 |
| Cook, IA; Leuchter, AF | 1 |
| Albano, D; Amchin, J; Ereshefsky, L; Klockowski, PM; Taylor, K; Zarycranski, W | 1 |
| Abouesh, AI; Clayton, AH; McGarvey, EL; Pinkerton, RC | 1 |
| Arendt-Nielsen, L; Enggaard, TP; Gram, LF; Klitgaard, NA; Sindrup, SH | 1 |
| Prater, JF | 1 |
| Apelqvist, G; Bengtsson, F; Bergqvist, PB; Hjorth, S; Kullingsjö, J; Lundmark, J; Wikell, C | 1 |
| Jacob, C; Luckhaus, C | 1 |
| Moulin, DE; Sumpton, JE | 1 |
| Chan, KW; Lim, HK; Scatina, JA; Sisenwine, S | 1 |
| Kumar, S; Oakley-Browne, M | 1 |
| Hibberd, C; Noble, J; Seckl, JR; Yau, JL | 1 |
| Ge, X; Lu, L; Ma, L; Pei, G; Su, F; Su, WJ; Yue, W | 1 |
| Ansseau, M; Pitchot, W | 2 |
| Allgulander, C; Hackett, D; Salinas, E | 1 |
| Nierenberg, AA | 1 |
| Devarajan, S; Dursun, SM; Haddad, PM | 1 |
| Martin, E; Martin, SD; Rai, SS; Richardson, MA; Royall, R | 1 |
| Sackeim, HA | 1 |
| Arikian, S; Casciano, J; Casciano, R; Doyle, J | 1 |
| Auclair, A; Gobert, A; Lejeune, F; Millan, MJ; Newman-Tancredi, A; Peglion, JL; Rivet, JM | 1 |
| Brocco, M; Dekeyne, A; La Rochelle, CD; MacSweeny, C; Millan, MJ; Papp, M; Peglion, JL | 1 |
| Desiderio, C; Fanali, S; Rudaz, S; Veuthey, JL | 1 |
| Brown, WA; Khan, A; Khan, SR; Leventhal, RM | 1 |
| Ansseau, M; Guelfi, JD; Kørsgaard, S; Timmerman, L | 1 |
| Anghelescu, I; Himmerich, H; Klawe, C; Szegedi, A | 1 |
| Linden, M; Ludewig, K; Munz, T | 1 |
| Grady-Weliky, TA; Hartmann, DM | 1 |
| Salinas, E; Silverstone, PH | 1 |
| Bartfai, T; Hökfelt, T; Holmberg, K; Kehr, J; Lendahl, U; Ogren, SO; Wang, FH; Wynick, D; Yamaguchi, M; Yoshitake, T | 1 |
| Dagge, A; Holzinger, J; Hornik, L; Körfer, R; Minami, K; Mirow, N; Schulz, U; Tenderich, G | 1 |
| Drummer, OH; Goeringer, KE; McIntyre, IM | 1 |
| Franke, L; Uebelhack, R | 1 |
| Bender, D; Danielsen, E; Gee, AD; Gjedde, A; Hansen, SB; Ishizu, K; Poulsen, PH; Smith, DF; Østergaard, L | 1 |
| Ishigooka, J | 1 |
| Perry, CM; Wellington, K | 1 |
| Conway, CR; Nelson, LA | 1 |
| Dumora, F; Jarry, C; Matoga, M; Pehourcq, F; Titier, K | 1 |
| Boskailo, E; Djuric-Bijedic, Z; Lewis, J; Pavkovic, I; Smajkic, A; Weine, S | 1 |
| Ablon, JS; Bouffard, SM; Cohen, LS; Collins, MH; Morabito, C; Nonacs, RM; Viguera, AC | 1 |
| Morrow, TJ | 1 |
| Addis, A; Brochu, J; Chambers, C; Einarson, A; Einarson, TR; Fatoye, B; Koren, G; Lavigne, SV; Mastroiacovo, P; Matsui, D; Sarkar, M; Schuler, L | 1 |
| Cherkaoui, S; Rudaz, S; Varesio, E; Veuthey, JL | 1 |
| Judge, R | 1 |
| Buchalter, EN; Lantz, MS | 1 |
| Gupta, N | 1 |
| Cheng, CY; Hong, CJ; Huo, SJ; Tsai, SJ; Wu, WH | 1 |
| Freeman, EW; Kunz, NR; McPherson, M; Rickels, K; Upton, GV; Yonkers, KA | 1 |
| Joseph, M; McCue, RE | 1 |
| Altshuler, L; Dunn, WA; Hendrick, V; Wertheimer, A | 1 |
| Bymaster, FP; Dreshfield-Ahmad, LJ; Hemrick-Luecke, SK; Nelson, DL; Shaw, JL; Thompson, L; Threlkeld, PG; Wong, DT | 1 |
| Dunn, AJ; Swiergiel, AH | 1 |
| Abrams, M; Cook, IA; Leuchter, AF; Morgan, M; Witte, EA | 1 |
| Entsuah, AR; Huang, H; Thase, ME | 1 |
| Brault, Y; Hackett, D; Meoni, P; Salinas, E | 1 |
| Manier, DH; Shelton, RC; Sulser, F | 1 |
| Boskailo, E; Durić-Bijedić, Z; Lewis, J; Pavković, I; Smajkić, A; Weine, S | 1 |
| Dvorak, SR | 1 |
| Davis, MW; Fisher, AA | 1 |
| Acharya, S; Jainer, AK | 1 |
| Dremencov, E; Gur, E; Lerer, B; Newman, ME; Van De Kar, LD | 1 |
| Hackett, LP; Ilett, KF; Kohan, R; Kristensen, JH; Paech, M; Rampono, J | 1 |
| Härtel, B; Kalso, E; Tasmuth, T | 1 |
| Brocco, M; Dekeyne, A; Girardon, S; Millan, MJ; Veiga, S | 1 |
| Bae, JH; Lee, JG; Moon, DG | 1 |
| Kazimi, S; Sena, SF; Wu, AH | 1 |
| Moiin, A; Sanchez, JE; Yashar, B; Yashar, SS | 1 |
| Kroenke, K | 1 |
| Ames, D; Harrigan, S; Kirby, D | 1 |
| Bagby, RM; Kennedy, SH; Vanderkooy, JD | 1 |
| Baker, GB; Kennedy, SH; Masellis, M; McCann, SM; McIntyre, RS; McKay, G; Raskin, J | 1 |
| Ismail, M; Lyster, G | 1 |
| Bandelow, B; Boerner, RJ; Linden, M; Riemann, D; Schwarzer, W; Wittchen, HU | 1 |
| Höfler, M; Hoyer, J; Krause, P; Wittchen, HU | 1 |
| Grube, M; Pfeffer, F | 1 |
| Agustine, PE; Do Monte, FH; Lanziotti, VM; Russi, M; Santos, JG | 1 |
| Ahlner, J; Apelqvist, G; Baumann, P; Bengtsson, F; Eap, CB; Josefsson, M; Wikell, C | 1 |
| Anderson, I; Dempster, C; Freemantle, N; Glanville, J; Smith, D | 1 |
| Elizagarate, E; Gonzalez, N; Gonzalez-Pinto, A; Gutierrez, M; Mico, JA; Perez de Heredia, JL | 1 |
| Dawson, AH; Isbister, GK; Prior, FH; Whyte, IM | 1 |
| Agarwal, SA; Malouf, AJ; Ng, B; Sanbrook, GM | 1 |
| Amsterdam, JD; Hornig-Rohan, M | 1 |
| Bass, KI; Bolden-Watson, C; Clayton, AH; Croft, HA; Donahue, RM; Jamerson, BD; Leadbetter, RA; Metz, A; Montano, CB; Pradko, JF | 1 |
| Pallay, AG; Pedersen, RD; Rudolph, RL | 1 |
| Linnebur, SA; Pace, WD; Saseen, JJ | 1 |
| Alexopoulos, GS; Hackett, D; Katz, IR; Reynolds, CF | 1 |
| Culpepper, L | 1 |
| Durkin, JP | 1 |
| Makhija, SN; Vavia, PR | 2 |
| Abrams, M; Cook, IA; Leuchter, AF; Morgan, M; Rosenberg, S; Stubbeman, WF; Uijtdehaage, SH; Witte, E | 1 |
| Berndt, ER; Crown, WH; Finkelstein, SN; Ling, D; Wan, GJ | 1 |
| Benabarre, A; Colom, F; Goikolea, JM; Martinez-Arán, A; Reinares, M; Torrent, C; Vieta, E | 1 |
| van Meter, S; Weisler, RH | 1 |
| Biggio, G; Dazzi, L; Ladu, S; Seu, E; Vacca, G; Vignone, V | 1 |
| Audia, JE; Katofiasc, MA; Nissen, J; Thor, KB | 1 |
| Mulder, RT; Porter, R | 1 |
| Apelqvist, G; Bengtsson, F; Bergqvist, PB; Hjorth, S; Kullingsjö, J; Wikell, C | 1 |
| Andrade, L; Artes, R; Gorenstein, C; Moreno, RA | 1 |
| Koerselman, GF; van Noorden, MS; Vergouwen, AC | 1 |
| De Bleeker, E; De Nayer, A; Evrard, JL; Fossion, P; Geerts, S; Leyman, S; Linkowski, P; Mignon, A; Ruelens, L; Schittecatte, M; Van Eeckhoutte, I | 1 |
| Bengtsson, F; Björk, H; Lundmark, J; Reis, M | 1 |
| Dorne, JL; Renwick, AG; Slob, W; Walton, K | 1 |
| Kaplan, EM | 1 |
| Balant, LP; Balant-Gorgia, AE; Bertschy, G; Brachet, A; Gex-Fabry, M; Rudaz, S; Veuthey, JL | 1 |
| Durand, JP; Goldwasser, F | 1 |
| Sleijfer, DT; Wymenga, AN | 1 |
| Cohen, NL; Kennedy, SH; Lam, RW; Wan, DD | 1 |
| Denys, D; van Megen, H; Westenberg, H | 1 |
| Bydder, SA; Spry, NA | 1 |
| Cantillon, M; Davidson, JR; Hackett, D; Haudiquet, V; Meoni, P | 1 |
| Dougherty, JA; Shafi, T; Young, H | 1 |
| Jha, A; Tomar, R | 1 |
| Argyropoulos, S; Hardy, J; Nutt, DJ | 1 |
| Brusman-Lovins, L; King, KH; Malhotra, S; McElroy, SL; Welge, JA | 1 |
| Anghelescu, I; Dahmen, N; Klawe, C | 1 |
| Sageman, S | 1 |
| Carson, SW; DeVane, CL; Eisele, G; Levin, GM; Nelson, LA; Preston, SL | 1 |
| Ciroldi, M; Deray, G; Fardet, L; Izzedine, H; Launay-Vacher, V | 1 |
| Benkert, O; Muller, M; Szegedi, A | 1 |
| Sevincok, L; Uygur, B | 1 |
| Entsuah, R; Hackett, D; Silverstone, PH | 1 |
| Bateman, DN; Denieul, S; Jarvie, D; Kelly, C; Oliver, JJ | 1 |
| Mbaya, P | 1 |
| Berigan, T | 1 |
| Frare, F; Perugi, G; Ruffolo, G; Toni, C; Torti, C | 1 |
| Aguglia, E; Albert, U; Bogetto, F; Maina, G | 1 |
| Arias, F; Carrasco, JL; Chamorro, L; Díaz-Marsá, M; Ferrando, L; Ibáñez, A; Jordá, L; Martín-Ballesteros, E; Martín-Carrasco, M; Montes, JM; Padín, J; Sáiz-Ruiz, J | 1 |
| Hackett, D; Haudiquet, V; Mahé, V; Montgomery, SA | 1 |
| Denys, D; Heijnen, CJ; Kavelaars, A; Westenberg, H | 1 |
| Pfuhlmann, B; Reif, A | 1 |
| Dikici, S; Kadiroglu, AK; Kara, IH; Yilmaz, ME | 1 |
| Buckley, NA; McManus, PR | 1 |
| Lin, HN; Shang, CY; Soong, WT | 1 |
| Ferner, RE; Langford, NJ; Martin, U; Ruprah, M | 1 |
| Bobkiewicz-Kozłowska, T; Kus, K; Nowakowska, E | 1 |
| Dimellis, D | 1 |
| Entsuah, R; Rudolph, RL; Stahl, SM | 1 |
| Burton, D; Camilleri, M; Chial, HJ; Olden, KW; Stephens, D; Thomforde, G | 1 |
| Denys, DA; Glas, G; Tenney, NH; van Megen, HJ; Westenberg, HG | 1 |
| Allgulander, C; Hirschfeld, RM; Nutt, DJ | 1 |
| Thase, ME; Trivedi, M | 1 |
| Artigas, F; Nutt, DJ; Shelton, R | 1 |
| Rudolph, RL | 1 |
| Li, XM; Steven Richardson, J; Xu, H | 1 |
| Beyer, CE; Boikess, S; Dawson, LA; Luo, B | 1 |
| Ansseau, M; Charlier, C; Pinto, E; Plomteux, G | 1 |
| Anderle, MJ; Davidson, RJ; Irwin, W; Kalin, NH | 1 |
| Fortier, LP; Roy, S | 1 |
| Haack, M; Hinze-Selch, D; Koethe, D; Kraus, T; Pollmächer, T; Schuld, A | 1 |
| Gastó, C; Marcos, T; Navarro, V; Portella, MJ; Rodamilans, M; Torra, M | 1 |
| Bellodi, L; Bertani, A; Bussi, R; Caldirola, D; Cucchi, M; Perna, G | 1 |
| Sternbach, H | 1 |
| Baumann, P; Brawand-Amey, M; Eap, CB; Lessard, E; O'Hara, G; Turgeon, J; Yessine, MA | 1 |
| Crystal, S; Olfson, M; Sambamoorthi, U; Walkup, JT | 1 |
| Pan, JJ; Shen, WW | 1 |
| Rickels, K; Rynn, M | 1 |
| Barnes, A; Davies, J; Jones, IK; Lloyd, KR; Pilowsky, LS | 1 |
| Gupta, S; Masand, PS | 2 |
| Hazell, P | 2 |
| Bhatia, SC; Grant, KM; Sattar, SP | 1 |
| Briley, M | 2 |
| Casciano, R | 1 |
| Dunleavy III, JJ; Marshall, BL; McAdam, DB; Napolitano, DA; Tessing, JL; Varrell, J | 1 |
| Dragicevic, A; Grözinger, M; Härtter, S; Hiemke, C; Müller, MJ; Shams, M | 1 |
| Howe, C; Ravasia, S | 1 |
| Burrows, GD; Gupta, RK; Tiller, JW | 1 |
| Adamou, M; Hale, AS | 1 |
| Bekers, O; Drent, M; du Bois, RM; Gorgels, AP; Hansell, DM; Nicholson, AG; Singh, S; van Suylen, RJ | 1 |
| Buckley, NA; Dawson, AH; Whyte, IM | 1 |
| Bate, A; Hägg, S; Spigset, O | 1 |
| Bach, FW; Gram, LF; Jensen, TS; Madsen, C; Sindrup, SH | 1 |
| Malek-Ahmadi, P | 1 |
| Chen, J; Entsuah, AR; Mallick, R; Schatzberg, AF | 1 |
| Connor, H | 1 |
| Alloui, A; Ardid, D; Chapuy, E; Eschalier, A; Hernandez, A; Marchand, F; Pelissier, T | 1 |
| Beddingfield, JJ; Mack, JE; Reeves, RR | 1 |
| Hsiao, MC; Liu, CY | 3 |
| Collins, ED; Fischman, MW; Foltin, RW; Haney, M; Hart, CL; Ward, AS | 1 |
| Stewart, DE | 2 |
| Allen, A; Birnbaum, M; Friedberg, J; Hollander, E; Koran, LM; Wasserman, S | 1 |
| Dawson, LA; Li, P | 1 |
| Frampton, C; Joyce, PR; Mulder, RT; Porter, R | 1 |
| Alvarez Iniesta, I; García-Parajuá, P; Magariños, M | 1 |
| Bennetts, BH; Beumont, PJ; Nunn, KP; Russell, JD; Urwin, RE; Wilcken, B | 1 |
| Chodera, A; Kus, K; Nowakowska, E | 1 |
| Alloui, A; Ardid, D; Chapuy, E; Eschalier, A; Hernandez, A; Jourdan, D; Marchand, F; Pelissier, T | 1 |
| Hackett, D; Haudiquet, V; Salinas, E | 1 |
| Falissard, B | 1 |
| Douglas, JE; Jenkins, EA; Montealegre-Orjuela, M; Smith, AG | 1 |
| Hackett, D; Meoni, P; Otto, MW; Pollack, MH; Simon, N | 1 |
| Iraqi, AH | 1 |
| Dogru, A; Onal, A; Soykan, N; Uyar, M | 1 |
| Brezault, C; Durand, JP; Goldwasser, F | 1 |
| Marazziti, D | 1 |
| Alloui, A; Alvarez, P; Ardid, D; Authier, N; Eschalier, A; Hernández, A; Marchand, F; Pelissier, T | 1 |
| de Moor, RA; Egberts, AC; Mourad, L; ter Haar, J | 1 |
| AL-Shurbaji, A; Annas, A; Dahl, ML; Lindh, JD; Meurling, L | 1 |
| Fava, GA; Mangelli, L | 1 |
| Calleri, E; Cherkaoui, S; Geiser, L; Prat, J; Rudaz, S; Veuthey, JL | 1 |
| Akdeniz, F; Donat, O; Gonul, AS; Vahip, S | 1 |
| Datto, CJ; DiFilippo, S; Katz, IR; Oslin, DW; Streim, JE; Ten Have, TR; Weintraub, D | 1 |
| Silk, KR; Yager, J | 1 |
| Blahak, C; Capelle, HH; Grips, E; Krauss, JK; Weigel, R; Wöhrle, JC | 1 |
| Arguisola, MS; Tavakoli, SA | 1 |
| Clinckers, R; Ebinger, G; Meeusen, R; Michotte, Y; Piacentini, MF; Sarre, S | 1 |
| Aiso, JY; Gutierrez, MA; Stimmel, GL | 1 |
| Maidment, ID | 1 |
| Bunker, CB; Clark, JA; Porter, W; Sidwell, RU; Swift, S; Thompson, EM; Yan, CL | 1 |
| Bourin, M; David, DJ; Gardier, AM; Jego, G; Jolliet, P; Przybylski, C | 1 |
| Bloem, BR; Brouwer, OF; de Beaufort, AJ; Lammers, GJ; Roofthooft, DW | 1 |
| Grauer, MT; Holsboer, F; Uhr, M | 1 |
| Roxanas, MG | 1 |
| Ak, I; Aksu, G; Sayar, K; Tosun, M | 1 |
| Ansani, NT; Schober, CE | 1 |
| Burger, H; de Geus, F; Denys, D; van Megen, H; Westenberg, H | 1 |
| Dierkes, W; Huppertz-Helmhold, S; Sauer, H | 1 |
| Dierkes, W; Linden, M; Ludewig, K; Munz, T | 1 |
| Bymaster, FP; Evans, DC; Hemrick-Luecke, SK; Koch, S; Nelson, DL; Perry, KW; Thompson, LK; Threlkeld, PG | 1 |
| Pei, Q; Sharp, T; Sprakes, M; Tordera, R; Zetterström, TS | 1 |
| Borgeat, F; Hättenschwiler, J; Khazaal, Y; Mattia, M; Stankovic, M; Zullino, DF | 1 |
| Lenox-Smith, AJ; Reynolds, A | 1 |
| Aït-Ameur, A; Bertschy, G; Favre, S; Muscionico, M; Ragama-Pardos, E; Roth, L | 1 |
| Denys, D; van der Wee, N; van Megen, HJ; Westenberg, HG | 2 |
| Amsterdam, JD; Brunswick, DJ | 1 |
| Goetz, MP; Loprinzi, CL | 1 |
| Einen, M; Hecht, M; Kushida, CA; Lin, L; Mignot, E; Taheri, S; Umetsu, DT | 1 |
| Baudendistel, TE; Khurana, RN | 1 |
| Iodice, AJ; McCall, WV | 1 |
| Abali, O; Mukaddes, NM | 1 |
| Doty, JD; Krygiel, AS; Mazur, JE | 1 |
| DeVane, CL | 1 |
| Chakrabarti, S; Jhirwal, OP | 1 |
| Alloui, A; Ardid, D; Constandil, L; Eschalier, A; Hernández, A; Laurido, C; Marchand, F; Pelissier, T; Soto-Moyano, R | 1 |
| Balant, LP; Balant-Gorgia, AE; Bertschy, G; Gex-Fabry, M; Rudaz, S; Veuthey, JL | 1 |
| Bond, GR; Steele, PE; Uges, DR | 1 |
| Cheng, KT; DeVane, CL; Donovan, JL; Liston, HL; Markowitz, JS; Risch, SC; Willard, L | 1 |
| Burrows, GD; Norman, TR; Olver, JS | 1 |
| Fontes, CL; Geissler, EC; Harada, AS; Wan, GJ; Yu-Isenberg, KS | 1 |
| Ozcetin, A; Sahin, I; Sencan, I | 1 |
| Kranzler, J; Nemeroff, CB; Owens, MJ; Plott, SJ; Rao, SG; Vaishnavi, SN | 1 |
| Bowers, L; Callaghan, P; Clark, N; Evers, C | 1 |
| Bella Cueto, F; Len Abad, O; Pardo Ortega, MV; Sánchez Aguilar, G; Tort Brutau, J | 1 |
| Hwang, JP; Tsai, SJ; Yang, CH | 1 |
| Fountoulakis, KN; Iacovides, A; St Kaprinis, G | 1 |
| Hu, YZ; Liu, T; Sheng, R | 1 |
| Houlihan, DJ | 1 |
| Silva, RR | 1 |
| Bharucha, A; Lenze, EJ; Mulsant, BH; Pollock, BG; Reynolds, CF; Shear, MK | 1 |
| Barton, D; Loprinzi, CL | 1 |
| Basta-Kaim, A; Bosmans, E; Budziszewska, B; Kajta, M; Kenis, G; Kubera, M; Maes, M; Scharpe, S | 1 |
| Lenox-Smith, A | 2 |
| Lucassen, PL; olde Hartman, TC; van Rijswijk, E | 1 |
| Burns, RB; Hartman, EE | 1 |
| Talley, NJ | 1 |
| Burton, D; Camilleri, M; Chial, HJ; Delgado-Aros, S; Ferber, I; McKinzie, S; Zinsmeister, AR | 1 |
| Hackett, D; Lader, M; Meoni, P | 1 |
| Angulo, J; Cuevas, B; Cuevas, P; Gupta, S; Sáenz de Tejada, I | 1 |
| Eisner, M; Hopayian, K; Laurence, M | 1 |
| Burke, WJ | 1 |
| Bateman, DN; Chick, J; Good, AM; Kelly, CA; Masterton, G | 1 |
| Bateman, DN; Dhaun, N; Good, AM; Kelly, CA; Laing, WJ; Strachan, FE | 1 |
| Millan, MJ; Pei, Q; Rochat, C; Sharp, T; Sprakes, M | 2 |
| Entsuah, R; Hackett, D; Kunz, NR; Montgomery, SA; Rudolph, RL | 1 |
| Mueck, AO; Seeger, H | 1 |
| Bo-Hua, Z; He, L; Hong-Ju, Y; Jun-Wei, W; Nan, Z; Wei-Guo, S; Wei-Xiu, Y; Zhe-Hui, G; Zheng-Hua, G; Zhi-Pu, L; Zhong-Wei, J | 1 |
| Spence, D | 1 |
| Carella, A; Cheok, A; Ginovart, N; Houle, S; Hussey, D; Meyer, JH; Potter, WZ; Sagrati, S; Spencer, EP; Wilson, AA | 1 |
| Kavirajan, H | 1 |
| Athan, E; Jones, SL; O'Brien, D | 1 |
| Alloui, A; Ardid, D; Constandil, L; Eschalier, A; Hernández, A; Laurido, C; Marchand, F; Mondaca, M; Pelissier, T; Soto-Moyano, R | 1 |
| DiCaudo, DJ; Kelley, LA | 1 |
| Kavitha, CV; Rangappa, KS | 1 |
| Lurie, SD; Makari-Judson, G; Reuben, SS | 1 |
| Berrocoso, E; Micó, JA; Rojas-Corrales, MO | 1 |
| Stearns, V | 1 |
| Albano, D; Grothe, DR; Scheckner, B | 1 |
| Bothmer, J; Huusom, AK; Montgomery, SA | 1 |
| Norman, TR; Olver, JS | 1 |
| Alamo, C; López-Muñoz, F; Rubio, G; San, L | 1 |
| Girardi, P; Kotzalidis, GD; Manfredi, G; Pacchiarotti, I; Ruberto, A; Tatarelli, R | 1 |
| Cinciripini, L; Cinciripini, P; De Moor, C; Minna, J; Tomlinson, G; Tsoh, J; Wetter, D | 1 |
| Baboolal, NS | 1 |
| Forssell, H; Hampf, G; Kalso, E; Tasmuth, T; Tenovuo, O | 1 |
| Hemrick-Luecke, SK; Iyengar, S; Simmons, RM; Webster, AA; Xu, JY | 1 |
| Bystritsky, A; Kelsey, JE; Mangano, RM; Pollack, MH; Stein, MB | 1 |
| Ferrier, N; Harrison, CL; Young, AH | 1 |
| Hindmarch, I; Rigney, U; Stanley, N; Trick, L | 1 |
| Azen, SP; Chou, CP; James Gauderman, W; Leuchter, AF; Marie-Mitchell, A | 1 |
| Boyer, P; Hackett, D; Mahé, V | 1 |
| Goli, V; Kunz, NR; Lei, D; Rowbotham, MC | 1 |
| Li, XM; Luo, C; Richardson, JS; Xu, H | 1 |
| Hackett, D; Lydiard, RB; Pitrosky, B; White, C | 1 |
| Hansen, LK | 1 |
| Karp, JF | 1 |
| Andrews, G; Carter, R; Donnelly, M; Haby, MM; Heuzenroeder, L; Mihalopoulos, C; Rossell, R; Vos, T | 1 |
| Allgulander, C; Dahl, AA; Emilien, G; Lepola, U; Mangano, R; Sjödin, I; Zhang, J | 1 |
| Chae, JH; Kim, JJ; Lee, C; Lee, CU; Lee, SJ; Pae, CU; Paik, IH | 1 |
| Delgado, PL | 1 |
| Gillman, PK | 1 |
| Houghton, WC; Scammell, TE; Thorpy, M | 1 |
| Carnes, CA; Pickworth, KK; Raman, SV; Votolato, NA | 1 |
| Khan, A; Mangano, R; Rickels, K | 1 |
| Casciano, R; Chen, J; Geissler, EC; Mallick, R; Panish, JM; Trivedi, MH; Wan, GJ | 1 |
| Brandes, M; Cassano, P; Cohen, LS; Leblanc, GA; Lyster, A; Soares, CN | 1 |
| Kehr, J; Scheel-Krüger, J; Weikop, P | 2 |
| Berrocoso, E; Gibert-Rahola, J; Micó, JA; Rojas-Corrales, MO | 1 |
| Chand, PK; Kalyani, GS; Murthy, P | 1 |
| Boncompagni, G; Ferioli, V; Manes, A; Melloni, C; Nanni, S | 1 |
| Dziedzicka-Wasylewska, M; Filip, M; Inan, SY; Przegaliński, E; Wydra, K | 1 |
| Bielski, RJ; Chang, CC; Ventura, D | 1 |
| Becker, OV; Glenn, T; Ketter, TA; Marsh, WK; Rasgon, NL | 1 |
| Pavlovic, ZM | 1 |
| Lublin, H; Povlsen, UJ | 1 |
| Buchkremer, G; Laske, C; Leyhe, T; Wormstall, H | 1 |
| Devanand, D; Fitzsimmons, L; Miyazaki, M; Roose, SP; Sackeim, H; Seidman, S; Turret, N | 1 |
| Demitrack, MA | 1 |
| Courtney, DB | 1 |
| Kaprinis, G; Kogeorgos, J; Nimatoudis, I; Theodoropoulou, S; Vidalis, A; Zissis, NP | 1 |
| Goodman, M; Grossman, R; Mitropoulou, V; New, A; Reynolds, D; Schmeidler, J; Siever, LJ; Silverman, J | 1 |
| Chamberlain, JC; Jones, L; Weiss, NT | 1 |
| Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Unsal, M; Yaris, E; Yaris, F | 1 |
| Bertolín-Guillén, JM; Climent-Díaz, B; Navarré-Gimeno, A | 1 |
| Aït-Ameur, A; Bertschy, G; Ferrero, F; Muscionico, M; Osiek, C; Ragama-Pardos, E; Roth, L | 1 |
| Allard, P; Behnke, K; Gram, L; Hanson, M; Søgaard, J; Timdahl, K | 1 |
| Khawaja, XZ; Liang, JJ; Storm, S | 1 |
| Devanand, DP; Fitzsimons, L; Juszczak, N; Nobler, MS; Roose, SP; Sackeim, HA; Turret, N | 1 |
| Mazeh, D; Melamed, Y; Saraf, R; Shahal, B | 1 |
| Alpert, JE; Bottiglieri, T; Burns, A; Fava, M; Mahal, Y; Mischoulon, D; Nierenberg, AA; Papakostas, G; Petersen, T; Worthington, JJ | 1 |
| Lopina, ST; Yang, H | 1 |
| Beyazyürek, M; Celik, T; Kayir, H; Sağlam, E; Uzbay, IT | 1 |
| Bannon, KM | 1 |
| Dunewicz, M; Grégoire, G; Précourt, A; Williamson, DR | 1 |
| Bondeson, J; Jewell, DP; Sullivan, BA; Thompson, IW | 1 |
| Atmaca, M; Baran, A; Berilgen, MS; Bulut, S; Mungen, B; Tekatas, A | 1 |
| Gonzalez-Arriaza, HL; Krahn, LE | 1 |
| Altun Ugur, B; Arikan, E; Guldiken, B; Guldiken, S; Kara, M; Tugrul, A | 1 |
| Mitchell, PB | 1 |
| Borges, KD; Cunha, GM; de Bruin, GS; de Bruin, VM; de Oliveira, RA; dos Santos-Filho, EA; Viana, GS | 1 |
| Baumann, P; Brawand-Amey, M; Brocard, M; Ciusani, E; Eap, CB; Zullino, DF | 1 |
| He, J; Li, XM; Richardson, JS; Xu, H | 1 |
| Cates, ME; Phelps, NJ | 1 |
| Albano, D; Zajecka, JM | 1 |
| Silverstone, PH | 1 |
| Shelton, CI | 1 |
| Liappas, J; Paparrigopoulos, T; Rabavilas, A; Tzavellas, E | 1 |
| Reuben, SS | 1 |
| Conca, A; König, P; Moll, W; Waschgler, R | 1 |
| Evans, ML; Jaffe, RB; McClish, K; Morgan, KS; Pritts, E; Vittinghoff, E | 1 |
| Araba, A; Blanchard, R; Desta, Z; Flockhart, DA; Hayden, J; Hayes, DF; Ho, H; Jin, Y; Lee, KH; Lemler, S; Li, L; Nguyen, A; Rae, JM; Skaar, T; Stearns, V; Storniolo, AM; Ullmer, L; Ward, B; Weinshilboum, RM | 1 |
| Yanik, M | 1 |
| Basterzi, AD; Goka, E; Yuksel, FV | 1 |
| Galgali, RB; Iby, N; Kurpad, SS; Pradeep, RJ; Srinivasan, K; Victor, G | 1 |
| Abrams, M; Cook, IA; DeBrota, DJ; Hunter, AM; Leuchter, AF; Morgan, ML; Potter, WZ; Siegman, B | 1 |
| Basinski, J; Begley, A; Dew, MA; Farhi, P; Mulsant, BH; Reynolds, CF; Whyte, EM | 1 |
| Hsiao, MC; Lin, YH; Liu, CY | 1 |
| Bilbao-Garay, J; de Lucas-Taracena, MT; Montañes-Rada, F; Ortiz-Ortiz, ME | 1 |
| Baydinç, YC; Ergin, H; Kiliç, S | 1 |
| Guest, JF; Lenox-Smith, A; Russ, J | 1 |
| Benson, BE; Dunn, RT; Ketter, TA; Kimbrell, TA; Little, JT; Luckenbaugh, DA; Post, RM; Willis, MW | 1 |
| Aydemir, O; Deveci, A; Taneli, F | 1 |
| de Guzman, MH; Goldberg, I; Ong, PY; Thiagalingam, S | 1 |
| Gelenberg, AJ; Liebowitz, MR; Munjack, D | 1 |
| Asnis, G; Bradwejn, J; Liebowitz, MR; Mangano, RM | 1 |
| Disci, R; Ertas, M; Kiziltan, E; Ozyalcin, SN; Talu, GK; Yucel, B | 1 |
| Lange, CL | 1 |
| Albertson, T; Camilleri, C; Offerman, S | 1 |
| Carey, TS; Gartlehner, G; Gaynes, BN; Hansen, RA; Lohr, KN; Randolph, LC | 1 |
| Bloch, DA; Ciraulo, AM; Ciraulo, DA; Elkashef, A; Knapp, CM; Leiderman, DB; LoCastro, J; Montgomery, MA; Sarid-Segal, O | 1 |
| Alevizos, B; Alevizos, E; Vaidakis, N | 1 |
| Ezra, DG; Storoni, M; Whitefield, LA | 1 |
| Fernandez, JL; Francois, C; Montgomery, S | 1 |
| Grignon, S; Trottier, M | 1 |
| Annemans, L; Demyttenaere, K; Hemels, ME; Hudry, J | 1 |
| Florkowski, A; Gałecki, P; Kołodziejska, I; Nowakowski, T; Pawełczyk, A; Pietras, T; Zboralski, K | 1 |
| Alloui, A; Bonnefont, J; Chapuy, E; Clottes, E; Eschalier, A | 1 |
| Ding, BK; Jin, KH; Ma, H; Qin, XS; Xie, SF | 1 |
| Addington, S; Dichter, GS; Freid, CM; Shelton, RC; Tomarken, AJ | 1 |
| Hauser, P; Hisley, KC; Lefkowitz, DM; Marano, C; Obuchowski, A; Regenold, WT | 1 |
| Kus, K; Nowakowska, E | 1 |
| Biggio, G; Cherchi, G; Dazzi, L; Seu, E | 1 |
| Bourin, M; Clénet, F; Hascoët, M; Nic Dhonnchadha, BA; Ripoll, N | 1 |
| Almási, J; Rihmer, Z | 1 |
| Bergeron, L; Boulé, M; Perreault, S | 1 |
| Kennedy, SH; Lam, RW | 1 |
| Alexandre, J; Durand, JP; Goldwasser, F; Guillevin, L | 1 |
| Katzman, M | 1 |
| Huande, L; Juan, H; Zhiling, Z | 1 |
| Cunha, A; Gazalle, FK; Kapczinski, F; Lima, MS; Schmitt, R; Souza, J | 1 |
| Eloranta, A; Hallikainen, T; Repo-Tiihonen, E; Tiihonen, J | 1 |
| Hill, D; Mines, D; Novelli, L; Yu, H | 1 |
| Hemels, ME; Toumi, I; Wade, AG | 1 |
| Berger, M; Feige, B; Nissen, C; Nofzinger, E; Riemann, D; Voderholzer, U | 1 |
| Bourin, M; Hascoët, M; Nic Dhonnchadha, BA; Ripoll, N; Sébille, V | 1 |
| Egberts, TC | 1 |
| Bastiaens, L | 1 |
| Entsuah, R; Padmanabhan, SK; Shelton, C; Vinall, PE | 1 |
| Claassen, JA; Gelissen, HP | 1 |
| Bannink, M; Bontenbal, M; Seynaeve, C; van Gool, AR | 1 |
| Han, D; Wang, EC | 1 |
| Posternak, MA; Zimmerman, M | 1 |
| Gillam, DM; Nelson, JE; Roberts, BT; Turner, RC | 1 |
| Bannan, N | 1 |
| Andersen, OK; Arendt-Nielsen, L; Disci, R; Kiziltan, E; Koknel Talu, G; Ozyalcin, S; Yucel, A; Yucel, B | 1 |
| Cela, R; Garcia-Jares, C; Lamas, JP; Llompart, M; Salgado-Petinal, C | 1 |
| Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
| Fennell, J; Hussain, M | 1 |
| Gould, GG; Hensler, JG; Rossi, DV; Valdez, M | 1 |
| Kootstra-Ros, JE; van Baalen-Benedek, EH; van der Weide, J | 1 |
| Aronow, WS; Beck, G; Ness, J | 1 |
| Ciraulo, DA; Hennen, J; Jensen, JE; Ke, Y; Knapp, C; Kwak, T; Meyer, AA; Nassar, LE; Renshaw, PF; Sarid-Segal, O; Streeter, CC | 1 |
| Bourin, M; Hascoët, M; Massé, F | 1 |
| Einarson, TR; van Baardewijk, M; Vis, PM | 2 |
| Baldomero, EB; Calvo, CG; Cercós, CL; López, RP; Ruiloba, JV; Ubago, JG | 1 |
| Ladd, CO; Loughhead, A; Newport, DJ; Ragan, KA; Stowe, ZN | 1 |
| Chen, Z; Haimano, S; Li, X; Li, XM; Xu, H | 1 |
| Apelqvist, G; Bengtsson, F; Kugelberg, FC; Wikell, C | 1 |
| Altamirano, AV; Frazer, A; Gould, GG; Javors, MA | 1 |
| Briley, M; Grady, MM; Moret, C; Stahl, SM | 1 |
| Biglia, N; Cacciari, F; Kubatzki, F; Maggiorotto, F; Ponzone, R; Roagna, R; Sismondi, P; Torta, R | 1 |
| Carpenter, D; Connor, K; Davidson, J; Krishnan, R; Krulewicz, S; Nemeroff, C; Owens, M; Watkins, L | 1 |
| Florkowski, A; Gałecki, P; Gruszczyński, W; Kołodziejska, I; Mikołajczyk, I; Zboralski, K | 1 |
| Augsburger, M; Liaudet, L; Oddo, M; Pacher, P; Pascale, P | 1 |
| Cantillon, M; Entsuah, R; Kornstein, SG; Thase, ME | 1 |
| Hanekamp, BB; Hofstra, LS; Ligtenberg, JJ; Tulleken, JE; van der Werf, TS; Zijlstra, JG | 1 |
| Denys, DA; Tenneij, NH; van Megen, HJ; Westenberg, HG | 1 |
| Cavanagh, J; Dempsey, MF; Dewar, D; Eersels, J; Patterson, J; Pimlott, S; Wyper, D | 1 |
| Ahokas, A; Bradwejn, J; Emilien, G; Salinas, E; Stein, DJ; Whitaker, T | 1 |
| Mathews, AW | 1 |
| Adjei, AA; Atherton, P; Barton, DL; Carpenter, LA; Collins, M; Fitch, TR; Flynn, PJ; Loprinzi, CL; Mincey, BA; Rummans, TA; Shanafelt, TD; Sloan, JA | 1 |
| Denys, D; Fluitman, S; Heijnen, C; Kavelaars, A; Westenberg, HG | 1 |
| Bhatt, J; Jangid, A; Singh, S; Subbaiah, G; Venkatesh, G | 1 |
| Burt, T; D'Souza, RF; George, T; Hopwood, M; Lam, W; Martin, AJ; Sir, A; Uguz, S; Vahip, S | 1 |
| Greiner, W; Kulp, W; von der Schulenburg, JM | 1 |
| Fava, M; Mallinckrodt, CH; Martinez, JM; Prakash, A; Watkin, JG; Wohlreich, MM | 1 |
| Alici, T; Aygoren, MO; Kayir, H; Saglam, E; Uzbay, IT | 1 |
| Botts, S | 1 |
| Shaw, MW; Sheard, JD | 1 |
| Bertschy, G; Carminati, GG; Deriaz, N | 1 |
| Brørs, O; Melien, Ø; Myhr, K; Skaali, T | 1 |
| De Vry, J; Magalas, Z; Tzschentke, TM | 2 |
| Doreswamy, S; Kavitha, CV; Mantelingu, K; Rangappa, KS; Shashidhara Prasad, J; Sridhar, MA; Swamy, SN | 1 |
| Fehér, LZ; Galsi, G; Hugyecz, M; Janka, Z; Juhász, A; Kálmán, J; Kovács, Z; Pákáski, M; Palotás, A; Puskás, LG; Rimanóczy, A; Szabó, Z | 1 |
| Baldwin, DS; Lader, M; Montgomery, SA; Nil, R | 1 |
| Anderson, C; Baile, W; Cinciripini, L; Cinciripini, PM; de Moor, C; Lam, C; Minna, JD; Tsoh, JY; Wetter, DW | 1 |
| Campagne, DM | 1 |
| Themelis, DG; Tzanavaras, PD; Verdoukas, A | 1 |
| Bexton, B; Han, D; Lelorier, J; Monfared, AA; Sheehy, O | 1 |
| Lang, AE; Voon, V | 1 |
| Giordani, S; Lucca, A; Magri, L; Rossini, D; Smeraldi, E; Zanardi, R | 1 |
| Beljean, M; Cutroneo, P; Luu, RP; Siouffi, AM | 1 |
| Baker, RA; Benkert, O; Heinrich, C; Heukels, A; Kohnen, R; Philipp, M; Schutte, AJ; Simmons, JH; Szegedi, A; van der Vegte-Senden, M | 1 |
| Ballon, JS; Schulman, MC | 1 |
| Beck, MG; Digmann, RR; Phillips, BB | 1 |
| Benattia, I; Graepel, J; Kroenke, K; Messina, N; Musgnung, J | 1 |
| D'Souza, DN; Iyengar, S; Pritchett, YL; Raskin, J; Smith, TR; Wernicke, JF; Wong, K | 1 |
| Chen, WJ; Chu, PL; Lu, TC; Tsai, KC; Wu, CS | 1 |
| Foster, DJ; Fowlkes, A; Good, DC; Sawaki, L | 1 |
| Altshuler, LL; Denicoff, KD; Frye, MA; Grunze, H; Keck, PE; Kupka, RW; Leverich, GS; Martinez, MI; McElroy, SL; Nolen, WA; Post, RM; Suppes, T | 1 |
| Sezer, Z; Tekol, Y; Yaba, G | 1 |
| Ahmedov, V; Gültekin, H | 1 |
| Peres, MF; Vieira, DS | 1 |
| Liau, CH; Shen, WW; Su, KP | 1 |
| Al-Adwani, A | 1 |
| Lakatos, L; Rihmer, Z | 1 |
| Barton, D; Bearden, JD; Dakhil, SR; Fitch, TR; Kugler, JW; Levitt, R; Loprinzi, CL; Mailliard, JA; Nikcevich, DA; Sloan, JA; Tschetter, LK | 1 |
| Albertazzi, P | 1 |
| Barnes, MJ; Daiss, JO; Mills, JS; Montana, JG; Showell, GA; Tacke, R; Warneck, JB | 1 |
| Millan, MJ | 1 |
| Blashki, G; Keks, N | 1 |
| Aricioğlu, F; Buldanlioğlu, U; Ozyalçin, NS; Salanturoğlu, G | 1 |
| Drummer, OH; Rodda, KE | 1 |
| Biggs, MM; Fava, M; Luther, JF; Niederehe, G; Nierenberg, AA; Ritz, L; Rush, AJ; Shores-Wilson, K; Stewart, JW; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Amann, B; Hegerl, U; Juckel, G; Mergl, R; Mulert, C; Padberg, F; Pogarell, O; Sterr, A | 1 |
| Baca, E; Garcia-Calvo, C; Prieto, R; Roca, M | 1 |
| Hackett, D; Tedeschi, MA; Wan, GJ; Zhang, HF | 1 |
| Efremidis, M; Evangelou, D; Kardaras, F; Korantzopoulos, P; Letsas, K; Pappas, L | 1 |
| Andersen, HF; Kennedy, SH; Lam, RW | 1 |
| Kennedy, SH | 1 |
| Roose, S; Schatzberg, A | 1 |
| Allen, KR | 1 |
| Almarza, E; Ballesteros, S; Martínez, MA | 1 |
| Papadimitriou, GN; Psarros, C; Sakkas, P; Soldatos, CR; Theleritis, CG | 1 |
| Balme, B; Becuwe, C; Dalle, S; Thomas, L | 1 |
| Higuchi, T; Honda, K; Kamijima, K; Kitahara, S; Tanaka, S; Yamada, M | 1 |
| Begley, AE; Kirshne, MA; Mulsant, BH; Pollock, BG; Reynolds, CF; Romkes, M; Whyte, EM | 1 |
| Chen, Z; Dyck, L; Haimanot, S; He, J; Li, X; Li, XM; Xu, H | 1 |
| Allen, A; Dell'Osso, B; Hollander, E; Nestadt, G | 1 |
| Sicot, R | 1 |
| Dervaux, A | 1 |
| Keltner, NL; Lee, SI | 1 |
| Blier, P; de Montigny, C; Debonnel, G; Hébert, C; Lavoie, N; Saint-André, E | 2 |
| Czubak, A; Florek, E; Jodynis-Liebert, J; Kus, K; Nowakowska, E | 1 |
| Khan, A; Shelton, RC; Thase, ME | 1 |
| Asnis, G; Benattia, I; Davidson, J; Musgnung, JJ; Rothbaum, BO; Tucker, P | 1 |
| Renneberg, B; Ströhle, A | 1 |
| Briggs, SD; Case, M; Corya, SA; Sanger, TM; Tollefson, G; Williamson, D | 1 |
| Hsiao, CC | 1 |
| Barbiroli, B; Bernardi, F; Cicognani, A; Lin, L; Lodi, R; Mignot, E; Montagna, P; Parmeggiani, A; Plazzi, G; Posar, A; Scano, MC; Tonon, C | 1 |
| Bourgeois, JA; Brunberg, JA; Farzin, F; Hagerman, P; Hagerman, R; Hessl, D; Tassone, F; Zhang, L | 1 |
| Anghelescu, I; Luborzewski, A; Regen, F; Schindler, F | 1 |
| Aydin, C; Bildik, T; Erermis, S; Gokcen, S; Korkmaz, S; Ozbaran, B; Tamar, M | 1 |
| Bahk, WM; Chae, JH; Jun, TY; Kim, TS; Pae, CU; Rhee, WI; Yoon, SJ | 1 |
| Birnbaum, HG; Gelwicks, S; Le, TK; Mareva, MN; Robinson, RL; Rosen, A; Wu, EQ | 1 |
| Rasker, JJ; Taal, E; van de Laar, MA; Zijlstra, TR | 1 |
| Kapur, B; Koren, G; Moretti, M | 1 |
| Estes, LL; Taylor, JJ; Wilson, JW | 1 |
| Kim, YK; Lee, KM | 1 |
| Bjerrum, OJ; Blackburn-Munro, G; Broløs, T; Rode, F | 1 |
| Connolly, A; Stewart, S; Taylor, D | 1 |
| Akgoz, S; Akkaya, C; Kirli, S; Sarandol, A; Saygin Eker, S; Yazicioglu, B | 1 |
| Kasper, S; Montgomery, SA; Pande, AC; Tobias, K; Zornberg, GL | 1 |
| Egger, C; Geretsegger, C; Muehlbacher, M; Nickel, M; Stuppaeck, C | 1 |
| Davies, HM; Ni, A | 1 |
| Akgoz, S; Akkaya, C; Eker, SS; Kirli, S; Sivrioglu, EY | 1 |
| Eckert, L; Lançon, C | 1 |
| Cook, IA; Hunter, AM; Leuchter, AF; Morgan, ML | 1 |
| Connor, KM; Davidson, JR; Payne, V | 1 |
| Andersen, HF; Montgomery, SA | 1 |
| Altshuler, LL; Denicoff, KD; Frye, MA; Grunze, H; Keck, PE; Kitchen, CM; Kupka, RW; Leverich, GS; McElroy, S; Mintz, J; Nolen, WA; Post, RM; Suppes, T; Walden, J | 1 |
| Abad-Santos, F; Adan-Manes, J; Ayuso-Mateos, JL; López-Rodríguez, R; Novalbos, J | 1 |
| Emilien, G; Gao, B; Koponen, H; Lepola, U; Pollack, MH; Salinas, E; Simon, NM; Tzanis, E; Whitaker, T; Worthington, JJ | 1 |
| Cottraux, J | 1 |
| Gregoriou, S; Kalogeromitros, D; Papadimitriou, GN; Papageorgiou, CC; Rabavilas, AD; Syrigou, E; Theleritis, CG | 1 |
| Begley, AE; Johnson, EM; Mulsant, BH; Pollock, BG; Reynolds, CF; Weber, E; Whyte, E | 1 |
| Scott, JR; Taylor, D | 1 |
| Valenstein, M | 1 |
| Biggs, MM; Davis, L; Fava, M; Luther, JF; McGrath, PJ; Niederehe, G; Nierenberg, AA; Rush, AJ; Shores-Wilson, K; Stewart, JW; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Mattes, JA | 1 |
| Krol, DG; Nolen, WA | 1 |
| Arneth, B; Dragicevic, A; Härtter, S; Hiemke, C; Kaiser, R; Lackner, K; Müller, MJ; Shams, ME | 1 |
| Carter, WG; Shillcutt, SD | 1 |
| Butler, R; Carney, S; Cipriani, A; Geddes, J; Hatcher, S; Price, J; Von Korff, M | 1 |
| Clayton, AH; Haight, BR; Johnston, JA; Modell, JG; Thase, ME; Thompson, AH | 1 |
| Corral, M; Kendrick, K; Misri, S; Wardrop, AA | 1 |
| Horne, MK; Sarma, A | 1 |
| Abozguia, K; Chudley, S; Gammage, M | 1 |
| Cornwall, L; Foran, K; Forrest, S; Ingram, G; McAllister-Williams, RH; McMahon, L; Rajwal, M; Taylor, M | 1 |
| Bandelow, B | 1 |
| Ahmed, S; Baldwin, D; Benattia, I; Davidson, J; Kuper, E; Musgnung, J; Pedersen, R; Stein, DJ | 1 |
| Austin, MP; Bolisetty, S; Oei, J; Pakalapati, RK | 1 |
| Eastwood, BJ; Jones, CK; Need, AB; Shannon, HE | 1 |
| Malek-Ahmadi, P; Prabhu, F | 1 |
| Bach, FW; Jensen, TS; Otto, M; Sindrup, SH | 1 |
| Fotiou, F; Fountoulakis, KN; Gerasimou, G; Grammatikos, P; Iacovides, A; Kaprinis, G; Karamouzis, M | 1 |
| Cornwall, PL; Foran, K; Forrest, S; Ingram, G; McAllister-Williams, RH; McMahon, L; Rajwal, MS; Taylor, M | 1 |
| Christodoulou, C; Douzenis, A; Lykouras, L; Michopoulos, I | 1 |
| Eckert, L; Falissard, B | 1 |
| Baud, FJ; Bloch, V; Deye, N; Mégarbane, B | 1 |
| Leighton, JA; Luckritz, TC; Patel, BM; Rady, MY; Wells, CD; Zornik, JM | 1 |
| Li, HD; Liu, W; Wang, F | 1 |
| Bateman, DN; Thanacoody, HK; Waring, WS | 1 |
| Kornstein, SG | 2 |
| Andrews, E; Mines, D; Roskell, N; Rubino, A; Tennis, P; Weich, S | 1 |
| Deshauer, D | 1 |
| Gendron, A; McIntyre, A | 1 |
| Bremner, JD; Charney, DS; Vermetten, E; Vythilingam, M | 1 |
| Chen, TT; Cinciripini, PM; Lam, CY; Minna, JD; Minnix, JA; Robinson, JD; Tomlinson, GE; Wetter, DW | 1 |
| Ehret, MJ; Levin, GM; Narasimhan, M; Rathinavelu, A | 1 |
| Baune, BT; Caliskan, S; Todder, D | 2 |
| Dunner, DL; Haman, KL; Hirschfeld, RM; Kiev, A; Lydiard, RB; Rapaport, MH; Shelton, RC; Smith, WT; Zajecka, JM | 1 |
| Agogué, C; Bérard, A; Carceller, AM; Ferreira, E; Francoeur, D; Martin, BZ; St-André, M | 1 |
| Alexopoulos, GS; Carpenter, D; Docherty, JP; Katz, IR; Reynolds, CF | 1 |
| Cai, HL; Li, HD; Liu, W | 1 |
| Burstein, AH; Gibbs, MA; Marek, GJ; Marek, K; Rogers, JF; Seibyl, JP; Shang, Y; Stiger, T | 1 |
| Feldman, MD; Stone, TE; Swanson, C | 1 |
| Azzouz, F; Carpenter, JS; Elam, JL; Johns, S; Johnson, CS; Monahan, PO; Shelton, RC; Storniolo, AM | 1 |
| Conti, M; Frasnelli, M; Rosetti, M; Tesei, A; Zoli, W | 1 |
| Kaufmann, M; Loibl, S; Mehta, KM; Schwedler, K; Strohmeier, R; von Minckwitz, G | 1 |
| Bing-Ren, X; Cai-Yun, W; Wei, Z | 1 |
| Rush, AJ | 2 |
| Kunz, NR; Riddle, MA; Rynn, MA; Yeung, PP | 1 |
| Berman, SA; Packer, S | 1 |
| Fernández, AS; López-García, P; Navarro, JS; Sádaba, B; Santos, PM; Vidal, JP | 1 |
| Altunbaşak, A; Celik, O; Demirdaş, A; Eren, I; Naziroğlu, M; Ozmen, I; Uğuz, AC; Uz, E | 1 |
| Barbui, C; Cipriani, A; Geddes, JR | 1 |
| Appéré-De-Vecchi, C; Dagorn, J; De Jonghe, B; Fangio, P; Lachérade, JC; Outin, H; Terville, JP | 1 |
| Entsuah, R; Ferguson, JM; Khan, A; Mangano, R; Tzanis, E | 1 |
| Khazaal, Y | 1 |
| Sheehan, DV; Sheehan, KH | 1 |
| Djogovic, D; Hudson, D | 1 |
| Howell, C; Waring, WS; Wilson, AD | 2 |
| Anderson, LW; Asafu-Adjaye, EB; Faustino, PJ; Kwon, H; Tawakkul, MA; Volpe, DA; Yu, LX | 1 |
| Nageswara Rao, R; Narasa Raju, A | 1 |
| Artiges, E; Bragulat, V; Frouin, V; Martinot, JL; Paillère-Martinot, ML; Poline, JB | 1 |
| Akinpeloye, HO; Hamzah, Z; Hannan, N; Meagher, D | 1 |
| Emslie, GJ; Kunz, NR; Yeung, PP | 1 |
| Georgiadis, G; Harmoussi, S; Karageorgiou, K; Mitsikostas, D; Thomaidis, T; Vlaikidis, N; Zissis, NP | 1 |
| Mulsant, BH | 1 |
| de Leeuw, FE; Heeren, TJ; Hulshoff Pol, HE; Janssen, J; Kahn, RS; Kok, RM; Lampe, IK; Schnack, HG | 1 |
| Archambaud, F; Buhl, C; Chouinard, G; Corruble, E; Hardy, P; Prigent, A; Schuster, JP | 1 |
| Dhir, A; Kulkarni, SK | 6 |
| Colombo, C; De Ronchi, D; Mandelli, L; Rossini, D; Serretti, A; Tarricone, I; Zanardi, R | 1 |
| Fernandez, JL; Llorca, PM | 1 |
| Alam, F; Ashim, S; Bennett, D; Mbaya, P | 1 |
| Albani, F; Montagna, P; Plazzi, G; Provini, F; Riva, R | 1 |
| Ghaemi, SN; Wingo, AP | 1 |
| Ball, S; Detke, M; Dinkel, J; Dunayevich, E; Erickson, J; Hartford, J; Kornstein, S; Liebowitz, M; Pigott, T; Russell, J; Walker, D | 1 |
| Emslie, GJ; Findling, RL; Kunz, NR; Li, Y; Yeung, PP | 1 |
| Carandang, C; Carrey, N; Gardner, DM; Kutcher, S; Santor, D | 1 |
| Berrocoso, E; Mico, JA | 2 |
| Correa, H; da Rocha, FF | 1 |
| Dermietzel, R; Faustmann, PM; Haghikia, A; Vollmar, P | 1 |
| Bauer, M; Froud, DM; Jain, R; Kajdasz, DK; Perahia, DG; Pritchett, YL; Raskin, J; Russell, JM; Spencer, KA; Thase, ME; Walker, DJ | 1 |
| Domula, M; Felber, W; Gallinat, J; Lang, UE; Schmidt, E; Schulze, D; Stogowski, D; Tugtekin, SM | 1 |
| Allgulander, C; Sheehan, DV | 1 |
| Damsbo, N; Hemels, ME; Le Lay, A; Stage, KB; Sørensen, J | 1 |
| Connor, K; Davidson, JR; Vaishnavi, S | 1 |
| Field, M; Hibbert, E; Roxanas, M | 1 |
| Swart, KJ; Theron, HB; van der Merwe, MJ; van der Westhuizen, JH | 1 |
| Biggs, MM; Fava, M; Friedman, ES; Hollon, SD; Luther, JF; McGrath, PJ; Niederehe, G; Nierenberg, AA; Rush, AJ; Thase, ME; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Bieling, PJ; Kennedy, SH; Konarski, JZ; Lau, MA; Mayberg, HS; McIntyre, RS; Segal, ZV | 2 |
| Chang, YY; Chong, MY; Lee, Y; Lin, PY; Yeh, WC | 1 |
| Dierkes, W; Linden, M; Munz, T | 1 |
| Alves Valle, E; Araújo Silva, S; Avila de Melo, R; da Costa Júnior, AL; de Souza Neto, JJ; de Vasconcelos Cunha, UG; Faria Alves, VX; Lopes Rocha, F; Magalhães Scoralick, F; Martins de Oliveira, F; Mendes Brega, R; Sakurai, E | 1 |
| Boovariwala, A; Ginovart, N; Houle, S; Meyer, JH; Rusjan, P; Sagrati, S; Sokolov, S; Spencer, EP; Voineskos, AN; Wilson, AA | 1 |
| Deforce, D; Denys, D; Van Nieuwerburgh, F; Westenberg, HG | 1 |
| Goldman-Levine, JD; Pereira, CE | 1 |
| Araya, AV; Fiedler, JL; Fritsch, R; Gatica, H; Herrera, L; Rojas, G; Rojas, P; Rojas, R; Silva, H | 1 |
| Heerdink, ER; van Dijk, L; Volkers, AC | 1 |
| Albano, AM; Entusah, AR; March, JS; Rynn, M; Tourian, KA | 1 |
| Heeren, TJ; Kok, RM; Nolen, WA | 2 |
| Ajwani, N; Lee, C; Lim, HK; Pae, CU; Patkar, AA | 1 |
| Firmin, D; Fleuret, C; Greco, M; Legoupil, D; Misery, L; Morvan, C; Roguedas, AM | 1 |
| Aharonovich, E; Bisaga, A; Brooks, DJ; Garawi, F; Levin, FR; Mariani, J; Nunes, EV; Raby, W; Rubin, E | 1 |
| Kowalski, T; Maier, C; Reinacher-Schick, A; Schlegel, U | 1 |
| Amore, M; Cesta, R; Fanali, S; Mandrioli, R; Mercolini, L; Raggi, MA | 1 |
| Entsuah, R; Mangano, R; Pollack, M; Simon, NM; Tzanis, E; Zhang, Y | 1 |
| Hendset, M; Hermann, M | 1 |
| Bravo-Mehmedbasić, A; Kucukalić, A; Kulenović, AD; Suljić-Mehmedika, E | 1 |
| Ashton, AK; Longdon, MC | 1 |
| Dubarek, W; Kucia, K | 1 |
| Ligtenberg, JJ; Meertens, JH; Monteban-Kooistra, WE; Tulleken, JE; Zijlstra, JG | 1 |
| Chen, YC; Lu, RB; Wu, YS | 1 |
| Berlim, MT; Turecki, MG | 1 |
| Barbuzza, O; Borgia, F; Guarneri, B; Vaccaro, M | 1 |
| Heeren, T; Kok, R; Nolen, W | 2 |
| Ahmed, S; Dunner, DL; Ferguson, JM; Friedman, ES; Gelenberg, AJ; Hirschfeld, RM; Keller, MB; Kocsis, JH; Kornstein, SG; Musgnung, J; Nemeroff, CB; Ninan, PT; Pedersen, RD; Rothschild, AJ; Schatzberg, AF; Shelton, RC; Thase, ME; Trivedi, MH; Yan, B; Zajecka, JM | 2 |
| Tassin, JP | 1 |
| Bertilsson, L; Hynninen, VV; Kurkinen, K; Laine, K; Neuvonen, PJ; Olkkola, KT | 1 |
| Ana Rodriguez, Y; Cabrera Gisbert, MV; Cáceres Anillo, D; Morillo Velarde, C | 1 |
| Gannon, RL; Millan, MJ | 1 |
| Robinson-Papp, J; Simpson, DM | 1 |
| Black, JL; McAlpine, DE; Mrazek, DA; O'Kane, DJ | 1 |
| Ahmed, S; Haudiquet, V; Stahl, SM | 1 |
| Demeter, CA; Findling, RL; Greenhill, LL; Kotler, LA; McNamara, NK; Myers, C; O'Riordan, MA; Reed, MD | 1 |
| Ahmed, S; Dunlop, BW; Dunner, DL; Ferguson, JM; Friedman, ES; Gelenberg, AJ; Hirschfeld, RM; Keller, MB; Kocsis, JH; Kornstein, SG; Nemeroff, CB; Ninan, PT; Pedersen, R; Rothschild, AJ; Schatzberg, AF; Schmidt, M; Shelton, RC; Thase, ME; Trivedi, MH; Yan, B; Zajecka, JM | 1 |
| Djogovic, D; Hudson, D; Jacka, M | 1 |
| Heeren, TJ; Kok, RM; Nolen, WA; Vink, D | 1 |
| Gillman, K | 1 |
| Benattia, I; Demitrack, M; Entsuah, R; Nemeroff, CB; Sloan, DM; Thase, ME | 1 |
| Aviv, A; Barak, Y; Mazeh, D; Shahal, B; Zemishlani, H | 1 |
| Fava, M; Papakostas, GI; Thase, ME | 1 |
| Hay-Schmidt, A; Larsen, MH; Mikkelsen, JD; Rønn, LC | 1 |
| Bramness, JG; Engeland, A; Furu, K | 1 |
| Becker, T; Koesters, M; Weinmann, S | 2 |
| Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A | 1 |
| Jagadheesan, K; Lusicic, A | 1 |
| Alexander, AL; Davidson, RJ; Johnstone, T; Kalin, NH; Nitschke, JB; Polis, S; Somerville, LH; Whalen, PJ | 1 |
| Spindler, PE | 1 |
| Agarwal, A; Ferrari, P; Macmillan, J; Singer, R | 1 |
| Baum, NH; Torti, DC | 1 |
| Källén, B; Lennestål, R | 1 |
| Kirch, W; Mueck-Weymann, M; Siepmann, M; Siepmann, T; Ziemssen, T | 1 |
| Klier, CM; Mossaheb, N; Saria, A; Schloegelhofer, M; Zernig, G | 1 |
| Fernández Rodríguez, E; García García, S; Ruiz Ginés, JA; Ruiz Ginés, MA; Tze Kiong, E | 1 |
| Bolaman, Z; Kadikoylu, G; Yavasoglu, I | 1 |
| Bose, A; Gommoll, C; Korotzer, A; Li, D | 1 |
| Alvarez, E; Guilleminault, C; Lemoine, P | 1 |
| Byrd, EH; Chismar, R; Dey, S; Holtzheimer, PE; Kelley, ME; McDonald, WM; McWhorter, K; Meeks, TW; Mufti, M; Quinn, S; Vito, N; Young, R | 1 |
| Bares, M; Cerná, L; Kopecek, M; Raszka, M; Seifertová, D; Sulak, J | 1 |
| Altindag, A; Gunes, M | 1 |
| Alpert, JE; Balasubramani, GK; Biggs, MM; Carmin, CN; Fava, M; Howland, R; Leuchter, A; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR; Zisook, S | 1 |
| Begg, DP; Hallam, KT; Norman, TR; Olver, JS | 1 |
| Barahona Rondón, L; Iguarán Mengual, A; Morera Montes, J; Oria Fernández, A | 1 |
| Bennema, P; Deij, MA; Meekes, H; van Eupen, J; Verwer, P; Vlieg, E | 1 |
| Borah, M; Radhakrishnan, M; Ramamoorthy, R | 1 |
| de Pisa, E; Girardi, P; Kotzalidis, GD; Patrizi, B; Ruberto, G; Savoja, V | 1 |
| Alexandrino-Silva, C; de Andrade, AG; de Toledo Ferraz Alves, TC; Nadalini Mauá, FH | 1 |
| Safarinejad, MR | 1 |
| Fosaas, K; Hendset, M; Hermann, M; Hjerpset, M; Refsum, H | 1 |
| Jürgens, TP; Koch, HJ; Leinisch, E | 1 |
| Allen, A; Baker, BR; Friedberg, J; Greenberg, JL; Hadley, SJ; Hollander, E; Kaplan, A; Priday, L; Simeon, D | 1 |
| Cho, SH; Chung, SJ; Kim, D; Koo, HM; Lim, YT; Oh, KS; Park, HY; Yuk, SH | 1 |
| Akkaya, C; Cangur, S; Eker, SS; Kirli, S; Sarandol, A; Sarandol, E | 1 |
| Kho, KH | 1 |
| Ekman, M; Jönsson, B; Khandker, R; Ovanfors, A; Sobocki, P | 1 |
| Cotroneo, A; Davoli, A; De Fazio, P; De Fazio, S; De Sarro, G; Gallelli, L; Gareri, P; Seminara, G | 1 |
| Chen, MC; Lane, HY; Lin, CH; Lin, CY; Lin, KS | 1 |
| Abebe, K; Asarnow, JR; Birmaher, B; Brent, D; Clarke, G; DeBar, L; Emslie, G; Hughes, C; Iyengar, S; Keller, M; Kennard, B; Leonard, H; McCracken, J; Melhem, N; Onorato, M; Porta, G; Ritz, L; Ryan, N; Spirito, A; Strober, M; Suddath, R; Vitiello, B; Wagner, KD; Zelazny, J | 1 |
| Beyer, CE; Lin, Q; Platt, B; Rahman, Z; Ring, RH; Rosenzweig-Lipson, S; Schechter, LE; Young, K | 1 |
| Begré, S; Gerber, M; Traber, M; von Känel, R | 3 |
| Coupland, NJ | 1 |
| Berk, M; Malhi, GS; Ng, F | 1 |
| Bosse, GM; Collins, AM; Spiller, HA | 1 |
| Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH | 1 |
| Amsterdam, JD; Shults, J | 2 |
| Alves, TC; D'Elia, G; de Andrade, AG; Della Mônica, M | 1 |
| Han, C; Joe, SH; Jung, IK; Ko, YH; Lee, BH; Masand, PS; Pae, CU; Patkar, AA | 1 |
| Case, K; Cramer-Bornemann, M; Hurwitz, TD; Kim, SW; Schenck, CH | 1 |
| Höjer, J; Hulting, J; Salmonson, H | 1 |
| Hagemann, T; McGoodwin, L; Miller, T | 1 |
| Cox, SK; Reeves, RR | 1 |
| Brousse, G; Geneste, J; Llorca, PM; Schmidt, J; Schmitt, A | 1 |
| Patel, BN; Sanyal, M; Sharma, N; Shrivastav, PS | 1 |
| Lyons, JE; Symon, J | 1 |
| Jiang, Q; Lenox-Smith, AJ | 1 |
| Bria, P; Camardese, G; Picello, A | 1 |
| Carpenter, DJ; Krulewicz, S; Nemeroff, CB; Owens, MJ; Plott, SJ; Sheehan, DV; Simon, JS; Thase, ME | 1 |
| Aparicio, N; De Boer, WA; Jansen, JB; Laheij, RJ; Tan, AC; Van den Hazel, S; van Kerkhoven, LA; Witteman, BJ | 1 |
| Il'ina, NA | 2 |
| Berry, BD; Colucci, VJ | 1 |
| Bares, M; Brunovsky, M; Höschl, C; Kopecek, M; Kozeny, J; Krajca, V; Novak, T; Sos, P; Stopkova, P | 1 |
| Fulton, K; Kennedy, SH; Rasmussen, J; Rizvi, S | 1 |
| Bakish, D; Ball, S; Duenas, H; Erickson, J; Hallberg, C; Nicolini, H; Russell, JM; Sagman, D; Spann, M | 1 |
| Amsterdam, JD; Shults, J; Shwarz, M; Wang, CH | 1 |
| Ninan, PT; Poole, RM; Stiles, GL | 1 |
| Altamura, AC; D'Urso, N; Dell'osso, B; Fumagalli, S; Mundo, E; Russo, M | 1 |
| Algayres, JP; Béchade, D; Blondon, H; Bonnefoy, S; Carmoi, T; Desramé, J | 1 |
| Freemantle, N | 1 |
| Bonaccorso, S; Girardi, P; Matrisciano, F; Nicoletti, F; Panaccione, I; Ricciardi, A; Ruberto, A; Scaccianoce, S; Shelton, RC; Tatarelli, R; Wang, L | 1 |
| Mostany, R; Pazos, A; Valdizán, EM | 1 |
| Gourion, D | 1 |
| Anderson, IM; Haddad, PM; Tint, A | 1 |
| Balcioglu, I; Bayar, R; Dalkiran, M; Emul, M; Keles, I; Samim, S; Yildirim, E | 1 |
| Dehé, C; Gagnadoux, F; Hureaux, J; Person, C; Priou, P; Racineux, JL; Urban, T | 1 |
| Ahmed, S; Baldwin, DS; Davidson, J; Musgnung, J; Pedersen, R; Rothbaum, BO; Stein, DJ | 1 |
| Hinrichs, JW; Loovers, HM; Scholten, B; van der Weide, J | 1 |
| Birkenhäger, TK; Bruijn, JA; Mulder, PG; Pluijms, E; van den Broek, WW; van Os, E | 1 |
| Casillas-Lara, L; Rueda-Villar, T; Ruiz-Doblado, S | 1 |
| Chugunov, AV; Gulieva, AE; Kamchatnov, PR; Kunel'skaia, NL; Umarova, KhIa | 1 |
| Tang, X; Tian, L; Zhang, Y | 1 |
| Pearlstein, T | 1 |
| Ghosh, B; Kaushalkumar, D; Singh, G; Somsekhar, V | 1 |
| Khandker, RK; Kruzikas, DT; McLaughlin, TP | 1 |
| Concheiro, M; Cruz, A; de Castro, A; López-Rivadulla, M; Quintela, O | 1 |
| de Abajo, FJ; García-Rodríguez, LA | 1 |
| Kelly, BD | 1 |
| Celik, H; Erdinc, A; Gurates, B; Kumru, S; Polat, A; Simsek, M | 1 |
| Chrzanowski, W; Gee, M; Hewett, K; Krishen, A; Leary, MO; Milanova, V; Millen, L; Modell, J; Savela, A; Schmitz, M | 1 |
| Allgulander, C; Nutt, D | 1 |
| Allgulander, C; Lecrubier, Y; Nutt, D; Peters, T; Wittchen, U | 1 |
| Allgulander, C; Ball, S; Detke, M; Erickson, J; Nutt, D; Russell, J; Spann, M; Walker, D | 1 |
| Harrison, C; Lane, C; Steen, N; Vanoli, A; Young, A | 1 |
| Lugoboni, F; Quaglio, G; Schifano, F | 1 |
| Kirch, W; Mueck-Weymann, M; Oertel, R; Pittrow, D; Siepmann, M; Siepmann, T | 1 |
| Barlow, DH; Brown, TA; Ciraulo, D; Devine, E; Duade, J; Farchione, T; Gulliver, SB; Kamholz, BW; Morissette, SB | 1 |
| Buijs, C; de Jong, RS; de Vries, EG; Marike Boezen, H; Maurer, JM; Mom, CH; Mourits, MJ; Nieboer, P; Willemse, PH; Wymenga, AN | 1 |
| Garg, R; Kumar, A | 1 |
| Katona, C | 1 |
| Barnes, MJ; Cheng, FH; Daiss, JO; Mills, JS; Montana, JG; Naylor, RJ; Ngan, MP; Rudd, JA; Tacke, R; Wai, MK; Warneck, JB | 1 |
| Li, XY; Meng, J; Qin, XY; Sun, XL; Wen, AD; Zhou, J | 1 |
| Davis, LL; Fava, M; Luther, JF; Nierenberg, AA; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Kim, YK; Lee, HY | 1 |
| Jureidini, J; Mintzes, B | 1 |
| Castro, R; de Groot, AA; Michel, MC; Oelke, M; Ruhe, HG | 1 |
| Acharya, N; D'Souza, DN; Seeger, J; Strombom, I; Wernicke, JF | 1 |
| Ehret, MJ; Grgas, M; Sopko, MA | 1 |
| Dekker, J; Peen, J; Schoevers, RA; van Aalst, G; Van, HL | 1 |
| Boyer, P; Brisard, C; Ganguly, R; Germain, JM; Lepola, U; Montgomery, S; Padmanabhan, SK; Tourian, KA | 1 |
| Ahmed, S; Baldwin, DS; Benattia, I; Davidson, J; Musgnung, J; Pedersen, R; Rothbaum, BO; Stein, DJ | 1 |
| Millet, B | 1 |
| Buitelaar, JK; Roobol, TH | 1 |
| Muneoka, K; Shioda, S; Shirayama, Y; Takigawa, M | 1 |
| Kálmán, J | 1 |
| Alici, T; Celik, T; Ceyhan, M; Göktalay, G; Kayir, H; Ulusoy, GK; Uzbay, TI; Yildirim, M | 1 |
| Kaplan, P; Kora, K | 1 |
| Cunningham, JL; Wichman, CL | 1 |
| Deuschle, M; Frankhauser, P; Gilles, M; Kopf, D; Lederbogen, F; Onken, V; Schilling, C; Weber-Hamann, B | 1 |
| Berlanga, C; Estrada-Camarena, E; Fernández-Guasti, A; Rivera, NM | 1 |
| Bianca, S; Caccamese, S; Carter, GT | 1 |
| Flockhart, DA; Hayes, DF; Henry, NL; Riba, M; Stearns, V | 1 |
| Balch, AH; Berman, RM; Boulton, DW; Mallikaarjun, S; Patel, CG; Reeves, RA; Royzman, K | 1 |
| Cunha, FT; Ladeira, RB; Nicolato, R; Salgado, JV; Teixeira, AL | 1 |
| Bunchapattanasakda, C; Kongsakon, R | 1 |
| Jaehde, U; Jung, A; Kirch, W; Lindauer, A; Oertel, R; Siepmann, M; Siepmann, T; Ziemssen, T | 1 |
| Ahmed, S; Dunlop, BW; Friedman, ES; Keller, M; Kocsis, JH; Kornstein, SG; Li, T; Ninan, PT; Pedersen, R; Thase, M; Yan, B | 1 |
| Hartung, HP; Hemmer, B; Kalluri, SR; Nessler, S; Vollmar, P | 1 |
| Bootzin, E; Millan, MJ; O'Donnell, JM; Zhang, HT; Zhao, Z | 1 |
| Bennema, P; Deij, MA; Meekes, H; van Eupen, JT; Vlieg, E; Westheim, R | 1 |
| Chen, CH; Lu, ML | 1 |
| Biescas López, R; Borderías Clau, L; Garrapiz López, FJ; Marcén Letosa, M; Marigil Gómez, MA; Val Adán, P | 1 |
| Altshuler, LL; Black, DO; Frye, MA; Grunze, H; Helleman, G; Keck, PE; Kupka, R; Leverich, GS; McElroy, SL; Mintz, J; Nolen, WA; Post, RM; Suppes, T | 1 |
| Graham, A; Gray, JA; Waring, WS | 1 |
| Vitiello, B | 1 |
| Abrams, M; Cook, IA; DeBrota, DJ; Hunter, AM; Leuchter, AF; McGrouther, CC; Morgan, ML; Potter, WZ; Siegman, B | 1 |
| Ara, A; Banu, N; Zafir, A | 1 |
| Cook, IA; Hunter, AM; Leuchter, AF; Ravikumar, S | 1 |
| Barrot, M; Doridot, S; Freund-Mercier, MJ; Hein, L; Petit-Demoulière, N; Tessier, LH; Yalcin, I | 1 |
| Tack, J; Van Oudenhove, L | 1 |
| Barsottini, OG; Dutra, LA; Felix, EP; Pedroso, JL | 1 |
| Aslan, E; Başterzi, AD; Delialioğlu, N; Taşdelen, B; Tot Acar, S; Yazici, A; Yazici, K | 1 |
| Gross, A; Kowalski, P; Kłys, M; Rojek, S | 1 |
| Diaz-Rojas, J; Einarson, TR; Jaramillo, LE; Lopera, MM; Machado, M | 1 |
| Ahmed, S; Burczynski, ME; Isler, JA; Jiang, Q; Nichols, AI; Patroneva, A; Paul, J; Preskorn, S; Silman, H | 1 |
| Hardy-Baylé, MC; Passerieux, C | 1 |
| Chan, JH; Chen, CH; Robson, D; Tan, HK | 1 |
| Bahk, WM; Chae, JH; Jun, TY; Jung, YE; Seo, HJ; Woo, YS | 1 |
| Bauer, M; Freemantle, N; Moeller, HJ; Tharmanathan, P; Volz, HP | 1 |
| Joeris, A; Kessler, U; Nelle, M; Schwendener Scholl, K; Treichel, M | 1 |
| Asarnow, JR; Birmaher, B; Brent, D; Clarke, G; DeBar, L; Emslie, G; Iyengar, S; Keller, M; Kennard, B; Leonard, H; Mayes, T; McCracken, J; Porta, G; Ritz, L; Ryan, N; Shamseddeen, W; Spirito, A; Strober, M; Suddath, R; Vitiello, B; Wagner, KD | 1 |
| Kyomen, HH; Whitfield, TH | 1 |
| Ahmed, S; Baldwin, DS; Davidson, JR; Musgnung, J; Pedersen, R; Rothbaum, BO; Stein, DJ; Tian, XW | 1 |
| Butters, MA; Dew, MA; Driscoll, HC; Lenze, EJ; Miller, MD; Mulsant, BH; Pollock, BG; Reynolds, CF; Sheffrin, M | 1 |
| Abib, E; Cruz, AC; Ifa, DR; Nakaie, CR; Pereira, R; Suenaga, EM; Tominga, M | 1 |
| Asarnow, J; Birmaher, B; Brent, DA; Clarke, GN; Debar, LL; Emslie, GJ; Iyengar, S; Keller, MB; Kennard, B; Leonard, H; Mayes, TL; McCracken, JT; Onorato, M; Porta, G; Ritz, L; Ryan, ND; Spirito, A; Strober, M; Suddath, R; Vitiello, B; Zelazny, J | 1 |
| Carpenter, EC; Mason, LW; Randhawa, KS | 1 |
| Entsuah, R; Nemeroff, CB; Sheehan, DV; Thase, ME | 1 |
| Arocha, L; Fazzino, F; Lima, L; Mata, S; Morles, M; Obregón, F; Rojas, A | 1 |
| Hung, CI; Liu, CY; Wang, SJ | 1 |
| Burslem, K; Greenstreet, L; Knight, C; Lenox-Smith, A | 1 |
| Bares, M; Brunovsky, M; Höschl, C; Kopecek, M; Kozeny, J; Novak, T; Sos, P; Stopkova, P | 1 |
| Bauer, M; Jiang, Q; Loeschmann, PA; Moeller, HJ; Ninan, PT; Schmitt, AB; Volz, HP | 1 |
| Caykoylu, A; Ekinci, O; Kuloglu, M | 1 |
| Campbell, GM; Case, M; Corya, SA; Henley, DB; Osuntokun, O; Thase, ME; Trivedi, MH; Watson, SB | 1 |
| Sanderson, K | 1 |
| Haeusler, JM | 1 |
| Gallup, AC; Gallup, GG | 1 |
| Cheng, WJ; Huang, MC; Yang, MS | 1 |
| Brown, L; Eliasziw, M; Lavorato, DH; McLaren, L; Patten, SB; Williams, JV | 1 |
| Heeren, TJ; Kok, RM; Nolen, WA; van Baarsen, C | 1 |
| Curcio, R; Nicoli, R; Rudaz, S; Veuthey, JL | 1 |
| Caltagirone, C; Cravello, L; Spalletta, G | 1 |
| Andersohn, F; Garbe, E; Schade, R; Suissa, S | 1 |
| Weissman, MM | 1 |
| Bukh, JD; Dam, H; Jørgensen, MB; Plenge, P | 1 |
| Asnis, G; Liebowitz, MR; Mangano, R; Tzanis, E | 1 |
| Altshuler, LL; Frye, MA; Grunze, H; Hellemann, G; Keck, PE; Kupka, RW; Leverich, GS; McElroy, SL; Nolen, WA; Post, RM; Sugar, CA; Suppes, T | 1 |
| Møller, LR; Østergaard, JR | 1 |
| Anderson, GM; Fontenot, MB; McFatter, RM; Musso, MW | 1 |
| Arneth, B; Härtter, S; Hiemke, C; Shams, M | 1 |
| Spadone, C | 1 |
| Dekker, J; Hendriksen, M; Koelen, J; Kool, S; Peen, J; Schoevers, R; van Aalst, G; Van, HL | 1 |
| Avissar, S; Golan, M; Matuzany-Ruban, A; Miroshnik, N; Schreiber, G | 1 |
| Ash, P; Jacob, MK | 1 |
| Hollander, E | 1 |
| Germain, JM; Guico-Pabia, C; Jiang, Q; Kornstein, SG; Ninan, PT; Thase, ME | 1 |
| Clayton, AH; Guico-Pabia, C; Kornstein, SG; Rosas, G; Tourian, KA | 1 |
| Hassan, M; Marcus, SC; Olfson, M | 1 |
| Hawley, P | 1 |
| Arnow, BA; Barkin, JL; Dowling, F; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Rothbaum, BO; Trivedi, MH; Wisniewski, SR | 1 |
| Agudo, JL; Aniorte, JP; Arroyo, VC; Hallal, H | 1 |
| Bariya, SH; Gohel, MC | 1 |
| Beaulac-Baillargeon, L; Boucher, N; Koren, G | 1 |
| Cooke, JD; Grover, LM; Spangler, PR | 1 |
| Amsterdam, J; Hilbe, JM; Kim, H; Shults, J; Sun, W; Ten-Have, T; Tu, X | 1 |
| Callan, JA; Howland, RH | 1 |
| Batysheva, TT; Boĭko, AN; Guseva, ME; Kamchatnov, PR; Kostenko, EV; Nesterova, OS; Otcheskaia, OV; Zaĭtsev, KA; Zhuravleva, EIu | 1 |
| Bolton, JM; Leung, S; Metge, CJ; Sareen, J; Targownik, LE | 1 |
| Albayrak, A; Bayir, Y; Cadirci, E; Hacimuftuoglu, A; Halici, Z; Koc, F; Polat, B; Suleyman, H | 1 |
| Arellano, J; Baird, J; Benedict, A; De Cock, E | 1 |
| Dukes, E; Mychaskiw, M; Oster, G; Rejas, J; Sofrygin, O; Vera-Llonch, M | 1 |
| de Blas, MM; de Chávez, MG; Epifanio, MM; García-Cabeza, I | 1 |
| Kumar, IJ; Rajasekhar, D; Venkateswarlu, P | 1 |
| Cook, IA; Hunter, AM; Korb, AS; Leuchter, AF | 2 |
| Martinez, DN; Martinez, TT | 1 |
| Isbister, GK | 1 |
| Kodaka, F; Koga, M; Miyata, H; Nakayama, K | 1 |
| Alpert, JE; Denninger, JW; Devlin, P; Fava, M; Greenwald, S; Iosifescu, DV; Mischoulon, D | 1 |
| Cooper, T; Dillingham, EM; Garcia, K; Haskett, RF; Isenberg, K; McCall, WV; Mulsant, BH; Prudic, J; Rosenquist, P; Sackeim, HA | 1 |
| Guico-Pabia, CJ; Lobello, K; Nichols, AI; Paul, J; Preskorn, SH | 1 |
| Duffull, SB; Friberg, LE; Hackett, LP; Isbister, GK; Kumar, VV; Oscarsson, S | 1 |
| Glover, BA; Knight, BT; Newport, DJ; Ritchie, JC; Stowe, ZN; Zach, EB | 1 |
| Azam, F; Kao, J; Leung, L; Oganesian, A; Shilling, AD; Tran, J; Watanyar, A; Young-Sciame, R | 1 |
| Cook, IA; Hunter, AM; Leuchter, AF; Muthén, BO | 1 |
| Barceló, B; Castanyer, B; Puiguriguer, J; Yates, C | 1 |
| Smith, E | 1 |
| Batten, LA; Blier, P; Chenu, F; Hébert, C; Ladstaetter, E; Zernig, G | 1 |
| Baker, RA; Berman, RM; Carlson, BX; Eudicone, JM; Mankoski, R; Nelson, JC; Pikalov, A; Tran, QV | 1 |
| Barrio, RJ; Goicolea, MA; Gómez-Caballero, A; Sánchez, A; Ugarte, A; Unceta, N | 1 |
| Beyer, S; Demling, J; Kornhuber, J | 1 |
| Andersen, HF; Kornstein, SG; Larsson, S; Li, D; Mao, Y; Papakostas, GI | 1 |
| Akkaya, C; Cangur, S; Eker, SS; Kirli, S; Sarandol, A | 1 |
| Birkenhäger, TK; Boks, MP; Breteler, LM; Bruijn, JA; Burger, H; Janzing, JG; Nolen, WA; Ramaekers, GM; van den Broek, WW; van der Loos, ML; Verkes, RJ; Wijkstra, J | 1 |
| Amsterdam, JD; Shults, J; Wang, G | 1 |
| Chung, SK; Hong, JP; Kang, EH; Kim, EJ; Kim, S; Lee, IS; Lee, SY; Oh, KS; Park, JE; Woo, JM; Yu, BH | 1 |
| Deuschle, M; Frankhauser, P; Gilles, M; Hamann, B; Kopf, D; Lederbogen, F; Lewicka, S; Onken, V; Römer, B; Schilling, C | 1 |
| Mancini, C; Patterson, B; Simpson, W; Van Ameringen, M | 1 |
| Brahm, NC; Pondrom, MF | 1 |
| Saussele, T | 1 |
| Dunlop, BW; Dunner, DL; Friedman, ES; Gelenberg, A; Goldstein, C; Holland, P; Keller, MB; Kocsis, JH; Kornstein, SG; Pedersen, R; Rothschild, AJ; Shelton, R; Thase, ME; Trivedi, MH; Zajecka, JM | 1 |
| Benedet, J; Carvalho-Silva, M; Jeremias, GC; Quevedo, J; Rezin, GT; Rochi, N; Santos, PM; Scaini, G; Streck, EL | 1 |
| Anand, JS; Habrat, B; Korolkiewicz, R; Sut, M | 1 |
| Brent, DA | 1 |
| Başterzi, AD; Buturak, V; Cimen, B; Eskandari, G; Taşdelen, B; Tot Acar, S; Yazici, A; Yazici, K | 1 |
| Garg, R; Gaur, V; Kumar, A; Kumar, P | 2 |
| Bekers, O; Drent, M; Koek, GH; Kuijpers, PM; Limantoro, I; Wijnen, PA | 1 |
| Parabia, MH; Shah, GR; Surati, KR; Thaker, BT | 1 |
| Arnheim, K | 1 |
| Arend, MZ; Bernardi, LS; Borgmann, SH; Cardoso, SG; Murakami, FS; Oliveira, PR | 1 |
| Boog, G; Gommier, B; Jacopin-Bruneau, L; Pierre, F | 1 |
| Castagna, F; Favretto, D; Ferrara, SD; Frison, G; Stocchero, G; Trevisanuto, D; Vogliardi, S | 1 |
| Barton, DL | 1 |
| De Roover, A; Delbouille, MH; Delwaide, J; Detry, O; Hans, MF; Honoré, P; Monard, J | 1 |
| Asarnow, JR; Birmaher, B; Brent, DA; Clarke, G; Emslie, G; Goldstein, BI; Mayes, T; Onorato, M; Ryan, N; Shamseddeen, W; Spirito, A; Vitiello, B; Wagner, KD; Zelazny, J | 1 |
| Bergen, H; Cooper, J; Hawton, K; Kapur, N; Murphy, E; Stalker, C; Waters, K | 1 |
| Birkenhäger, TK; Boks, MP; Breteler, LM; Bruijn, JA; Burger, H; Janzing, JG; Nolen, WA; van den Broek, WW; van der Loos, ML; Verkes, RJ; Wijkstra, J | 1 |
| Fava, M; Gaynes, BN; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Laje, G; McMahon, FJ; Perlis, RH; Rush, AJ | 1 |
| Bariya, SH; Gohel, M | 1 |
| Anghelescu, IG; Dierkes, W; Loeschmann, PA; Schmitt, AB; Volz, HP | 1 |
| Grønli, O; Olstad, R; Stensland, GØ; Wynn, R | 1 |
| Devane, CL; Fareed, J; Halaris, A; Hoppensteadt, D; Iqbal, O; Piletz, JE; Sinacore, J; Zhu, H | 1 |
| Donovan, JW; Helmick, T; Kane, BG; Kane, KE; Pierog, JE | 1 |
| Bonato, PS; da Fonseca, P | 2 |
| Rachin, AP; Sergeev, AV | 1 |
| Evoniuk, G; Gee, MD; Hewett, K; Krishen, A; Le Clus, A; Modell, JG; Wunderlich, HP | 1 |
| Bosker, FJ; Dagyte, G; de Jager, T; de Klerk, OL; den Boer, JA; Dierckx, RA; Meerlo, P; Van Waarde, A; Visser, AK; Willemsen, AT | 1 |
| Bouchard, P; Irani, J; Mottet, N; Oba, R; Salomon, L | 1 |
| Bonelli, RM; Holl, AK; Holl, EM; Painold, A; Wilkinson, L | 1 |
| Gourion, D; Montagne, A; Olié, JP; Poirier, MF; Rostin, M | 1 |
| Birmaher, B; Brent, D; Clarke, G; DeBar, L; Devlin, B; Emslie, G; Ferrell, R; Keller, M; Mayes, T; Melhem, N; Onorato, M; Ryan, N; Vitiello, B; Wagner, KD; Zelazny, J | 1 |
| Bergeron, R; Blier, P; Hébert, C; Laberge, L; Tremblay, P; Ward, HE | 1 |
| Fonseca, L; Machado, A; Rodrigues, M | 1 |
| Benedetti, F; Bernasconi, A; Colombo, C; Dallaspezia, S; Radaelli, D; Smeraldi, E | 1 |
| Deuschle, M; Gilles, M; Hamann-Weber, B; Kopf, D; Lederbogen, F; Luppa, P; Paslakis, G | 1 |
| Ball, RM; Jakary, S; Kohn, B; Levine, RA; Nunez, R; Pegg, J; Peterson, E; Pocock, JR; Rodriguez, AI; Walker, EM | 1 |
| Baumer, C; Koren, G; O'Brien, L; Sachs, H; Thieme, D | 1 |
| Obara, I; Przewlocka, B; Wordliczek, J; Wrzosek, A | 1 |
| Angermeier, T; Deuschle, M; Frankhauser, P; Gilles, M; Kopf, D; Lederbogen, F; Onken, V; Schilling, C; Weber-Hamann, B; Westphal, S | 1 |
| Barrera-Groba, C; Hillyard, SG; Tighe, R | 1 |
| Edwards, TR; Hince, DA; Hood, SD; Kalk, N; Lenox-Smith, A; Lingford-Hughes, AR; Melichar, JK; Nutt, DJ; Taylor, LG | 1 |
| Bortolatto, CF; Jesse, CR; Nogueira, CW; Wilhelm, EA | 1 |
| Boerner, RJ | 1 |
| Andersen, CL; Videbech, P | 1 |
| Aikman, MS; Haeusler, JM; Seabolt, J; Werts, E; Wright, CW | 1 |
| Orenstein, H; Raskind, MA | 1 |
| Li, F; Li, N; Qin, F; Qin, T; Zhang, Y | 1 |
| Baldovino, A; Delucchi, L; Martino, P; Pessina, P; Rodrigues, A | 1 |
| Assimes, TL; Dell'aniello, S; Martinez, C; Mines, D; Suissa, S | 1 |
| Taylor, D | 1 |
| Desmarais, JE; Looper, KJ | 1 |
| Amara, G; Ben Hadj Ali, B; Ben Nasr, S; Saada, W | 1 |
| Albertini, JP; Artigou, JY; Avramova, B; Charniot, JC; Kidouche, R; Monsuez, JJ; Vignat, N | 1 |
| Howland, RH | 1 |
| Aartsen, M; Heeren, T; Kok, RM; Nolen, WA | 1 |
| Hay-Schmidt, A; Larsen, MH; Mikkelsen, JD; Sandi, C | 1 |
| Drummer, OH; Gerostamoulos, D; Pilgrim, JL | 1 |
| Hoda, Q; Shahnawaz, S; Siddiqui, Z | 1 |
| Bach, A; Deuschle, M; Feuerhack, A; Frankhauser, P; Gilles, M; Hamann, B; Kopf, D; Lederbogen, F; Onken, V; Scharnholz, B; Schilling, C | 1 |
| Osterfeld, ND; Uttner, I; Wolf, RC | 1 |
| Brophy, JM; Etminan, M; Mikelberg, FS | 1 |
| Guan, T; Li, G; Tang, X; Wang, J | 1 |
| Hegerl, U; Heinritz, W; Kopf, A; Strauss, M | 1 |
| Chan, AN; Gunja, N; Ryan, CJ | 1 |
| Despiégel, N; François, C; Guelfucci, F; Saragoussi, D; Toumi, M; Wade, AG | 1 |
| Caroselli, C; Ricci, G | 1 |
| Dunlop, BW; Friedman, ES; Keller, M; Kornstein, SG; Li, T; Ninan, P; Pedersen, R; Rothschild, AJ | 1 |
| Bitter, I; Karamustafalioglu, O; Koponen, H; Mohr, P; Sartorius, N; Seifritz, E; Svestka, J | 1 |
| Levine, MN | 1 |
| Kim, JH; Kim, JJ; Kim, S; Lee, H; Lee, JH; Min, BH; Rhee, JC; Rhee, PL; Son, HJ; Suh, YJ | 1 |
| Benedet, J; Borges, LS; Gomes, LM; Pezente, DP; Quevedo, J; Rezin, GT; Rochi, N; Santos, PM; Scaini, G; Streck, EL | 1 |
| Chassin, MR; Howell, EA; Leventhal, H; Mora, PA | 1 |
| Despiégel, N; Lam, RW; Lönn, SL | 1 |
| Deuschle, M; Frankhauser, P; Gilles, M; Kopf, D; Lederbogen, F; Onken, V; Scharnholz, B; Schilling, C; Weber-Hamann, B | 1 |
| Abrams, M; Cook, IA; Hunter, AM; Leuchter, AF | 2 |
| Feinberg, SS | 1 |
| Launiainen, T; Ojanperä, I; Rasanen, I; Vuori, E | 1 |
| Ahlner, J; Bengtsson, F; Carlsson, B; Josefsson, M; Karlsson, L; Kingbäck, M; Kugelberg, FC | 1 |
| Guico-Pabia, CJ; Jiang, Q; Lobello, KW; Nichols, AI; Ninan, PT; Patroneva, A; Paul, J; Preskorn, SH | 1 |
| John, J; Kandasamy, M; Ravi, S; Shekar, R; Srinivas, N; Srinivas, P; Subramaniam, K; Thangam, S | 1 |
| Christoph, M; Ebner, B; Ibrahim, K; Kolschmann, S; Schön, S; Stolte, D; Strasser, RH | 1 |
| Crystal, SC; Grosberg, BM; Hutchinson, S; Robbins, MS | 1 |
| Chang, CH; Chen, SJ; Tsai, HC | 1 |
| Ahlner, J; Bengtsson, F; Carlsson, B; Hiemke, C; Josefsson, M; Karlsson, L; Kugelberg, FC; Schmitt, U | 2 |
| Amr, YM; Yousef, AA | 1 |
| Bujoreanu, IS; DeMaso, DR; Ibeziako, P | 1 |
| Asarnow, JR; Birmaher, B; Brent, D; Clarke, G; DeBar, L; Emslie, GJ; Iyengar, S; Keller, M; Kennard, B; Mayes, T; McCracken, J; Onorato, M; Porta, G; Ryan, N; Spirito, A; Strober, M; Vitiello, B; Wagner, KD; Zelazny, J | 1 |
| Dunner, DL; Friedman, ES; Gelenberg, A; Keller, MB; Kocsis, JH; Kornstein, SG; Rothschild, AJ; Shelton, RC; Thase, ME; Trivedi, MH; Zajecka, JM | 1 |
| Doherty, DA; Emery, LI; Gregson, J; Hickey, M; Saunders, CM | 1 |
| Bérard, A; Broy, P; Nakhai-Pour, HR | 1 |
| Diukova, GM; Kovalchuk, MO; Semenov, RV; Toropina, GG; Troshneva, A | 1 |
| Aboelwafa, AA; Basalious, EB | 1 |
| Baker, DR; Kasprzyk-Hordern, B; Kondakal, VV | 1 |
| Saarto, T; Wiffen, PJ | 1 |
| Baranchuk, A; Digby, G; Machaalany, J; Malik, P; Methot, M; Redfearn, D; Simpson, CS | 1 |
| Brito, GA; Carvalho, RS; de Andrade, GM; de Souza, CM; Holanda-Pinto, SA; Neves, JC; Pinto, LM | 1 |
| Ghosh, A; Grover, S; Shah, R | 1 |
| Agius, M; Gardner, J; Liu, K; Zaman, R | 3 |
| Agius, M; Davis, A; Gilhooley, M; Zaman, R | 1 |
| Caratan, S; Mihanović, M; Presecki, P; Silić, A; Vuina, AL | 1 |
| Erden, F; Gacar, N; Göçmez, SS; Ulak, G; Utkan, T | 1 |
| Cao, L; Chen, J; Cui, X; Fang, Y; Gao, K; Hong, W; Jiang, K; Nierenberg, AA; Wang, Y; Wu, Z; Xu, Y; Yi, Z; Yuan, C | 1 |
| Tutuian, R | 1 |
| Burda, K; Czubak, A; Golembiowska, K; Kus, K; Metelska, J; Nowakowska, E | 1 |
| Gaur, V; Kumar, A | 1 |
| Deuschle, M; Gilles, M; Paslakis, G | 1 |
| Bi, X; Fang, S; He, J; Kong, J; Li, XM; Wang, D; Wu, J; Xu, H; Yan, B; Yang, Y; Zhang, Y | 1 |
| Choi, TK; Kim, SJ; Lee, E; Lee, HS; Lee, SH; Seok, JH | 1 |
| Seywert, AJ | 1 |
| Chang, HH; Chen, PS; Chi, MH; Gean, PW; Lee, IH; Lee, SY; Lu, RB; Yang, YK | 1 |
| Danchenko, N; Despiegel, N; Maman, K; Marteau, F; Nordström, G | 1 |
| Fujiwara, M; Fujiwara, S; Ide, S; Ikeda, K; Ishihara, K; Minami, M; Sora, I; Uhl, GR | 1 |
| Deshpande, A; Ing, A; Rizo, C; Seeman, N | 1 |
| Arias, LH; Carvajal, A; del Pozo, JG; Lobato, CT; Ortega, S; Velasco, A | 1 |
| Bosma, J; Heres, M; Hilgevoord, AA; Honig, A; Hoppenbrouwers, CJ; Wennink, HJ | 1 |
| Katiyar, S; Kukade, G; Mahesh, R; Pandey, DK; Rudra, A; Viyogi, S | 1 |
| Gelenberg, A; Keller, M; Kocsis, JH; Kornstein, SG; Li, T; Ninan, P; Pedersen, R; Thase, ME; Trivedi, MH | 1 |
| Abeynaike, L; Rajapakse, S; Wickramarathne, T | 1 |
| Becker, T; Grouven, U; Kaiser, T; Kerekes, MF; Koesters, M; Kreis, J; Kromp, M; Schueler, YB; Weinmann, S; Wieseler, B | 1 |
| Bourgeois, JA; Cogswell, JB; Hagerman, RJ; Hall, DA; Nguyen, DV; Olichney, J; Ortigas, MC; Schneider, A | 1 |
| Plesnicar, BK | 1 |
| Agius, M; Bugler, R; Tavormina, G; Zaman, R | 1 |
| Akhondzadeh, S; Hazrati, N; Mohammadi, MR; Rezaie, F; Rezazadeh, SA; Tabrizi, M; Zarinara, AR | 1 |
| Bokde, AL; Brückmann, H; Frodl, T; Hampel, H; Koutsouleris, N; Linn, J; Meisenzahl, E; Möller, HJ; Scheuerecker, J; Schoepf, V; Wiesmann, M | 1 |
| Castro, E; Pazos, A; Valdizan, EM; Vidal, R; Vilaró, MT | 1 |
| Raj, YP | 1 |
| Selbst, SM | 1 |
| Del Casale, A; Girardi, P; Innamorati, M; Lester, D; Mancini, M; Pompili, M; Serafini, G; Tatarelli, R | 1 |
| Chang, HH; Chen, PS; Chi, MH; Gean, PW; Lu, RB; Wang, HC; Yang, YK; Yeh, TL | 1 |
| Gattani, S; Nerkar, PP | 1 |
| Bérard, A; Ramos, É; St-André, M | 1 |
| Blanca-Tamayo, M; Gimeno-de la Fuente, V; Navarro-Artieda, R; Salvatella-Pasant, J; Sicras-Mainar, A | 1 |
| Baillés, E; Bargalló, N; Boget, T; Carreño, M; Donaire, A; Matrai, S; Pintor, L; Rumia, J; Setoain, X | 1 |
| Lobello, K; Musgnung, J; Ninan, PT; Pedersen, R; Reddy, S | 1 |
| Cook, IA; Hunter, AM; Leuchter, AF | 2 |
| Berilgen, MS | 1 |
| Bordeleau, L; Ennis, M; Goodwin, PJ; Haq, R; Jugovic, O; Loprinzi, CL; Pritchard, KI; Warr, D | 1 |
| Böttiger, BW; Dagtekin, O; Marcus, H; Müller, C; Spöhr, F | 1 |
| Alexander, J; Chaudhary, J; McKenny, B | 1 |
| Kourti, PV; Samanidou, VF | 1 |
| Krass, M; Vasar, E; Volke, V; Wegener, G | 1 |
| Bhagia, J; Biernacka, JM; Courson, VL; Langman, LJ; McAlpine, DE; Moyer, TP; Mrazek, DA; O'Kane, DJ; Stevens, SR | 1 |
| Aran, A; Einen, M; Lin, L; Mignot, E; Nishino, S; Plazzi, G | 1 |
| Chang, JP; Su, KP; Wu, CC | 1 |
| Bedor, DC; Bonifácio, FN; de Santana, DP; de Sousa, CE; Gonçalves, TM; Homero de Souza Filho, J; Leal, LB; Moreira, RC; Ramos, VL; Sardón, LL | 1 |
| Etemad, B; Gallop, RJ; Khalid-Khan, S; Lohoff, FW; Rickels, K; Rynn, MA | 1 |
| Rueda-Villar, T; Ruiz-Doblado, S; Sanz-Cortes, S; Zurita-Gotor, P | 1 |
| Hasselstrøm, J | 1 |
| Goswami, D; Gurule, S; Khuroo, AH; Kumar, A; Monif, T | 1 |
| Bateman, DN; Graham, A; Gray, J; Howell, C; Waring, WS; Wilson, AD | 1 |
| Calabrese, F; Gabriel, C; Mocaer, E; Molteni, R; Racagni, G; Riva, MA | 1 |
| Esin, OR; Esin, RG; Naprienko, MV | 1 |
| Filatova, EG; Latysheva, NV; Naprienko, MV | 1 |
| Fisar, Z; Hroudová, J; Raboch, J | 1 |
| Chaney, A; Frodl, T; Lisiecka, D; Meisenzahl, E; Moeller, HJ; Scheuerecker, J; Schoepf, V; Whitty, P; Wiesmann, M | 1 |
| Haskett, R; Isenberg, K; Kimball, J; Lasater, B; McCall, WV; Prudic, J; Rosenquist, PB; Sackeim, HA | 1 |
| Cooper, NJ; Gordon, E; Koslow, SH; Nemeroff, CB; Rush, AJ; Schatzberg, AF; Williams, LM; Wisniewski, SR | 1 |
| Asarnow, JR; Birmaher, B; Brent, DA; Clarke, G; DeBar, L; Dickerson, J; Emslie, G; Iyengar, S; Keller, MB; Kennard, B; Lynch, F; Mayes, TL; McCracken, JT; Onorato, M; Porta, G; Ryan, ND; Spirito, A; Strober, M; Suddath, R; Vitiello, B; Wagner, KD; Zelazny, J | 1 |
| Eslick, GD; Fass, R | 1 |
| Dhir, A; Kessar, SV; Kulkarni, SK; Malik, S; Singh, KN | 1 |
| Robinson, RL; Swindle, RW; Ye, W; Zhao, Y | 1 |
| Focht, K; Jiang, Q; Kane, CP; Nichols, AI; Preskorn, SH | 1 |
| Angermeier, T; Deuschle, M; Gilles, M; Hummel, J; Kopf, D; Lederbogen, F; Luley, C; Weber-Hamann, B; Westphal, S | 1 |
| Duffull, SB; Isbister, GK; Kumar, VV | 1 |
| Berk, M; Liu, X; Wang, Y; Xiao, Z | 1 |
| Fuertes, L; García-Cano, I; Ortiz de Frutos, J; Vanaclocha, F | 1 |
| Dai, YC; Deng, N; Liu, W; Liu, XR | 1 |
| Macaluso, M; Preskorn, SH | 1 |
| Becker, T; Jin, WD; Koesters, M; Ma, YC; Weinmann, S; Zhang, Y | 1 |
| Liang, CS; Yang, FW | 1 |
| Ilias, I; Karaiskos, D; Liappas, I; Paparrigopoulos, T; Tzavellas, E | 1 |
| Ancock, B; Cuevas, C; Lung, D; Zaid, U | 1 |
| Goldsmith, L; Moncrieff, J | 1 |
| Asarnow, JR; Birmaher, B; Brent, D; Clarke, G; DeBar, L; Dickerson, JF; Emslie, G; Iyengar, S; Keller, MB; Kennard, B; Lynch, FL; Mayes, T; McCracken, JT; Onorato, M; Porta, G; Ryan, ND; Spirito, A; Strober, M; Suddath, RL; Vitiello, B; Wagner, KD; Zelazny, J | 1 |
| Ciszowski, K; Gawlikowski, T; Krzyzanowska-Kierepka, E; Szpak, D | 1 |
| Fulda, S; Himmerich, H; Plümäkers, B; Rink, L; Sheldrick, AJ | 1 |
| Cessot, A; Coriat, R; Deplanque, G; Durand, JP; Goldwasser, F; Gornet, JM; Herait, P; Mir, O; Mitry, E; Montheil, V; Raymond, E; Scotte, F; Yataghene, Y | 1 |
| Alexander, J; Nillsen, A | 1 |
| Ben-Hamadi, R; Dworak, H; Erder, MH; Ramakrishnan, K; Signorovitch, J; Wu, EQ; Yu, AP | 1 |
| Bachmeier, CJ; Beaulieu-Abdelahad, D; Ganey, NJ; Levin, GM; Mullan, MJ | 1 |
| Barańska-Rybak, W; Cubała, WJ; Kozicka, D; Nowicki, R; Roszkiewicz, J; Sokołowska-Wojdyło, M | 1 |
| Rakun, R; Ružić, K; Sabljić, V | 1 |
| Aubry, JM; Bertschy, G; Bondolfi, G; Gex-Fabry, M; Kosel, M; Malafosse, A; Perroud, N; Uher, R | 1 |
| Baldinetti, F; Bandelow, B; Herman, B; Kasper, S; Mandel, FS; Nivoli, G; Petralia, A; Van Ameringen, M | 1 |
| Corbeil, P; McDonald, J; Pourcher, E | 1 |
| Bradshaw, DA; Crosby, MI; McLay, RN | 1 |
| Iastrebov, DV | 1 |
| Asarnow, JR; Birmaher, B; Brent, D; Clarke, G; Emslie, G; Goldstein, T; Keller, MB; Mayes, T; Perel, J; Porta, G; Ryan, ND; Sakolsky, D; Wagner, KD; Woldu, H | 1 |
| Ding, ZB; Lu, L; Shi, HS; Wang, SJ; Wu, P; Zhu, WL | 1 |
| Bartell, SE; Furlong, ET; Logue, A; Painter, MM; Schoenfuss, HL; Schultz, MM; Werner, SL | 1 |
| Cook, IA; Fava, M; Husain, MM; Kornstein, SG; Kurian, BT; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Shelton, RC; Stewart, JW; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Buhre, PJ; De Smet, PA; Hofman, A; Straus, S; Stricker, BH; Teichert, M; Uitterlinden, AG; Visser, LE | 1 |
| Liu, X; Mullins, CD; Wang, J | 1 |
| Beste, J; Blackwell, JC; Patel, BN | 1 |
| Bobo, WV; Chen, H; Cook, IA; Fava, M; Husain, MM; Kornstein, SG; Kurian, BT; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Shelton, RC; Stewart, JW; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Heo, DR; Jung, ID; Kim, D; Lee, CM; Lee, JS; Noh, KT; Park, JW; Park, YM; Shin, YK; Son, KH | 1 |
| Fiedler, JL; Fritsch, R; Jara, P; Rojas, PS; Rojas, RA | 1 |
| Hu, J; Huang, Y; Lin, VS; Liu, H; Slowing, II; Tang, J; Trewyn, BG | 1 |
| Henriques, T; Mastrogianni, O; Pouliopoulos, A; Psaroulis, K; Raikos, N; Spagou, K; Theodoridis, G; Tsoukali, H; Violante, D | 1 |
| King, KS; Neary, NM; Pacak, K | 1 |
| Brooks, WB | 1 |
| Praharaj, SK | 1 |
| Bhogale, GS; Nayak, R; Patil, NM | 1 |
| Joshi, PP; Klaper, RD; Thomas, MA | 1 |
| Du, G; Gao, X; Guo, X; Li, Z; Qin, X; Sun, H; Zhang, L; Zheng, X; Zhou, Y | 1 |
| Barak, Y; Baruch, Y; Swartz, M | 1 |
| Bahk, WM; Jun, TY; Jung, YE; Kim, KS | 1 |
| Millan, MJ; Serres, F; Sharp, T | 1 |
| Cassano, GB; Mula, M; Pini, S; Preve, M | 1 |
| Cure, MC; Demirdas, A; Eren, I; Kirbas, A; Sutcu, R; Yilmaz, M; Yilmaz, N | 1 |
| Alvarez, E; Artigas, F; Dragheim, M; Loft, H; Perez, V | 1 |
| Bacq, A; Balasse, L; Biala, G; Chevarin, C; Gardier, AM; Gautron, S; Giros, B; Guiard, B; Hamon, M; Louis, F; Martres, MP; Schinkel, A; Vialou, V | 1 |
| Asarnow, JR; Berk, M; Birmaher, B; Brent, DA; Clarke, G; Emslie, G; Keller, M; Mayes, T; McCracken, J; Porta, G; Spirito, A; Vitiello, B; Wagner, KD | 1 |
| Aisa, B; Briones, A; Dobarro, M; Gagno, S; Martisova, E; Ramírez, M; Solas, M; Tordera, R | 1 |
| Guico-Pabia, CJ; Jiang, Q; Ninan, PT; Thase, ME | 1 |
| Kovatsi, L; Nazyropoulou, C; Samanidou, V | 1 |
| Abdel-Wahab, BA; Salama, RH | 1 |
| Baldwin, DS; Lyndon, G; Schweizer, E; Xu, Y | 1 |
| Ahlner, J; Bengtsson, F; Carlsson, B; Josefsson, M; Karlsson, L; Kingbäck, M; Kugelberg, FC; Zackrisson, AL | 1 |
| Crits-Christoph, P; Gallop, R; Gibbons, MB; Hamilton, JL; Newman, MG; Pastva, AM; Rickels, K; Ring-Kurtz, S | 1 |
| Cuestas, E; Cuestas, ME | 1 |
| Davidson, RJ; Heller, AS; Johnstone, T; Kalin, NH; Kolden, GG; Light, SN; Peterson, MJ | 2 |
| Bäumer, T; Brüggemann, N; Gerloff, C; Klein, C; Münchau, A; Zittel, S | 1 |
| Aquino, TD; Hodge, R; Lohoff, FW; Narasimhan, S; Rickels, K | 1 |
| Garakani, A; Gorman, JM; Martinez, JM; Yehuda, R | 2 |
| Dusetzina, SB; Ellis, AR; Farley, JF; Gaynes, BN; Hansen, RA; Miller, WC; Stürmer, T | 2 |
| Püttmann, W; Rúa-Gómez, PC | 3 |
| Adriaansz, S; Beijnen, JH; Boekhout, AH; Dalesio, OB; Foekema-Töns, JH; Nuijen, B; Schellens, JH; Sprangers, S; van den Bosch, J; Vincent, AD | 1 |
| Barton, DL; Loprinzi, CL; Qin, R | 1 |
| Ananiev, J; Cardoso, J; Kupcova, G; Sucha, N; Tchernev, G; Trafeli, J | 1 |
| Davis, LL; Fava, M; Friedman, ES; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S | 1 |
| Borowicz, KK; Czuczwar, SJ; Gołyska, D; Luszczki, JJ | 1 |
| Baldwin, DS; Davidson, J; Pedersen, R; Rothbaum, BO; Stein, DJ; Szumski, A | 1 |
| Croy, I; Haehner, A; Landis, BN | 1 |
| Dey, S; Kandhwal, K; Khuroo, AH; Mishra, S; Monif, T; Nazarudheen, S; Reyar, S; Thudi, NR | 1 |
| de Silva, VA; Hanwella, R | 1 |
| Dai, MH; Han, Y; Li, DQ | 1 |
| Aquino, TD; Etemad, B; Lohoff, FW; Multani, PK; Narasimhan, S; Rickels, K | 1 |
| Kostek, H; Kujawa, A; Majewska, M; Pyra, E; Szponar, J | 1 |
| Attof, R; Malfroy, S; Perdrix, JP; Piriou, V; Tassin, C | 1 |
| Bostic, JQ | 1 |
| Asarnow, JR; Birmaher, B; Brent, DA; Clarke, G; Emslie, G; Keller, MB; Mayes, T; Porta, G; Ryan, ND; Shamseddeen, W; Wagner, KD | 1 |
| Alexander, R; Archer, G; Evoniuk, G; Graff, O; Krishnan, KR; Lavergne, A; Learned, S; Moate, R; Modell, JG; Ratti, E; Roychowdhury, S; Zamuner, S | 1 |
| George, N; Ings, JS; Peter, MC; Servos, MR; Vijayan, MM | 1 |
| Fava, M; Kallenberg, G; Lebowitz, B; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S | 1 |
| Capron, A; Classen, JF; Hantson, P; Haufroid, V; Marchandise, S; Vinetti, M | 1 |
| Frölich, L; Hausner, L; Janke, C; Kranaster, L; Sartorius, A | 1 |
| Capua, AD; Castrogiovanni, A; Ciani, V; Lazzeri, L; Luisi, S; Pacchierotti, C; Pasquini, R; Petraglia, F | 1 |
| Bundgaard, C; Garmer, M; Jensen, CJ | 1 |
| Barber, JP; Barrett, MS; Gallop, R; Rickels, K; Rynn, MA | 1 |
| Barbui, C; Churchill, R; Cipriani, A; Furukawa, TA; Nakagawa, A; Omori, IM; Watanabe, N | 1 |
| Jann, MW; Momary, K; Penzak, SR; Spratlin, V; Turner, D; VanDenBerg, C; Wright, A; Zhang, H | 1 |
| Lee, KU; Lee, YM | 1 |
| Alanis, LR; Grégio, AM; Lima, AA; Machado, MÂ; Mattioli, TM; Silva, Sd | 1 |
| De Vry, J; Flik, G; Folgering, JH; Tzschentke, TM | 1 |
| Seeger, J; Strombom, I; Turnbull, B; Xue, F; Zhu, S | 1 |
| Gattani, SG; Nerkar, PP | 2 |
| Baker, DR; Kasprzyk-Hordern, B | 1 |
| Cooper-Kazaz, R | 1 |
| Bian, Z; Hu, J; Liu, H; Tang, J; Xu, S | 1 |
| Horrillo, I; Martisova, E; Meana, JJ; Ortega, JE; Ramírez, MJ; Solas, M; Tordera, RM | 1 |
| Amsterdam, J; Guerra, MW; Shults, J; Ten-Have, T | 1 |
| Hung, CI; Liu, CY; Wang, SJ; Yang, CH | 1 |
| Asarnow, JR; Brent, D; Clarke, G; Emslie, GJ; Iyengar, S; Keller, M; Onorato, M; Porta, G; Ritz, L; Ryan, N; Vitiello, B; Wagner, KD; Zelanzny, J | 1 |
| Asarnow, JR; Birmaher, B; Brent, DA; Clarke, G; Emslie, GJ; Keller, MB; Porta, G; Ryan, N; Shamseddeen, W; Wagner, KD | 1 |
| Cairns, MJ; Day, TA; Hinwood, M; Tynan, RJ; Walker, FR; Weidenhofer, J | 1 |
| Amiri, S; Farhang, S; Ghoreishizadeh, MA; Malek, A; Mohammadzadeh, S | 1 |
| He, Z; Liu, Y; Sun, J; Sun, M; Sun, Y; Zhao, N | 1 |
| Chong, CR; Horowitz, JD; Neil, CJ; Nguyen, TH | 1 |
| Baker, RA; Bennetts, JS; Cardinal, T; Tully, PJ | 1 |
| Knapp, LE; Miceli, JJ; Ramey, TS; Rickels, K; Shiovitz, TM; Weaver, JJ | 1 |
| Brown, CH; Davis, J; Gibbons, RD; Hur, K; Mann, JJ | 1 |
| Karp, JF; Lotrich, F; Mazumdar, S; Morone, N; Morse, JQ; Reynolds, CF; Rollman, BL; Weiner, DK | 1 |
| Kocsis, JH | 1 |
| Barbini, B; Benedetti, F; Colombo, C; Dallaspezia, S; Fulgosi, MC; Gavinelli, C; Smeraldi, E | 1 |
| Bekinschtein, P; Garagoli, F; Katche, C; Medina, JH; Slipczuk, L; Tomaiuolo, M; Weisstaub, N | 1 |
| Liu, MM; Shi, HS; Si, JJ; Sun, LL; Suo, L; Wu, P; Yang, CH; Yang, JL; Zhang, Y; Zhu, WL | 1 |
| Liu, J; Qiao, W; Ren, L; Sun, Y; Wang, S; Yang, Y | 1 |
| Badin, J; Bretaudeau Deguigne, M; Francino, MC; Perrotin, D; Turcant, A | 1 |
| Brown, CH; Davis, JM; Gibbons, RD; Hur, K; Mann, JJ | 1 |
| Charoenphandhu, J; Charoenphandhu, N; Krishnamra, N; Lapmanee, S | 1 |
| Aquino, TD; Lohoff, FW; Multani, PK; Narasimhan, S; Rickels, K | 1 |
| Cui, J; Du, GH; Gao, XX; Li, ZF; Li, ZY; Liu, XJ; Qin, XM; Sun, HF; Zhang, LZ; Zhou, YZ | 1 |
| Avari, J; Mahgoub, N | 1 |
| Deckert, J; Greiner, C; Haen, E; Hiemke, C; Jabs, B; Pfuhlmann, B; Unterecker, S | 1 |
| Elhanany, S; Gasser, G; Gelman, F; Gun, J; Lev, O; Pankratov, I; Werner, P | 1 |
| Rittmannsberger, H; Werl, R | 1 |
| Carlini, VP; Chavan, RA; de Barioglio, SR; de Cuneo, MF; Ponzio, MF; Poretti, MB; Rask-Andersen, M; Sawant, RS; Schiöth, HB | 1 |
| Weder, N | 1 |
| Rubin, DH | 1 |
| Asarnow, JR; Birmaher, B; Brent, DA; Clarke, G; Dickerson, JF; Dietz, LJ; Emslie, G; Keller, M; Kennard, B; Lynch, FL; Mayes, T; McMakin, DL; Olino, TM; Porta, G; Ryan, ND; Shamseddeen, W; Spirito, A; Wagner, KD | 1 |
| Bech, P; Lunde, M; Martiny, K; Plenge, P | 1 |
| Abbas, G; Dar, A; Naqvi, S | 1 |
| Girbig, D; Igl, BW; Lehmann, T; Obendorf, M; Patchev, VK; Prelle, K | 1 |
| Bao, W; Dunlop, BW; Holland, P; Keller, MB; Ninan, PT | 1 |
| Balasubramani, GK; Davis, LL; Fava, M; Gaynes, BN; Howland, RH; Pilkinton, P; Rush, AJ; Trivedi, MH; Wisniewski, SR; Zisook, S | 1 |
| Friedman, JH; Weintraub, D | 1 |
| Black, KJ; Brodsky, M; Christine, CW; Como, PG; Elmer, L; Factor, SA; Fernandez, HH; Horn, S; Hyson, HC; Jiang, W; Juncos, J; Kurlan, R; Lyness, JM; Manning, C; Marsh, L; McDermott, MP; McDonald, W; Panisset, M; Pearson, N; Pfeiffer, R; Press, D; Richard, IH; Rottenberg, D; Serrano Ramos, C; Shulman, L; Singer, C; Slevin, J | 1 |
| Gordeev, SA; Posokhov, SI; Turbina, LG; Zus'man, AA | 1 |
| Hudson, AL; Lalies, MD; Silverstone, P | 1 |
| Bailey, JE; Craig, K; Dawson, GR; Diaper, A; Dourish, CT; Nutt, DJ; Osman-Hicks, V; Rich, AS | 1 |
| Kovatsi, L; Livanos, A; Njau, S; Pantazidou, K; Samanidou, V | 1 |
| Chen, YC; Feng, SF; Shi, TY; Tan, QR; Wang, WN | 1 |
| Bagcivan, I; Gursoy, S; Ozdemir, E | 1 |
| Al-Najjar, T; Ali, BA; Nazer, LH; Shankar, G | 1 |
| Bai, HM; Han, LX; Li, CY; Liu, Y; Song, XZ; Wang, J; Xie, Q | 1 |
| Brozinski, JM; Kronberg, L; Lahti, M; Oikari, A; Segner, H | 1 |
| Frank, D; Janssens, U; Meyer, I | 1 |
| Santamaria-Cano, J | 1 |
| Chiang, KT; Ho, PS; Liang, CS; Su, HC | 1 |
| Acharya, V; Farside, A; MacNeill, R; Moussallie, M; Stromeyer, R; Urbanowicz, B | 1 |
| Bleich, S; Frieling, H; Herbst, D; Nedeljkov, V; Nedeljkov-Jancic, R; Pavlovic, D; Ribback, S; Wendt, M | 1 |
| Chen, J; Cui, D; Fang, Y; Hong, W; Li, Z; Qi, D; Wang, Z; Yi, Z; Yu, S; Yuan, C; Zhang, C | 1 |
| Fava, M; Haley, CL; Kurian, BT; Morris, DW; Nierenberg, AA; Rush, AJ; Sung, SC; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Chang, JS; Ha, K; Ha, TH; Her, JY; Park, T; Yi, SH; Yoo, CS; Yoon, IY | 1 |
| Klaper, RD; Thomas, MA | 1 |
| Delagrange, P; Elizalde, N; García-García, AL; Tordera, RM; Venzala, E | 1 |
| De Berardis, D; Di Giannantonio, M; Di Iorio, G; Di Nicola, M; Gambi, F; Janiri, L; Martinotti, G; Onofrj, M; Sepede, G | 1 |
| Akhtar, M; Khanam, R; Najfi, H; Vohora, D | 1 |
| De Winter, S; Decoutere, L; Fagard, K; Schrooten, M; Spriet, I; Tournoy, J; Vander Weyden, L | 1 |
| Deuschle, M; Gilles, M; Gronau, W; Kopf, D; Lecei, O; Lederbogen, F; Roth, HJ; Scharnholz, B; Schilling, C; Terhardt, J; Weber-Hamann, B | 1 |
| Charoenphandhu, J; Charoenphandhu, N; Krishnamra, N; Lapmanee, S; Teerapornpuntakit, J | 1 |
| Barbui, C; Churchill, R; Cipriani, A; Furukawa, TA; Imperadore, G; Purgato, M; Signoretti, A; Trespidi, C; Watanabe, N | 1 |
| Srivastava, AK; Yadav, D; Yadav, K | 1 |
| Bahk, WM; Jun, TY; Jung, YE; Song, HR; Wang, HR; Woo, YS | 1 |
| Solomon, IC; Warren, KA | 1 |
| Liu, XH; Qin, J; Wang, Y; Wen, ZY; Yang, JL; Yu, JJ; Zhang, Y | 1 |
| Holsboer, F; Perisic, T; Rein, T; Yu, S; Zimmermann, N; Zschocke, J | 1 |
| Canny, LM; Coleman, KA; Meaney, JV; Palmer, TL; Radalj, LM; Xavier, VY | 1 |
| Fennell, J; Grocott, MP; Sevastru, S; Wakatsuki, M | 1 |
| Lohoff, FW; Narasimhan, S; Rickels, K | 1 |
| Leelahanaj, T | 1 |
| Nieoczym, D; Poleszak, E; Socała, K; Wlaź, P; Wyska, E | 1 |
| Chien, YL; Huang, E; Lin, YH | 1 |
| Deuschle, M; Gilles, M; Hellweg, R; Lang, UE; Lederbogen, F; Scharnholz, B | 1 |
| Choi, YH; Cui, J; Du, GH; Gao, XX; Li, ZY; Qin, XM; Tan, XJ; Tian, JS; Xing, J; Zheng, XY; Zhou, YZ | 1 |
| Auchincloss, EL; Occhiogrosso, M | 1 |
| Campbell, JJ; George, M | 1 |
| Shahani, L | 1 |
| Fava, M; Perlis, RH; Perroud, N; Uher, R | 1 |
| Portmann, S; Stadlmann, S; Terracciano, LM; Tschopp, S | 1 |
| Barbui, C; Cipriani, A; Furukawa, TA; Koesters, M; Nosè, M; Omori, IM; Purgato, M; Trespidi, C | 1 |
| Eriksson, AC; Hägg, S; Hallbäck, I; Whiss, PA | 1 |
| Farde, L; Halldin, C; Takano, A | 1 |
| Ghio, L; Presta, A; Puppo, S | 1 |
| Cranswick, N; McCloskey, K; Ryan, MM; Ware, TL | 1 |
| Steiner, M | 1 |
| Barrera, M; Feldman, B; Koren, G; Nulman, I; Pulver, A; Rovet, J; Streiner, D | 1 |
| Humpston, CS; Robinson, ES; Wood, CM | 1 |
| Catalá, M; Feito, R; Valcárcel, Y | 1 |
| Berk, M; Freeman, RD; Ghanizadeh, A | 1 |
| Chiron, S; Fenet, H; Gomez, E; Li, Z | 1 |
| Dong, J; Fei, Y; Li, J; Pan, W; Peng, Y | 1 |
| Borade, G; Pund, S; Rasve, G | 1 |
| Ahmad, SI; Dutta, L; Khuroo, A; Mishra, S; Monif, T; Mukherjee, SK | 1 |
| Bujalska-Zadrożny, M; Cegielska-Perun, K; Gąsińska, E; Makulska-Nowak, HE; Tatarkiewicz, J | 1 |
| Berk, M; Bousman, CA; Byron, K; Ng, CH; Singh, AB | 2 |
| Dou, J; Hu, X; Liu, J; Shen-Tu, J; Wu, G; Wu, L; Xu, Q; Zhou, H | 1 |
| Balasubramani, GK; Kurian, B; Rush, AJ; Sung, SC; Trivedi, MH; Warden, D; Wisniewski, SR; Zisook, S | 1 |
| Avachat, AM; Bhandwalkar, MJ | 1 |
| Bujalska-Zadrożny, M; Cegielska-Perun, K; Makulska-Nowak, HE | 1 |
| Blum, WF; Colla, M; Daseking, E; Deuschle, M; Gilles, M; Heuser, I; Kopf, D; Krumm, B; Lederbogen, F; Schilling, C; Weber-Hamann, B; Wudy, SA | 1 |
| Polen, KN; Rasmussen, SA; Reefhuis, J; Riehle-Colarusso, T | 1 |
| Li, L; Lin, M; Qian, MC; Shen, XH; Sun, JS; Yang, JH; Zhang, J; Zhong, H | 1 |
| Cruz, R; Dennison, EA; Raidoo, BM; Raidoo, D | 1 |
| Adams, J; Graves, N; Solomon, D | 1 |
| Agosti, V; Bisaga, A; Brooks, DJ; Carpenter, KM; Levin, FR; Mariani, J; Nunes, EV; Pavlicova, M; Sullivan, MA | 1 |
| Batista, M; Bonbled, F; Capron, A; Dugernier, T; Fonseca, S; Hantson, P; Haufroid, V; Simon, M | 1 |
| Cooper, T; Haskett, RF; Isenberg, K; McCall, WV; Mulsant, BH; Prudic, J; Rosenquist, PB; Sackeim, HA | 1 |
| Brus, O; Carlborg, A; Engström, I; Ljung, T; Nordenskjöld, A; von Knorring, L | 1 |
| Aisa, B; Guereñu, G; Martisova, E; Ramírez, MJ | 1 |
| Neher, JO; Sarkissian, A; Singh, R; St Anna, L | 1 |
| Douroumis, D; Farrell, TP; Levina, M; Maniruzzaman, M; Morgan, DJ; Nokhodchi, A; Palmer, D; Rajabi-Siahboomi, AR | 1 |
| Gibson-Helm, M; Sayakhot, P; Teede, HJ; Vincent, A | 1 |
| Feng, W; Fenli, S; Huande, L; Ronghua, Z | 1 |
| Ahlner, J; Boel, LW; Brock, B; Jornil, J; Nielsen, TS; Rosendal, I; Zackrisson, AL | 1 |
| Kaddour, F; Khanfar, M; Sheikh Salem, M | 1 |
| Civitelli, R; Dixon, D; Doré, P; Garfield, LD; Lenze, EJ; Mulsant, BH; Reynolds, CF; Shea, ML; Teitelbaum, S | 1 |
| Hollender, J; Jeon, J; Kurth, D | 1 |
| Coplan, JD; Dwork, AJ; Fenton, AA; Fonseka, J; Glennon, E; Insanally, M; Park, S; Perera, TD; Persky, M; Sackeim, HA; Thirumangalakudi, L | 1 |
| Balcerkiewicz, M; Burda, K; Grześkowiak, E; Kus, K; Nowakowska, E; Ratajczak, P; Sadowski, C; Szkutnik-Fiedler, D | 1 |
| Oliveira, L; Salgado, A; Salgado, JV; Sierra-Siegert, M | 1 |
| Lai, CH | 1 |
| Andrade, C | 1 |
| Chen, S; Feng, ZP; Guo, Z; Huang, J; Mu, N; Wang, H; Wang, R; Wen, Q; Zheng, W; Zhou, X | 1 |
| Dziurkowska, E; Wesolowski, M | 1 |
| Assié, MB; Auclair, AL; Bardin, L; Cussac, D; Depoortère, R; Heusler, P; Marien, M; Martel, JC; Newman-Tancredi, A; O'Connor, JA | 1 |
| Huang, X; Ji, JL; Li, C; Luo, YL; Wang, B | 1 |
| Corcoran, M; Ermer, J; Haffey, MB; Harlin, B; Lasseter, K; Martin, P; Purkayastha, J; Richards, C; Roesch, B | 1 |
| Ahlner, J; Bengtsson, F; Carlsson, B; Green, H; Jakobsen Falk, I; Karlsson, L; Kugelberg, FC; Zackrisson, AL | 1 |
| Dorries, KM; Dunner, DL; Gelenberg, AJ; Ninan, PT; Pedersen, R; Rothschild, AJ | 1 |
| Buckley, G; Fayyad, R; Focht, K; Guico-Pabia, CJ; Kane, CP; Lobello, K; Nichols, AI; Preskorn, SH | 1 |
| Alén, F; de Fonseca, FR; de Heras, RG; Gorriti, MÁ; Orio, L; Pozo, MÁ; Ramírez-López, MT | 1 |
| Balasubramani, GK; Daly, E; Gaynes, BN; Kurian, BT; Lesser, I; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR | 1 |
| Begley, AE; Blumberger, D; Butters, M; Dew, MA; Joel, I; Lenze, EJ; Mazumdar, S; Mulsant, BH; Reynolds, CF | 1 |
| Cao, L; Chen, J; Fang, Y; Hong, W; Peng, D; Wu, Z; Yuan, C; Zhang, C | 1 |
| Asarnow, JR; Birmaher, B; Brent, DA; Clarke, GN; Emslie, GJ; He, J; Hilton, R; Keller, MB; Mansoor, BM; Mayes, T; Porta, G; Rengasamy, M; Ryan, ND; Shamseddeen, W; Wagner, KD | 1 |
| Castro, E; Diaz, A; Pazos, A; Vidal, R | 1 |
| Asarnow, JR; Birmaher, B; Brent, DA; Clarke, GN; Emslie, GJ; He, J; Hilton, RC; Keller, MB; Mansoor, B; Mayes, T; Porta, G; Rengasamy, M; Ryan, N; Shamseddeen, W; Wagner, KD | 1 |
| Cooper, AJ; Lohoff, FW; Rickels, K | 1 |
| Carlsson, J; Ekstrøm, M; Elklit, A; Mortensen, EL; Sonne, C | 1 |
| Chang, HH; Chen, PS; Chi, MH; Gean, PW; Lee, IH; Lu, RB; Tsai, HC; Yang, YK | 1 |
| Geber, C; Hiemke, C; Ostad Haji, E; Schlicht, K; Tadić, A | 1 |
| Berk, M; Dodd, S; Kelin, K; Mancini, M; Schacht, A | 1 |
| Chen, W; Li, X; Wu, H; Xing, B; Yu, E | 1 |
| Ghormode, D; Grover, S; Somaiya, M | 1 |
| Hopkins, SC; Koblan, KS; Reasner, DS | 1 |
| Charoenphandhu, J; Charoenphandhu, N; Lapmanee, S | 1 |
| Ago, Y; Fujita, K; Hiramatsu, N; Kawanai, T; Matsuda, T; Takuma, K; Umehara, M | 1 |
| Barbui, C; Godman, B; Gustafsson, LL; Miranda, J; Persson, M; Skiöld, P; Wettermark, B | 1 |
| Anderson, GL; Caan, B; Carpenter, JS; Cohen, LS; Ensrud, KE; Freeman, EW; Guthrie, KA; Joffe, H; Kroenke, K; Lacroix, AZ; Larson, JC; Newton, KM; Reed, SD; Sammel, MD; Sherman, S; Sternfeld, B | 1 |
| Angelo, LJ; Lee, KC | 1 |
| Avisar, D; Lester, Y; Mamane, H; Zucker, I | 1 |
| Bowler, J; Davies, G; Wilhelm, T; Wilson, H | 1 |
| Filov, I; Gerazova, VP; Marinov, P; Novotni, A; Ristevska-Dimitrovska, G; Shishkov, R; Stefanovski, B; Vujovik, V | 1 |
| De Berardis, D; Di Giannantonio, M; Ferrara, M; Mazza, M; Moschetta, FS; Serroni, N; Tempesta, D | 1 |
| Chua, EW; Foulds, J; Kennedy, MA; Miller, AL | 1 |
| Birkenhäger, TK; Bruijn, JA; Mulder, PG; van den Broek, WW; Vermeiden, M | 1 |
| Brakoulias, V | 1 |
| Greenberg, H; Wang, J | 1 |
| Etkin, A; Gordon, E; Grieve, SM; Harris, A; Korgaonkar, MS; Koslow, SH; Nemeroff, CB; Schatzberg, AF; Williams, LM; Wisniewski, S | 1 |
| Aziz, M; Poole, KA; Weber, N | 1 |
| Bonanno, G; Bonifacino, T; Gabriel, C; Mallei, A; Milanese, M; Mocaer, E; Musazzi, L; Popoli, M; Racagni, G; Tardito, D; Treccani, G | 1 |
| Al-Amin, MM; Rahman, MM; Rana, MS; Reza, HM; Uddin, MM | 1 |
| Bachmeier, C; Beaulieu-Abdelahad, D; Levin, GM; Mullan, M; Reed, J | 1 |
| Haukland, LU; Hovden, IA; Kutzsche, S; Stiris, T | 1 |
| Gibiino, S; Marsano, A; Serretti, A | 1 |
| Bailey, JE; Craig, K; Dawson, GR; Diaper, A; Dourish, CT; Nutt, DJ; Rich, AS; Wilson, SJ | 1 |
| Chen, Y; Faries, DE; Lipkovich, I; Liu, X; Obenchain, RL; Zagar, A | 1 |
| Aarya, KR; Grover, S; Sharma, A | 1 |
| Cooper, AJ; Lohoff, FW; Narasimhan, S; Rickels, K | 1 |
| Fujii, T; Kobayashi, D; Natori, A; Okajima, Y; Yamaguchi, N | 1 |
| Bousman, C; Byron, K; Ng, C; Peh, LH; Sarris, J; Schweitzer, I; Singh, A; Smith, DJ; Tan, CH | 1 |
| Bech, BH; Christensen, J; Kjaersgaard, MI; Olsen, J; Parner, ET; Pedersen, LH; Sørensen, MJ; Vestergaard, M | 1 |
| Exadaktylos, AK; Offinger, A; Weiler, S | 1 |
| Birmaher, B; Brent, D; Clarke, G; Emslie, GJ; He, J; Hilton, R; Mansoor, B; Mayes, TL; Porta, G; Rengasamy, M; Ryan, N; Shamseddeen, W; Spirito, A; Wagner, KD | 1 |
| Barlow, DH; Brown, B; Brown, TA; Ciraulo, DA; Devine, E; Eisenmenger, K; Farchione, T; Gulliver, SB; Kamholz, BW; Knapp, CM; Morissette, SB | 1 |
| Barak, Y; Baratz-Goldstein, R; Hostovsky, A; Pick, CG; Rubovitch, V; Schreiber, S; Volis, I | 1 |
| Etemad, B; Gallop, R; Lohoff, FW; Mandos, LA; Rickels, K; Rynn, MA | 1 |
| Civitelli, R; Dixon, D; Garfield, LD; Kennedy, JL; Lenze, EJ; Müller, DJ; Mulsant, BH; Reynolds, CF; Teitelbaum, SL; Todorov, AA | 1 |
| Adams, PT; Frizzell, B; Griffin, L; Lesser, GJ; Moose, D; Naughton, M; Radford, JE; Shaw, EG; Tomlinson, WV; Vitolins, MZ; Vuky, J | 1 |
| He, J; Hou, J; Kurihara, H; Lin, F; Tian, J; Xing, Y | 1 |
| Eurviriyanukul, K; Maneeton, B; Maneeton, N; Srisurapanont, M | 1 |
| Bognár, Z; Gazdag, G; Vonyik, G | 1 |
| Chesson, AL; DelRosso, LM; Hoque, R; Munir, S | 1 |
| Bijlsma, EY; Chan, JS; Millan, MJ; Olivier, B; Oosting, RS; Veening, JG; Waldinger, MD | 1 |
| Altman, RB; Klein, TE; Sangkuhl, K; Stingl, JC; Turpeinen, M | 1 |
| Chen, Y; Gan, J; Tan, Q; Wang, H; Xue, Y; Zhang, L; Zhang, R; Zhang, Y | 1 |
| Ferentinos, P; Gournellis, R; Michopoulos, I; Oulis, P | 1 |
| Charlier, P; Falissard, B; Maria, AS; Millet, B; Naudet, F; Reymann, JM | 1 |
| Stevens, AW; Tak, LM | 1 |
| Miller, MC | 1 |
| Davidson, RJ; Heller, AS; Johnstone, T; Kalin, NH; Kolden, GG; Peterson, MJ | 1 |
| Groot, PC | 1 |
| Bernardi, LS; Campos, CE; Cardoso, SG; Cuffini, SL; Ferreira, FF; Kuminek, G; Monti, GA; Oliveira, PR | 1 |
| Ali, J; Baboota, S; Haque, S; Md, S; Sahni, JK | 1 |
| Caballero, J; Omidian, H; Park, P | 1 |
| Basnet, A; Bjerrum, OJ; Butler, M; Butler, S; Gordh, TE; Honoré, PH; Kristensen, K | 1 |
| Berk, M; Bousman, CA; Ng, CH; Singh, AB | 1 |
| Hadidi, S; Shahabadi, N | 1 |
| Boillot, C; Casellas, C; Fenet, H; Gómez, E; Martínez Bueno, MJ; Munaron, D | 1 |
| Scheinfeld, N | 1 |
| Han, LX; Li, CY; Li, YK; Liu, FD; Liu, Y; Song, XZ; Wang, J; Xie, Q | 1 |
| Namdari, B | 1 |
| de Bodinat, C; Lejoyeux, M; Matharan, S | 1 |
| Ratkiewicz, M; Splaingard, M | 1 |
| Holland, PJ; Keller, MB; Kornstein, SG; Nemeroff, CB; Ninan, PT; Pedersen, RD; Rothschild, AJ; Thase, ME; Trivedi, MH | 1 |
| Deckert, J; Lauer, M; Pfuhlmann, B; Proft, F; Riederer, P; Unterecker, S | 1 |
| Deckert, J; Hempel, S; Pfuhlmann, B; Proft, F; Reif, A; Riederer, P; Unterecker, S | 1 |
| Roy-Byrne, P | 1 |
| Hoge, EA; Keshaviah, A; Pollack, MH; Simon, NM; Stein, MB; Van Ameringen, M; Worthington, JW | 1 |
| Cavanagh, J; Ferrell, W; Krishnadas, R; Lumsden, MA; Nicol, A; Pimlott, SL; Sassarini, J | 1 |
| Veltishchev, DY | 1 |
| Bounartzi, M; Kantiranis, N; Malamataris, S; Nikolakakis, I; Panagopoulou, A | 1 |
| Bonnet, U; Khalil-Boutros, Y | 1 |
| Bisesi, JH; Bridges, W; Klaine, SJ | 1 |
| Berm, EJ; Brummel-Mulder, E; Hak, E; Maring, JG; Paardekooper, J; Wilffert, B | 1 |
| Cruz, DA; Javors, MA; Murrell, MD; Thompson, PM | 1 |
| Moran, J; Varatharaj, A | 1 |
| Ellis, N; Garcia, A; Nakama, H; O'Brien, K | 1 |
| Alberti, S; Chiesa, A; Han, C; Lee, SJ; Lia, L; Pae, CU; Patkar, AA; Serretti, A | 1 |
| Ago, Y; Fujita, K; Higashino, K; Kita, Y; Matsuda, T; Takuma, K; Umehara, M | 1 |
| Aziz, MT; Good, BL; Lowe, DK | 1 |
| Begley, A; Butters, MA; Koenig, AM; Ogbagaber, S; Reynolds, CF; Wahed, AS | 1 |
| Alves, G; Falcão, A; Llerena, A; Magalhães, P | 1 |
| Desmet, G; Guillarme, D; Périat, A; Rudaz, S; Tyteca, E | 1 |
| Bombardier, CH; Brooks, L; Bryce, TN; Chiodo, A; Dijkers, MP; Fann, JR; Forchheimer, M; Richards, JS; Tate, DG | 1 |
| Chen, C; Gu, C; Lv, Q | 1 |
| Carmody, T; Kurian, KR; Lesser, I; Morris, D; Myers, A; Rush, AJ; Toups, M; Trivedi, MH; Warden, D; Zisook, S | 1 |
| Bellomo, G; Dalò, V; Gramaglia, C; Meola, S; Pollarolo, P; Prosperini, P; Ressico, F; Rolla, R; Torre, E; Vidali, M; Zeppegno, P | 1 |
| Cooper, N; Gross, JJ; McRae, K; Rekshan, W; Williams, LM | 1 |
| Auinger, P; Christine, CW; Factor, SA; Juncos, J; Leentjens, AF; Lyness, JM; Marsh, L; McDonald, W; Moonen, AJ; Panisset, M; Pfeiffer, R; Richard, IH; Rottenberg, D; Serrano Ramos, C; Shulman, L; Singer, C; Slevin, J; Wijers, A | 1 |
| Bares, M; Brunovsky, M; Höschl, C; Kopecek, M; Novak, T; Sos, P; Stopkova, P | 1 |
| Kallikazaros, IE; Katsi, VK; Makris, T; Marketou, M; Stefanadis, CI; Tousoulis, D; Vamvakou, G; Vardas, P | 1 |
| Bandelow, B; Wedekind, D | 1 |
| Saxena, S; Sumner, J | 1 |
| Lohoff, FW; Narasimhan, S; Saung, WT | 1 |
| Eap, CB; Gründer, G; Henkel, K; Paulzen, M; Reich, A; Tauber, S | 1 |
| Ali, J; Baboota, S; Fazil, M; Haque, S; Kumar, M; Md, S; Sahni, JK | 1 |
| Kinder, B; Litner, J; Panganiban, B | 1 |
| Ansary, A; Ibhanesebhor, S; Manjunatha, C | 1 |
| Cavender, HM; Cooke, JD; Grover, LM; Lima, HK | 1 |
| Guerra, MW; Shults, J | 1 |
| Ceschi, A; Kupferschmidt, H; Monnet-Tschudi, F; Rauber-Lüthy, C; Reichert, C; Reichert, P | 1 |
| de Langen, CJ; Gillman, PK; Kooy, A; Top, WM | 1 |
| Hermann, M; Moe, HL; Molden, E; Waade, RB | 1 |
| Abed, A; Banafshe, HR; Hajhashemi, V; Mesdaghinia, A; Minaiyan, M | 1 |
| Anderson, GL; Caan, B; Carpenter, JS; Cohen, L; Ensrud, KE; Freeman, EW; Guthrie, KA; Hunt, J; Joffe, H; LaCroix, AZ; Larson, JC; Manson, JE; Newton, KM; Reed, SD; Rexrode, KM; Shifren, J; Sternfeld, B | 1 |
| Choi, TK; Kim, B; Lee, MH; Lee, SH | 1 |
| Jagla, G; Makuch, W; Mika, J; Obara, I; Przewlocka, B; Wordliczek, J | 1 |
| Crits-Christoph, P; Gallop, R; Gibbons, MB; Markell, HM; Newman, MG; Rickels, K | 1 |
| Afshari, D; Baziyar, M; Bostani, A; Mahmoodi, M; Moradian, N; Razazian, N | 1 |
| Bosman, J; Larmené-Beld, KH; Smit, JP; ter Horst, PG; van der Veen, EL; Wieringa, A | 1 |
| Austin, PC; Gomes, T; Ho, JM; Juurlink, DN; Mamdani, M; Straus, SE | 1 |
| Cohen, L; Freeman, EW; Guthrie, KA; Joffe, H; LaCroix, AZ; Larson, JC; Manson, JE; Mitchell, CM; Newton, KM; Reed, SD; Shifren, JL | 1 |
| Best, C; Gesto, M; Melnyk-Lamont, N; Vijayan, MM | 1 |
| Dew, MA; Karp, JF; Rej, S | 1 |
| Faingold, CL; Kommajosyula, SP; Long, X; Plath, K; Randall, M | 1 |
| Ait Tayeb, AEK; Becquemont, L; Corruble, E; Dutech, C; Ellul, P; Gressier, F; Hardy, P; Monfort, J; Verstuyft, C | 1 |
| Chen, Y; Groppi, A; Morini, L; Stramesi, C; Vignali, C | 1 |
| Cherian, AV; Math, SB; Narayanaswamy, JC; Reddy, YC; Viswanath, B | 1 |
| Becker, T; Kösters, M; Staudigl, L | 1 |
| Groppe, S; Gründer, G; Hiemke, C; Paulzen, M; Tauber, SC; Veselinovic, T | 1 |
| Huang, X; Ji, JL; Li, C; Mao, YS; Wang, H | 2 |
| Chang, YH; Chen, PS; Chen, SH; Chen, SL; Cheng, LY; Chu, CH; Chuang, HY; Lee, IH; Lu, RB; Wang, YS; Yang, YK; Yeh, TL | 1 |
| Brignone, M; Ereshefsky, L; Francois, C; Lançon, C; Llorca, PM; Rive, B; Salah, S | 1 |
| Chu, SH; Cleeland, CS; Geng, Y; Lee, ES; Lee, YJ; Wang, XS | 1 |
| Ahmad Panahi, H; Alaei, HS | 1 |
| Bisaga, A; Glass, A; Kelly, MA; Levin, FR; Mariani, JJ; Nunes, EV; Pavlicova, M; Sullivan, MA | 1 |
| Davis, ML; Hofmann, SG; Smits, JA | 1 |
| Smith, SM; Trinkley, KE; VanderWeide, LA | 1 |
| Deckert, J; Hempel, S; Kopf, J; Olmes, D; Pfuhlmann, B; Proft, F; Reif, A; Riederer, P; Schmidt, B; Unterecker, S | 1 |
| Bouckaert, F; Kho, KH; Kok, RM; Sienaert, P; Spaans, HP; Stek, ML; van den Berg, JF; Verwijk, E | 1 |
| Caan, B; Carpenter, JS; Ensrud, KE; Freeman, EW; Guthrie, KA; Hohensee, C; Joffe, H; LaCroix, AZ; Landis, CA; Manson, J; Newton, KM; Otte, J; Reed, SD; Shifren, JL; Sternfeld, B; Woods, NF | 1 |
| Birkenhäger, TK; Kamperman, AM; van den Broek, WW; Vermeiden, M; Vulink, ME | 1 |
| Ebrahimi, M; Ebrahimitalab, A; Es'haghi, Z; Mohammadinejad, A | 1 |
| Chen, CY; Hung, CI; Liu, CY; Wang, SJ; Yang, CH | 1 |
| Deuschle, M; Gilles, M; Gronau, W; Lederbogen, F; Paslakis, G; Schilling, C; Weber-Hamann, B | 1 |
| Brvar, M; Koželj, G; Mašič, LP | 1 |
| Bombardier, CH; Fann, JR; Forchheimer, M; Heinemann, AW; Neumann, HD; Tate, DG | 1 |
| Dikshit, M; Shukla, S; Singh, KP; Singh, M | 1 |
| Makuch, W; Mika, J; Przewlocka, B; Rojewska, E; Zychowska, M | 1 |
| Hardenbicker, P; Nilson, E; Schlüsener, MP; Schulz, M; Ternes, TA; Viergutz, C | 1 |
| Ameri, AH; Jafari, MT; Saraji, M | 1 |
| Bury, TB; Dworkin-Brodsky, AD; Fong, PP; Jasion, CM; Kell, RC | 1 |
| Akbudak, M; Belli, H; Tabo, A; Ural, C | 1 |
| Alves, G; Falcão, A; LLerena, A; Magalhães, P; Rodrigues, M | 1 |
| Luther, JF; Rush, AJ; Sung, SC; Trivedi, MH; Wisniewski, SR | 1 |
| Chen, CJ; Chen, CY; Ho, PS; Huang, SY; Jang, FL; Kuo, SC; Liang, CS; Lu, RB; Shyu, JF; Wan, FJ; Yeh, YW; Yen, CH | 1 |
| Gray, VC; Hughes, RN | 1 |
| Barber, JK; Bombardier, CH; Brooks, L; Chiodo, AE; Fann, JR; Heinemann, AW; McCullumsmith, C; Richards, JS; Tate, DG; Temkin, NR; Wilson, CS | 1 |
| Arnow, BA; Boyce, PM; Day, CV; DeBattista, C; Etkin, A; Harris, AW; John Rush, A; Rekshan, W; Schatzberg, AF; Williams, LM | 1 |
| Bombardier, CH; Brooks, L; Fann, JR; Heinemann, AW; McCullumsmith, CB; Richards, JS; Tate, DG; Temkin, NR; Warms, C; Warren, AM; Wilson, CS | 1 |
| Filippov, G; Gislum, M; Montgomery, S; Wang, G | 1 |
| Chen, S; Hu, Y; Qian, P; Wang, W; Wu, P; Yang, J; Zhang, S; Zhang, W; Zhu, Y | 1 |
| Arnow, BA; Blasey, C; Etkin, A; Kulkarni, J; Luther, JF; Palmer, DM; Rekshan, W; Rush, AJ; Schatzberg, AF; Williams, LM | 1 |
| DeBattista, C; Etkin, A; Lazzeroni, LC; Murphy, GM; Schatzberg, AF; Williams, LM | 1 |
| Chen, J; Gong, W; Li, Z; Mu, J; Shao, W; Wu, Q; Xie, P; Xu, F; Yang, D; Yang, J; Yang, Y; Zhang, J | 1 |
| Artama, M; Engeland, A; Furu, K; Gissler, M; Haglund, B; Kieler, H; Malm, H; Nørgaard, M; Selmer, R; Stephansson, O; Valdimarsdottir, UA; Zoega, H | 1 |
| Ivanets, NN; Iziumina, TA; Kinkulkina, MA; Tikhonova, YG | 1 |
| Emilsson, JF; Eriksson, E; Hieronymus, F; Nilsson, S | 1 |
| Banzi, R; Cusi, C; Moja, L; Randazzo, C; Sterzi, R; Tedesco, D | 1 |
| Aho, KA; Kaushik, G; Thomas, MA | 1 |
| Aydin, A; Boysan, M; Güzel Özdemir, P; Selvi, Y; Smolensky, MH; Yilmaz, E | 1 |
| Pieróg, M; Poleszak, E; Serefko, A; Szopa, A; Wlaź, A; Wlaź, P; Wośko, S; Wróbel, A; Wyska, E | 1 |
| Anderson, GL; Caan, B; Carpenter, JS; Cohen, LS; Ensrud, KE; Freeman, EW; Guthrie, KA; Joffe, H; LaCroix, AZ; Larson, JC; Manson, JE; Newton, KM; Reed, SD; Rexrode, K; Skaar, TC; Sternfeld, B | 1 |
| Gavrilova, SI; Kalyn, YB; Kornilov, VV; Safarova, TP; Sheshenin, VS; Shipilova, ES; Yakovleva, OB | 1 |
| Eliasson, E; Haslemo, T; Lindh, JD; Mannheimer, B; Molden, E | 1 |
| Domingues, DS; Miranda, LF; Queiroz, ME | 1 |
| Bai, S; Chen, Z; Dong, M; Hu, Q; Hu, Z; Li, P; Liang, Z; Shen, P; Wang, H; Xie, P; Zhong, X; Zhu, D | 1 |
| Fay, B; Gründer, G; Haen, E; Hiemke, C; Paulzen, M; Schoretsanitis, G; Unholzer, S | 1 |
| Buszewsk, B; Gajewski, J; Karakula-Juchnowicz, H; Morylowska-Topolska, J; Petruczynik, A; Szultka-Mlynska, M; Waksmundzka-Hajnosi, M; Wroblewski, K | 1 |
| Eliasson, E; Haslemo, T; Ingelman-Sundberg, M; Jukić, MM; Molden, E | 1 |
| Akamune, IE; Gilbert, B | 1 |
| Barabás-Hajdu, E; Budău, M; Hancu, G; Lupu, D; Milan, A | 1 |
| Asami, Y; Boucher, M; Kato, M; Pappadopulos, E; Prieto, R; Wajsbrot, DB; Wang, X | 1 |
| Gündüz, Ş; Kandeğer, A; Selvi, Y | 1 |
| Domingo-Echaburu, S; Hernandez, R; Lertxundi, U; Medrano, J; Orive, G | 1 |
| Du, X; Gong, H; Lei, M; Tan, Q; Wei, J; Wu, L; Zhao, L; Zhao, R | 1 |
| Braganca, C; Cetran, L; Goncalves, R; Hertzog, T; Labadie, M | 1 |
| Boyce, P; Chen, R; Feng, L; Hu, Y; Shi, H; Wang, G; Wang, X; Xiao, L; Yang, R; Zhou, J; Zhu, X | 1 |
| Conca, A; De Donatis, D; Florio, V; Giupponi, G; Mercolini, L; Porcelli, S; Serretti, A; Zernig, G | 1 |
| Cao, CS; Huang, L; Zhan, Z | 1 |
| Aldosary, F; Blier, P; James, JS; Norris, S; Ritchie, JC; Tremblay, P | 1 |
| Filipczyk, K; Gorczyca, P; Kosowski, M; Kunert, Ł; Okopień, B; Piegza, M; Pudlo, R; Smolarczyk-Kosowska, J; Wojciechowski, M | 1 |
| Ahmad, S; Fazli, AA; Khan, NA; Khuroo, A; Kumar, V; Panigrahy, BK; Raza, SN; Wani, TU; Zarger, BA | 1 |
| Coutens, B; Guiard, BP; Rampon, C; Yrondi, A | 1 |
255 review(s) available for venlafaxine hydrochloride and cyclohexanol
| Article | Year |
|---|---|
Nefazodone and venlafaxine: two new agents for the treatment of depression.
Topics: Antidepressive Agents; Consumer Product Safety; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Family Practice; Humans; Norepinephrine; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1995 |
Safety and tolerance profile of venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Drug Tolerance; Humans; Venlafaxine Hydrochloride | 1995 |
Rapid onset of action of venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Controlled Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Humans; Long-Term Care; Time Factors; Venlafaxine Hydrochloride | 1995 |
Clinical utility of venlafaxine in comparison with other antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Venlafaxine Hydrochloride | 1995 |
Pharmacologic profile and efficacy of venlafaxine.
Topics: Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Venlafaxine Hydrochloride | 1995 |
Venlafaxine: a structurally unique and novel antidepressant.
Topics: Absorption; Animals; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Double-Blind Method; Drug Interactions; Humans; Rats; Venlafaxine Hydrochloride | 1995 |
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1995 |
Venlafaxine. A review of its pharmacology and therapeutic potential in depression.
Topics: Animals; Antidepressive Agents, Second-Generation; Cardiovascular System; Central Nervous System; Cyclohexanols; Depression; Dosage Forms; Dose-Response Relationship, Drug; Drug Interactions; Humans; Synaptic Transmission; Venlafaxine Hydrochloride | 1995 |
Pharmacologic treatment of rapid ejaculation.
Topics: 1-Naphthylamine; Adult; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Dose-Response Relationship, Drug; Ejaculation; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Venlafaxine Hydrochloride | 1995 |
Evolutionary trends in the pharmacotherapeutic management of depression.
Topics: Adolescent; Adult; Age Factors; Aged; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Child; Clinical Trials as Topic; Cyclohexanols; Decision Trees; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Humans; Piperazines; Placebos; Recurrence; Selective Serotonin Reuptake Inhibitors; Trazodone; Triazoles; Venlafaxine Hydrochloride | 1994 |
Venlafaxine: a heterocyclic antidepressant.
Topics: Antidepressive Agents, Second-Generation; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclohexanols; Depression; Drug Interactions; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1994 |
Antidepressant drug selection: criteria and options.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Interactions; Follow-Up Studies; Humans; Monoamine Oxidase Inhibitors; Venlafaxine Hydrochloride | 1994 |
The role of venlafaxine in rational antidepressant therapy.
Topics: Age Factors; Aged; Ambulatory Care; Animals; Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Hospitalization; Humans; Male; Rats; Receptors, Neurotransmitter; Venlafaxine Hydrochloride | 1994 |
Geriatric depression: brain imaging correlates and pharmacologic considerations.
Topics: Age Factors; Aged; Antidepressive Agents; Brain; Bupropion; Cerebrovascular Circulation; Cyclohexanols; Depressive Disorder; Humans; Intracranial Arteriosclerosis; Magnetic Resonance Imaging; Models, Neurological; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Tomography, X-Ray Computed; Venlafaxine Hydrochloride | 1994 |
Depression in the medically ill: choosing an antidepressant.
Topics: Antidepressive Agents; Cerebrovascular Disorders; Clinical Trials as Topic; Comorbidity; Cyclohexanols; Decision Making; Dementia; Depressive Disorder; Humans; Neoplasms; Parkinson Disease; Prevalence; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1994 |
Cardiovascular safety in depressed patients: focus on venlafaxine.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Heart Conduction System; Humans; Hypertension; Hypotension, Orthostatic; Incidence; Placebos; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1995 |
New approaches to the treatment of depression.
Topics: Antidepressive Agents, Second-Generation; Brain; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Dopamine; Duloxetine Hydrochloride; Humans; Receptors, Dopamine; Receptors, GABA; Receptors, Neurotransmitter; Receptors, Serotonin; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 1996 |
The diagnosis and treatment of late-life depression.
Topics: Age Factors; Aged; Antidepressive Agents; Anxiety Disorders; Bupropion; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Monoamine Oxidase Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Sex Factors; Trazodone; Triazoles; Venlafaxine Hydrochloride | 1996 |
Antidepressant options: venlafaxine in perspective.
Topics: Antidepressive Agents, Second-Generation; Brain; Cyclohexanols; Depressive Disorder; Humans; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Dose-response relationship with venlafaxine.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Norepinephrine; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Serotonin; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Clinical evaluation of venlafaxine.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Drug-drug interactions involving antidepressants: focus on venlafaxine.
Topics: Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 Enzyme Inhibitors; Depressive Disorder; Drug Interactions; Humans; Isoenzymes; Liver; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1996 |
The safety and tolerability of venlafaxine hydrochloride: analysis of the clinical trials database.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1996 |
Effectiveness of venlafaxine treatment in a broad spectrum of depressed patients: a meta-analysis.
Topics: Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1995 |
New antidepressant drugs and the treatment of depression in the medically ill patient.
Topics: Adjustment Disorders; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder; Drug Interactions; Humans; Patient Care Team; Piperazines; Selective Serotonin Reuptake Inhibitors; Sick Role; Triazoles; Venlafaxine Hydrochloride | 1996 |
Etrank: a ranking procedure for handling missing data in clinical trials: application to venlafaxine extended-release depression clinical trial.
Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Data Interpretation, Statistical; Depression; Humans; Longitudinal Studies; Mathematical Computing; Software; Statistics as Topic; Venlafaxine Hydrochloride | 1996 |
Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1996 |
Venlafaxine: a novel antidepressant that has a dual mechanism of action.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Cyclohexanols; Depressive Disorder; Humans; Norepinephrine; Receptors, Adrenergic; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Antidepressant discontinuation: a review of the literature.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Incidence; Monoamine Oxidase Inhibitors; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride | 1997 |
Newer antidepressants and the discontinuation syndrome.
Topics: Adverse Drug Reaction Reporting Systems; Cyclohexanols; Dizziness; Fluoxetine; Headache; Humans; Incidence; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride | 1997 |
Antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1997 |
Safety and tolerability of the new antidepressants.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Headache; Humans; Mianserin; Mirtazapine; Nausea; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Triazoles; Venlafaxine Hydrochloride | 1997 |
Development of new antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder; Drug Approval; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Neurotransmitter Uptake Inhibitors; Receptors, Adrenergic; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
Antidepressant use in the elderly. Current status of nefazodone, venlafaxine and moclobemide.
Topics: Aged; Aging; Antidepressive Agents; Benzamides; Cyclohexanols; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Inhibitors; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1997 |
Antidepressant withdrawal reactions.
Topics: Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clomipramine; Cyclohexanols; Drug Administration Schedule; Female; Humans; Male; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Trazodone; Venlafaxine Hydrochloride | 1997 |
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1997 |
Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs.
Topics: 1-Naphthylamine; Antidepressive Agents; Cyclohexanols; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1997 |
Antidepressants in the treatment of premenstrual dysphoric disorder.
Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Female; Humans; Lithium; Luteal Phase; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Terminology as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Pharmacotherapy of borderline personality disorder.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Borderline Personality Disorder; Clinical Trials as Topic; Cyclohexanols; Female; Humans; Lithium; Male; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
The use of newer antidepressants for panic disorder.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Dopamine; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Neurotransmitter Uptake Inhibitors; Norepinephrine; Piperazines; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Triazoles; Venlafaxine Hydrochloride | 1998 |
A meta-analysis of the effects of venlafaxine on anxiety associated with depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1998 |
New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Humans; Isoenzymes; Mianserin; Mirtazapine; Piperazines; Risk Factors; Triazoles; Venlafaxine Hydrochloride | 1998 |
Psychopharmacology of ADHD: children and adolescents.
Topics: Adolescent; Age Factors; Amphetamines; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Cyclohexanols; Dextroamphetamine; Drug Administration Schedule; Fluoxetine; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Pemoline; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Addressing comorbidity in adults with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clinical Trials as Topic; Comorbidity; Cyclohexanols; Dopamine; Dopamine Antagonists; Epinephrine; Humans; Mental Disorders; Norepinephrine; Prevalence; Psychotropic Drugs; Serotonin; Venlafaxine Hydrochloride | 1998 |
Pharmacokinetic interactions of antidepressants.
Topics: Antidepressive Agents; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Fluvoxamine; Humans; Mixed Function Oxygenases; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1998 |
Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Depressive Disorder; Diastole; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Posture; Proportional Hazards Models; Regression Analysis; Venlafaxine Hydrochloride | 1998 |
Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Depressive Disorder; Drug Prescriptions; Humans; Monoamine Oxidase Inhibitors; Piperazines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1998 |
Mechanism of action of antidepressant medications.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Down-Regulation; History, 20th Century; Humans; Monoamine Oxidase Inhibitors; Receptors, Adrenergic; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Glucocorticoid; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
Antidepressant effectiveness in severe depression and melancholia.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Humans; Morpholines; Reboxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
Treatment of major depression: is improvement enough?
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Psychiatric Status Rating Scales; Psychometrics; Risk Factors; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
The patient with comorbid depression and anxiety: the unmet need.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Clinical Trials as Topic; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Placebos; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder; Humans; Piperazines; Triazoles; Venlafaxine Hydrochloride | 1998 |
Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs.
Topics: Aged; Ambulatory Care; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Electroconvulsive Therapy; Hospitalization; Humans; Multicenter Studies as Topic; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
[Two new antidepressants: mirtazapine and venlafaxine].
Topics: Adrenergic alpha-Antagonists; Benzamides; Cyclohexanols; Depressive Disorder; Drug Interactions; Female; Humans; Male; Mianserin; Mirtazapine; Moclobemide; Monoamine Oxidase Inhibitors; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 1999 |
[Specifics of a dual action: toward new and more effective antidepressants?].
Topics: Acetylcholine; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Brain; Cyclohexanols; Depressive Disorder; Dopamine; Endocrine System; Enzymes; Homeostasis; Homovanillic Acid; Monoamine Oxidase; Norepinephrine; Serotonin; Venlafaxine Hydrochloride | 1999 |
[Psychopharmacological profile of venlafaxine].
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Humans; Norepinephrine; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
[Is there a relationship between clinical efficacy and antidepressant dosage in major depression?].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Imipramine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
[Therapeutic action lag time and resistance to treatment].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Dibenzocycloheptenes; Drug Resistance; Fluoxetine; Hospitalization; Humans; Severity of Illness Index; Time Factors; Venlafaxine Hydrochloride | 1999 |
Mirtazapine: clinical overview.
Topics: Adrenergic alpha-Antagonists; Aged; Antidepressive Agents, Tricyclic; Clomipramine; Controlled Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Humans; Meta-Analysis as Topic; Mianserin; Middle Aged; Mirtazapine; Placebos; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Antidepressant treatment of the depressed patient with insomnia.
Topics: Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 1999 |
Practical considerations for the treatment of depression in elderly and very elderly long-term care patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Depressive Disorder; Humans; Long-Term Care; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
Pharmacokinetic considerations of antidepressant use in the elderly.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Biotransformation; Bupropion; Creatinine; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Female; Half-Life; Humans; Intestinal Absorption; Liver; Male; Middle Aged; Piperazines; Triazoles; Venlafaxine Hydrochloride | 1999 |
Evolution of remission as the new standard in the treatment of depression.
Topics: Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Mianserin; Mirtazapine; Prevalence; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
The functional anatomy, neurochemistry, and pharmacology of anxiety.
Topics: Adrenergic Uptake Inhibitors; Amygdala; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clomipramine; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Norepinephrine; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 1999 |
Overview of antidepressants currently used to treat anxiety disorders.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder.
Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1999 |
[Venlafaxine and its discontinuation syndrome].
Topics: Adult; Antidepressive Agents, Second-Generation; Attention; Cyclohexanols; Dose-Response Relationship, Drug; Female; Humans; Memory Disorders; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride; Visual Acuity | 1999 |
SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Morpholines; Piperazines; Reboxetine; Structure-Activity Relationship; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2000 |
[Venlafaxine withdrawal syndrome: report of six cases and review of the literature].
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Fatigue; Female; Gastrointestinal Diseases; Hallucinations; Headache; Humans; Male; Middle Aged; Paresthesia; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Time Factors; Venlafaxine Hydrochloride | 2000 |
Neuropharmacology of venlafaxine.
Topics: Adenylyl Cyclases; Anxiety Disorders; Corticotropin-Releasing Hormone; Cyclohexanols; Electroencephalography; Humans; Locus Coeruleus; Raphe Nuclei; Receptors, Adrenergic, beta; Selective Serotonin Reuptake Inhibitors; Sleep, REM; Synaptic Transmission; Venlafaxine Hydrochloride | 2000 |
Antidepressant efficacy of venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Humans; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Efficacy of venlafaxine in the treatment of severe depression.
Topics: Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Venlafaxine and treatment-resistant depression.
Topics: Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Efficacy of venlafaxine in geriatric depression.
Topics: Aged; Cyclohexanols; Depressive Disorder, Major; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Use of venlafaxine in children and adolescents: a review of current literature.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Autistic Disorder; Child; Conduct Disorder; Cyclohexanols; Depressive Disorder; Humans; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2000 |
Use of venlafaxine in other psychiatric disorders.
Topics: Anxiety; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fibromyalgia; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Trichotillomania; Venlafaxine Hydrochloride | 2000 |
Pharmacoeconomic studies of antidepressants: focus on venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Buspirone; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Drug Tolerance; Fluoxetine; Fluvoxamine; Humans; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Lethal combination of tramadol and multiple drugs affecting serotonin.
Topics: Adult; Alcoholism; Analgesics, Opioid; Cyclohexanols; Dibenzothiazepines; Drug Interactions; Fatal Outcome; Humans; Lorazepam; Male; MEDLINE; Mental Processes; Quetiapine Fumarate; Receptors, Serotonin; Seizures; Selective Serotonin Reuptake Inhibitors; Smoking; Tramadol; Trazodone; Venlafaxine Hydrochloride | 2000 |
Antidepressants, old and new. A review of their adverse effects and toxicity in overdose.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Dopamine Uptake Inhibitors; Drug Interactions; Drug Overdose; Humans; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Venlafaxine Hydrochloride | 2000 |
Venlafaxine XR in the treatment of anxiety.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Psychopharmacologic treatment of adolescent depression.
Topics: Adolescent; Child; Cyclohexanols; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2001 |
Evidence of early onset of antidepressant effect in randomized controlled trials.
Topics: Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Mianserin; Mirtazapine; Personality Inventory; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Possible neurobiological mechanisms underlying faster onset of antidepressant action.
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Norepinephrine; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Pharmacology of rapid-onset antidepressant treatment strategies.
Topics: Antidepressive Agents, Tricyclic; Autoreceptors; Cyclohexanols; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Hippocampus; Humans; Mianserin; Mirtazapine; Norepinephrine; Pindolol; Pyramidal Cells; Raphe Nuclei; Receptor, Serotonin, 5-HT1B; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Do some antidepressants work faster than others?
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
The health economic impact of antidepressant usage from a payer's perspective: a multinational study.
Topics: Acute Disease; Algorithms; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Drug Costs; Europe; Health Care Costs; Health Policy; Humans; North America; Venlafaxine Hydrochloride | 2001 |
[Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Humans; Milnacipran; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
Venlafaxine extended-release: a review of its use in the management of major depression.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Interactions; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
The pharmacoeconomics of venlafaxine in depression.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Cost-Benefit Analysis; Cyclohexanols; Depression; Drug Utilization Review; Humans; Managed Care Programs; Selective Serotonin Reuptake Inhibitors; United States; Venlafaxine Hydrochloride | 2001 |
Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Cyclohexanols; Drug Administration Schedule; gamma-Aminobutyric Acid; Humans; Monoamine Oxidase Inhibitors; Norepinephrine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Clinical Trials as Topic; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Drug Administration Schedule; Humans; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Remission Induction; Survival Analysis; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Humans; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Beyond estrogen: new alternatives for the management of hot flashes.
Topics: Cyclohexanols; Estrogens; Estrogens, Non-Steroidal; Female; Hot Flashes; Humans; Isoflavones; Middle Aged; Phytoestrogens; Placebos; Plant Preparations; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2002 |
Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Female; Humans; Logistic Models; Male; Middle Aged; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2002 |
Treatment of generalized anxiety disorder.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Cognitive Behavioral Therapy; Cyclohexanols; Follow-Up Studies; Humans; Paroxetine; Psychotherapy; Pyrimidines; Relaxation Therapy; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Generalized anxiety disorder in primary care: emerging issues in management and treatment.
Topics: Adaptation, Psychological; Adolescent; Adult; Anxiety Disorders; Cognitive Behavioral Therapy; Comorbidity; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Physicians, Family; Prevalence; Primary Health Care; Recurrence; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; United States; Venlafaxine Hydrochloride | 2002 |
Management of hot flushes in breast cancer patients.
Topics: Adrenergic alpha-Agonists; Breast Neoplasms; Cyclohexanols; Female; Hot Flashes; Humans; Megestrol Acetate; Venlafaxine Hydrochloride | 2002 |
Combining antidepressants for treatment-resistant depression: a review.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Humans; Mianserin; Monoamine Oxidase Inhibitors; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Venlafaxine: a new class of antidepressant.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder; Humans; Venlafaxine Hydrochloride | 2002 |
An overview of the clinical efficacy of mirtazapine.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
[Pharmacological justification for the use of new antidepressant drugs].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Piperazines; Triazoles; Venlafaxine Hydrochloride | 2002 |
Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2002 |
Long-term treatment strategies in anxiety disorders.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Female; Humans; Male; Prevalence; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2002 |
Optimizing treatment outcomes for patients with depression and generalized anxiety disorder.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Humans; Paroxetine; Psychotherapy; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Mechanism of action of antidepressants.
Topics: Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Humans; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2002 |
Achieving remission from depression with venlafaxine and venlafaxine extended release: a literature review of comparative studies with selective serotonin reuptake inhibitors.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Multicenter Studies as Topic; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Pharmacotherapy of generalized anxiety disorder.
Topics: Algorithms; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Humans; Paroxetine; Psychotherapeutic Processes; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Drug Interactions; Humans; Mianserin; Mirtazapine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Triazoles; Venlafaxine Hydrochloride; Weight Gain | 2002 |
Depression in children and adolescents.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Child; Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder; Electroconvulsive Therapy; Humans; Hypericum; Lithium; Monoamine Oxidase Inhibitors; Phytotherapy; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
New hope in the treatment of painful symptoms in depression.
Topics: Animals; Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Cyclopropanes; Depressive Disorder; Duloxetine Hydrochloride; Humans; Milnacipran; Pain; Thiophenes; Venlafaxine Hydrochloride | 2003 |
Treating generalized anxiety disorder.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Cognitive Behavioral Therapy; Cyclohexanols; Humans; Imipramine; Paroxetine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2003 |
A pharmacoeconomic evaluation of major depressive disorder.
Topics: Antidepressive Agents, Second-Generation; Cost-Benefit Analysis; Critical Pathways; Cyclohexanols; Decision Trees; Depressive Disorder, Major; Economics, Pharmaceutical; Humans; Venlafaxine Hydrochloride | 2003 |
Dual action antidepressants and some important considerations.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Second-Generation; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Histamine H1 Antagonists; Humans; Mianserin; Milnacipran; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Venlafaxine Hydrochloride; Weight Gain | 2003 |
Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.
Topics: Algorithms; Ambulatory Care; Analysis of Variance; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Humans; Outcome Assessment, Health Care; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Terminology as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Physical symptoms of depression: unmet needs in special populations.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Age Factors; Antidepressive Agents; Child; Comorbidity; Cyclohexanols; Delivery of Health Care; Depressive Disorder; Diagnosis, Differential; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain; Poverty; Selective Serotonin Reuptake Inhibitors; Sex Factors; Thiophenes; Venlafaxine Hydrochloride | 2003 |
Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies.
Topics: Adolescent; Adult; Anxiety Disorders; Chi-Square Distribution; Confidence Intervals; Cyclohexanols; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
The safety of SSRIs in generalised anxiety disorder: any reason to be anxious?
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Cyclohexanols; Humans; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 2003 |
Venlafaxine: a 2003 update.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
The use of antidepressants to treat attention deficit hyperactivity disorder in adults.
Topics: Adult; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Clinical Trials as Topic; Cyclohexanols; Humans; Propylamines; Venlafaxine Hydrochloride | 2003 |
[Pharmacotherapy of generalized anxiety disorder: state of the art].
Topics: Adolescent; Adult; Age Factors; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Benzodiazepines; Child; Child, Preschool; Cyclohexanols; Double-Blind Method; Humans; Meta-Analysis as Topic; Paroxetine; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Time Factors; Venlafaxine Hydrochloride | 2003 |
Antidepressant monotherapy for bipolar type II major depression.
Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Bipolar Disorder; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Male; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
A hot flash on tamoxifen metabolism.
Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cyclohexanols; Cytochrome P-450 CYP2D6; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Fluoxetine; Hot Flashes; Humans; Hydroxylation; Paroxetine; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Venlafaxine Hydrochloride | 2003 |
Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea.
Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Delayed-Action Preparations; Drug Tolerance; Half-Life; Humans; Nausea; Paroxetine; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2003 |
Improving antidepressant adherence.
Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Health Promotion; Humans; Paroxetine; Patient Compliance; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2003 |
The treatment of depression with different formulations of venlafaxine: a comparative analysis.
Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Venlafaxine Hydrochloride | 2004 |
Treatment considerations for anxiety in the elderly.
Topics: Aged; Anxiety Disorders; Cognition Disorders; Cyclohexanols; Diagnosis, Differential; Humans; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2003 |
Making sense of the evidence regarding nonhormonal treatments for hot flashes.
Topics: Acetates; Activities of Daily Living; Algorithms; Amines; Cyclohexanecarboxylic Acids; Cyclohexanols; Decision Trees; Drug Monitoring; Drug Therapy, Combination; Evidence-Based Medicine; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Menopause; Middle Aged; Nursing Assessment; Patient Selection; Quality of Life; Selective Serotonin Reuptake Inhibitors; Self Care; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Selective versus multi-transmitter antidepressants: are two mechanisms better than one?
Topics: Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Humans; Patient Care Planning; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Hormone therapy after endometrial cancer.
Topics: Age Distribution; Aged; Chemotherapy, Adjuvant; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometrial Neoplasms; Estrogens; Female; Germany; Hormone Replacement Therapy; Humans; Hysterectomy; Incidence; Middle Aged; Neoplasm Staging; Norpregnenes; Progestins; Raloxifene Hydrochloride; Risk Assessment; Survival Analysis; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Management of hot flashes in breast cancer survivors and men with prostate cancer.
Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Complementary Therapies; Contraceptives, Oral, Synthetic; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Male; Medroxyprogesterone; Menopause, Premature; Paroxetine; Prostatic Neoplasms; Quality of Life; Selective Serotonin Reuptake Inhibitors; Survivors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Treatment of pain syndromes with venlafaxine.
Topics: Analgesics; Animals; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Humans; Pain; Pain, Postoperative; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2004 |
New formulations of existing antidepressants: advantages in the management of depression.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chemistry, Pharmaceutical; Cyclohexanols; Delayed-Action Preparations; Depression; Drug Evaluation; Fluoxetine; Humans; Mianserin; Mirtazapine; Molecular Conformation; Venlafaxine Hydrochloride | 2004 |
Impact of gastrointestinal symptom severity on response to venlafaxine extended-release in patients with generalized anxiety disorder.
Topics: Adult; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Male; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Australia; Cost-Benefit Analysis; Cyclohexanols; Disability Evaluation; Humans; Imipramine; Mental Health Services; Panic Disorder; Paroxetine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2004 |
Common pathways of depression and pain.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Brain; Chronic Disease; Cyclohexanols; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Neurodegenerative Diseases; Neuronal Plasticity; Neurons; Norepinephrine; Pain; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Pharmacotherapy for cataplexy.
Topics: Antidepressive Agents; Cataplexy; Central Nervous System Stimulants; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Humans; Long-Term Care; Sodium Oxybate; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Clinical experience with dual action antidepressants in different chronic pain syndromes.
Topics: Antidepressive Agents; Chronic Disease; Cyclohexanols; Cyclopropanes; Duloxetine Hydrochloride; Humans; Milnacipran; Pain; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Can monoamine-based therapies be improved?
Topics: Adrenergic beta-Antagonists; Antidepressive Agents; Biogenic Monoamines; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Duloxetine Hydrochloride; Humans; Receptors, Biogenic Amine; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials.
Topics: Adolescent; Child; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2004 |
Therapeutic drug monitoring of non-tricyclic antidepressant drugs.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cytochrome P-450 Enzyme System; Drug Monitoring; Humans; Mianserin; Piperazines; Selective Serotonin Reuptake Inhibitors; Trazodone; Triazoles; Venlafaxine Hydrochloride | 2004 |
The role of venlafaxine in the treatment of obsessive-compulsive disorder.
Topics: Clinical Trials as Topic; Cyclohexanols; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
SNRIs in the management of acute major depressive disorder.
Topics: Acute Disease; Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Placebos; Randomized Controlled Trials as Topic; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Qualitative review of SNRIs in anxiety.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Double-Blind Method; Humans; Norepinephrine; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Serotonin; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Long-term management of major depressive disorder: are differences among antidepressant treatments meaningful?
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Humans; Long-Term Care; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Depression in children and adolescents.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Child; Cyclohexanols; Depressive Disorder; Humans; Monoamine Oxidase Inhibitors; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2004 |
Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Outpatients; Quality of Life; Randomized Controlled Trials as Topic; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Treatment Refusal; Venlafaxine Hydrochloride | 2005 |
Simultaneous bilateral acute angle closure glaucoma following venlafaxine treatment.
Topics: Acute Disease; Cyclohexanols; Female; Glaucoma, Angle-Closure; Humans; Irritable Bowel Syndrome; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
[Review of antidepressants from the TCAs to the third generation drugs].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Combinations; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Piperazines; Pyrimidines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Trazodone; Triazoles; Venlafaxine Hydrochloride | 2004 |
Serotonin toxicity associated with concomitant use of linezolid.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Child, Preschool; Cyclohexanols; Drug Interactions; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Serotonin Agents; Serotonin Syndrome; Venlafaxine Hydrochloride | 2005 |
Using metaanalysis to evaluate evidence: practical tips and traps.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Evidence-Based Medicine; Humans; Meta-Analysis as Topic; Outcome and Process Assessment, Health Care; Randomized Controlled Trials as Topic; Seasonal Affective Disorder; Selective Serotonin Reuptake Inhibitors; Trazodone; Venlafaxine Hydrochloride | 2005 |
Venlafaxine in the treatment of anxiety disorders.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Cyclohexanols; Humans; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis.
Topics: Antidepressive Agents; Anxiety Disorders; Cyclohexanols; Female; Humans; Imipramine; Male; Paroxetine; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Remission from depression : a review of venlafaxine clinical and economic evidence.
Topics: Antidepressive Agents, Second-Generation; Cost of Illness; Cyclohexanols; Depression; Humans; Remission Induction; Secondary Prevention; Venlafaxine Hydrochloride | 2005 |
Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder.
Topics: Adolescent; Adult; Cost of Illness; Cost-Benefit Analysis; Cyclohexanols; Decision Trees; Depressive Disorder, Major; Duloxetine Hydrochloride; Economics, Pharmaceutical; Health Care Costs; Humans; Middle Aged; Models, Econometric; Norepinephrine; Ontario; Outpatients; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.
Topics: Antidepressive Agents; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; In Vitro Techniques; Milnacipran; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride; Vesicular Monoamine Transport Proteins | 2005 |
Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials.
Topics: Adult; Cyclohexanols; Data Collection; Delayed-Action Preparations; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Patient Dropouts; Randomized Controlled Trials as Topic; Review Literature as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Discontinuation symptoms in depression and anxiety disorders.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paroxetine; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Withholding Treatment | 2007 |
Venlafaxine and serious withdrawal symptoms: warning to drivers.
Topics: Adult; Automobile Driving; Cyclohexanols; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2005 |
[1+1 or 2x1? Another form of dual antidepressive mechanism of action].
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Clinical Trials as Topic; Cyclohexanols; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride | 2005 |
Managing depressive and anxiety disorders with escitalopram.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalopram; Cyclohexanols; Depressive Disorder; Humans; Models, Economic; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Stereoisomerism; Venlafaxine Hydrochloride | 2006 |
Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
Topics: Citalopram; Cyclohexanols; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Mianserin; Mirtazapine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Trazodone; Venlafaxine Hydrochloride | 2006 |
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Brain; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Dopamine; Dopamine Uptake Inhibitors; Drug Delivery Systems; Drug Design; Drug Therapy, Combination; Humans; Morpholines; Nerve Net; Neurons; Norepinephrine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2006 |
Treatment of anxiety disorders with venlafaxine XR.
Topics: Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Humans; Product Surveillance, Postmarketing; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Humans; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
Topics: Adrenergic Uptake Inhibitors; Clomipramine; Controlled Clinical Trials as Topic; Cyclohexanols; Double-Blind Method; Drug Resistance; Duloxetine Hydrochloride; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Placebos; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Lamotrigine add-on therapy to venlafaxine treatment in adolescent-onset bipolar II disorder: a case report covering an 8-month observation period.
Topics: Adolescent; Age of Onset; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Cyclohexanols; Drug Therapy, Combination; Humans; Lamotrigine; Male; Psychiatric Status Rating Scales; Treatment Outcome; Triazines; Venlafaxine Hydrochloride | 2006 |
Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Duloxetine Hydrochloride; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Regression Analysis; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
[Psychotherapies: what is the impact on the cortical and subcortical levels?].
Topics: Brain; Cyclohexanols; Depression; Humans; Obsessive-Compulsive Disorder; Phobic Disorders; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Depression in adults.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Electroconvulsive Therapy; Humans; Hypericum; Monoamine Oxidase Inhibitors; Morpholines; Phytotherapy; Plant Preparations; Psychotherapy; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Defining response and remission in anxiety disorders: toward an integrated approach.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Humans; Personality Assessment; Personality Inventory; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Current approaches to the pharmacologic treatment of anxiety disorders.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Brain; Cyclohexanols; Drug Approval; Humans; Monoamine Oxidase Inhibitors; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; United States; United States Food and Drug Administration; Venlafaxine Hydrochloride | 2007 |
Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Overdose; Female; Humans; Long QT Syndrome; Male; Retrospective Studies; Tachycardia; Venlafaxine Hydrochloride | 2007 |
Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder, Major; Humans; Meta-Analysis as Topic; Models, Econometric; Quality of Life; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Generalized anxiety disorder: raising the expectations of treatment.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2002 |
Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder.
Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Compounding; Humans; Practice Patterns, Physicians'; Stress Disorders, Post-Traumatic; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
[Painful hyperexcitability syndrome with oxaliplatin containing chemotherapy. Clinical features, pathophysiology and therapeutic options].
Topics: Adrenergic Uptake Inhibitors; Amifostine; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcium Carbonate; Calcium Gluconate; Colorectal Neoplasms; Cyclohexanols; Humans; Hyperalgesia; Magnesium Chloride; Nerve Fibers; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Peripheral Nerves; Rats; Selective Serotonin Reuptake Inhibitors; Sodium Channels; Venlafaxine Hydrochloride | 2008 |
[Applications and safety of modern antidepressants in patients with liver diseases].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cyclopropanes; Depressive Disorder; Humans; Liver Diseases; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Piperazines; Risk Factors; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 2007 |
Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse.
Topics: Animals; Behavior; Central Nervous System Stimulants; Cyclohexanols; Dextroamphetamine; Dopamine; Humans; Illicit Drugs; Morphine; Motor Activity; Narcotics; Nicotiana; p-Chloroamphetamine; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Substance-Related Disorders; Venlafaxine Hydrochloride | 2008 |
Safety profile of treatment in diabetic peripheral neuropathic pain.
Topics: Administration, Topical; Analgesics; Anesthetics, Local; Anticonvulsants; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Capsaicin; Cyclohexanols; Diabetic Neuropathies; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Pain; Pregabalin; Thiophenes; Venlafaxine Hydrochloride | 2007 |
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2008 |
Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches.
Topics: Bupropion; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Humans; Patient Dropouts; Remission Induction; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
Managing hot flashes in men being treated for prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents; Combined Modality Therapy; Complementary Therapies; Cyclohexanols; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Male; Megestrol Acetate; Orchiectomy; Prostatic Neoplasms; Testosterone; Venlafaxine Hydrochloride | 2007 |
[A clinical challenge. Pragmatic treatment of migraine and concomitant depression].
Topics: Amitriptyline; Analgesics, Non-Narcotic; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antiemetics; Arrhythmias, Cardiac; Cross-Over Studies; Cyclohexanols; Depression; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Fluoxetine; Humans; Migraine Disorders; Polypharmacy; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2008 |
[Is it advisable to combine electroconvulsive therapy (ECT) with psychotropics?].
Topics: Combined Modality Therapy; Cyclohexanols; Drug Interactions; Electroconvulsive Therapy; Humans; Lithium Compounds; Practice Guidelines as Topic; Psychotic Disorders; Psychotropic Drugs; Safety; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study.
Topics: Adult; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Double-Blind Method; Female; Fluoxetine; Gastrointestinal Diseases; Headache; Humans; Hypertension; Male; Middle Aged; Respiratory Tract Infections; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
[Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].
Topics: Affect; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Mianserin; Mirtazapine; Patient Satisfaction; Personality Inventory; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Suicide Prevention; Thiophenes; Time Factors; Treatment Refusal; Venlafaxine Hydrochloride | 2008 |
Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Humans; Odds Ratio; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Perinatal depression: treatment options and dilemmas.
Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Case-Control Studies; Cyclohexanols; Depression, Postpartum; Depressive Disorder; Female; Fetal Diseases; Humans; Infant, Newborn; Lithium Carbonate; Perinatology; Pregnancy; Selective Serotonin Reuptake Inhibitors; Valproic Acid; Venlafaxine Hydrochloride | 2008 |
Are SNRIs more effective than SSRIs? A review of the current state of the controversy.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Depressive Disorder; Humans; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
New antidepressants for older people: a critical review of the evidence base.
Topics: Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Fluoxetine; Humans; Patient Care Team; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
Tolerability of amine uptake inhibitors in urologic diseases.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Cyclohexanols; Duloxetine Hydrochloride; Humans; Meta-Analysis as Topic; Norepinephrine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Urologic Diseases; Venlafaxine Hydrochloride | 2006 |
Desvenlafaxine: another "me too" drug?
Topics: Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Costs; Drug Interactions; Humans; Remission Induction; Venlafaxine Hydrochloride | 2008 |
[Genomical and metabolomical abnormalities in Alzheimer disease and in experimental models].
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antidepressive Agents; Apolipoprotein E4; Benzodiazepines; Citalopram; Cyclohexanols; Disease Models, Animal; Gene Expression Regulation; Humans; Hungary; Mianserin; Mirtazapine; Oxidative Stress; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antineoplastic Agents, Hormonal; Biotransformation; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Delayed-Action Preparations; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Hot Flashes; Humans; Middle Aged; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
[Mood disorders].
Topics: Adolescent; Adult; Age Factors; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Hospitalization; Humans; Male; Mood Disorders; Personality Disorders; Pregnancy; Prognosis; Psychotherapy; Psychotropic Drugs; Recurrence; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Suicide; Time Factors; Venlafaxine Hydrochloride; Young Adult | 2008 |
The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Humans; Middle Aged; Psychiatric Status Rating Scales; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Is there a correlation between venlafaxine therapy during pregnancy and a higher incidence of necrotizing enterocolitis?
Topics: Colectomy; Colon; Cyclohexanols; Depression; Enterocolitis, Necrotizing; Female; Humans; Ileum; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Twins; Venlafaxine Hydrochloride | 2009 |
Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Reference Values; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Statistics, Nonparametric; Time Factors; Venlafaxine Hydrochloride | 2009 |
Change in formulation and its potential clinical and pharmacoeconomic value: example of extended release venlafaxine.
Topics: Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Compounding; Drug Therapy; Humans; Models, Biological; United States; United States Food and Drug Administration; Venlafaxine Hydrochloride | 2009 |
[Severe forms of depression: the efficacy of escitalopram].
Topics: Antidepressive Agents, Second-Generation; Citalopram; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Follow-Up Studies; Humans; Paroxetine; Personality Inventory; Psychometrics; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
An integrated analysis of the efficacy of desvenlafaxine compared with placebo in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2009 |
Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Thiophenes; Time Factors; Venlafaxine Hydrochloride; Young Adult | 2009 |
Pharmacotherapy for social anxiety disorder: an update.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Drug Resistance; Humans; Monoamine Oxidase Inhibitors; Phobic Disorders; Psychotropic Drugs; Randomized Controlled Trials as Topic; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
[Anxiety disorders: diagnosis and therapy from the family physician's perspective].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Behavior Therapy; Cognitive Behavioral Therapy; Cyclohexanols; Diagnosis, Differential; Family Practice; Humans; Panic Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Interactions between tamoxifen and antidepressants via cytochrome P450 2D6.
Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Venlafaxine Hydrochloride | 2009 |
[Cholinesterase inhibitors and depression in the elderly].
Topics: Aged; Antidepressive Agents, Second-Generation; Cholinesterase Inhibitors; Cognition Disorders; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Male; Neuropsychological Tests; Venlafaxine Hydrochloride | 2010 |
Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Norepinephrine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2010 |
Differential outcomes from metabolic ratios in the identification of CYP2D6 phenotypes--focus on venlafaxine and O-desmethylvenlafaxine.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Biological Availability; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Female; Genotype; Humans; India; Male; Phenotype; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Therapeutic Equivalency; Venlafaxine Hydrochloride | 2010 |
Psychiatric concerns in pediatric epilepsy.
Topics: Adolescent; Amines; Anxiety Disorders; Bipolar Disorder; Child; Child, Preschool; Cyclohexanecarboxylic Acids; Cyclohexanols; Epilepsy; Gabapentin; gamma-Aminobutyric Acid; Humans; Mental Disorders; Norepinephrine; Pregabalin; Selective Serotonin Reuptake Inhibitors; Valproic Acid; Venlafaxine Hydrochloride; Young Adult | 2010 |
Antidepressants for neuropathic pain: a Cochrane review.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Diabetic Neuropathies; Humans; Neuralgia; Neuralgia, Postherpetic; Randomized Controlled Trials as Topic; Risk; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
A systematic review of duloxetine and venlafaxine in major depression, including unpublished data.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Resistance; Duloxetine Hydrochloride; Humans; Pharmacological Phenomena; Randomized Controlled Trials as Topic; Remission Induction; Therapeutic Equivalency; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
CYP 2D6 PM status and antidepressant response to nortriptyline and venlafaxine: is it more than just drug metabolism?
Topics: Antidepressive Agents; Catalysis; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder; Humans; Nortriptyline; Substrate Specificity; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
What can we learn from Chinese randomized controlled trials? A systematic review and meta-analysis of Chinese venlafaxine studies.
Topics: Asian People; Cyclohexanols; Depressive Disorder; Humans; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2011 |
Efficacy and tolerability of venlafaxine versus specific serotonin reuptake inhibitors in treatment of major depressive disorder: a meta-analysis of published studies.
Topics: Adult; Antidepressive Agents, Second-Generation; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Evidence-Based Medicine; Female; Humans; Male; Odds Ratio; Predictive Value of Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
Mirtazapine versus other antidepressive agents for depression.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depression; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2011 |
Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine.
Topics: Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Suicide; Venlafaxine Hydrochloride | 2012 |
Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine.
Topics: Adolescent; Adult; Aged; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
[Diagnostic and therapeutic update in narcolepsy].
Topics: Adolescent; Adult; Age of Onset; Animals; Autoimmune Diseases; Benzhydryl Compounds; Cataplexy; Child; Clomipramine; Cyclohexanols; Delayed Diagnosis; Disease Models, Animal; Dogs; Genetic Predisposition to Disease; Histamine Agonists; HLA-DQ Antigens; HLA-DQ beta-Chains; Humans; Hypothalamus; Immunoglobulins, Intravenous; Intracellular Signaling Peptides and Proteins; Methylphenidate; Modafinil; Narcolepsy; Neuropeptides; Orexins; Polysomnography; Receptors, Antigen, T-Cell; Sodium Oxybate; Venlafaxine Hydrochloride | 2012 |
Citalopram versus other anti-depressive agents for depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depression; Humans; Morpholines; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
Venlafaxine-induced cholestatic hepatitis: case report and review of literature.
Topics: Adult; Antidepressive Agents, Second-Generation; Biopsy; Cholestasis, Intrahepatic; Cyclohexanols; Dose-Response Relationship, Drug; Female; Humans; Liver; Liver Function Tests; Venlafaxine Hydrochloride | 2012 |
Duloxetine versus other anti-depressive agents for depression.
Topics: Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Desvenlafaxine Succinate; Dibenzothiazepines; Duloxetine Hydrochloride; Fluoxetine; Humans; Paroxetine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Thiophenes; Venlafaxine Hydrochloride | 2012 |
Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD: a systematic review of non-controlled and controlled trials.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Cyclohexanols; Dose-Response Relationship, Drug; Humans; Methylphenidate; Research Design; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2013 |
Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Drug Resistance; Educational Status; Electroconvulsive Therapy; Female; Humans; Kaplan-Meier Estimate; Lithium Carbonate; Male; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales; Recurrence; Survival Analysis; Venlafaxine Hydrochloride | 2013 |
Clinical Inquiry: Do venlafaxine and gabapentin control hot flashes in women with a history of breast cancer?
Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Constipation; Cyclohexanecarboxylic Acids; Cyclohexanols; Dizziness; Dose-Response Relationship, Drug; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Off-Label Use; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder.
Topics: Acute Disease; Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Paroxetine; Recurrence; Thiophenes; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Specificity profile of venlafaxine and sertraline in major depression: metaregression of double-blind, randomized clinical trials.
Topics: Adrenergic Uptake Inhibitors; Cyclohexanols; Demography; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Randomized Controlled Trials as Topic; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2014 |
The efficacy of nonestrogenic therapy to hot flashes in cancer patients under hormone manipulation therapy: a systematic review and meta-analysis.
Topics: Amines; Antineoplastic Agents, Hormonal; Cyclohexanecarboxylic Acids; Cyclohexanols; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Neoplasms, Hormone-Dependent; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Humans; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
A patient with intractable attacks of cataplexy.
Topics: Adult; Cataplexy; Combined Modality Therapy; Cyclohexanols; Diagnosis, Differential; Electroencephalography; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Narcolepsy; Neuropsychological Tests; Polysomnography; Psychotherapy; Risk Assessment; Severity of Illness Index; Venlafaxine Hydrochloride; Video Recording | 2013 |
Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release?
Topics: Animals; Antidepressive Agents; Aza Compounds; Brain; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Buspirone; Cyclohexanols; Disease Models, Animal; Dopamine; Female; Humans; Indoles; Male; Norepinephrine; Paroxetine; Pyridines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Sexual Behavior, Animal; Sexual Dysfunction, Physiological; Synaptic Transmission; Venlafaxine Hydrochloride | 2014 |
PharmGKB summary: venlafaxine pathway.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Depression; Genetic Variation; Genotype; Humans; Metabolic Networks and Pathways; Mice; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors; Substrate Specificity; Venlafaxine Hydrochloride | 2014 |
Which placebo to cure depression? A thought-provoking network meta-analysis.
Topics: Antidepressive Agents; Biomedical Research; Clinical Trials as Topic; Cyclohexanols; Depression; Fluoxetine; Humans; Placebos; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics.
Topics: Adrenergic Uptake Inhibitors; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Duloxetine Hydrochloride; Humans; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2014 |
Treatment of hidradenitis supprurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pegabalin, duloxetine, and venlafaxine.
Topics: Acetaminophen; Amines; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Hidradenitis Suppurativa; Humans; Pain; Pain Management; Pregabalin; Pyrazoles; Selective Serotonin Reuptake Inhibitors; Sulfonamides; Thiophenes; Venlafaxine Hydrochloride | 2013 |
[Venlafaxine (velaxin) effectivity in treatment of depression: results of the recent investigations].
Topics: Cyclohexanols; Depressive Disorder; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2013 |
Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy.
Topics: Antineoplastic Agents; Cyclohexanols; Cyclopropanes; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Humans; Milnacipran; Neurotransmitter Uptake Inhibitors; Norepinephrine; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2014 |
Venlafaxine pharmacokinetics focused on drug metabolism and potential biomarkers.
Topics: Age Factors; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Biomarkers; Body Weight; Cyclohexanols; Cytochrome P-450 Enzyme System; Genetic Markers; Humans; Kidney Diseases; Liver Diseases; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Sex Factors; Smoking; Venlafaxine Hydrochloride | 2014 |
Novel antidepressant drugs, arterial hypertension and cardiovascular disease.
Topics: Animals; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Cardiovascular System; Cyclohexanols; Humans; Hypertension; Patents as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2013 |
A painful urologic emergency.
Topics: Cyclohexanols; Emergencies; Emergency Service, Hospital; Follow-Up Studies; Humans; Male; Middle Aged; Pain; Priapism; Risk Assessment; Treatment Outcome; Urologic Diseases; Urologic Surgical Procedures, Male; Venlafaxine Hydrochloride | 2014 |
[If the general practitioner has to decide: what is the evidence for the selection of antidepressants?].
Topics: Acetamides; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Evidence-Based Medicine; General Practice; Germany; Guideline Adherence; Humans; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies.
Topics: Acetamides; Adult; Aged; Antidepressive Agents; Benzofurans; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Humans; Hypnotics and Sedatives; Indoles; Male; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulfides; Thiophenes; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2014 |
Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.
Topics: Amitriptyline; Anticonvulsants; Antidepressive Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Carbamazepine; Central Nervous System; Cyclohexanols; Duloxetine Hydrochloride; Epothilones; Humans; Neoplasms; Neuralgia; Oxcarbazepine; Peripheral Nervous System Diseases; Pyrazines; Taxoids; Thalidomide; Thiophenes; Venlafaxine Hydrochloride; Vinca Alkaloids | 2015 |
Update on the efficacy of pharmacotherapy for social anxiety disorder: a meta-analysis.
Topics: Antidepressive Agents; Antipsychotic Agents; Cyclohexanols; Humans; Monoamine Oxidase Inhibitors; Paroxetine; Phenelzine; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia.
Topics: Cyclohexanols; Fibromyalgia; Humans; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Topics: Adrenergic Uptake Inhibitors; Adult; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Norepinephrine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Tension-Type Headache; Venlafaxine Hydrochloride | 2015 |
Enantioselective analysis of venlafaxine and its active metabolites: A review on the separation methodologies.
Topics: Antidepressive Agents; Chromatography, Liquid; Cyclohexanols; Desvenlafaxine Succinate; Electrophoresis, Capillary; Humans; Stereoisomerism; Tandem Mass Spectrometry; Venlafaxine Hydrochloride | 2021 |
Impact of Venlafaxine on Platelet Count and Activity-Case Report and Narrative Review.
Topics: Cyclohexanols; Humans; Platelet Count; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2022 |
Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine.
Topics: Animals; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Humans; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2022 |
531 trial(s) available for venlafaxine hydrochloride and cyclohexanol
| Article | Year |
|---|---|
Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology.
Topics: Adult; Antidepressive Agents; Brain; Brain Mapping; Cyclohexanols; Double-Blind Method; Electroencephalography; Female; Humans; Male; Psychometrics; Psychophysiology; Venlafaxine Hydrochloride | 1992 |
Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Drug Administration Schedule; Humans; Male; Venlafaxine Hydrochloride | 1992 |
Placebo-controlled trial of venlafaxine for the treatment of major depression.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1991 |
Venlafaxine in depressed outpatients.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Double-Blind Method; Humans; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1991 |
Venlafaxine: measuring the onset of antidepressant action.
Topics: Antidepressive Agents; Cyclohexanols; Depression; Follow-Up Studies; Humans; Placebo Effect; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 1995 |
Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia.
Topics: Adult; Aged; Body Weight; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1995 |
The pharmacokinetics of venlafaxine when given in a twice-daily regimen.
Topics: Adult; Antidepressive Agents, Second-Generation; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Cyclohexanols; Desvenlafaxine Succinate; Drug Administration Schedule; Female; Humans; Male; Venlafaxine Hydrochloride | 1995 |
Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and diazepam.
Topics: Adult; Antidepressive Agents, Second-Generation; Cross-Over Studies; Cyclohexanols; Diazepam; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Humans; Male; Single-Blind Method; Venlafaxine Hydrochloride | 1995 |
Venlafaxine treatment of panic disorder: a case series.
Topics: Adult; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1995 |
Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imipramine; Long-Term Care; Male; Venlafaxine Hydrochloride | 1994 |
A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Hospitalization; Humans; Male; Middle Aged; Personality Inventory; Venlafaxine Hydrochloride | 1994 |
Cumulative mean change procedure: application to a comparative trial of venlafaxine, imipramine, and placebo in the treatment of major depression.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Data Interpretation, Statistical; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1994 |
Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
Topics: Acute Disease; Adult; Ambulatory Care; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 1994 |
A comparison of venlafaxine, trazodone, and placebo in major depression.
Topics: Adult; Antidepressive Agents; Blood Pressure; Cyclohexanols; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Heart Rate; Humans; Male; Psychiatric Status Rating Scales; Single-Blind Method; Time Factors; Trazodone; Venlafaxine Hydrochloride | 1994 |
Acute effects of the novel antidepressant venlafaxine on cognitive event-related potentials (P300), eye blink rate and mood in young healthy subjects.
Topics: Adult; Affect; Antidepressive Agents; Blinking; Cognition; Cyclohexanols; Dose-Response Relationship, Drug; Double-Blind Method; Evoked Potentials; Female; Humans; Male; Neurotransmitter Uptake Inhibitors; Reference Values; Venlafaxine Hydrochloride | 1993 |
Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1993 |
Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Psychiatric Status Rating Scales; Psychometrics; Research Design; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Venlafaxine in obsessive-compulsive disorder.
Topics: Adrenergic Uptake Inhibitors; Cyclohexanols; Double-Blind Method; Humans; Obsessive-Compulsive Disorder; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Heart Rate; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1996 |
Dose-response relationship with venlafaxine.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Norepinephrine; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Serotonin; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Clinical evaluation of venlafaxine.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Efficacy of venlafaxine and placebo during long-term treatment of depression: a pooled analysis of relapse rates.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Recurrence; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 1996 |
Relatively low doses of cisapride in the treatment of nausea in patients treated with venlafaxine for treatment-refractory depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Cisapride; Cyclohexanols; Depressive Disorder; Drug Resistance; Female; Humans; Male; Middle Aged; Nausea; Piperidines; Psychiatric Status Rating Scales; Serotonin Antagonists; Venlafaxine Hydrochloride | 1996 |
Open treatment of obsessive-compulsive disorder with venlafaxine: a series of ten cases.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Obsessive-Compulsive Disorder; Venlafaxine Hydrochloride | 1996 |
Venlafaxine in depressed geriatric outpatients: an open-label clinical study.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Humans; Male; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1995 |
Venlafaxine in social phobia.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Male; Middle Aged; Phobic Disorders; Psychiatric Status Rating Scales; Retrospective Studies; Venlafaxine Hydrochloride | 1995 |
Venlafaxine in the treatment of borderline personality disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Borderline Personality Disorder; Cyclohexanols; Female; Humans; Male; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1995 |
An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Female; Humans; Male; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1995 |
Open-label trial of venlafaxine in adults with attention deficit disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Female; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1995 |
Pharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithium.
Topics: Administration, Oral; Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Desvenlafaxine Succinate; Drug Administration Schedule; Drug Interactions; Humans; Lithium; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1996 |
A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Venlafaxine Hydrochloride | 1996 |
An open-label evaluation of the long-term safety of oral venlafaxine in depressed elderly patients.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Depression; Electrocardiography; Female; Humans; Male; Sampling Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Venlafaxine hydrochloride and chronic pain.
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Cyclohexanols; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1996 |
Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cerebrovascular Circulation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Prefrontal Cortex; Tomography, Emission-Computed; Venlafaxine Hydrochloride | 1996 |
A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Sleep; Venlafaxine Hydrochloride | 1996 |
Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Venlafaxine Hydrochloride | 1996 |
Curvaceous model of recovery from depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder; Humans; Models, Statistical; Piperazines; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 1997 |
Venlafaxine in the treatment of children and adolescents with major depression.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1997 |
An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Child; Cyclohexanols; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Interviews as Topic; Male; Parents; Psychiatric Status Rating Scales; Psychological Tests; Reaction Time; Venlafaxine Hydrochloride | 1996 |
Efficacy of venlafaxine in depressive illness in general practice.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Cyclohexanols; Depression; Double-Blind Method; Family Practice; Female; Humans; Imipramine; Male; Middle Aged; Placebo Effect; Prospective Studies; Social Adjustment; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
A randomised, double-blind, parallel-group comparison of venlafaxine and dothiepin in geriatric patients with major depression.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Dothiepin; Double-Blind Method; Female; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Differential pharmacological treatment response in high angry hostile and low angry hostile depressed patients: a retrospective analysis.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Analysis of Variance; Anger; Cyclohexanols; Depressive Disorder; Desipramine; Female; Hostility; Humans; Male; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Demonstration of clomipramine and venlafaxine occupation at serotonin reuptake sites in man in vivo.
Topics: Adult; Brain; Carrier Proteins; Clomipramine; Cocaine; Cyclohexanols; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Thorax; Venlafaxine Hydrochloride | 1997 |
Once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression. Venlafaxine XR 208 Study Group.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antidepressive Agents, Second-Generation; Chi-Square Distribution; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Longitudinal Studies; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Nausea; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine.
Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1997 |
Venlafaxine in dysthymic disorder.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysthymic Disorder; Female; Humans; Male; Personality Inventory; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder; Dizziness; Double-Blind Method; Female; Humans; Male; Nausea; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cohort Studies; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
A benefit-risk analysis of once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression.
Topics: Antidepressive Agents, Second-Generation; Cost-Benefit Analysis; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Humans; Nausea; Selective Serotonin Reuptake Inhibitors; Statistics as Topic; Venlafaxine Hydrochloride | 1997 |
Pharmacokinetics and effect of food on the bioavailability of orally administered venlafaxine.
Topics: Administration, Oral; Adult; Area Under Curve; Biological Availability; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Female; Food-Drug Interactions; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and ethanol.
Topics: Adult; Central Nervous System Depressants; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Drug Interactions; Ethanol; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression.
Topics: Adult; Aged; Ambulatory Care; Anorexia; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Placebos; Psychiatric Status Rating Scales; Sleep Wake Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
Long-term treatment of geropsychiatric depressed patients with venlafaxine.
Topics: Adrenergic Uptake Inhibitors; Age Factors; Aged; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Recurrence; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Absolute bioavailability and electroencephalographic effects of conventional and extended-release formulations of venlafaxine in healthy subjects.
Topics: Adult; Area Under Curve; Biological Availability; Cross-Over Studies; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Electroencephalography; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
The influence of cimetidine on the disposition kinetics of the antidepressant venlafaxine.
Topics: Adolescent; Adult; Anti-Ulcer Agents; Antidepressive Agents; Cimetidine; Cross-Over Studies; Cyclohexanols; Drug Interactions; Female; Humans; Male; Venlafaxine Hydrochloride | 1998 |
Comparison of venlafaxine and imipramine in depressive illness.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Family Practice; Female; Humans; Imipramine; Male; Middle Aged; Patient Care Team; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens.
Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Automobile Driving; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Mianserin; Psychomotor Performance; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Once- versus twice-daily venlafaxine therapy in major depression: a randomized, double-blind study.
Topics: Adult; Ambulatory Care; Cyclohexanols; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Half-Life; Humans; Linear Models; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
Low-dose venlafaxine treatment in panic disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Female; Humans; Male; Panic Disorder; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1998 |
Effect of venlafaxine on the pharmacokinetics of alprazolam.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Biotransformation; Cyclohexanols; Drug Interactions; Female; Humans; Male; Venlafaxine Hydrochloride | 1998 |
A controlled trial of venlafaxine in trichotillomania: interim phase I results.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Trichotillomania; Venlafaxine Hydrochloride | 1998 |
Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk.
Topics: Adult; Antidepressive Agents; Area Under Curve; Breast Feeding; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Female; Humans; Infant; Infant, Newborn; Milk, Human; Tissue Distribution; Venlafaxine Hydrochloride | 1998 |
Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.
Topics: Adult; Antidepressive Agents, Second-Generation; Antineoplastic Agents; Cyclohexanols; Female; Hot Flashes; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
Withdrawal and rebound symptoms associated with abrupt discontinuation of venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Recurrence; Substance Withdrawal Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.
Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Fluoxetine; Humans; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
Effect of venlafaxine on the pharmacokinetics of terfenadine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Interactions; Female; Histamine H1 Antagonists; Humans; Male; Terfenadine; Venlafaxine Hydrochloride | 1998 |
A large open-label study of venlafaxine in depressed outpatients by community-based physicians.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Community Medicine; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Dysthymic Disorder; Family Practice; Female; Humans; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia | 1998 |
Efficacy and tolerability of venlafaxine in the treatment of primary dysthymia.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Dysthymic Disorder; Female; Humans; Male; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Brain; Bupropion; Cross-Over Studies; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Serotonin; Venlafaxine Hydrochloride | 1999 |
[Prophylaxis of migraine: open study with venlafaxine in 42 patients].
Topics: Adolescent; Adult; Cyclohexanols; Female; Humans; Male; Middle Aged; Migraine Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Therapy of early poststroke depression with venlafaxine: safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial.
Topics: Aged; Antidepressive Agents, Second-Generation; Cerebrovascular Disorders; Cyclohexanols; Depression; Female; Humans; Male; Venlafaxine Hydrochloride | 1999 |
Effect of venlafaxine on CYP1A2-dependent pharmacokinetics and metabolism of caffeine.
Topics: Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Caffeine; Central Nervous System Stimulants; Cyclohexanols; Cytochrome P-450 CYP1A2; Desvenlafaxine Succinate; Drug Interactions; Female; Humans; Male; Patient Dropouts; Time Factors; Venlafaxine Hydrochloride | 1999 |
Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Middle Aged; Placebos; Prospective Studies; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Pharmacoeconomic analysis of venlafaxine in the treatment of major depressive disorder.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Models, Economic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
The effects of venlafaxine on social activity level in depressed outpatients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Interpersonal Relations; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Comparison of the effects of venlafaxine, paroxetine and desipramine on the pupillary light reflex in man.
Topics: Adrenergic Uptake Inhibitors; Adult; Cross-Over Studies; Cyclohexanols; Desipramine; Double-Blind Method; Humans; Male; Paroxetine; Reflex, Pupillary; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antidepressive Agents, Second-Generation; Cyclohexanols; Hot Flashes; Humans; Male; Middle Aged; Pilot Projects; Prostatic Neoplasms; Severity of Illness Index; Venlafaxine Hydrochloride | 1999 |
[The concept of resistant depression and therapeutic strategies, particularly, with venlafaxine].
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Humans; Paroxetine; Remission, Spontaneous; Severity of Illness Index; Venlafaxine Hydrochloride | 1999 |
Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders.
Topics: Adolescent; Cyclohexanols; Female; Humans; Male; Personality Disorders; Phobic Disorders; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Buspirone; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Placebos; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Venlafaxine in treatment-resistant major depression: a Canadian multicenter, open-label trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Canada; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1999 |
Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein.
Topics: Adrenergic alpha-Agonists; Adult; Blood Pressure; Cross-Over Studies; Cyclohexanols; Desipramine; Double-Blind Method; Drug Interactions; Hand; Heart Rate; Humans; Male; Methoxamine; Norepinephrine; Paroxetine; Salivation; Selective Serotonin Reuptake Inhibitors; Vasoconstriction; Veins; Venlafaxine Hydrochloride | 1999 |
Acute effects of venlafaxine and paroxetine on serotonergic transmission in human volunteers.
Topics: Adolescent; Adult; Area Under Curve; Clomipramine; Cyclohexanols; Human Growth Hormone; Humans; Male; Nausea; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Tryptophan; Venlafaxine Hydrochloride; Vomiting | 1999 |
Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Costs and Cost Analysis; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Managed Care Programs; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Female; Humans; Male; Middle Aged; Paroxetine; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations.
Topics: Chromatography, High Pressure Liquid; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Dextrorphan; Fluoxetine; Humans; Isoenzymes; Paroxetine; Phenotype; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Venlafaxine in the treatment of dysthymia: an open-label study.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Administration Schedule; Dysthymic Disorder; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Patient Dropouts; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia | 1999 |
Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study.
Topics: Adult; Affective Disorders, Psychotic; Cyclohexanols; Delusions; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluvoxamine; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Venlafaxine treatment of cocaine abusers with depressive disorders.
Topics: Adult; Antidepressive Agents, Second-Generation; Cocaine-Related Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Desipramine; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Treatment Failure; Venlafaxine Hydrochloride | 2000 |
Venlafaxine versus fluoxetine in the treatment of atypical anorectic outpatients: a preliminary study.
Topics: Adolescent; Adult; Anorexia Nervosa; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Personality Inventory; Venlafaxine Hydrochloride | 1999 |
Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
Topics: Adult; Aged; Ambulatory Care; Cyclohexanols; Depressive Disorder; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Seizure activity and safety in combined treatment with venlafaxine and ECT: a pilot study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Blood Pressure; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Electrocardiography; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Seizures; Venlafaxine Hydrochloride | 2000 |
Double-blind comparison of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia.
Topics: Adolescent; Adult; Ambulatory Care; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Personality Inventory; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Fluoxetine; Humans; Immune Tolerance; Lymphocyte Activation; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Venlafaxine Hydrochloride | 2000 |
Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans.
Topics: Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Cyclohexanols; Cytochrome P-450 CYP2D6; Genotype; Heart; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Hospitalization; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Venlafaxine Hydrochloride | 2000 |
The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2000 |
Venlafaxine monotherapy in women with bipolar II and unipolar major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Retrospective Studies; Sex Factors; Venlafaxine Hydrochloride | 2000 |
Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Outpatients; Psychiatric Status Rating Scales; Severity of Illness Index; Venlafaxine Hydrochloride | 2000 |
The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population.
Topics: Administration, Oral; Adult; Alleles; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Genotype; Humans; Japan; Male; Mixed Function Oxygenases; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Venlafaxine Hydrochloride | 2000 |
Efficacy of venlafaxine and predictors of response in a prospective open-label study of patients with treatment-resistant major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Comorbidity; Cyclohexanols; Depressive Disorder; Drug Resistance; Female; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2000 |
A randomized, double-blind, parallel-group comparison of venlafaxine and clomipramine in outpatients with major depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1998 |
Lithium augmentation of venlafaxine: an open-label trial.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antimanic Agents; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2000 |
Venlafaxine treatment stimulates blood platelet activity.
Topics: Antidepressive Agents, Second-Generation; Blood Platelets; Cyclohexanols; Flow Cytometry; Humans; P-Selectin; Platelet Adhesiveness; Venlafaxine Hydrochloride | 2000 |
Effect of venlafaxine on imipramine metabolism.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP2D6; Desipramine; Drug Interactions; Humans; Imipramine; Male; Middle Aged; Phenotype; Venlafaxine Hydrochloride | 2000 |
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.
Topics: Antidepressive Agents, Second-Generation; Breast Neoplasms; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Venlafaxine Hydrochloride | 2000 |
Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor.
Topics: Adult; Citalopram; Cognition; Cyclohexanols; Double-Blind Method; Humans; Male; Norepinephrine; Psychological Tests; Psychomotor Performance; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2000 |
Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study.
Topics: Adolescent; Adult; Alcoholism; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Cocaine-Related Disorders; Comorbidity; Cyclohexanols; Humans; Middle Aged; Pilot Projects; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Morpholines; Reboxetine; Venlafaxine Hydrochloride | 2001 |
Sustained response to open-label venlafaxine in drug-resistant major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Mental Status Schedule; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Dextromethorphan; Dextrorphan; Drug Interactions; Female; Fluoxetine; Humans; Male; Metabolic Clearance Rate; Phenotype; Selective Serotonin Reuptake Inhibitors; Time Factors; Urinalysis; Venlafaxine Hydrochloride | 2001 |
Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans.
Topics: Adult; Analgesics; Antidepressive Agents, Second-Generation; Cold Temperature; Cross-Over Studies; Cyclohexanols; Dose-Response Relationship, Drug; Double-Blind Method; Electric Stimulation; Female; Humans; Male; Pain; Pain Measurement; Pain Threshold; Pressure; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Anxiety Disorders; Chronic Disease; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2001 |
Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings.
Topics: Adult; Antidepressive Agents, Second-Generation; Basal Ganglia; Brain; Cyclohexanols; Depressive Disorder; Female; Frontal Lobe; Gyrus Cinguli; Humans; Limbic System; Magnetic Resonance Imaging; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotherapy; Regional Blood Flow; Technetium Tc 99m Exametazime; Temporal Lobe; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Databases, Factual; Depression; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Risk; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide Prevention; Suicide, Attempted; United States; United States Food and Drug Administration; Venlafaxine Hydrochloride | 2001 |
Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2001 |
Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
Topics: Adult; Anxiety Disorders; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms.
Topics: Adult; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Association study of the 5-HT(6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Receptors, Serotonin; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Venlafaxine in the treatment of premenstrual dysphoric disorder.
Topics: Adult; Cyclohexanols; Double-Blind Method; Female; Humans; Premenstrual Syndrome; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
Changes in brain function of depressed subjects during treatment with placebo.
Topics: Adult; Cerebral Cortex; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Placebo Effect; Venlafaxine Hydrochloride | 2002 |
Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Humans; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Venlafaxine in neuropathic pain following treatment of breast cancer.
Topics: Analgesics; Breast Neoplasms; Cross-Over Studies; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Female; Humans; Mastectomy; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Postoperative Complications; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Cytochrome P-450 CYP2D6; Dopamine Uptake Inhibitors; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Can improvement in well-being and functioning be distinguished from depression improvement in antidepressant clinical trials?
Topics: Activities of Daily Living; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Controlled Clinical Trials as Topic; Cyclohexanols; Depression; Factor Analysis, Statistical; Female; Humans; Imipramine; Male; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Venlafaxine Hydrochloride | 2002 |
Early changes in prefrontal activity characterize clinical responders to antidepressants.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Prefrontal Cortex; Single-Blind Method; Venlafaxine Hydrochloride | 2002 |
A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Social adjustment in depressed patients treated with venlafaxine and amitriptyline.
Topics: Adult; Aged; Amitriptyline; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Venlafaxine Hydrochloride | 2002 |
Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Belgium; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2002 |
Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Steady-state concentration of venlafaxine enantiomers: model-based analysis of between-patient variability.
Topics: Adult; Age Factors; Antidepressive Agents, Second-Generation; Cyclohexanols; Desvenlafaxine Succinate; Drug Interactions; Female; Humans; Male; Middle Aged; Sex Factors; Stereoisomerism; Structure-Activity Relationship; Venlafaxine Hydrochloride | 2002 |
Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.
Topics: Adult; Aged; Ambulatory Care; Antipsychotic Agents; Cyclohexanols; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Body Weight; Bulimia; Comorbidity; Cyclohexanols; Female; Humans; Middle Aged; Obesity; Psychiatric Status Rating Scales; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
A pharmacokinetic drug-drug interaction study of venlafaxine and indinavir.
Topics: Adult; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Female; HIV Protease Inhibitors; Humans; Indinavir; Male; Phenotype; Venlafaxine Hydrochloride | 2001 |
Venlafaxine open-label treatment of patients with obsessive-compulsive disorder.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Venlafaxine Hydrochloride | 2002 |
Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine.
Topics: Adolescent; Adult; Affect; Aged; Aged, 80 and over; Anxiety; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Placebos; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Safety and efficacy of high dose of venlafaxine XL in treatment resistant major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Pressure; Body Weight; Cyclohexanols; Depressive Disorder; Drug Resistance; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Pulse; Social Behavior; Venlafaxine Hydrochloride | 2002 |
Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Outpatients; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study.
Topics: Acute Disease; Adult; Ambulatory Care; Clomipramine; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Personality Assessment; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Efficacy of venlafaxine in major depression resistant to selective serotonin reuptake inhibitors.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2002 |
Effectiveness of venlafaxine, extended release formulation, in the short-term and long-term treatment of generalized anxiety disorder: results of a survival analysis.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Humans; Psychiatric Status Rating Scales; Survival Analysis; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health.
Topics: Adult; Buspirone; Colon; Cyclohexanols; Double-Blind Method; Fasting; Female; Gastric Emptying; Gastrointestinal Motility; Humans; Male; Middle Aged; Paroxetine; Postprandial Period; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Tomography, Emission-Computed, Single-Photon; Venlafaxine Hydrochloride | 2003 |
Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder.
Topics: Adult; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Social Behavior; Venlafaxine Hydrochloride | 2003 |
Venlafaxine: the relationship between dose, plasma concentration and clinical response in depressive patients.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biotransformation; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2002 |
Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine.
Topics: Adult; Aged; Antipsychotic Agents; Body Mass Index; Body Weight; Cross-Over Studies; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Leptin; Longitudinal Studies; Male; Mianserin; Middle Aged; Mirtazapine; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2002 |
Single-blind comparison of venlafaxine and nortriptyline in elderly major depression.
Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Nortriptyline; Psychiatric Status Rating Scales; Single-Blind Method; Venlafaxine Hydrochloride | 2003 |
Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.
Topics: Adult; Aged; Analgesics, Non-Narcotic; Cross-Over Studies; Cyclohexanols; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Neuralgia; Neurotransmitter Uptake Inhibitors; Norepinephrine; Pain Measurement; Polyneuropathies; Pressure; Serotonin; Touch; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.
Topics: Algorithms; Ambulatory Care; Analysis of Variance; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Humans; Outcome Assessment, Health Care; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Terminology as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Effective open-label treatment of premenstrual dysphoric disorder with venlafaxine.
Topics: Administration, Oral; Adult; Affect; Cyclohexanols; Female; Humans; Premenstrual Syndrome; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Venlafaxine in treatment-resistant obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Child; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Pilot Projects; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Cyclohexanols; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Female; GABA Modulators; Humans; Male; Middle Aged; Patient Dropouts; Personality Inventory; Placebo Effect; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Statistical considerations about the question of a selection of discriminating centres in the analysis of clinical trial. In response to the paper: "A method for controlling for a high response rate in a comparison of venlafaxine XR and diazepan in the sh
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Bias; Cyclohexanols; Data Collection; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Female; GABA Modulators; Humans; Male; Middle Aged; Placebo Effect; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquine.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Debrisoquin; Drug Interactions; Female; Genotype; Half-Life; Humans; Ketoconazole; Male; Middle Aged; Phenotype; Venlafaxine Hydrochloride; White People | 2003 |
Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents.
Topics: Aged; Aged, 80 and over; Cyclohexanols; Depressive Disorder; Female; Frail Elderly; Geriatric Assessment; Humans; Male; Middle Aged; Nursing Homes; Patient Dropouts; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Venlafaxine treatment of fibromyalgia.
Topics: Adrenergic Uptake Inhibitors; Adult; Anxiety; Cyclohexanols; Depression; Female; Fibromyalgia; Humans; Pain; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
A score for predicting response to pharmacotherapy in obsessive-compulsive disorder.
Topics: Adolescent; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Double-Blind Method; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Predictive Value of Tests; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2003 |
Efficacy and safety of venlafaxine ER vs. amitriptyline ER in patients with major depression of moderate severity.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride | 2003 |
A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Primary Health Care; Quality of Life; Selective Serotonin Reuptake Inhibitors; United Kingdom; Venlafaxine Hydrochloride | 2003 |
Lithium augmentation in venlafaxine non-responders: an open study.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Male; Middle Aged; Personality Inventory; Sulfates; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Cyclohexanols; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Patient Dropouts; Psychological Tests; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Venlafaxine in children and adolescents with attention deficit hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Cyclohexanols; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Time course of clinical response to venlafaxine: relevance of plasma level and chirality.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Desvenlafaxine Succinate; Female; Humans; Male; Middle Aged; Severity of Illness Index; Stereoisomerism; Venlafaxine Hydrochloride | 2004 |
Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.
Topics: Administration, Oral; Adult; Alprazolam; Area Under Curve; Breath Tests; Carbon Radioisotopes; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Drug Administration Schedule; Erythromycin; Fluoxetine; Half-Life; Humans; Male; Middle Aged; Molecular Probes; Piperazines; Sertraline; Triazoles; Venlafaxine Hydrochloride | 2004 |
A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Drug Resistance; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Hospitalization; Humans; Male; Paroxetine; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Buspirone; Colon; Compliance; Cyclohexanols; Double-Blind Method; Fasting; Female; Humans; Male; Pain; Postprandial Period; Pressure; Reference Values; Selective Serotonin Reuptake Inhibitors; Sensory Thresholds; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 2003 |
Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Psychometrics; Somatoform Disorders; Venlafaxine Hydrochloride | 2004 |
Venlafaxine versus placebo in the preventive treatment of recurrent major depression.
Topics: Adult; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Observer Variation; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2004 |
Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of postmastectomy pain syndrome.
Topics: Analgesics; Cyclohexanols; Female; Humans; Mastectomy; Middle Aged; Pain Measurement; Pain, Postoperative; Perioperative Care; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Constipation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Primary Health Care; Psychiatric Status Rating Scales; Sweating; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Reboxetine adjunct for partial or nonresponders to antidepressant treatment.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Personality Inventory; Prospective Studies; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood.
Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Counseling; Cyclohexanols; Double-Blind Method; Female; Ganglionic Stimulants; Genotype; Humans; Male; Middle Aged; Nicotine; Placebos; Polymorphism, Genetic; Receptors, Dopamine D2; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial.
Topics: Adult; Aged; Analgesics; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Facial Pain; Female; Humans; Male; Middle Aged; Pain Measurement; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial.
Topics: Adult; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Outpatients; Patient Dropouts; Phobic Disorders; Psychiatric Status Rating Scales; Reproducibility of Results; Single-Blind Method; Suicide; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treated in
Topics: Aged; Cognition; Cyclohexanols; Depressive Disorder; Disorders of Excessive Somnolence; Dizziness; Dothiepin; Double-Blind Method; Drug Administration Schedule; Female; Flicker Fusion; Humans; Male; Narcolepsy; Nausea; Psychometrics; Psychomotor Performance; Time Factors; Venlafaxine Hydrochloride | 2004 |
Predictors of improved mood over time in clinical trials for major depression.
Topics: Adult; Affect; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2004 |
Social adjustment in generalised anxiety disorder: a long-term placebo-controlled study of venlafaxine extended release.
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Social Adjustment; Venlafaxine Hydrochloride | 2004 |
Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study.
Topics: Aged; Cyclohexanols; Delayed-Action Preparations; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Pain Measurement; Reaction Time; Venlafaxine Hydrochloride | 2004 |
Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety Disorders; Control Groups; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Phobic Disorders; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Personality Assessment; Personality Inventory; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Social Behavior; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Efficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Luteal Phase; Premenstrual Syndrome; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Patient Dropouts; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia | 2004 |
An open trial of venlafaxine for the treatment of late-life atypical depression.
Topics: Age of Onset; Aged; Antidepressive Agents; Chi-Square Distribution; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Venlafaxine Hydrochloride | 2004 |
Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder. A double-blind, randomized, placebo controlled study.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Greece; Humans; Male; Outpatients; Psychiatric Status Rating Scales; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Efficacy of open-label venlafaxine in subjects with major depressive disorder: associations with neuroendocrine response to serotonergic and noradrenergic probes.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Antidepressive Agents, Second-Generation; Clonidine; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Norepinephrine; Personality Inventory; Pyrimidines; Serotonin; Serotonin Receptor Agonists; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Body Weight; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Severity of Illness Index; Venlafaxine Hydrochloride | 2004 |
An open treatment trial of venlafaxine for elderly patients with dysthymic disorder.
Topics: Aged; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2004 |
Venlafaxine for the treatment of depressive episode during the course of schizophrenia.
Topics: Adult; Aged; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Venlafaxine Hydrochloride | 2004 |
S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine.
Topics: Adult; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; S-Adenosylmethionine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2004 |
Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2004 |
Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Central Nervous System Depressants; Cyclohexanols; Depressive Disorder; Ethanol; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Patient Dropouts; Psychiatric Status Rating Scales; Socioeconomic Factors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2005 |
Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.
Topics: Antidepressive Agents; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Female; Hot Flashes; Humans; Libido; Postmenopause; Quality of Life; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo.
Topics: Adolescent; Adult; Brain Mapping; Causality; Cyclohexanols; Double-Blind Method; Electroencephalography; Female; Humans; Interview, Psychological; Male; Middle Aged; Placebo Effect; Prefrontal Cortex; Reference Values; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Geriatric Assessment; Humans; Lithium; Male; Nortriptyline; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Venlafaxine extended release for the treatment of patients with premature ejaculation: a pilot, single-blind, placebo-controlled, fixed-dose crossover study on short-term administration of an antidepressant drug.
Topics: Adult; Antidepressive Agents, Second-Generation; Cross-Over Studies; Cyclohexanols; Erectile Dysfunction; Humans; Male; Middle Aged; Placebos; Single-Blind Method; Venlafaxine Hydrochloride | 2005 |
Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Brain Mapping; Bupropion; Case-Control Studies; Cerebral Cortex; Cross-Over Studies; Cyclohexanols; Demography; Depressive Disorder; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Psychiatric Status Rating Scales; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; Cyclohexanols; Demography; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Severity of Illness Index; Statistics, Nonparametric; Venlafaxine Hydrochloride | 2005 |
Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Nausea; Paroxetine; Phobic Disorders; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Analysis of Variance; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Phobic Disorders; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
The efficacy and safety of venlafaxine in the prophylaxis of migraine.
Topics: Adolescent; Adult; Aged; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine without Aura; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.
Topics: Adolescent; Adult; Antidepressive Agents; Benzothiazoles; Cocaine-Related Disorders; Cyclohexanols; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Paroxetine; Pentoxifylline; Phosphodiesterase Inhibitors; Pramipexole; Riluzole; Selective Serotonin Reuptake Inhibitors; Thiazoles; Venlafaxine Hydrochloride | 2005 |
Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Health Care Costs; Humans; Male; Middle Aged; Prospective Studies; Quality of Life; Venlafaxine Hydrochloride | 2005 |
[Efficiency and safety of citalopram and venlafaxine in treatment of depressive disorders in elderly patients].
Topics: Aged; Citalopram; Cognition; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2004 |
Do venlafaxine XR and paroxetine equally influence negative and positive affect?
Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Paroxetine; Personality Assessment; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Effects of venlafaxine treatment on clozapine plasma levels in schizophrenic patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Chromatography, High Pressure Liquid; Clozapine; Cyclohexanols; Depression; Humans; Male; Middle Aged; Schizophrenia; Venlafaxine Hydrochloride | 2005 |
Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Fluoxetine; Humans; Paroxetine; Placebos; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study.
Topics: Ambulatory Care; Antidepressive Agents, Tricyclic; Attitude to Health; Cohort Studies; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Humans; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Tachyphylaxis; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.
Topics: Adult; Aged; Analgesics; Chronic Disease; Cyclohexanols; Double-Blind Method; Electric Stimulation; Female; Hot Temperature; Humans; Hyperalgesia; Male; Middle Aged; Neuralgia; Pain Measurement; Pain Threshold; Pain, Intractable; Peripheral Nervous System Diseases; Physical Stimulation; Placebos; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Antioxidants; Benzothiazoles; Cocaine-Related Disorders; Cyclohexanols; Double-Blind Method; Female; gamma-Aminobutyric Acid; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nicotine; Pramipexole; Prefrontal Cortex; Protons; Retrospective Studies; Thiazoles; Time Factors; Venlafaxine Hydrochloride | 2005 |
Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Female; Humans; Male; Middle Aged; Odds Ratio; Remission Induction; Time Factors; Treatment Failure; Venlafaxine Hydrochloride | 2005 |
Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Humans; Middle Aged; Perimenopause; Vasomotor System; Venlafaxine Hydrochloride | 2005 |
Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors.
Topics: Adolescent; Adult; Breast Neoplasms; Cyclohexanols; Drug Administration Schedule; Female; Hot Flashes; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Survivors; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Effects of paroxetine and venlafaxine XR on heart rate variability in depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2005 |
[Trazodone and venlafaxine in treatment of depressive disorders].
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Trazodone; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment.
Topics: Adult; Ambulatory Care; Behavior Therapy; Combined Modality Therapy; Cyclohexanols; Female; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study.
Topics: Adult; Analysis of Variance; Anxiety; Capsules; Cholesterol; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Fear; Female; Heart Rate; Humans; Male; Panic Disorder; Patient Compliance; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.
Topics: Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Female; Hot Flashes; Humans; Middle Aged; Pilot Projects; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Failure; Venlafaxine Hydrochloride | 2005 |
Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive compulsive disorder.
Topics: Adult; Cyclohexanols; Cytokines; Double-Blind Method; Female; Humans; Killer Cells, Natural; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2006 |
Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.
Topics: Adult; Ambulatory Care; Blood Pressure; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Health Status; Humans; Male; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Substance Withdrawal Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Counseling; Cyclohexanols; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Patient Selection; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Antidepressant treatment outcomes of psychogenic movement disorder.
Topics: Adult; Ambulatory Care; Anxiety Disorders; Chronic Disease; Citalopram; Combined Modality Therapy; Comorbidity; Conversion Disorder; Cyclohexanols; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Hypochondriasis; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial.
Topics: Adult; Citalopram; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Transcranial Magnetic Stimulation; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Humans; Mianserin; Middle Aged; Mirtazapine; Patient Compliance; Psychiatric Status Rating Scales; Tablets; Time Factors; Venlafaxine Hydrochloride | 2006 |
Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder.
Topics: Ambulatory Care; Anxiety Disorders; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Health Status; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pilot Projects; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.
Topics: Amines; Amitriptyline; Analysis of Variance; Cyclohexanecarboxylic Acids; Cyclohexanols; Diabetic Neuropathies; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Atomoxetine enhances a short-term model of plasticity in humans.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Atomoxetine Hydrochloride; Biomechanical Phenomena; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Movement; Neuronal Plasticity; Propylamines; Thumb; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride | 2006 |
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Bupropion; Cohort Studies; Cross-Sectional Studies; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Lithium; Male; Psychiatric Status Rating Scales; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Cyclohexanols; Drug Therapy, Combination; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Failure; Venlafaxine Hydrochloride | 2006 |
A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
Topics: Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Demography; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2006 |
Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Platelets; Blood Pressure; Cyclohexanols; Desipramine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Paroxetine; Piperazines; Reference Values; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time Factors; Triazoles; Tyramine; Venlafaxine Hydrochloride | 2007 |
Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Blood Platelets; Blood Pressure; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Severity of Illness Index; Time Factors; Treatment Outcome; Tyramine; Venlafaxine Hydrochloride | 2007 |
Treatment with venlafaxine extended release after SSRI nonresponse or intolerance: a randomized comparison of standard- and higher-dosing strategies.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2006 |
A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
Topics: Benzodiazepines; Brief Psychiatric Rating Scale; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Mass Screening; Middle Aged; Olanzapine; Prospective Studies; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Refusal; Venlafaxine Hydrochloride | 2006 |
Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Chi-Square Distribution; Cyclohexanols; Dehydroepiandrosterone; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychological Tests; Remission Induction; Statistics, Nonparametric; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sweating; Venlafaxine Hydrochloride; Weight Gain | 2006 |
Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
Topics: Adrenergic Uptake Inhibitors; Aged; Amines; Amitriptyline; Analgesia; Analgesics; Brain; Cohort Studies; Cost-Benefit Analysis; Cyclohexanecarboxylic Acids; Cyclohexanols; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Norepinephrine; Pain Measurement; Pain Threshold; Placebo Effect; Serotonin; Thiophenes; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2006 |
Validation of a Dutch translation of the fibromyalgia impact questionnaire.
Topics: Activities of Daily Living; Adult; Aged; Antidepressive Agents, Second-Generation; Balneology; Cross-Cultural Comparison; Cyclohexanols; Double-Blind Method; Female; Fibromyalgia; Health Status Indicators; Humans; Language; Male; Middle Aged; Netherlands; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Humans; Interleukin-12; Male; Middle Aged; Paroxetine; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: a randomized, open-labeled clinical trial.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Cyclohexanols; Depressive Disorder, Major; Drug Evaluation; Drug Interactions; Female; Humans; Male; Middle Aged; Morpholines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Venlafaxine Hydrochloride | 2006 |
Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine.
Topics: Adult; Anticonvulsants; Anxiety Disorders; Cyclohexanols; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Placebos; Pregabalin; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Severity of Illness Index; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression.
Topics: Adult; Biomarkers; Brain; Brain Mapping; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Placebos; Prefrontal Cortex; Psychiatric Status Rating Scales; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Theta Rhythm; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Kava in generalized anxiety disorder: three placebo-controlled trials.
Topics: Anxiety Disorders; Cyclohexanols; Double-Blind Method; Female; Humans; Kava; Male; Middle Aged; Phytotherapy; Plant Preparations; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Escitalopram versus venlafaxine XR in the treatment of depression.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Quality of Life; Remission Induction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
Topics: Adjuvants, Pharmaceutic; Adult; Affect; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Risk Factors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Topics: Adult; Agoraphobia; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Inventory; Psychometrics; Quality of Life; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.
Topics: Age of Onset; Aged; Arrhythmias, Cardiac; Cardiovascular Diseases; Cognition Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Monitoring; Electrocardiography; Female; Guidelines as Topic; Heart Rate; Humans; Hypertension; Hypotension, Orthostatic; Male; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tachycardia; Venlafaxine Hydrochloride | 2006 |
Keeping our eyes on STAR*D.
Topics: Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Placebos; Research Design; Tranylcypromine; Treatment Outcome; Triiodothyronine; Venlafaxine Hydrochloride | 2006 |
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Interviews as Topic; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Tranylcypromine; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder; Desvenlafaxine Succinate; Female; Genotype; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Venlafaxine Hydrochloride | 2006 |
A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Patient Compliance; Psychiatric Status Rating Scales; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.
Topics: Adult; Ambulatory Care; Cyclohexanols; Delayed-Action Preparations; Dizziness; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Headache; Humans; Longitudinal Studies; Male; Nausea; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Health-related quality of life and its predictive role for analgesic effect in patients with painful polyneuropathy.
Topics: Adult; Aged; Aged, 80 and over; Analgesia; Analgesics; Cross-Over Studies; Cyclohexanols; Drug Resistance; Female; Health Status; Humans; Hypericum; Male; Middle Aged; Pain Measurement; Pain Threshold; Pain, Intractable; Placebos; Polyneuropathies; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Valproic Acid; Venlafaxine Hydrochloride | 2007 |
Beyond remission: rationale and design of the Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study.
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; History, Ancient; Humans; Secondary Prevention; Venlafaxine Hydrochloride | 2006 |
Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Inventory; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms.
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Double-Blind Method; Female; Gene Frequency; Genotype; Homozygote; Humans; Linkage Disequilibrium; Male; Middle Aged; Nicotine; Nicotinic Agonists; Phenotype; Polymorphism, Genetic; Receptors, Dopamine D2; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Venlafaxine Hydrochloride | 2007 |
Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Arousal; Bipolar Disorder; Circadian Rhythm; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Motor Activity; Quetiapine Fumarate; Sleep; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder.
Topics: Adult; Antidepressive Agents; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging study.
Topics: Adult; Capsules; Cocaine; Cyclohexanols; Delayed-Action Preparations; Dopamine Plasma Membrane Transport Proteins; Humans; Iodine Radioisotopes; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tomography, Emission-Computed, Single-Photon; Venlafaxine Hydrochloride | 2007 |
Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
Topics: Adult; Breast Neoplasms; Cyclohexanols; Disease-Free Survival; Double-Blind Method; Female; Hot Flashes; Humans; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
Topics: Adult; Aged; Breast Neoplasms; Clonidine; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials.
Topics: Adolescent; Age Factors; Ambulatory Care; Anxiety Disorders; Child; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Endpoint Determination; Humans; Meta-Analysis as Topic; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release.
Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Disabled Persons; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Outpatients; Panic Disorder; Quality of Life; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Long-term, open-label venlafaxine extended-release treatment in children and adolescents with major depressive disorder.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Severity of Illness Index; Time Factors; Venlafaxine Hydrochloride | 2007 |
A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache.
Topics: Adult; Ambulatory Care; Analgesics; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Outpatients; Pain Measurement; Placebo Effect; Tension-Type Headache; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Leukoaraiosis; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Fibers, Myelinated; Nortriptyline; Venlafaxine Hydrochloride | 2007 |
Cardiovascular effects of high dose venlafaxine XL in patients with major depressive disorder.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Statistics as Topic; Venlafaxine Hydrochloride | 2007 |
Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial.
Topics: Adult; Anxiety Disorders; Cyclohexanols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials.
Topics: Adolescent; Algorithms; Child; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Endpoint Determination; Female; Humans; Male; Placebos; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Topics: Adolescent; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Severity of Illness Index; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.
Topics: Adult; Ambulatory Care; Antidepressive Agents; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cross-Over Studies; Cyclohexanols; Decision Trees; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial.
Topics: Adult; Brain; Cerebral Cortex; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Limbic System; Male; Middle Aged; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
A placebo-controlled double-blind randomized study of venlafaxine in the treatment of depression in dementia.
Topics: Aged; Cyclohexanols; Dementia; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride | 2007 |
Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.
Topics: Adult; Antidepressive Agents; Citalopram; Corpus Striatum; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Venlafaxine Hydrochloride | 2007 |
Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial.
Topics: Adult; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Polymorphism, Genetic; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Early response to venlafaxine antidepressant correlates with lower ACTH levels prior to pharmacological treatment.
Topics: Adrenocorticotropic Hormone; Adult; Antidepressive Agents, Second-Generation; Circadian Rhythm; Cyclohexanols; Depressive Disorder; Female; Humans; Hydrocortisone; Male; Middle Aged; Pilot Projects; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Anxiety Disorders; Child; Confidence Intervals; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Pediatrics; Psychiatric Status Rating Scales; Regression Analysis; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Nortriptyline; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2007 |
Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cocaine-Related Disorders; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Methylphenidate; Retention, Psychology; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.
Topics: Abortion, Spontaneous; Administration, Oral; Adult; Affective Disorders, Psychotic; Cyclohexanols; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Panic Disorder; Paroxetine; Pregnancy; Pregnancy, Unplanned; Remission Induction; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Venlafaxine efficacy and tolerability in the treatment of post-stroke depression.
Topics: Aged; Antidepressive Agents, Second-Generation; Cerebral Infarction; Cyclohexanols; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Personality Assessment; Personality Inventory; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Venlafaxine vs. paroxetine in the acute phase of treatment for major depressive disorder among Han Chinese population in Taiwan.
Topics: Acute Disease; Adult; Asian People; China; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Paroxetine; Pharmacogenetics; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.
Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Outpatients; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Effect of terbinafine and voriconazole on the pharmacokinetics of the antidepressant venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Biotransformation; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dealkylation; Desvenlafaxine Succinate; Drug Interactions; Enzyme Inhibitors; Genotype; Half-Life; Humans; Male; Naphthalenes; Phenotype; Polymorphism, Genetic; Pyrimidines; Reference Values; Terbinafine; Triazoles; Venlafaxine Hydrochloride; Voriconazole | 2008 |
Analysis of the rate of improvement of specific psychic and somatic symptoms of general anxiety disorder during long-term treatment with venlafaxine ER.
Topics: Adult; Anxiety Disorders; Cyclohexanols; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Venlafaxine Hydrochloride | 2007 |
Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Faculty; Female; Humans; Male; Norepinephrine; Parents; Pilot Projects; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Serotonin; Severity of Illness Index; Venlafaxine Hydrochloride | 2007 |
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Secondary Prevention; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lithium Compounds; Male; Middle Aged; Phenelzine; Recurrence; Remission Induction; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Double-Blind Method; Female; Fluoxetine; Gastrointestinal Diseases; Headache; Humans; Hypertension; Male; Middle Aged; Respiratory Tract Infections; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dizziness; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Male; Nausea; Paroxetine; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia | 2007 |
A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder.
Topics: Adult; Amygdala; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Facial Expression; Fear; Female; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Pattern Recognition, Visual; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
The effects of venlafaxine on autonomic functions in healthy volunteers.
Topics: Administration, Oral; Adrenergic Uptake Inhibitors; Adult; Analysis of Variance; Autonomic Nervous System; Capsules; Cyclohexanols; Electrocardiography; Heart Rate; Humans; Laser-Doppler Flowmetry; Least-Squares Analysis; Male; Reflex, Pupillary; Selective Serotonin Reuptake Inhibitors; Skin; Time Factors; Vasoconstriction; Venlafaxine Hydrochloride | 2007 |
Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Citalopram; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Personality Assessment; Personality Inventory; Psychometrics; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2008 |
Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine.
Topics: Acetamides; Adolescent; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prevalence; Sleep; Sleep Wake Disorders; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2007 |
A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression.
Topics: Aged; Antidepressive Agents; Cholinesterase Inhibitors; Citalopram; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Galantamine; Humans; Male; Middle Aged; Neuropsychological Tests; Pilot Projects; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents; Anxiety Disorders; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
An investigation of the effect of immediate and extended release venlafaxine on nocturnal melatonin and cortisol release in healthy adult volunteers.
Topics: Adult; Antidepressive Agents, Second-Generation; Body Temperature; Circadian Rhythm; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Melatonin; Saliva; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2008 |
Safety and efficacy of venlafaxine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomised study.
Topics: Adult; Cyclohexanols; Double-Blind Method; Ejaculation; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Venlafaxine Hydrochloride | 2008 |
An open-label trial of venlafaxine in body dysmorphic disorder.
Topics: Adolescent; Adult; Aged; Body Image; Cyclohexanols; Female; Humans; Male; Middle Aged; Psychophysiologic Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thyroid Hormones; Venlafaxine Hydrochloride | 2008 |
The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder.
Topics: Antidepressive Agents, Second-Generation; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Double-Blind Method; Humans; Markov Chains; Quality-Adjusted Life Years; Recurrence; Risk Factors; Venlafaxine Hydrochloride | 2008 |
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.
Topics: Adolescent; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment | 2008 |
Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
Topics: Administration, Oral; Adult; Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Capsules; Cyclohexanols; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Lithium Carbonate; Lithium Compounds; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Patient Dropouts; Prospective Studies; Somatoform Disorders; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia; Yawning | 2008 |
Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Topics: Adult; Antidepressive Agents, Second-Generation; Australia; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depression; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Europe; Female; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Failure; Venlafaxine Hydrochloride | 2008 |
Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Brain; Brain Chemistry; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nordefrin; Norepinephrine Plasma Membrane Transport Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time Factors; Venlafaxine Hydrochloride; Young Adult | 2008 |
Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depression; Double-Blind Method; Dyspepsia; Female; Humans; Male; Middle Aged; Placebos; Quality of Life; Venlafaxine Hydrochloride | 2008 |
A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR.
Topics: Acetamides; Adult; Antidepressive Agents, Second-Generation; Arousal; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Libido; Male; Middle Aged; Orgasm; Personality Inventory; Sexual Behavior; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial.
Topics: Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Psychophysiologic Disorders; Psychotherapy; Surveys and Questionnaires; Thiophenes; Venlafaxine Hydrochloride; Young Adult | 2009 |
Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Humans; Lithium Compounds; Male; Middle Aged; Patient Dropouts; Psychiatric Status Rating Scales; Psychometrics; Regression Analysis; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.
Topics: Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Cyclohexanols; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Female; Humans; Linear Models; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Half-Life; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Suicide; Venlafaxine Hydrochloride | 2008 |
Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis.
Topics: Adolescent; Adult; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Ethnicity; Female; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Chlorates; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
The efficacy of venlafaxine in the treatment of women with stress urinary incontinence.
Topics: Adult; Cyclohexanols; Double-Blind Method; Female; Humans; Patient Satisfaction; Placebos; Prospective Studies; Quality of Life; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Urinary Incontinence, Stress; Venlafaxine Hydrochloride | 2009 |
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Venlafaxine Hydrochloride | 2009 |
The effects of venlafaxine on cognitive functions and quantitative EEG in healthy volunteers.
Topics: Adult; Analysis of Variance; Brain; Cognition; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Electroencephalography; Eye Movements; Humans; Male; Neuropsychological Tests; Psychometrics; Psychomotor Performance; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2008 |
Differences between daily smokers, chippers, and nonsmokers with co-occurring anxiety and alcohol-use disorders.
Topics: Adolescent; Adult; Aged; Alcohol-Related Disorders; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cognitive Behavioral Therapy; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Middle Aged; Smoking; Venlafaxine Hydrochloride; Young Adult | 2008 |
Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study.
Topics: Adrenergic alpha-Agonists; Adult; Breast Neoplasms; Clonidine; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Humans; Middle Aged; Personality Inventory; Primary Health Care; Prognosis; Retreatment; Secondary Prevention; Sertraline; Venlafaxine Hydrochloride | 2008 |
Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants.
Topics: Adult; Antidepressive Agents; Biomarkers; Brain-Derived Neurotrophic Factor; Case-Control Studies; Chi-Square Distribution; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Matched-Pair Analysis; Neuropsychological Tests; Paroxetine; Reference Values; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Lithium Carbonate; Long-Term Care; Male; Middle Aged; Personality Inventory; Psychometrics; Retreatment; Tachyphylaxis; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2008 |
Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale.
Topics: Adaptation, Psychological; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Stress Disorders, Post-Traumatic; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Quinolones; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2010 |
Pharmacokinetic/pharmacodynamic modelling of venlafaxine: pupillary light reflex as a test system for noradrenergic effects.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Humans; Male; Models, Biological; Norepinephrine; Reflex, Pupillary; Venlafaxine Hydrochloride | 2008 |
Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75-225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Male; Recurrence; Risk Assessment; Time Factors; Treatment Failure; Venlafaxine Hydrochloride | 2008 |
Changes in brain function during administration of venlafaxine or placebo to normal subjects.
Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Brain; Chi-Square Distribution; Cyclohexanols; Double-Blind Method; Electroencephalography; Female; Humans; Male; Middle Aged; Placebos; Venlafaxine Hydrochloride | 2008 |
Outcome of late-life depression after 3 years of sequential treatment.
Topics: Age of Onset; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Humans; Nortriptyline; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Brain functional changes during placebo lead-in and changes in specific symptoms during pharmacotherapy for major depression.
Topics: Brain; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride | 2009 |
Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Biomarkers; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Male; Neurotransmitter Uptake Inhibitors; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sex Characteristics; Venlafaxine Hydrochloride | 2009 |
Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers.
Topics: Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Desvenlafaxine Succinate; Female; Genotype; Humans; Male; Middle Aged; Venlafaxine Hydrochloride; Young Adult | 2009 |
Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Weight Gain | 2009 |
Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Drug Resistance; Female; Fluoxetine; Humans; Male; Paroxetine; Personality Inventory; Prognosis; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo.
Topics: Adult; Analysis of Variance; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sex Factors; Stress Disorders, Post-Traumatic; Treatment Outcome; United States; Venlafaxine Hydrochloride; Violence; Wounds and Injuries | 2008 |
Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duloxetine Hydrochloride; Feasibility Studies; Female; Humans; Male; Personality Inventory; Pilot Projects; Piperazines; Quinolones; Thiophenes; Venlafaxine Hydrochloride | 2009 |
Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
Topics: Adolescent; Antidepressive Agents; Benzodiazepines; Citalopram; Cognitive Behavioral Therapy; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Suicide; Suicide, Attempted; Venlafaxine Hydrochloride | 2009 |
Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features.
Topics: Adult; Antidepressive Agents; Blood Pressure; Constipation; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dizziness; Double-Blind Method; Female; Fluoxetine; Heart Rate; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Statistics as Topic; Venlafaxine Hydrochloride; Xerostomia | 2009 |
Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Personality Assessment; Prefrontal Cortex; Psychometrics; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride | 2009 |
Early response as predictor of final remission in elderly depressed patients.
Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Humans; Middle Aged; Nortriptyline; Remission Induction; ROC Curve; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
The SNRI venlafaxine improves emotional unawareness in patients with post-stroke depression.
Topics: Aged; Cyclohexanols; Depressive Disorder; Emotions; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Self Concept; Stroke; Venlafaxine Hydrochloride | 2009 |
A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder.
Topics: Ambulatory Care; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Humans; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2009 |
Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.
Topics: Acute Disease; Adult; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Bupropion; Cyclohexanols; Demography; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Patient preference compared with random allocation in short-term psychodynamic supportive psychotherapy with indicated addition of pharmacotherapy for depression.
Topics: Adolescent; Adult; Aged; Algorithms; Choice Behavior; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Interview, Psychological; Male; Middle Aged; Psychotherapy, Brief; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
Normalization of GRK2 protein and mRNA measures in patients with depression predict response to antidepressants.
Topics: Adult; Antidepressive Agents; Biomarkers, Pharmacological; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; G-Protein-Coupled Receptor Kinase 2; Gene Expression Regulation; Humans; Leukocytes, Mononuclear; Male; Middle Aged; RNA, Messenger; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Liver Function Tests; Male; Middle Aged; Suicide; Venlafaxine Hydrochloride; Young Adult | 2009 |
Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Brain; Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Middle Aged; Positron-Emission Tomography; Venlafaxine Hydrochloride; Young Adult | 2009 |
A comparison of several approaches for choosing between working correlation structures in generalized estimating equation analysis of longitudinal binary data.
Topics: Antidepressive Agents, Second-Generation; Biometry; Computer Simulation; Cyclohexanols; Depressive Disorder, Major; Humans; Linear Models; Lithium Compounds; Longitudinal Studies; Prospective Studies; Randomized Controlled Trials as Topic; Regression Analysis; Venlafaxine Hydrochloride | 2009 |
Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Biomarkers; Brain Mapping; Cerebral Cortex; Cyclohexanols; Depression; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Gyrus Cinguli; Humans; Male; Middle Aged; Theta Rhythm; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
Frontal EEG predictors of treatment outcome in major depressive disorder.
Topics: Adolescent; Adult; Cyclohexanols; Depressive Disorder, Major; Electroencephalography; Female; Frontal Lobe; Humans; Male; Middle Aged; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects.
Topics: Adult; Aged; Antidepressive Agents; Combined Modality Therapy; Cross-Over Studies; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Prospective Studies; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder.
Topics: Antidepressive Agents; Brain Mapping; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Fluoxetine; Humans; Numerical Analysis, Computer-Assisted; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover study.
Topics: Area Under Curve; Capsules; Chemistry, Pharmaceutical; Citalopram; Cross-Over Studies; Cyclohexanols; Drugs, Generic; Humans; Male; Selective Serotonin Reuptake Inhibitors; Tablets; Therapeutic Equivalency; Venlafaxine Hydrochloride | 2009 |
Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studies.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2010 |
Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cyclohexanols; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Drug Dosage Calculations; Drug Therapy, Combination; Female; Humans; Imipramine; Male; Middle Aged; Quetiapine Fumarate; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2010 |
Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Somatosensory Disorders; Venlafaxine Hydrochloride | 2009 |
Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study.
Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Tachyphylaxis; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Effects of venlafaxine and fluoxetine on lymphocyte subsets in patients with major depressive disorder: a flow cytometric analysis.
Topics: Adult; Antidepressive Agents, Second-Generation; Antigens, CD; Cyclohexanols; Depressive Disorder, Major; Female; Flow Cytometry; Fluoxetine; Humans; Lymphocyte Subsets; Male; Statistics, Nonparametric; Venlafaxine Hydrochloride; Young Adult | 2010 |
Substance use and the treatment of resistant depression in adolescents.
Topics: Adolescent; Alcoholism; Antidepressive Agents, Second-Generation; Attention Deficit and Disruptive Behavior Disorders; Child Abuse; Child Abuse, Sexual; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Conduct Disorder; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Resistance; Drug Therapy, Combination; Family Conflict; Female; Humans; Illicit Drugs; Male; Personality Inventory; Psychometrics; Psychotropic Drugs; Risk Factors; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Suicidal Ideation; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Long-term response to successful acute pharmacological treatment of psychotic depression.
Topics: Adult; Affective Disorders, Psychotic; Antidepressive Agents; Antipsychotic Agents; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imipramine; Long-Term Care; Male; Middle Aged; Netherlands; Quetiapine Fumarate; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression.
Topics: Adolescent; Adult; Aged; Bupropion; Citalopram; Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Primidone; Remission Induction; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
Pharmacogenetics studies in STAR*D: strengths, limitations, and results.
Topics: Adult; Biomarkers; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Humans; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Receptors, Kainic Acid; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Topics: Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2010 |
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
Topics: Adenocarcinoma; Androgen Antagonists; Autonomic Agents; Cyclohexanols; Cyproterone Acetate; Double-Blind Method; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Male; Medroxyprogesterone Acetate; Prospective Studies; Prostatic Neoplasms; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Combating depression in Huntington's disease: effective antidepressive treatment with venlafaxine XR.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Huntington Disease; Irritable Mood; Male; Middle Aged; Nausea; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
[Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; France; Humans; Male; Middle Aged; Milnacipran; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide Prevention; Venlafaxine Hydrochloride; Young Adult | 2009 |
Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study.
Topics: Adolescent; Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder; Female; Genotype; Humans; Logistic Models; Male; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide, Attempted; Tacrolimus Binding Proteins; Treatment Failure; Venlafaxine Hydrochloride | 2010 |
Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
Topics: Adult; Antidepressive Agents; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Psychometrics; Secondary Prevention; Venlafaxine Hydrochloride | 2010 |
Changes in medial prefrontal cortex neural responses parallel successful antidepressant combination of venlafaxine and light therapy.
Topics: Adult; Antidepressive Agents, Second-Generation; Cognition; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Phototherapy; Pilot Projects; Prefrontal Cortex; Venlafaxine Hydrochloride | 2009 |
Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Antidepressive Agents; Case-Control Studies; Cyclohexanols; Dehydroepiandrosterone Sulfate; Depression; Female; Humans; Hydrocortisone; Male; Mianserin; Middle Aged; Mirtazapine; Saliva; Secondary Prevention; Sex Factors; Venlafaxine Hydrochloride | 2010 |
Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial.
Topics: Acupuncture Therapy; Adult; Aged; Analgesics; Antidepressive Agents, Second-Generation; Breast Neoplasms; Cyclohexanols; Estrogen Replacement Therapy; Female; Follow-Up Studies; Hot Flashes; Humans; Middle Aged; Postmenopause; Prognosis; Quality of Life; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Retinol-Binding Proteins, Plasma; Venlafaxine Hydrochloride | 2010 |
Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Body Mass Index; Capsules; Cross-Over Studies; Cyclohexanols; Delayed-Action Preparations; Humans; Male; Middle Aged; Tablets; Therapeutic Equivalency; Venlafaxine Hydrochloride; Young Adult | 2009 |
The course of adverse effects of nortriptyline and venlafaxine in elderly patients with major depression.
Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Cross-Sectional Studies; Cyclohexanols; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Hospitals, Psychiatric; Humans; Male; Middle Aged; Netherlands; Nortriptyline; Personality Assessment; Risk Factors; Venlafaxine Hydrochloride | 2009 |
Correlation between patient and clinician assessments of depression severity in the PREVENT study.
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Severity of Illness Index; Statistics as Topic; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
Topics: Adult; Anxiety; Chest Pain; Chi-Square Distribution; Cross-Over Studies; Cyclohexanols; Delayed-Action Preparations; Depression; Double-Blind Method; Esophageal Diseases; Esophageal pH Monitoring; Female; Humans; Male; Manometry; Placebos; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Circadian Rhythm; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Hydrocortisone; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Saliva; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Second-Generation; Brain; California; Causality; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Mood Disorders; Psychiatric Status Rating Scales; Severity of Illness Index; Suicide; Venlafaxine Hydrochloride | 2010 |
Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Middle Aged; Phenotype; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2010 |
Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain.
Topics: Acute Disease; Adult; Amines; Analgesics; Breast Neoplasms; Chronic Disease; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Mastectomy, Radical; Mastectomy, Segmental; Middle Aged; Morphine; Pain Measurement; Pain, Postoperative; Perioperative Care; Statistics, Nonparametric; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Failure; Venlafaxine Hydrochloride | 2010 |
Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Long-Term Care; Longitudinal Studies; Male; Middle Aged; Quality of Life; Secondary Prevention; Social Adjustment; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2010 |
Optimization and in vivo pharmacokinetic study of a novel controlled release venlafaxine hydrochloride three-layer tablet.
Topics: Adult; Antidepressive Agents, Second-Generation; Cross-Over Studies; Cyclohexanols; Delayed-Action Preparations; Humans; Male; Metabolic Clearance Rate; Tablets; Venlafaxine Hydrochloride | 2010 |
Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; China; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Remission Induction; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder.
Topics: Adult; Alleles; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Neuropsychological Tests; Pharmacogenetics; Polymorphism, Single Nucleotide; Taiwan; Venlafaxine Hydrochloride | 2010 |
Efficacy and tolerability of venlafaxine extended release in patients with major depressive disorder.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Personality Inventory; Psychometrics; Slovenia; Venlafaxine Hydrochloride; Young Adult | 2010 |
Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Methylphenidate; Outpatients; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Basal Ganglia; Brain; Cyclohexanols; Depressive Disorder, Major; Emotions; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Mianserin; Mirtazapine; Prefrontal Cortex; Psychiatric Status Rating Scales; Time Factors; Venlafaxine Hydrochloride | 2011 |
Duloxetine versus venlafaxine in the treatment of unipolar and bipolar depression.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Retrospective Studies; Thiophenes; Venlafaxine Hydrochloride | 2010 |
TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients.
Topics: Adult; Asian People; Case-Control Studies; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Gene Frequency; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Taiwan; Treatment Outcome; Tryptophan Hydroxylase; Venlafaxine Hydrochloride; Young Adult | 2011 |
Efficiency of venlafaxine in patients with psychogenic nonepileptic seizures and anxiety and/or depressive disorders.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder; Electroencephalography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Seizures; Statistics, Nonparametric; Venlafaxine Hydrochloride; Video Recording; Young Adult | 2010 |
Patient outcomes with education, drug therapy, and support: a study of venlafaxine ER-treated outpatients with major depressive disorder.
Topics: Adult; Ambulatory Care; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Patient Education as Topic; Patient Satisfaction; Primary Health Care; Program Evaluation; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Social Support; Surveys and Questionnaires; Time Factors; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2010 |
Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.
Topics: Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Breast Neoplasms; Cross-Over Studies; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Middle Aged; Patient Preference; Surveys and Questionnaires; Survivors; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Relative bioavailability of two formulations of venlafaxine extended-release 75-mg capsules in healthy brazilian male volunteers: A single-dose, randomized-sequence, open-label, two-period crossover study in the fasting and fed states.
Topics: Administration, Oral; Adult; Area Under Curve; Biological Availability; Brazil; Capsules; Cross-Over Studies; Cyclohexanols; Delayed-Action Preparations; Fasting; Humans; Male; Selective Serotonin Reuptake Inhibitors; Therapeutic Equivalency; Venlafaxine Hydrochloride | 2010 |
Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release.
Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Neural correlates of treatment outcome in major depression.
Topics: Adult; Affect; Antidepressive Agents; Biomarkers; Cerebral Cortex; Cyclohexanols; Depressive Disorder, Major; Face; Female; Frontal Lobe; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nerve Net; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2011 |
Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.
Topics: Antidepressive Agents; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Middle Aged; Nortriptyline; Quality of Life; Time Factors; Venlafaxine Hydrochloride | 2011 |
International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Australia; Citalopram; Cognition; Cyclohexanols; Decision Support Techniques; Depressive Disorder, Major; Electroencephalography; Emotions; Europe; Female; Humans; Male; Middle Aged; Neuropsychological Tests; New Zealand; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Behavior; Time Factors; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2011 |
Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.
Topics: Activities of Daily Living; Adolescent; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Suicidal Ideation; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Pharmacokinetics of venlafaxine extended release 75 mg and desvenlafaxine 50 mg in healthy CYP2D6 extensive and poor metabolizers: a randomized, open-label, two-period, parallel-group, crossover study.
Topics: Adult; Area Under Curve; Chromatography, Liquid; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Desvenlafaxine Succinate; Female; Genotype; Humans; Male; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Tandem Mass Spectrometry; Venlafaxine Hydrochloride; Young Adult | 2011 |
Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Prospective Studies; Triglycerides; Venlafaxine Hydrochloride | 2011 |
Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings.
Topics: Adolescent; Cognitive Behavioral Therapy; Combined Modality Therapy; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2011 |
Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Norepinephrine; Remission Induction; Serotonin; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2011 |
Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Norepinephrine; Patient Dropouts; Pregabalin; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2009 |
[Treatment-resistant depressions in borderline psychiatry].
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Drug Administration Schedule; Drug Resistance; Female; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2011 |
Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Monitoring; Drug Resistance; Drug Substitution; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Venlafaxine Hydrochloride | 2011 |
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Middle Aged; Personality Inventory; Recurrence; Selective Serotonin Reuptake Inhibitors; Self Report; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Brain Mapping; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Follow-Up Studies; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Psychiatric Status Rating Scales; Theta Rhythm; Venlafaxine Hydrochloride | 2011 |
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Depression; Depressive Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outpatients; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT1A; Sulfides; Treatment Outcome; Venlafaxine Hydrochloride; Vortioxetine | 2012 |
Suicide attempts and nonsuicidal self-injury in the treatment of resistant depression in adolescents: findings from the TORDIA study.
Topics: Adolescent; Antidepressive Agents; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Drug Substitution; Female; Humans; Male; Proportional Hazards Models; Selective Serotonin Reuptake Inhibitors; Self Mutilation; Suicide Prevention; Venlafaxine Hydrochloride | 2011 |
Clinical outcomes following switch from venlafaxine ER to desvenlafaxine in nonresponders and responders.
Topics: Adolescent; Adult; Aged; Algorithms; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Drug Resistance; Drug Substitution; Female; Humans; Male; Middle Aged; Placebos; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2011 |
Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR?
Topics: Adult; Analgesics; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; gamma-Aminobutyric Acid; Humans; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Pregabalin; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
Combined medication and cognitive therapy for generalized anxiety disorder.
Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Reduced right ventrolateral prefrontal cortex activity while inhibiting positive affect is associated with improvement in hedonic capacity after 8 weeks of antidepressant treatment in major depressive disorder.
Topics: Adult; Anhedonia; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Emotions; Female; Fluoxetine; Follow-Up Studies; Functional Laterality; Humans; Image Processing, Computer-Assisted; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Prefrontal Cortex; Psychiatric Status Rating Scales; Pupil; Surveys and Questionnaires; Venlafaxine Hydrochloride; Young Adult | 2011 |
Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Analgesics; Breast Neoplasms; Clonidine; Cyclohexanols; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Suicide; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo.
Topics: Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Psychiatric Status Rating Scales; Resilience, Psychological; Stress Disorders, Post-Traumatic; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
Establishing bioequivalence of racemic venlafaxine formulations using stereoselective assay method: Is it necessary?
Topics: Adult; Chemistry, Pharmaceutical; Cyclohexanols; Humans; Male; Stereoisomerism; Therapeutic Equivalency; Venlafaxine Hydrochloride; Young Adult | 2011 |
Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Anxiety Disorders; Cyclohexanols; Double-Blind Method; Female; Gene Frequency; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptors, Serotonin, 5-HT2; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Treatment-resistant depressed youth show a higher response rate if treatment ends during summer school break.
Topics: Adolescent; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Female; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Social Adjustment; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Neurotransmitter Uptake Inhibitors; Paroxetine; Placebos; Tropanes; Venlafaxine Hydrochloride | 2012 |
Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Regression Analysis; Risk Factors; Self Report; Single-Blind Method; Suicidal Ideation; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2011 |
Use of venlafaxine in psychiatric disorders and climacteric syndrome: is a therapeutic bridge?
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Climacteric; Cyclohexanols; Drug Repositioning; Female; Humans; Mental Disorders; Middle Aged; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Ethnicity; Female; Humans; Male; Middle Aged; Patient Dropouts; Psychiatric Status Rating Scales; Psychotherapy, Brief; Sertraline; Sex Characteristics; Venlafaxine Hydrochloride | 2012 |
Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir.
Topics: Adult; Antidepressive Agents; Capsules; Cyclohexanols; Delayed-Action Preparations; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Interactions; Female; Half-Life; HIV Protease Inhibitors; Humans; Indinavir; Male; Metabolic Clearance Rate; Selective Serotonin Reuptake Inhibitors; Tablets; Venlafaxine Hydrochloride; Young Adult | 2012 |
Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Female; Humans; Likelihood Functions; Male; Middle Aged; Personality Inventory; Psychometrics; Quality of Life; Sertraline; United States; Venlafaxine Hydrochloride; Young Adult | 2012 |
Negative impact of migraine on quality of life after 4 weeks of treatment in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Migraine Disorders; Psychiatric Status Rating Scales; Quality of Life; Severity of Illness Index; Venlafaxine Hydrochloride | 2012 |
Out of the black box: treatment of resistant depression in adolescents and the antidepressant controversy.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Labeling; Drug Resistance; Humans; Patient Selection; Selective Serotonin Reuptake Inhibitors; Suicide Prevention; Venlafaxine Hydrochloride | 2012 |
Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study.
Topics: Adolescent; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder, Major; Drug Interactions; Drug Resistance; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sleep Wake Disorders; Trazodone; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
Double-blind controlled trial of venlafaxine for treatment of adults with attention deficit/hyperactivity disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Anxiety Disorders; Citalopram; Cyclohexanols; Double-Blind Method; Drug Therapy, Combination; Europe; Female; gamma-Aminobutyric Acid; Humans; Kaplan-Meier Estimate; Least-Squares Analysis; Linear Models; Male; Middle Aged; Odds Ratio; Paroxetine; Placebos; Pregabalin; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2012 |
Addressing both depression and pain in late life: the methodology of the ADAPT study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Behavior Therapy; Comorbidity; Cyclohexanols; Depression; Female; Humans; Low Back Pain; Male; Middle Aged; Problem Solving; Research Design; Venlafaxine Hydrochloride | 2012 |
Variation in the catechol-O-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Anxiety; Catechol O-Methyltransferase; Cyclohexanols; Female; Gene Frequency; Genotype; Humans; Male; Middle Aged; Mutation; Pharmacogenetics; Venlafaxine Hydrochloride; Young Adult | 2012 |
Does prior antidepressant treatment of major depression impact brain function during current treatment?
Topics: Adult; Antidepressive Agents; Cohort Studies; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Los Angeles; Male; Middle Aged; Neurons; Prefrontal Cortex; Psychiatric Status Rating Scales; Self Report; Single-Blind Method; Theta Rhythm; Venlafaxine Hydrochloride | 2012 |
Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression.
Topics: Adolescent; Affect; Anhedonia; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Resistance; Drug Substitution; Female; Humans; Longitudinal Studies; Male; Personality Assessment; Psychometrics; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
A short-term double-blind randomized controlled pilot trial with active or placebo pindolol in patients treated with venlafaxine for major depression.
Topics: Adult; Aged; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
Recovery and subsequent recurrence in patients with recurrent major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Psychiatric Status Rating Scales; Recovery of Function; Risk Factors; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.
Topics: Adolescent; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Substance-Related Disorders; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Parkinson Disease; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride | 2012 |
Evaluation of the effects of venlafaxine and pregabalin on the carbon dioxide inhalation models of Generalised Anxiety Disorder and panic.
Topics: Administration, Inhalation; Adult; Anxiety Disorders; Blood Pressure; Carbon Dioxide; Cyclohexanols; Double-Blind Method; Female; gamma-Aminobutyric Acid; Heart Rate; Humans; Male; Panic; Pregabalin; Surveys and Questionnaires; Venlafaxine Hydrochloride; Young Adult | 2013 |
The modulation of venlafaxine on cortical activation of language area in healthy subjects with fMRI study.
Topics: Adult; Brain Mapping; Cerebral Cortex; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Humans; Language; Language Tests; Magnetic Resonance Imaging; Male; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2012 |
Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-α) in the Chinese patients with major depressive disorder: a prospective longitudinal study.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Asian People; Cyclohexanols; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Suicidal Ideation; Tumor Necrosis Factor-alpha; Up-Regulation; Venlafaxine Hydrochloride; Young Adult | 2013 |
The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Personality Inventory; Prognosis; Prospective Studies; Psychometrics; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
Patterns of cardiorespiratory coordination in young women with recurrent major depressive disorder treated with escitalopram or venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Autonomic Nervous System; Case-Control Studies; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Entropy; Female; Heart Rate; Humans; Recurrence; Respiratory Rate; Venlafaxine Hydrochloride | 2012 |
Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study.
Topics: Acetamides; Adolescent; Adult; Anhedonia; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Patient Dropouts; Pilot Projects; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2012 |
Treatment with mirtazapine and venlafaxine increases noradrenaline excretion in depressed patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Norepinephrine; Venlafaxine Hydrochloride | 2012 |
Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder.
Topics: Antidepressive Agents; Anxiety Disorders; Biomarkers, Pharmacological; Cyclohexanols; Double-Blind Method; Haplotypes; Humans; Pharmacogenetics; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT2A; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride; White People | 2013 |
Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment.
Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Development of a simple LC-MS/MS method for determination of rebamipide in human plasma and its application to a bioequivalence study.
Topics: Alanine; Anti-Ulcer Agents; Area Under Curve; Calibration; Chromatography, High Pressure Liquid; Cross-Over Studies; Cyclohexanols; Female; Half-Life; Humans; Male; Quality Control; Quinolones; Reproducibility of Results; Tablets; Tandem Mass Spectrometry; Therapeutic Equivalency; Venlafaxine Hydrochloride; Young Adult | 2012 |
Relationships between changes in sustained fronto-striatal connectivity and positive affect in major depression resulting from antidepressant treatment.
Topics: Affect; Antidepressive Agents; Biological Availability; Brain Mapping; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Nerve Net; Nucleus Accumbens; Psychiatric Status Rating Scales; Reward; Sickness Impact Profile; Treatment Outcome; Venlafaxine Hydrochloride; Visual Cortex | 2013 |
Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
Topics: Adolescent; Adult; Age of Onset; Aged; Antidepressive Agents, Second-Generation; Bupropion; Child Abuse; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Mianserin; Middle Aged; Mirtazapine; Placebos; Psychiatric Status Rating Scales; Quality of Life; Recurrence; Self Report; Severity of Illness Index; Single-Blind Method; Suicidal Ideation; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Analysis of Variance; Antidepressive Agents; Biomarkers; Body Mass Index; Cyclohexanols; Depression; Female; Humans; Leptin; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Time Factors; Treatment Outcome; Up-Regulation; Venlafaxine Hydrochloride; Weight Gain; Young Adult | 2013 |
[Effects of apolipoprotein E genetic polymorphism on susceptibility of depression and efficacy of antidepressants].
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Apolipoproteins E; Cyclohexanols; Depression; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Paroxetine; Polymorphism, Genetic; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders.
Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Dronabinol; Female; Humans; Male; Marijuana Abuse; Medication Adherence; Recurrence; Selective Serotonin Reuptake Inhibitors; Treatment Failure; Venlafaxine Hydrochloride | 2013 |
Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Drug Resistance; Educational Status; Electroconvulsive Therapy; Female; Humans; Kaplan-Meier Estimate; Lithium Carbonate; Male; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales; Recurrence; Survival Analysis; Venlafaxine Hydrochloride | 2013 |
Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antimanic Agents; Cognition; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Sample Size; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.
Topics: Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bone Resorption; Collagen Type I; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Peptide Fragments; Peptides; Procollagen; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2013 |
Role of hippocampal neurogenesis in mnemonic segregation: implications for human mood disorders.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Cyclohexanols; Hippocampus; Male; Memory; Mood Disorders; Neurogenesis; Neurons; Placebos; Psychomotor Performance; Rats; Rats, Long-Evans; Stress, Psychological; Venlafaxine Hydrochloride | 2013 |
An open-label investigation of the pharmacokinetic profiles of lisdexamfetamine dimesylate and venlafaxine extended-release, administered alone and in combination, in healthy adults.
Topics: Adolescent; Adult; Antidepressive Agents; Cross-Over Studies; Cyclohexanols; Dextroamphetamine; Drug Therapy, Combination; Female; Humans; Lisdexamfetamine Dimesylate; Male; Reference Values; Venlafaxine Hydrochloride; Young Adult | 2013 |
Sexual functioning in patients with recurrent major depressive disorder enrolled in the PREVENT study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Personality Inventory; Psychometrics; Secondary Prevention; Sexual Dysfunction, Physiological; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2013 |
Cytochrome P450 2D6 phenoconversion is common in patients being treated for depression: implications for personalized medicine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Depression; Female; Humans; Male; Middle Aged; Phenotype; Precision Medicine; Venlafaxine Hydrochloride | 2013 |
Increase in work productivity of depressed individuals with improvement in depressive symptom severity.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depression; Drug Therapy, Combination; Efficiency; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Work; Young Adult | 2013 |
Dynamic prediction of treatment response in late-life depression.
Topics: Age of Onset; Aged; Aged, 80 and over; Aripiprazole; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Piperazines; Predictive Value of Tests; Psychiatric Status Rating Scales; Quinolones; Remission Induction; Severity of Illness Index; Signal Detection, Psychological; Symptom Assessment; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Buspirone; China; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Remission Induction; Risperidone; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
The bi-directional relationship between parent-child conflict and treatment outcome in treatment-resistant adolescent depression.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Conflict, Psychological; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Female; Humans; Male; Parent-Child Relations; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
Topics: Adolescent; Anxiety; Attention Deficit and Disruptive Behavior Disorders; Behavioral Symptoms; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Fluoxetine; Humans; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Female; Genotype; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Receptors, Opioid, mu; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; White People; Young Adult | 2013 |
Treatment of traumatized refugees with sertraline versus venlafaxine in combination with psychotherapy - study protocol for a randomized clinical trial.
Topics: Clinical Protocols; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Denmark; Humans; Psychiatric Status Rating Scales; Refugees; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
The change of insulin levels after six weeks antidepressant use in drug-naïve major depressive patients.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Body Mass Index; Case-Control Studies; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Risk; Severity of Illness Index; Venlafaxine Hydrochloride; Young Adult | 2013 |
Catechol-O-methyltransferase genotype as modifier of superior responses to venlafaxine treatment in major depressive disorder.
Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Catechol O-Methyltransferase; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Genotype; Humans; Male; Methionine; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Psychiatric Status Rating Scales; Time Factors; Valine; Venlafaxine Hydrochloride; Young Adult | 2013 |
A double-blind randomized study comparing plasma level-targeted dose imipramine and high-dose venlafaxine in depressed inpatients.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imipramine; Inpatients; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2013 |
Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Brain; California; Citalopram; Clinical Protocols; Cognition; Cyclohexanols; Depressive Disorder, Major; Diffusion Tensor Imaging; Emotions; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; New South Wales; Predictive Value of Tests; Prospective Studies; Psychiatric Status Rating Scales; Research Design; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Changes in cardiovascular function after venlafaxine but not pregabalin in healthy volunteers: a double-blind, placebo-controlled study of orthostatic challenge, blood pressure and heart rate.
Topics: Adrenergic Uptake Inhibitors; Adult; Blood Pressure; Calcium Channel Blockers; Cyclohexanols; Double-Blind Method; Female; gamma-Aminobutyric Acid; Heart Rate; Humans; Male; Posture; Pregabalin; Venlafaxine Hydrochloride; Young Adult | 2013 |
Genetic polymorphisms in the PACAP and PAC1 receptor genes and treatment response to venlafaxine XR in generalized anxiety disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Drug Administration Schedule; Female; Genetic Variation; Genotype; Humans; Male; Neuropeptides; Pharmacogenetics; Pituitary Adenylate Cyclase-Activating Polypeptide; Polymorphism, Genetic; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
The bidirectional relationship between body mass index and treatment outcome in adolescents with treatment-resistant depression.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Body Mass Index; Child; Citalopram; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
The effects of venlafaxine and cognitive behavioral therapy alone and combined in the treatment of co-morbid alcohol use-anxiety disorders.
Topics: Adult; Alcohol Drinking; Alcohol-Related Disorders; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Medication Adherence; Relaxation Therapy; Venlafaxine Hydrochloride | 2013 |
Remission of generalized anxiety disorder after 6 months of open-label treatment with venlafaxine XR.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Female; Humans; Logistic Models; Male; Middle Aged; Neuroticism; Outcome Assessment, Health Care; Predictive Value of Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors; Venlafaxine Hydrochloride | 2013 |
Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyclohexanols; Double-Blind Method; Hot Flashes; Humans; Male; Middle Aged; Prostatic Neoplasms; Quality of Life; Selective Serotonin Reuptake Inhibitors; Soybean Proteins; Venlafaxine Hydrochloride | 2013 |
Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes?
Topics: Affect; Antidepressive Agents; Conditioning, Classical; Cyclohexanols; Depressive Disorder, Major; Drug Tolerance; Electroencephalography; Female; Humans; Learning; Models, Biological; Statistics, Nonparametric; Substance-Related Disorders; Venlafaxine Hydrochloride | 2013 |
Efficacy of repetitive transcranial magnetic stimulation in the prevention of relapse of depression: study protocol for a randomized controlled trial.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; China; Clinical Protocols; Combined Modality Therapy; Cyclohexanols; Depression; Humans; Middle Aged; Psychiatric Status Rating Scales; Research Design; Secondary Prevention; Severity of Illness Index; Single-Blind Method; Time Factors; Transcranial Magnetic Stimulation; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Increased prefrontal cortex activity during negative emotion regulation as a predictor of depression symptom severity trajectory over 6 months.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depression; Depressive Disorder, Major; Double-Blind Method; Emotions; Fluoxetine; Functional Neuroimaging; Humans; Prefrontal Cortex; Venlafaxine Hydrochloride | 2013 |
Donepezil provides positive effects to patients treated with gabapentin for neuropathic pain: an exploratory study.
Topics: Adult; Aged; Algorithms; Amines; Analgesics; Cyclohexanecarboxylic Acids; Cyclohexanols; Donepezil; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Indans; Male; Middle Aged; Neuralgia; Neuroprotective Agents; Pain Measurement; Piperidines; Quality of Life; Sample Size; Venlafaxine Hydrochloride | 2014 |
The effects of venlafaxine on cortical motor area activity in healthy subjects: a pilot study.
Topics: Administration, Oral; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Brain Mapping; Brain Waves; China; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Drug Administration Schedule; Functional Laterality; Hand Strength; Healthy Volunteers; Humans; Magnetic Resonance Imaging; Male; Motor Activity; Motor Cortex; Pilot Projects; Reaction Time; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2014 |
How to switch to agomelatine after an unsuccessful try with paroxetine or venlafaxine.
Topics: Acetamides; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Drug Substitution; Female; Humans; Male; Middle Aged; Paroxetine; Venlafaxine Hydrochloride | 2015 |
Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study.
Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Menopause; Middle Aged; Placebos; Proportional Hazards Models; Recurrence; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Clonazepam; Cyclohexanols; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phobic Disorders; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Venlafaxine alters microvascular perfusion, [¹²³I]-beta-CIT binding and BDI scores in flushing postmenopausal women.
Topics: Aged; Brain; Cyclohexanols; Endothelium, Vascular; Female; Hot Flashes; Humans; Microvessels; Middle Aged; Postmenopause; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Skin; Tomography, Emission-Computed, Single-Photon; Venlafaxine Hydrochloride | 2014 |
Screening for neuropathic pain after spinal cord injury with the spinal cord injury pain instrument (SCIPI): a preliminary validation study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cross-Sectional Studies; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Principal Component Analysis; Psychometrics; Reproducibility of Results; ROC Curve; Self Report; Spinal Cord Injuries; Surveys and Questionnaires; United States; Venlafaxine Hydrochloride; Young Adult | 2014 |
Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
Topics: Adult; Antidepressive Agents; Bupropion; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Mianserin; Middle Aged; Mirtazapine; Placebos; Recurrence; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Effects of antidepressant medication on emotion regulation in depressed patients: an iSPOT-D report.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Emotions; Female; Humans; Male; Middle Aged; Repression, Psychology; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2014 |
QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder.
Topics: Algorithms; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Computer-Assisted; Double-Blind Method; Electroencephalography; Female; Humans; Male; Middle Aged; Prefrontal Cortex; Reproducibility of Results; Sensitivity and Specificity; Theta Rhythm; Transcranial Magnetic Stimulation; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
Venlafaxine extended-release treatment of hoarding disorder.
Topics: Adult; California; Cyclohexanols; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Female; Hoarding Disorder; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride | 2014 |
Lack of influence of DAT1 and DRD2 gene variants on antidepressant response in generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Dopamine Plasma Membrane Transport Proteins; Double-Blind Method; Female; Gene Frequency; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2014 |
Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
Topics: Adult; Cyclohexanols; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Combined medication and CBT for generalized anxiety disorder with African American participants: reliability and validity of assessments and preliminary outcomes.
Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Black or African American; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Reproducibility of Results; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Evaluation of the efficacy and safety of pregabalin, venlafaxine, and carbamazepine in patients with painful diabetic peripheral neuropathy. A randomized, double-blind trial.
Topics: Adult; Affect; Aged; Analgesics; Analgesics, Non-Narcotic; Carbamazepine; Cyclohexanols; Diabetic Neuropathies; Double-Blind Method; Female; Follow-Up Studies; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain Measurement; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sleep; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Concentrations of venlafaxine and its main metabolite O-desmethylvenlafaxine during pregnancy.
Topics: Adult; Cyclohexanols; Desvenlafaxine Succinate; Female; Humans; Postpartum Period; Pregnancy; Pregnancy Outcome; Pregnancy Trimesters; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2014 |
Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial.
Topics: Adult; Cyclohexanols; Double-Blind Method; Dyspareunia; Estradiol; Estrogens; Female; Hot Flashes; Humans; Middle Aged; Orgasm; Perimenopause; Postmenopause; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Vagina; Venlafaxine Hydrochloride | 2014 |
Environmental levels of the antidepressant venlafaxine impact the metabolic capacity of rainbow trout.
Topics: Animals; Antidepressive Agents; Blood Glucose; Cyclohexanols; Gluconeogenesis; Glucose; Glycolysis; Handling, Psychological; Hydrocortisone; Liver; Liver Glycogen; Oncorhynchus mykiss; Receptors, Glucocorticoid; Stress, Physiological; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2014 |
Treating concurrent chronic low back pain and depression with low-dose venlafaxine: an initial identification of "easy-to-use" clinical predictors of early response.
Topics: Aged; Antidepressive Agents, Second-Generation; Chronic Pain; Cyclohexanols; Depression; Female; Humans; Low Back Pain; Male; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Venlafaxine, paroxetine and milnacipran for major depressive disorder: a pragmatic 24-week study.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Milnacipran; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR?
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Marijuana Smoking; Middle Aged; Substance Withdrawal Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcome.
Topics: Adolescent; Adult; Aged; Alleles; Antidepressive Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Female; Genotype; Humans; Male; Middle Aged; Norepinephrine Plasma Membrane Transport Proteins; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride; Young Adult | 2014 |
Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Male; Nortriptyline; Remission Induction; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes.
Topics: Cyclohexanols; Double-Blind Method; Estradiol; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Perimenopause; Sleep; Sleep Initiation and Maintenance Disorders; Venlafaxine Hydrochloride | 2015 |
Early improvement as a predictor of eventual antidepressant treatment response in severely depressed inpatients.
Topics: Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Predictive Value of Tests; Severity of Illness Index; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
Increased platelet count after treatment with venlafaxine or mirtazapine in depressed patients.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Platelet Count; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2015 |
Differences in quality of life outcomes among depressed spinal cord injury trial participants.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Health Status; Humans; Male; Mental Health; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Spinal Cord Injuries; Venlafaxine Hydrochloride; Young Adult | 2015 |
Open-longitudinal study of the effect of dissociative symptoms on the response of patients with panic disorder to venlafaxine.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Dissociative Disorders; Dose-Response Relationship, Drug; Female; Humans; Longitudinal Studies; Male; Middle Aged; Panic Disorder; Psychiatric Status Rating Scales; Socioeconomic Factors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Bupropion; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Outpatients; Predictive Value of Tests; Single-Blind Method; Sleep Initiation and Maintenance Disorders; Substance-Related Disorders; Surveys and Questionnaires; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2015 |
Efficacy of venlafaxine XR for the treatment of pain in patients with spinal cord injury and major depression: a randomized, controlled trial.
Topics: Adolescent; Adult; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Medication Adherence; Middle Aged; Neuralgia; Nociceptive Pain; Pain; Psychiatric Status Rating Scales; Spinal Cord Injuries; Trauma Severity Indices; Venlafaxine Hydrochloride; Young Adult | 2015 |
Impairment and distress patterns distinguishing the melancholic depression subtype: an iSPOT-D report.
Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Risk Factors; Sertraline; Symptom Assessment; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
Venlafaxine extended-release for depression following spinal cord injury: a randomized clinical trial.
Topics: Adolescent; Adult; Chronic Disease; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Spinal Cord Injuries; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind study.
Topics: Adolescent; Adult; Aged; Anxiety; Asia; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sulfides; Venlafaxine Hydrochloride; Vortioxetine; Young Adult | 2015 |
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
Topics: Adult; Antidepressive Agents; Anxiety; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Outpatients; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
Topics: Adult; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Genotype; Humans; Logistic Models; Male; Middle Aged; Polymorphism, Single Nucleotide; Remission Induction; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
Comparison of venlafaxine alone versus venlafaxine plus bright light therapy combination for severe major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Phototherapy; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms.
Topics: Citalopram; Cyclohexanols; Dietary Supplements; Double-Blind Method; Estradiol; Estrogens; Exercise; Fatty Acids, Omega-3; Female; Hot Flashes; Humans; Middle Aged; Monitoring, Physiologic; Outcome Assessment, Health Care; Perimenopause; Postmenopause; Selective Serotonin Reuptake Inhibitors; Vasomotor System; Venlafaxine Hydrochloride; Yoga | 2015 |
Clustering patients by depression symptoms to predict venlafaxine ER antidepressant efficacy: Individual patient data analysis.
Topics: Antidepressive Agents; Cluster Analysis; Cyclohexanols; Data Analysis; Depression; Depressive Disorder, Major; Double-Blind Method; Humans; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2020 |
Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder: an 8-week, randomized, single-blind, active-controlled study.
Topics: Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Postmenopause; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2021 |
1194 other study(ies) available for venlafaxine hydrochloride and cyclohexanol
| Article | Year |
|---|---|
The disposition of venlafaxine enantiomers in dogs, rats, and humans receiving venlafaxine.
Topics: Adult; Animals; Antidepressive Agents; Chlorobenzenes; Chromatography, High Pressure Liquid; Chromatography, Liquid; Cyclohexanols; Dogs; Humans; Male; Mass Spectrometry; Naproxen; Rats; Rats, Inbred Strains; Stereoisomerism; Venlafaxine Hydrochloride | 1992 |
Coexisting major depression and obsessive-compulsive disorder treated with venlafaxine.
Topics: Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drugs, Investigational; Humans; Male; Obsessive-Compulsive Disorder; Venlafaxine Hydrochloride | 1990 |
DMI, Wy-45,030, Wy-45,881 and ciramadol inhibit locus coeruleus neuronal activity.
Topics: Animals; Antidepressive Agents; Benzylamines; Cyclohexanols; Desipramine; Electrophysiology; In Vitro Techniques; Locus Coeruleus; Male; Neurons; Piperoxan; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Venlafaxine Hydrochloride | 1985 |
An open-label, dose-finding study of WY-45,030, a novel bicyclic antidepressant.
Topics: Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Venlafaxine Hydrochloride | 1988 |
An open-label, variable-dose study of WY-45,030 (venlafexine) in depressed outpatients.
Topics: Adult; Aged; Antidepressive Agents; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Outpatients; Venlafaxine Hydrochloride | 1988 |
Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative.
Topics: Animals; Antidepressive Agents, Tricyclic; Biological Assay; Brain; Cyclohexanols; Desipramine; Dopamine; Guinea Pigs; Imipramine; Monoamine Oxidase Inhibitors; Muscle Contraction; Norepinephrine; Rats; Serotonin; Synaptosomes; Venlafaxine Hydrochloride | 1986 |
Toxic interaction of venlafaxine and isocarboxazide.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Drug Interactions; Humans; Isocarboxazid; Male; Monoamine Oxidase Inhibitors; Mydriasis; Selective Serotonin Reuptake Inhibitors; Shivering; Sweating; Venlafaxine Hydrochloride | 1995 |
Presynaptic Ca2+/calmodulin-dependent protein kinase II: autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake.
Topics: Amino Acid Sequence; Animals; Antidepressive Agents, Second-Generation; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cerebral Cortex; Cyclohexanols; Cytosol; Fluvoxamine; Hippocampus; Male; Molecular Sequence Data; Neurotransmitter Uptake Inhibitors; Norepinephrine; Paroxetine; Phosphorylation; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Synaptic Vesicles; Synaptosomes; Time Factors; Venlafaxine Hydrochloride | 1995 |
Clarification of venlafaxine chemistry, pharmacology, and pharmacokinetics.
Topics: Antidepressive Agents, Second-Generation; Chemistry, Pharmaceutical; Clinical Trials as Topic; Cyclohexanols; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1995 |
A case report of venlafaxine toxicity.
Topics: Adult; Antidepressive Agents, Second-Generation; Central Nervous System; Cyclohexanols; Diphenhydramine; Female; Humans; Thiothixene; Venlafaxine Hydrochloride | 1995 |
Phenelzine and venlafaxine interaction.
Topics: Adult; Akathisia, Drug-Induced; Cyclohexanols; Dizziness; Drug Interactions; Drug Therapy, Combination; Female; Humans; Phenelzine; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Sweating; Venlafaxine Hydrochloride | 1995 |
Venlafaxine: a novel antidepressant.
Topics: Antidepressive Agents, Second-Generation; Caregivers; Cyclohexanols; Depressive Disorder; Female; Humans; Middle Aged; Stress, Psychological; Treatment Outcome; Venlafaxine Hydrochloride | 1995 |
Serotonin reuptake inhibitors in Raynaud's phenomenon.
Topics: 1-Naphthylamine; Adult; Aged; Cyclohexanols; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Raynaud Disease; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1995 |
Venlafaxine and severe tinnitus.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Tinnitus; Venlafaxine Hydrochloride | 1995 |
Effects of venlafaxine treatment for ADHD in a child.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Cyclohexanols; Female; Humans; Hypertension; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1995 |
Venlafaxine for adult ADHD.
Topics: Age Factors; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1995 |
Venlafaxine: a new antidepressant drug.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Venlafaxine Hydrochloride | 1994 |
Venlafaxine for treatment-resistant unipolar depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Personality Assessment; Personality Inventory; Treatment Outcome; Venlafaxine Hydrochloride | 1994 |
Venlafaxine marketed as antidepressant.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Humans; Selective Serotonin Reuptake Inhibitors; Tablets; Venlafaxine Hydrochloride | 1994 |
Treatment option for depression offered in the United States.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Drug Approval; Humans; United States; Venlafaxine Hydrochloride | 1994 |
FDA approved new drug bulletin: rocuronium bromide, venlafaxine hydrochloride.
Topics: Adult; Androstanols; Child; Cyclohexanols; Drug Interactions; Female; Humans; Patient Education as Topic; Pregnancy; Rocuronium; United States; United States Food and Drug Administration; Venlafaxine Hydrochloride | 1994 |
The effect of renal disease on the disposition of venlafaxine.
Topics: Analysis of Variance; Cyclohexanols; Desvenlafaxine Succinate; Female; Humans; Kidney Failure, Chronic; Male; Neurotransmitter Uptake Inhibitors; Renal Dialysis; Venlafaxine Hydrochloride | 1994 |
Pharmacokinetics of venlafaxine and O-desmethylvenlafaxine in laboratory animals.
Topics: Administration, Oral; Animals; Animals, Laboratory; Antihypertensive Agents; Biological Availability; Cyclohexanols; Desvenlafaxine Succinate; Dogs; Female; Injections, Intravenous; Macaca mulatta; Male; Metabolic Clearance Rate; Mice; Neurotransmitter Uptake Inhibitors; Rats; Rats, Sprague-Dawley; Species Specificity; Venlafaxine Hydrochloride | 1994 |
A high-performance liquid chromatographic method for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in biological fluids.
Topics: Animals; Antidepressive Agents; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Dogs; Half-Life; Humans; Indicators and Reagents; Mice; Rats; Spectrophotometry, Ultraviolet; Venlafaxine Hydrochloride | 1994 |
Venlafaxine--a new antidepressant.
Topics: Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Humans; Neurotransmitter Uptake Inhibitors; Venlafaxine Hydrochloride | 1994 |
Venlafaxine exhibits pre-clinical antidepressant activity in the resident-intruder social interaction paradigm.
Topics: Aggression; Animals; Antidepressive Agents; Cyclohexanols; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Exploratory Behavior; Interpersonal Relations; Male; Rats; Rats, Wistar; Venlafaxine Hydrochloride | 1993 |
Metabolic disposition of 14C-venlafaxine in mouse, rat, dog, rhesus monkey and man.
Topics: Adult; Animals; Biotransformation; Chromatography, Gas; Chromatography, High Pressure Liquid; Cyclohexanols; Dogs; Feces; Female; Humans; Macaca mulatta; Male; Mass Spectrometry; Mice; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Species Specificity; Spectrophotometry, Ultraviolet; Venlafaxine Hydrochloride | 1993 |
Venlafaxine: a new dimension in antidepressant pharmacotherapy.
Topics: Ambulatory Care; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Hospitalization; Humans; Venlafaxine Hydrochloride | 1993 |
Venlafaxine for treatment of obsessive-compulsive disorder.
Topics: Adult; Cyclohexanols; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1995 |
Treatment of chronic fatigue syndrome with venlafaxine.
Topics: Adult; Bupropion; Cyclohexanols; Fatigue Syndrome, Chronic; Female; Humans; Killer Cells, Natural; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Possible venlafaxine withdrawal syndrome.
Topics: Adult; Cyclohexanols; Depressive Disorder; Fatigue; Female; Gastrointestinal Diseases; Headache; Humans; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride | 1996 |
Treatment of obsessive-compulsive disorder with venlafaxine.
Topics: Adult; Cyclohexanols; Drug Administration Schedule; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Venlafaxine for the treatment of chronic pain.
Topics: Adult; Antidepressive Agents, Second-Generation; Back Pain; Chronic Disease; Cyclohexanols; Depressive Disorder; Female; Humans; Pain; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Venlafaxine.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Interactions; Female; Humans; Seizures; Tranylcypromine; Venlafaxine Hydrochloride | 1996 |
Serotonin syndrome induced by administration of venlafaxine and phenelzine.
Topics: Antidepressive Agents; Central Nervous System Diseases; Cyclohexanols; Depressive Disorder; Humans; Male; Middle Aged; Phenelzine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Syndrome; Venlafaxine Hydrochloride | 1996 |
Venlafaxine oxidation in vitro is catalysed by CYP2D6.
Topics: Catalysis; Cyclohexanols; Cytochrome P-450 CYP2D6; Humans; Methylation; Microsomes, Liver; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1996 |
Venlafaxine withdrawal symptoms.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Administration Schedule; Dysthymic Disorder; Humans; Male; Phobic Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1996 |
Three new antidepressants.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Interactions; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1996 |
Serotonin syndrome from venlafaxine-tranylcypromine interaction.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Diarrhea; Diazepam; Drug Interactions; Humans; Hypnotics and Sedatives; Intensive Care Units; Male; Receptors, Serotonin; Salivation; Selective Serotonin Reuptake Inhibitors; Tranylcypromine; Treatment Outcome; Tremor; Venlafaxine Hydrochloride | 1996 |
Distribution of venlafaxine in three postmortem cases.
Topics: Acetaminophen; Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Bile; Chlordiazepoxide; Chromatography, Gas; Cyclohexanols; Diphenhydramine; Humans; Kidney; Liver; Male; Methylation; Middle Aged; Nortriptyline; Reference Standards; Selective Serotonin Reuptake Inhibitors; Suicide; Venlafaxine Hydrochloride | 1996 |
Drug craving and other negative reactions after abrupt substitution of nefazodone for other serotonergic agents.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Paroxetine; Piperazines; Recurrence; Serotonin Agents; Substance-Related Disorders; Triazoles; Venlafaxine Hydrochloride | 1996 |
Venlafaxine withdrawal reactions.
Topics: Cyclohexanols; Depressive Disorder; Dizziness; Female; Humans; Male; Middle Aged; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1996 |
Comparing speeds of effectiveness of two treatments.
Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Drug Therapy; Humans; Statistics as Topic; Time Factors; Venlafaxine Hydrochloride | 1996 |
Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Biotransformation; Cyclohexanols; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Humans; Microsomes, Liver; Phenacetin; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 1996 |
Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Dose-Response Relationship, Drug; Humans; Male; Monoamine Oxidase Inhibitors; Myoclonus; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Selegiline; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride | 1997 |
Serotonin syndrome due to venlafaxine and maintenance tranylcypromine therapy.
Topics: Antidepressive Agents, Second-Generation; Coma; Cyclohexanols; Drug Interactions; Female; Fever; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome; Tranylcypromine; Venlafaxine Hydrochloride | 1997 |
Venlafaxine and metabolites are very weak inhibitors of human cytochrome P450-3A isoforms.
Topics: Alprazolam; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; GABA Modulators; Humans; In Vitro Techniques; Isoenzymes; Microsomes, Liver; Oxidoreductases, N-Demethylating; Venlafaxine Hydrochloride | 1997 |
Seizure resulting from a venlafaxine overdose.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Drug Interactions; Drug Overdose; Female; Humans; Monoamine Oxidase Inhibitors; Phenelzine; Seizures; Suicide, Attempted; Venlafaxine Hydrochloride | 1997 |
Venlafaxine and ecchymosis.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Coagulation Tests; Cyclohexanols; Depressive Disorder; Ecchymosis; Female; Humans; Venlafaxine Hydrochloride | 1997 |
Urinary retention with venlafaxine-haloperidol combination.
Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Drug Therapy, Combination; Haloperidol; Humans; Male; Urinary Retention; Venlafaxine Hydrochloride | 1997 |
Venlafaxine and urinary incontinence: possible association.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Male; Middle Aged; Urinary Incontinence; Venlafaxine Hydrochloride | 1997 |
Effects of venlafaxine in the sleep architecture of rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Electroencephalography; Male; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sleep, REM; Venlafaxine Hydrochloride | 1997 |
Efficacy of papaverine addition for treatment-refractory major depression.
Topics: Buspirone; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Lithium; Middle Aged; Papaverine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
Venlafaxine-induced increased libido and spontaneous erections.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Libido; Male; Middle Aged; Penile Erection; Venlafaxine Hydrochloride | 1997 |
Spontaneous male orgasm in association with venlafaxine.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Ejaculation; Humans; Male; Middle Aged; Orgasm; Penile Erection; Venlafaxine Hydrochloride; Walking | 1997 |
Venlafaxine induced serotonin syndrome occurring after abstinence from phenelzine for more than two weeks.
Topics: Adult; Cyclohexanols; Drug Administration Schedule; Humans; Male; Phenelzine; Selective Serotonin Reuptake Inhibitors; Serotonin; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride | 1997 |
Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Amitriptyline; Animals; Clomipramine; Cyclohexanols; Male; Neurons; Paroxetine; Piperazines; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 1997 |
Benztropine in the treatment of venlafaxine-induced sweating.
Topics: Benztropine; Cyclohexanols; Depressive Disorder; Female; Humans; Hyperhidrosis; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sweating; Venlafaxine Hydrochloride | 1997 |
Pharmacologic properties of venlafaxine.
Topics: Adrenergic Uptake Inhibitors; Adult; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Dopamine Uptake Inhibitors; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
Channeling of three newly introduced antidepressants to patients not responding satisfactorily to previous treatment.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Utilization; Humans; Mianserin; Middle Aged; Mirtazapine; Netherlands; Sertraline; Venlafaxine Hydrochloride | 1997 |
Venlafaxine-induced hyponatremia.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Humans; Hyponatremia; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
Toxicity in venlafaxine overdose.
Topics: Adult; Antidepressive Agents, Second-Generation; Coma; Cyclohexanols; Dose-Response Relationship, Drug; Drug Overdose; Humans; Male; Neurologic Examination; Psychotic Disorders; Venlafaxine Hydrochloride | 1997 |
Comment: seizure resulting from venlafaxine overdose.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Overdose; Female; Humans; Male; Seizures; Venlafaxine Hydrochloride | 1997 |
Venlafaxine-induced reset osmostat syndrome: case of a 79-year-old depressed woman.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Venlafaxine Hydrochloride; Water-Electrolyte Balance | 1997 |
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Fluoxetine; Fluvoxamine; Frozen Sections; Humans; Hydroxylation; Imipramine; In Vitro Techniques; Lethal Dose 50; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Venlafaxine Hydrochloride | 1997 |
Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.
Topics: Adult; Antidepressive Agents; Clonazepam; Cyclohexanols; Depressive Disorder; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hypotension; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride | 1997 |
PET neuroimaging with [11C]venlafaxine: serotonin uptake inhibition, biodistribution and binding in living pig brain.
Topics: Animals; Antidepressive Agents; Blood Platelets; Brain Chemistry; Cyclohexanols; Female; Selective Serotonin Reuptake Inhibitors; Serotonin; Swine; Tissue Distribution; Tomography, Emission-Computed; Venlafaxine Hydrochloride | 1997 |
Syndrome of inappropriate ADH secretion attributed to the serotonin re-uptake inhibitors, venlafaxine and paroxetine.
Topics: Aged; Aged, 80 and over; Cyclohexanols; Female; Humans; Inappropriate ADH Syndrome; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
Overdose of venlafaxine--a new antidepressant.
Topics: Adult; Alcoholism; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Overdose; Emergency Service, Hospital; Humans; Male; Suicide, Attempted; Venlafaxine Hydrochloride | 1997 |
Suspected complication of treatment with venlafaxine.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Humans; Middle Aged; Research Design; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
Venlafaxine hydrochloride (Effexor) relieves thermal hyperalgesia in rats with an experimental mononeuropathy.
Topics: Administration, Oral; Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Evaluation, Preclinical; Hot Temperature; Hyperalgesia; Male; Neuralgia; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Venlafaxine-fluoxetine-nortriptyline interaction.
Topics: Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Nortriptyline; Venlafaxine Hydrochloride | 1997 |
Designing a new generation of antidepressant drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cyclopropanes; Drug Design; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Rats; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 1997 |
Erythromelalgia: response to serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Cyclohexanols; Erythromelalgia; Female; Fluoxetine; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1997 |
Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat.
Topics: Animals; Cyclobutanes; Cyclohexanols; Eating; Fenfluramine; Fluoxetine; Male; Neurotransmitter Uptake Inhibitors; Obesity; Rats; Rats, Sprague-Dawley; Venlafaxine Hydrochloride | 1997 |
Application of a first-pass effect model to characterize the pharmacokinetic disposition of venlafaxine after oral administration to human subjects.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Biological Availability; Cyclohexanols; Humans; Male; Metabolic Clearance Rate; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
Withdrawal syndrome after discontinuation of venlafaxine.
Topics: Age Factors; Aged; Cyclohexanols; Depressive Disorder; Female; Gastrointestinal Diseases; Headache; Humans; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1997 |
Seizures, ventricular tachycardia, and rhabdomyolysis as a result of ingestion of venlafaxine and lamotrigine.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Cyclohexanols; Electrocardiography; Humans; Lamotrigine; Male; Rhabdomyolysis; Seizures; Suicide, Attempted; Tachycardia, Ventricular; Triazines; Venlafaxine Hydrochloride | 1997 |
Venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Mixed Function Oxygenases; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1997 |
Clinical considerations in managing nausea associated with venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Cisapride; Cyclohexanols; Depressive Disorder; Gastrointestinal Agents; Humans; Nausea; Piperidines; Venlafaxine Hydrochloride | 1997 |
Seizure activity and enzyme elevations after venlafaxine overdose.
Topics: Adult; Antidepressive Agents, Second-Generation; Creatine Kinase; Cyclohexanols; Depressive Disorder; Drug Overdose; Humans; L-Lactate Dehydrogenase; Male; Seizures; Suicide, Attempted; Venlafaxine Hydrochloride | 1997 |
Severe anticholinergic side effects with venlafaxine-fluoxetine combination.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Receptors, Cholinergic; Venlafaxine Hydrochloride | 1997 |
Functional magnetic resonance imaging studies of emotional processing in normal and depressed patients: effects of venlafaxine.
Topics: Adolescent; Adult; Brain; Cyclohexanols; Depressive Disorder; Echo-Planar Imaging; Emotions; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Visual Cortex; Visual Perception | 1997 |
A case of serotonin syndrome caused by venlafaxine and lithium.
Topics: Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Central Nervous System Diseases; Cyclohexanols; Drug Interactions; Female; Humans; Lithium Compounds; Middle Aged; Selective Serotonin Reuptake Inhibitors; Syndrome; Venlafaxine Hydrochloride | 1997 |
Rapid determination of venlafaxine and O-desmethylvenlafaxine in human plasma by high-performance liquid chromatography with fluorimetric detection.
Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Circadian Rhythm; Cyclohexanols; Desvenlafaxine Succinate; Humans; Linear Models; Osmolar Concentration; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Venlafaxine Hydrochloride | 1997 |
Hyponatremia with venlafaxine.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Humans; Hyponatremia; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Comment: venlafaxine overdose and seizure.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Overdose; Female; Humans; Seizures; Suicide, Attempted; Venlafaxine Hydrochloride | 1998 |
Breast enlargement during chronic antidepressant therapy.
Topics: Breast; Breast Diseases; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Hyperplasia; Male; Menopause; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Weight Gain | 1997 |
Remission of traumatic brain injury-induced compulsions during venlafaxine treatment.
Topics: Antidepressive Agents, Second-Generation; Craniotomy; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Head Injuries, Closed; Hematoma, Epidural, Cranial; Humans; Male; Middle Aged; Neurocognitive Disorders; Obsessive-Compulsive Disorder; Postoperative Complications; Recurrence; Venlafaxine Hydrochloride | 1998 |
Sleep changes after 4 consecutive days of venlafaxine administration in normal volunteers.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Female; Humans; Male; Restless Legs Syndrome; Sleep; Sleep Stages; Sleep Wake Disorders; Sleep, REM; Venlafaxine Hydrochloride | 1997 |
Simultaneous measurement of venlafaxine and its major metabolite, oxydesmethylvenlafaxine, in human plasma by high-performance liquid chromatography with coulometric detection and utilisation of solid-phase extraction.
Topics: Administration, Oral; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Humans; Paroxetine; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Venlafaxine Hydrochloride | 1998 |
Anticholinergic toxic syndrome with venlafaxine-desipramine combination.
Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cholinergic Antagonists; Cyclohexanols; Depressive Disorder; Desipramine; Drug Combinations; Humans; Male; Venlafaxine Hydrochloride | 1998 |
Serotonin syndrome induced by venlafaxine and fluoxetine: a case study in polypharmacy and potential pharmacodynamic and pharmacokinetic mechanisms.
Topics: Adult; Cyclohexanols; Depressive Disorder; Drug Interactions; Female; Fluoxetine; Humans; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 1998 |
[Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
Topics: Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Depression; Drug Administration Schedule; Humans; Hypertension; Nausea; Selective Serotonin Reuptake Inhibitors; Therapeutic Equivalency; Venlafaxine Hydrochloride | 1998 |
Antidepressant efficacy and cardiovascular safety of venlafaxine in young vs old patients with comorbid medical disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Mood Disorders; Risk Factors; Venlafaxine Hydrochloride | 1997 |
Withdrawal reactions associated with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hallucinations; Humans; Male; Risk Factors; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1998 |
Venlafaxine drug-drug interactions in clinical practice.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Drug Interactions; Female; Humans; Male; Middle Aged; Venlafaxine Hydrochloride | 1998 |
Synergistic benefits of serotonin and noradrenaline reuptake inhibition.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 1998 |
The effect of venlafaxine treatment on the behavioural and neurochemical changes in the olfactory bulbectomised rat.
Topics: Animals; Antidepressive Agents, Second-Generation; Body Temperature; Cerebral Cortex; Cyclohexanols; Male; Motor Activity; Olfactory Bulb; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Venlafaxine withdrawal syndrome.
Topics: Cyclohexanols; Depressive Disorder; Electroconvulsive Therapy; Humans; Male; Middle Aged; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1998 |
Use of bupropion with SRIs and venlafaxine.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Assessment; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
Venlafaxine augmentation with methylphenidate for treatment-refractory depression: a case report.
Topics: Aged; Antidepressive Agents, Second-Generation; Central Nervous System Stimulants; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Humans; Male; Methylphenidate; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Venlafaxine overdose.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Central Nervous System Depressants; Cyclohexanols; Drug Interactions; Drug Overdose; Ethanol; Humans; Male; Selective Serotonin Reuptake Inhibitors; Temazepam; Venlafaxine Hydrochloride | 1998 |
Serotonin syndrome in combined moclobemide and venlafaxine ingestion.
Topics: Adult; Benzamides; Central Nervous System Depressants; Cyclohexanols; Drug Interactions; Drug Overdose; Ethanol; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Syndrome; Venlafaxine Hydrochloride | 1998 |
Re: Severe anticholinergic side effects with venlafaxine-fluoxetine combination.
Topics: Cholinergic Antagonists; Cyclohexanols; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Receptors, Adrenergic; Receptors, Cholinergic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.
Topics: Animals; Antidepressive Agents, Second-Generation; Binding, Competitive; Brain; Carrier Proteins; Cyclohexanols; Fluoxetine; Imipramine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Radioligand Assay; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Symporters; Venlafaxine Hydrochloride | 1998 |
Lithium augmentation of venlafaxine in adolescent major depression.
Topics: Adolescent; Antidepressive Agents; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Psychotherapy; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
Serotonin syndrome induced by transitioning from phenelzine to venlafaxine: four patient reports.
Topics: Adult; Central Nervous System Diseases; Cyclohexanols; Drug Interactions; Female; Humans; Male; Middle Aged; Migraine Disorders; Monoamine Oxidase Inhibitors; Phenelzine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 1998 |
Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Male; Mice; Motor Activity; Pindolol; Piperazines; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Venlafaxine withdrawal reactions.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depression; Depressive Disorder; Dizziness; Fatigue; Female; Hallucinations; Headache; Humans; Male; Middle Aged; Nausea; Sensation Disorders; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride | 1998 |
Venlafaxine: loss of antidepressant effect and its management.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Recurrence; Venlafaxine Hydrochloride | 1998 |
Lack of beta adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine.
Topics: Adenylyl Cyclases; Animals; Brain; Brain Chemistry; Cyclic AMP; Cyclohexanols; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 1998 |
Withdrawal reaction associated with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Humans; Male; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1998 |
Breast pain associated with venlafaxine.
Topics: Adult; Breast; Breast Diseases; Cyclohexanols; Depressive Disorder; Edema; Female; Humans; Male; Pain; Selective Serotonin Reuptake Inhibitors; Sex Factors; Venlafaxine Hydrochloride | 1996 |
Comment: hyponatremia with venlafaxine.
Topics: Cyclohexanols; Humans; Hyponatremia; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Serotonin syndrome due to venlafaxine overdose.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Overdose; Humans; Male; Serotonin Syndrome; Venlafaxine Hydrochloride | 1998 |
Treatment of generalized anxiety disorder with venlafaxine: a series of 11 cases.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine.
Topics: Adrenergic Uptake Inhibitors; Animals; Cyclohexanols; Depression; Desipramine; Hippocampus; Injections, Intravenous; Iontophoresis; Male; Norepinephrine; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 1998 |
Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Resistance; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride; Veterans | 1998 |
Fatal venlafaxine overdose.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Overdose; Fatal Outcome; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Potentiation of the time-dependent, antidepressant-induced changes in the agonistic behaviour of resident rats by the 5-HT1A receptor antagonist, WAY-100635.
Topics: Agonistic Behavior; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzodiazepines; Central Nervous System Depressants; Cyclohexanols; Drug Implants; Drug Synergism; Ethanol; Fluoxetine; Interpersonal Relations; Male; Piperazines; Pyridines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Time Factors; Venlafaxine Hydrochloride | 1997 |
Comments on the APA Panic Disorder Guideline. American Psychiatric Association.
Topics: Caregivers; Cognitive Behavioral Therapy; Cyclohexanols; Follow-Up Studies; Humans; Panic Disorder; Practice Guidelines as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
Treatment of venlafaxine discontinuation symptoms with ondansetron.
Topics: Adult; Cyclohexanols; Depressive Disorder; Female; Humans; Ondansetron; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1998 |
Venlafaxine-tramadol similarities.
Topics: Analgesics, Opioid; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Models, Biological; Models, Psychological; Molecular Structure; Pain; Structure-Activity Relationship; Tramadol; Venlafaxine Hydrochloride | 1998 |
[Treatment attempt with thymoleptics in atypical facial pain].
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Facial Pain; Female; Humans; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
Prolonged bradycardia complicates antidepressive treatment with venlafaxine and ECT.
Topics: Adult; Antidepressive Agents, Second-Generation; Bradycardia; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Electroconvulsive Therapy; Humans; Male; Venlafaxine Hydrochloride | 1998 |
Discrepancies between the in vitro and in vivo 5-HT and norepinephrine re-uptake blocking properties of venlafaxine.
Topics: Animals; Brain; Cyclohexanols; Desipramine; In Vitro Techniques; Neurons; Norepinephrine; Paroxetine; Raphe Nuclei; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Synapses; Venlafaxine Hydrochloride | 1998 |
Venlafaxine-fluoxetine interaction.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cholinergic Antagonists; Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Effects of fluoxetine, phentermine, and venlafaxine on pulmonary arterial pressure and electrophysiology.
Topics: Animals; Blood Pressure; Cyclohexanols; Electric Conductivity; Electrophysiology; Fluoxetine; In Vitro Techniques; Male; Membrane Potentials; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Phentermine; Potassium Channel Blockers; Potassium Channels; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
A study involving venlafaxine overdoses: comparison of fatal and therapeutic concentrations in postmortem specimens.
Topics: Adult; Alcoholism; Antidepressive Agents, Second-Generation; Autopsy; Cyclohexanols; Depressive Disorder; Drug Overdose; Female; Humans; Substance Abuse Detection; Venlafaxine Hydrochloride | 1999 |
Effect of venlafaxine on pineal melatonin and noradrenaline in the male rat.
Topics: Animals; Cyclohexanols; Male; Melatonin; Norepinephrine; Pineal Gland; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Evaluating the tolerability of the newer antidepressants.
Topics: Antidepressive Agents; Bupropion; Central Nervous System Diseases; Citalopram; Cyclohexanols; Delayed-Action Preparations; Drug Information Services; Fluvoxamine; Gastrointestinal Diseases; Guidelines as Topic; Humans; Incidence; Paroxetine; Piperazines; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles; United States; United States Agency for Healthcare Research and Quality; Venlafaxine Hydrochloride | 1999 |
Effect of venlafaxine on the pharmacokinetics of risperidone.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety; Area Under Curve; Cyclohexanols; Desvenlafaxine Succinate; Exploratory Behavior; Female; Humans; Isoxazoles; Male; Metabolic Clearance Rate; Middle Aged; Paliperidone Palmitate; Psychomotor Performance; Pyrimidines; Risperidone; Venlafaxine Hydrochloride | 1999 |
Combination treatment with venlafaxine and bupropion.
Topics: Adult; Bupropion; Cyclohexanols; Depressive Disorder; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants.
Topics: Animals; Antimetabolites; Biotransformation; Calibration; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP2D6; Dealkylation; DNA, Complementary; Humans; In Vitro Techniques; Kinetics; Microsomes, Liver; Rabbits; Rats; Selective Serotonin Reuptake Inhibitors; Spectrophotometry, Ultraviolet; Transfection; Venlafaxine Hydrochloride | 1999 |
Acute liver damage possibly related to sertraline and venlafaxine ingestion.
Topics: Acute Disease; Adult; Antidepressive Agents; Cephalexin; Cephalosporins; Chemical and Drug Induced Liver Injury; Cyclohexanols; Drug Overdose; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide, Attempted; Venlafaxine Hydrochloride | 1999 |
Possible venlafaxine-induced mania.
Topics: Bipolar Disorder; Cyclohexanols; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the alpha 1-adrenergic, dopamine and serotonin systems.
Topics: 5-Hydroxytryptophan; Adrenergic alpha-Agonists; Aggression; Amphetamine; Animals; Antidepressive Agents; Body Temperature; Cyclohexanols; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Exploratory Behavior; Head Movements; Male; Mice; Motor Activity; Oxotremorine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 1999 |
Effect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteers.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Genotype; Humans; Male; Polymorphism, Genetic; Venlafaxine Hydrochloride | 1999 |
Redefining antidepressant efficacy toward long-term recovery.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Goals; Humans; Imipramine; Longitudinal Studies; Placebos; Risk Factors; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
Topics: Action Potentials; Adrenergic Uptake Inhibitors; Animals; Binding Sites; Cyclohexanols; Desipramine; Fenfluramine; Hippocampus; In Vitro Techniques; Locus Coeruleus; Male; Neurons; Norepinephrine; Paroxetine; Piperazines; Piperoxan; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Tyramine; Venlafaxine Hydrochloride | 1999 |
Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Birth Weight; Body Weight; Cyclohexanols; Female; Fluoxetine; Growth; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Venlafaxine Hydrochloride; Weight Gain | 1999 |
Venlafaxine in the treatment of resistant postpsychotic depressive symptoms of schizophrenia.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Drug Resistance; Humans; Male; Middle Aged; Schizophrenia; Venlafaxine Hydrochloride | 1999 |
Mergers and acquisitions among psychotropics: antidepressant takeover of anxiety may now be complete.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Drug Approval; Humans; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
Comparing the efficacy and safety of fluoxetine and venlafaxine in outpatient depression.
Topics: Ambulatory Care; Clinical Trials as Topic; Cyclohexanols; Drug Administration Schedule; Fluoxetine; Humans; Peer Review, Research; Research Design; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Spontaneous erections and libido increase associated with venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Libido; Male; Middle Aged; Parkinson Disease; Penile Erection; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1999 |
Altered open-field behavior in experimental chronic hepatic encephalopathy after single venlafaxine and citalopram challenges.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Chronic Disease; Citalopram; Cyclohexanols; Hepatic Encephalopathy; Locomotion; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 1999 |
Electrochemical behaviour of Venlafaxine and its determination in pharmaceutical products using square wave voltammetry.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Electrochemistry; Hydrogen-Ion Concentration; Solutions; Venlafaxine Hydrochloride | 1999 |
Cardiovascular and neurological toxicity of venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Brain; Cardiovascular System; Cyclohexanols; Cytochrome P-450 CYP2D6; Drug Overdose; Electrocardiography; Female; Humans; Kidney; Metabolic Clearance Rate; Phenotype; Venlafaxine Hydrochloride | 1999 |
Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Brain; Cyclohexanols; Dose-Response Relationship, Drug; Hippocampus; Injections, Intraperitoneal; Male; Pindolol; Prefrontal Cortex; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 1999 |
Venlafaxine-associated hepatitis.
Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Cyclohexanols; Female; Humans; Venlafaxine Hydrochloride | 1999 |
Dystonia as a side effect of nonneuroleptics.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Drug Interactions; Dystonia; Fluoxetine; Guanfacine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Venlafaxine Hydrochloride | 1999 |
Venlafaxine and bupropion combination therapy in a case of treatment-resistant depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Chronic Disease; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Psychiatric Status Rating Scales; Recurrence; Venlafaxine Hydrochloride | 1999 |
[Proofs of efficacy].
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Fluoxetine; Humans; Norepinephrine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
Extrapyramidal symptoms associated with the adjunct of nortriptyline to a venlafaxine-valproic acid combination.
Topics: Aged; Anticonvulsants; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Basal Ganglia Diseases; Bipolar Disorder; Cyclohexanols; Drug Combinations; Drug Interactions; Humans; Male; Nortriptyline; Valproic Acid; Venlafaxine Hydrochloride | 1999 |
Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism.
Topics: Adrenergic alpha-Antagonists; Animals; Cerebral Cortex; Cyclohexanols; Dose-Response Relationship, Drug; Idazoxan; Male; Norepinephrine; Oxadiazoles; Piperazines; Prazosin; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Venlafaxine Hydrochloride | 1999 |
Effect of venlafaxine hydrochloride in different preparations of isolated guinea-pig and rat organ tissues.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Animals; Cardiotonic Agents; Cyclohexanols; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Female; Guinea Pigs; Histamine; Ileum; In Vitro Techniques; Male; Muscle, Smooth; Norepinephrine; Rats; Selective Serotonin Reuptake Inhibitors; Uterus; Vas Deferens; Venlafaxine Hydrochloride | 1999 |
An acute ischaemic event associated with the use of venlafaxine: a case report and proposed pathophysiological mechanisms.
Topics: Aged; Antidepressive Agents, Second-Generation; Coronary Circulation; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Electrocardiography; Female; Humans; Myocardial Infarction; Norepinephrine; Platelet Aggregation; Serotonin; Venlafaxine Hydrochloride | 1999 |
Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes.
Topics: Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Electrophysiology; Guinea Pigs; Heart; Heart Ventricles; In Vitro Techniques; Kinetics; Myocardium; Selective Serotonin Reuptake Inhibitors; Sodium Channel Blockers; Time Factors; Venlafaxine Hydrochloride; Ventricular Function | 1999 |
Diaphoresis and pruritus with extended-release venlafaxine.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depression; Female; Humans; Pruritus; Sweating; Venlafaxine Hydrochloride | 1999 |
The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Animals; Cyclohexanols; Drug Synergism; Male; Mice; Mice, Inbred ICR; Narcotic Antagonists; Nociceptors; Pain Measurement; Receptors, Adrenergic; Receptors, Opioid; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 1999 |
Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules.
Topics: Adult; Capsules; Cyclohexanols; Delayed-Action Preparations; Diabetic Neuropathies; Humans; Male; Pain; Venlafaxine Hydrochloride | 1999 |
Venlafaxine versus fluoxetine.
Topics: Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Adjunctive lamotrigine treatment for major depression.
Topics: Adult; Antidepressive Agents; Clonazepam; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Lamotrigine; Lithium Carbonate; Middle Aged; Treatment Outcome; Triazines; Venlafaxine Hydrochloride | 1999 |
Antidepressant-induced bruxism successfully treated with gabapentin.
Topics: Acetates; Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bruxism; Cyclohexanecarboxylic Acids; Cyclohexanols; Depression; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Venlafaxine Hydrochloride | 1999 |
Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Weight; Cyclohexanols; Desipramine; Drinking Behavior; Eating; Endotoxins; Escherichia coli; Interleukin-10; Lipopolysaccharides; Male; Motor Activity; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 1999 |
Abnormal clotting and production of factor VIII inhibitor in a patient treated with venlafaxine.
Topics: Blood Coagulation Disorders; Cyclohexanols; Depressive Disorder, Major; Factor VIII; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
Once-daily venlafaxine XR compared with fluoxetine in outpatients with depression and anxiety.
Topics: Anxiety Disorders; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Neurotransmitter Uptake Inhibitors; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Priapism associated with venlafaxine use.
Topics: Adolescent; Cyclohexanols; Depression; Humans; Male; Priapism; Recurrence; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Venlafaxine Hydrochloride | 2000 |
Neuroleptic malignant syndrome after venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Dopamine Antagonists; Drug Interactions; Drug Therapy, Combination; Humans; Male; Neuroleptic Malignant Syndrome; Trifluoperazine; Venlafaxine Hydrochloride | 2000 |
Eosinophilic pneumonia and respiratory failure associated with venlafaxine treatment.
Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Biopsy; Cyclohexanols; Depressive Disorder, Major; Humans; Lung; Male; Prednisone; Pulmonary Eosinophilia; Respiratory Insufficiency; Tomography, X-Ray Computed; Venlafaxine Hydrochloride | 2000 |
Defense mechanisms and personality in depression.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Defense Mechanisms; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Patient Dropouts; Personality Disorders; Predictive Value of Tests; Psychiatric Status Rating Scales; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Venlafaxine-associated hepatitis.
Topics: Aged; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Cyclohexanols; Humans; Liver Function Tests; Male; Venlafaxine Hydrochloride | 2000 |
Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report.
Topics: Adult; Antidepressive Agents, Second-Generation; Asperger Syndrome; Autistic Disorder; Child; Child, Preschool; Cyclohexanols; Diagnosis, Differential; Female; Humans; Male; Retrospective Studies; Venlafaxine Hydrochloride | 2000 |
Fixed, dilated pupils in the ICU: another recoverable cause.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Carbamazepine; Coma; Cyclohexanols; Female; Humans; Intensive Care Units; Pupil Disorders; Venlafaxine Hydrochloride | 2000 |
Antidepressants upregulate messenger RNA levels of the neuroprotective enzyme superoxide dismutase (SOD1).
Topics: Amitriptyline; Animals; Antidepressive Agents; Bupropion; Cyclohexanols; Dose-Response Relationship, Drug; Doxepin; Gene Expression Regulation, Enzymologic; In Vitro Techniques; Neurons; PC12 Cells; Rats; RNA, Messenger; Superoxide Dismutase; Tumor Cells, Cultured; Up-Regulation; Venlafaxine Hydrochloride | 2000 |
Venlafaxine-induced serotonin syndrome with relapse following amitriptyline.
Topics: Adrenergic Uptake Inhibitors; Aged; Amitriptyline; Antidepressive Agents, Second-Generation; Cyclohexanols; Electroencephalography; Humans; Male; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2000 |
Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test.
Topics: Amygdala; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Biogenic Amines; Brain Chemistry; Cerebral Cortex; Corticosterone; Cyclohexanols; Depressive Disorder; Desipramine; Hormones; Hypothalamo-Hypophyseal System; Male; Motor Activity; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Swimming; Venlafaxine Hydrochloride | 2000 |
Benztropine for venlafaxine-induced night sweats.
Topics: Adult; Antidepressive Agents, Second-Generation; Benztropine; Borderline Personality Disorder; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Muscarinic Antagonists; Sleep Wake Disorders; Sweating; Venlafaxine Hydrochloride | 2000 |
Venlafaxine serum levels and CYP2D6 genotype.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Genotype; Humans; Venlafaxine Hydrochloride | 2000 |
Effect of acute treatment with YM992 on extracellular serotonin levels in the rat frontal cortex.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Cerebral Cortex; Citalopram; Cyclohexanols; Dose-Response Relationship, Drug; Extracellular Space; Fluorobenzenes; Fluoxetine; Frontal Lobe; Male; Morpholines; p-Chloroamphetamine; Piperidines; Rats; Rats, Wistar; Serotonin; Serotonin Agents; Serotonin Antagonists; Synaptosomes; Tritium; Venlafaxine Hydrochloride | 2000 |
Effect of acute treatment with YM992 on extracellular norepinephrine levels in the rat frontal cortex.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Citalopram; Cyclohexanols; Dose-Response Relationship, Drug; Extracellular Space; Fluorobenzenes; Fluoxetine; Frontal Lobe; Male; Morpholines; Norepinephrine; Piperidines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Venlafaxine Hydrochloride | 2000 |
Drug therapy in treatment-resistant depression.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Venlafaxine and paroxetine in treatment-resistant depression.
Topics: Cyclohexanols; Depression; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
Evidence of the dual mechanisms of action of venlafaxine.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Biological Transport, Active; Blood Platelets; Blood Pressure; Cyclohexanols; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Humans; Injections, Intravenous; Male; Maprotiline; Middle Aged; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Systole; Tyramine; Venlafaxine Hydrochloride | 2000 |
Newer antidepressants: a comparison of tolerability in general practice.
Topics: Adult; Aged; Antidepressive Agents; Cohort Studies; Cyclohexanols; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1999 |
Drug treatment for resistant depression.
Topics: Bias; Cyclohexanols; Drug Resistance; Humans; Mental Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
Topics: Adult; Cyclohexanols; Depressive Disorder; Female; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Ontario; Orgasm; Paroxetine; Prevalence; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Sexual Dysfunctions, Psychological; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
One-year costs of second-line therapies for depression.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cohort Studies; Comorbidity; Cyclohexanols; Depressive Disorder; Drug Costs; Female; Health Care Costs; Health Expenditures; Health Services; Humans; Independent Practice Associations; Male; Multivariate Analysis; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Venlafaxine HCl in the treatment of painful peripheral diabetic neuropathy.
Topics: Aged; Aged, 80 and over; Analgesia; Cyclohexanols; Diabetic Neuropathies; Female; Humans; Male; Middle Aged; Pain; Venlafaxine Hydrochloride | 2000 |
Marked increase of venlafaxine enantiomer concentrations as a consequence of metabolic interactions: a case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Biotransformation; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder; Drug Interactions; Humans; Male; Stereoisomerism; Venlafaxine Hydrochloride | 2000 |
Venlafaxine and fibromyalgia.
Topics: Adult; Cyclohexanols; Female; Fibromyalgia; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
Topics: Animals; Autoreceptors; Cyclohexanols; Dendrites; Dose-Response Relationship, Drug; Electric Stimulation; Electrophysiology; Locus Coeruleus; Male; Neurons; Norepinephrine; Piperazines; Pyramidal Cells; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Synapses; Time Factors; Venlafaxine Hydrochloride | 2000 |
Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
Topics: Adrenergic alpha-Agonists; Animals; Autoreceptors; Brimonidine Tartrate; Carrier Proteins; Cricetinae; Cyclohexanols; Dose-Response Relationship, Drug; Hippocampus; In Vitro Techniques; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Pyridines; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Symporters; Time Factors; Tritium; Venlafaxine Hydrochloride | 2000 |
Simultaneous stereoselective analysis of venlafaxine and O-desmethylvenlafaxine enantiomers in clinical samples by capillary electrophoresis using charged cyclodextrins.
Topics: Antidepressive Agents, Second-Generation; Cyclodextrins; Cyclohexanols; Desvenlafaxine Succinate; Electrophoresis, Capillary; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism; Venlafaxine Hydrochloride | 2000 |
SIADH with multiple antidepressants in a geriatric patient.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bupropion; Cyclohexanols; Depressive Disorder; Humans; Inappropriate ADH Syndrome; Mianserin; Mirtazapine; Risperidone; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Neuroleptic malignant syndrome after venlafaxine.
Topics: Animals; Cyclohexanols; Humans; Neuroleptic Malignant Syndrome; Rats; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Nonhormonal agents show promise against hot flashes.
Topics: Antidepressive Agents, Second-Generation; Antihypertensive Agents; Clonidine; Contraindications; Controlled Clinical Trials as Topic; Cyclohexanols; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Male; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study.
Topics: Animals; Antidepressive Agents; Autoradiography; Brain Chemistry; Carrier Proteins; Citalopram; Cyclohexanols; Desipramine; Fluoxetine; Gene Expression Regulation; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Organ Specificity; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins; Stereotaxic Techniques; Symporters; Trimipramine; Venlafaxine Hydrochloride | 2001 |
A mixed-drug intoxication involving venlafaxine and verapamil.
Topics: Antidepressive Agents, Second-Generation; Autopsy; Calcium Channel Blockers; Cause of Death; Cyclohexanols; Drug Interactions; Female; Humans; Middle Aged; Suicide; Venlafaxine Hydrochloride; Verapamil | 2000 |
Agranulocytosis during treatment with mianserin and venlafaxine.
Topics: Aged; Agranulocytosis; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Mianserin; Venlafaxine Hydrochloride | 2000 |
[St. Johns wort-venlafaxine interaction].
Topics: Cyclohexanols; Female; Humans; Hypericum; Male; Plants, Medicinal; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2000 |
A depressed myocardium.
Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathies; Chest Pain; Cyclohexanols; Electrocardiography; Heart; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tachycardia, Sinus; Venlafaxine Hydrochloride; Ventricular Function, Left | 2000 |
The decreased in vivo clearance of CYP2D6 substrates by CYP2D6*10 might be caused not only by the low-expression but also by low affinity of CYP2D6.
Topics: Alleles; Amino Acid Substitution; Antidepressive Agents, Second-Generation; Base Sequence; Cyclohexanols; Cytochrome P-450 CYP2D6; DNA Primers; DNA, Complementary; Gene Expression; Genetic Variation; Humans; In Vitro Techniques; Kinetics; Mutagenesis, Site-Directed; Polymorphism, Genetic; Recombinant Proteins; Saccharomyces cerevisiae; Spectrophotometry; Substrate Specificity; Venlafaxine Hydrochloride | 2000 |
Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
Topics: 5,7-Dihydroxytryptamine; Adrenergic beta-Antagonists; Animals; Cyclohexanols; Drug Synergism; Electrophysiology; Extracellular Space; Hippocampus; Injections, Intravenous; Male; Paroxetine; Pindolol; Piperazines; Pyramidal Cells; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Neurotransmitter; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Antagonists; Venlafaxine Hydrochloride | 2000 |
1-[2-(1-Hydroxycyclohexyl)-2-(4-methoxyphenyl)ethyl]dimethylammonium chloride (venlafaxine hydrochloride).
Topics: Antidepressive Agents, Second-Generation; Crystallography, X-Ray; Cyclohexanols; Hydrogen Bonding; Models, Molecular; Molecular Conformation; Venlafaxine Hydrochloride | 2000 |
Venlafaxine and its interaction with WAY 100635: effects on serotonergic unit activity and behavior in cats.
Topics: Aminopyridines; Animals; Behavior, Animal; Cats; Cyclohexanols; Drug Interactions; Male; Neurons; Piperazines; Pyridines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sodium Chloride; Venlafaxine Hydrochloride | 2000 |
Venlafaxine and vivid dreaming.
Topics: Adult; Cyclohexanols; Dreams; Female; Humans; Sleep Wake Disorders; Somatoform Disorders; Venlafaxine Hydrochloride | 2000 |
Reduced testosterone level in a venlafaxine treated patient.
Topics: Adult; Cyclohexanols; Depressive Disorder; Humans; Male; Selective Serotonin Reuptake Inhibitors; Testosterone; Venlafaxine Hydrochloride | 2000 |
Venlafaxine for the treatment of neuropathic pain.
Topics: Adult; Antidepressive Agents, Second-Generation; Back Pain; Cyclohexanols; Female; Humans; Venlafaxine Hydrochloride | 2000 |
Effective treatment of venlafaxine-induced noncyclical mastalgia with bromocriptine.
Topics: Antidepressive Agents, Second-Generation; Breast Diseases; Bromocriptine; Cyclohexanols; Depressive Disorder; Dopamine Agonists; Female; Humans; Middle Aged; Pain; Venlafaxine Hydrochloride | 2000 |
Generalized anxiety disorder in family practice patients.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Cyclohexanols; Depression; Diagnosis, Differential; Family Practice; Humans; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; United States; Venlafaxine Hydrochloride | 2000 |
Venlafaxine-induced painful ejaculation.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Ejaculation; Humans; Male; Middle Aged; Pain; Venlafaxine Hydrochloride | 2000 |
[A case report. Venlafaxine--new treatment of painful peripheral diabetic neuropathy].
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Diabetic Neuropathies; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women.
Topics: Adult; Amniotic Fluid; Antidepressive Agents; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cyclohexanols; Female; Fetal Blood; Fluvoxamine; Humans; Pregnancy; Sertraline; Spectrophotometry, Ultraviolet; Venlafaxine Hydrochloride | 2000 |
Do antidepressants affect motivation in conditioned place preference?
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Cocaine; Conditioning, Psychological; Cyclobutanes; Cyclohexanols; Dose-Response Relationship, Drug; Fluoxetine; Male; Motivation; Norepinephrine; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Venlafaxine in treatment of severe painful peripheral diabetic neuropathy.
Topics: Adult; Cyclohexanols; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Humans; Pain; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Review of the pharmacokinetics, pharmacogenetics, and drug interaction potential of antidepressants: focus on venlafaxine.
Topics: Aged; Cyclohexanols; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Drug Tolerance; Female; Genotype; Half-Life; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Efficacy, safety, and tolerability of venlafaxine XR in generalized anxiety disorder.
Topics: Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Drug Tolerance; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Venlafaxine versus sertraline for major depressive disorder.
Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Seizures associated with therapeutic doses of venlafaxine and trimipramine.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Drug Interactions; Female; Humans; Middle Aged; Seizures; Trimipramine; Venlafaxine Hydrochloride | 2000 |
Venlafaxine for hot flushes.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Hot Flashes; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Serotonergic antidepressants and urinary incontinence.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Female; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Urinary Incontinence; Venlafaxine Hydrochloride | 2000 |
Fluoxetine (Sarafem) for premenstrual dysphoric disorder.
Topics: Adult; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Nausea; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Weight Gain | 2001 |
Conduction disturbances associated with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Arrhythmias, Cardiac; Cyclohexanols; Electrocardiography; Female; Heart Conduction System; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
Critical use of venlafaxine serology to uncover genetic rapid metabolism.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Metabolic Clearance Rate; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Breast cancer and hot flashes. Options for relief.
Topics: Breast Neoplasms; Cyclohexanols; Female; Hot Flashes; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
Nonaqueous capillary electrophoresis-mass spectrometry for separation of venlafaxine and its phase I metabolites.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Desvenlafaxine Succinate; Electrophoresis, Capillary; Molecular Structure; Spectrometry, Mass, Electrospray Ionization; Venlafaxine Hydrochloride | 2001 |
Use of vancomycin silica stationary phase in packed capillary electrochromatography I. Enantiomer separation of basic compounds.
Topics: Acetates; Cyclohexanols; Electrophoresis, Capillary; Ethanolamines; Heterocyclic Compounds; Hydrogen-Ion Concentration; Molecular Structure; Propanolamines; Silicon Dioxide; Solutions; Tolperisone; Vancomycin; Venlafaxine Hydrochloride | 2001 |
Diphenhydramine alters the disposition of venlafaxine through inhibition of CYP2D6 activity in humans.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Diphenhydramine; Drug Interactions; Enzyme Inhibitors; Genotype; Histamine H1 Antagonists; Humans; Male; Phenotype; Venlafaxine Hydrochloride | 2001 |
Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.
Topics: 5-Hydroxytryptophan; Adult; Analysis of Variance; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Imipramine; Interferon-gamma; Interleukin-10; Male; Middle Aged; Venlafaxine Hydrochloride | 2001 |
Venlafaxine-associated mania.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
Lithium augmentation in venlafaxine-refractory depression.
Topics: Antimanic Agents; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Lithium Chloride; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
Venlafaxine occupation at the noradrenaline reuptake site: in-vivo determination in healthy volunteers.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Contrast Media; Cyclohexanols; Ephedrine; Female; Humans; Male; Neurons; Norepinephrine; Receptors, Adrenergic; Sympathetic Nervous System; Tomography, Emission-Computed; Venlafaxine Hydrochloride | 2001 |
Prefrontal changes and treatment response prediction in depression.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder, Major; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Prefrontal Cortex; Sertraline; Venlafaxine Hydrochloride | 2001 |
Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Recurrent depression with vagus nerve stimulation.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Electric Stimulation Therapy; Epilepsy; Humans; Male; Middle Aged; Vagus Nerve; Venlafaxine Hydrochloride | 2001 |
Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Biogenic Monoamines; Body Weight; Cyclohexanols; Male; Microdialysis; Rats; Rats, Sprague-Dawley; Tissue Distribution; Venlafaxine Hydrochloride | 2001 |
Venlafaxine withdrawal syndrome not prevented by maprotiline, but resolved by sertraline.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Maprotiline; Nausea; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2001 |
Treatment of neuropathic pain with venlafaxine.
Topics: Adult; Cyclohexanols; Female; Humans; Pain; Peripheral Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Simultaneous screen for microsomal stability and metabolite profile by direct injection turbulent-laminar flow LC-LC and automated tandem mass spectrometry.
Topics: Animals; Chromatography, Liquid; Cyclohexanols; Drug Evaluation, Preclinical; Haloperidol; Microsomes, Liver; Pharmaceutical Preparations; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Spectrometry, Mass, Electrospray Ionization; Venlafaxine Hydrochloride | 2001 |
Problems with ensuring a double blind.
Topics: Cyclohexanols; Delusions; Depressive Disorder; Double-Blind Method; Fluvoxamine; Humans; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
Short-term administration of fluoxetine and venlafaxine decreases corticosteroid receptor mRNA expression in the rat hippocampus.
Topics: Animals; Antidepressive Agents, Second-Generation; Corticosterone; Cyclohexanols; Fluoxetine; Gene Expression; Hippocampus; Male; Maze Learning; Memory; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; RNA, Messenger; Venlafaxine Hydrochloride | 2001 |
Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor.
Topics: Adrenergic Uptake Inhibitors; Animals; Conditioning, Psychological; Cyclohexanols; Dopamine Antagonists; Exploratory Behavior; Male; Morphine Dependence; Motor Activity; Norepinephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Sulpiride; Venlafaxine Hydrochloride | 2001 |
Venlafaxine-induced hair loss.
Topics: Alopecia; Cyclohexanols; Depressive Disorder; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Diagnosis, Differential; Dysthymic Disorder; Female; Humans; Paroxetine; Stroke; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2001 |
Functional brain circuits in major depression and remission.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Brain; Cyclohexanols; Depressive Disorder; Glucose; Humans; Neural Pathways; Psychotherapy; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Neuroimaging profiles and the differential therapies of depression.
Topics: Antidepressive Agents; Brain; Cyclohexanols; Depressive Disorder; Fluorodeoxyglucose F18; Glucose; Humans; Psychotherapy; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Topics: Animals; Brain Chemistry; Carrier Proteins; Citalopram; Clomipramine; Cyclohexanols; Electrophysiology; Humans; Ligands; Male; Membrane Glycoproteins; Membrane Transport Proteins; Morpholines; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; p-Chloroamphetamine; Rats; Rats, Wistar; Reboxetine; Receptors, Adrenergic, alpha; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Symporters; Venlafaxine Hydrochloride | 2001 |
S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Body Temperature; Carrier Proteins; Citalopram; Clomipramine; Cyclohexanols; Discrimination, Psychological; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Morpholines; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; p-Chloroamphetamine; Postural Balance; Rats; Rats, Wistar; Reaction Time; Reboxetine; Reserpine; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Symporters; Venlafaxine Hydrochloride | 2001 |
Use of vancomycin silica stationary phase in packed capillary electrochromatography. II. Enantiomer separation of venlafaxine and O-desmethylvenlafaxine in human plasma.
Topics: Antidepressive Agents, Second-Generation; Chromatography, Micellar Electrokinetic Capillary; Cyclohexanols; Desvenlafaxine Succinate; Sensitivity and Specificity; Silicon Dioxide; Stereoisomerism; Vancomycin; Venlafaxine Hydrochloride | 2001 |
Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction.
Topics: Agoraphobia; Alcoholism; Cyclohexanols; Depressive Disorder; Female; Fructose; Hallucinations; Humans; Infarction, Posterior Cerebral Artery; Middle Aged; Neuroprotective Agents; Obesity; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Topiramate; Venlafaxine Hydrochloride | 2001 |
[Depressive disorders and antidepressive therapy. A comparison of neurology practice and psychiatric clinic].
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Utilization; Female; Hospitals, Psychiatric; Humans; Male; Middle Aged; Neurology; Patient Admission; Patient Care Team; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Flushing in a menopausal woman taking venlafaxine.
Topics: Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Female; Flushing; Hot Flashes; Humans; Menopause; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
Microdialysis in freely moving mice: determination of acetylcholine, serotonin and noradrenaline release in galanin transgenic mice.
Topics: Acetylcholine; Animals; Chromatography, High Pressure Liquid; Cyclohexanols; Galanin; Hippocampus; Injections, Intraventricular; Mice; Mice, Knockout; Microdialysis; Movement; Muscarinic Antagonists; Neurochemistry; Neurons; Norepinephrine; Potassium; Scopolamine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride; Wakefulness | 2001 |
Successful use of cardiac allograft from serotonin antagonist intoxication.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Fluoxetine; Gastrointestinal Diseases; Heart Transplantation; Humans; Male; Postoperative Complications; Serotonin Antagonists; Suicide; Transplantation, Homologous; Venlafaxine Hydrochloride | 2001 |
Postmortem tissue concentrations of venlafaxine.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cause of Death; Chromatography, Liquid; Cyclohexanols; Female; Forensic Medicine; Humans; Liver; Male; Middle Aged; Tissue Distribution; Venlafaxine Hydrochloride | 2001 |
In vitro effects of St. John's wort extract and hyperforin on 5 HT uptake and efflux in human blood platelets.
Topics: Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Blood Platelets; Bridged Bicyclo Compounds; Cyclohexanols; Humans; Hypericum; In Vitro Techniques; Phloroglucinol; Plant Extracts; Reserpine; Serotonin; Terpenes; Venlafaxine Hydrochloride | 2001 |
[14C]Serotonin uptake and [O-methyl-11C]venlafaxine kinetics in porcine brain.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Carbon Radioisotopes; Cerebrovascular Circulation; Cyclohexanols; Female; Metabolic Clearance Rate; Radiochemistry; Serotonin; Swine; Synaptosomes; Tissue Distribution; Tomography, Emission-Computed; Venlafaxine Hydrochloride | 2001 |
The combined use of bupropion, lithium, and venlafaxine during ECT: a case of prolonged seizure activity.
Topics: Antidepressive Agents, Second-Generation; Antimanic Agents; Bupropion; Cyclohexanols; Electroconvulsive Therapy; Humans; Lithium Carbonate; Male; Middle Aged; Seizures; Time Factors; Venlafaxine Hydrochloride | 2001 |
Rapid high-performance liquid chromatographic measurement of venlafaxine and O-desmethylvenlafaxine in human plasma. Application to management of acute intoxications.
Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Humans; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Venlafaxine Hydrochloride | 2001 |
Venlafaxine in the treatment of postpartum depression.
Topics: Adult; Anxiety Disorders; Cyclohexanols; Depression, Postpartum; Depressive Disorder; Drug Administration Schedule; Female; Humans; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Abortion, Therapeutic; Birth Weight; Cyclohexanols; Depressive Disorder; Female; Gestational Age; Humans; Infant, Newborn; Maternal Exposure; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Smoking; Venlafaxine Hydrochloride | 2001 |
Addition of olanzapine for treatment-resistant depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Olanzapine; Pirenzepine; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
On-line capillary electrophoresis-electrospray mass spectrometry for the stereoselective analysis of drugs and metabolites.
Topics: Amphetamines; Cyclodextrins; Cyclohexanols; Electrophoresis, Capillary; Indicators and Reagents; Methadone; Pharmaceutical Preparations; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tropanes; Venlafaxine Hydrochloride | 2001 |
Once-daily venlafaxine extended release (XR) vs. fluoxetine for the treatment of depression.
Topics: Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Half-Life; Humans; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Pseudodementia. Cognitive decline caused by untreated depression may be reversed with treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Factitious Disorders; Female; Humans; Venlafaxine Hydrochloride | 2001 |
Venlafaxine-induced hypomanic switch in bipolar depression.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Cyclohexanols; Humans; Male; Venlafaxine Hydrochloride | 2001 |
Venlafaxine- and trazodone-induced serotonin syndrome.
Topics: Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Humans; Male; Middle Aged; Serotonin Syndrome; Trazodone; Venlafaxine Hydrochloride | 2001 |
Venlafaxine and breast-feeding.
Topics: Adult; Breast Feeding; Cyclohexanols; Depression, Postpartum; Desvenlafaxine Succinate; Female; Humans; Infant; Infant, Newborn; Male; Milk, Human; Venlafaxine Hydrochloride | 2001 |
Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.
Topics: Animals; Biogenic Monoamines; Carrier Proteins; Cell Line; Cyclohexanols; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Monoamine Oxidase; Nerve Tissue Proteins; Neurons; Norepinephrine Plasma Membrane Transport Proteins; Oxidopamine; p-Chloroamphetamine; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Sympatholytics; Symporters; Thiophenes; Venlafaxine Hydrochloride | 2001 |
The reductions in sweetened milk intake induced by interleukin-1 and endotoxin are not prevented by chronic antidepressant treatment.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Appetite; Body Weight; Brain; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Eating; Imipramine; Interleukin-1; Lipopolysaccharides; Male; Mice; Milk; Neuroimmunomodulation; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2001 |
Noradrenergic antidepressants: does chronic treatment increase or decrease nuclear CREB-P?
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cell Nucleus; Cells, Cultured; Cerebral Cortex; Cyclic AMP Response Element-Binding Protein; Cyclohexanols; Desipramine; Fibroblasts; Humans; Male; Morpholines; Rats; Rats, Sprague-Dawley; Reboxetine; Time Factors; Venlafaxine Hydrochloride | 2002 |
Sertralilne, paroxetine and venlafaxine in refugee post traumatic stress disorder with depression symptoms.
Topics: Adult; Antidepressive Agents; Bosnia and Herzegovina; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; United States; Venlafaxine Hydrochloride; Warfare | 2001 |
Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction.
Topics: Accidental Falls; Adult; Aged; Basal Ganglia Diseases; Cyclohexanols; Depressive Disorder; Dopamine Antagonists; Drug Interactions; Female; Humans; Metoclopramide; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline; Tibial Fractures; Venlafaxine Hydrochloride | 2002 |
Reporting of randomised trials.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Humans; Randomized Controlled Trials as Topic; Selection Bias; Venlafaxine Hydrochloride | 2002 |
Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Corticosterone; Cyclohexanols; Hippocampus; Hypothalamus; Male; Oxadiazoles; Oxytocin; Piperazines; Rats; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 2002 |
Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants.
Topics: Adult; Antidepressive Agents; Area Under Curve; Breast Feeding; Confidence Intervals; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Female; Humans; Infant; Lactation; Male; Milk, Human; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2002 |
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Ataxia; Citalopram; Cyclohexanols; Dose-Response Relationship, Drug; Environment; Hyperkinesis; Mice; Motor Activity; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2002 |
The effects of a selective noradrenaline reuptake inhibitor on the urethra: an in vitro and in vivo study.
Topics: Adrenergic Uptake Inhibitors; Animals; Cyclohexanols; Electric Stimulation; Female; Muscle Contraction; Pressure; Rabbits; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Urethra; Urinary Incontinence, Stress; Venlafaxine Hydrochloride | 2001 |
False-positive phencyclidine immunoassay results caused by venlafaxine and O-desmethylvenlafaxine.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cyclohexanols; Desvenlafaxine Succinate; False Positive Reactions; Female; Humans; Immunoassay; Male; Middle Aged; Phencyclidine; Venlafaxine Hydrochloride | 2002 |
Treatment of erythromelalgia with a serotonin/noradrenaline reuptake inhibitor.
Topics: Cyclohexanols; Erythromelalgia; Humans; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2002 |
A 75-year-old man with depression.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Coronary Artery Bypass; Coronary Disease; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Family; Humans; Male; Prevalence; Psychotherapy; Retirement; United States; Venlafaxine Hydrochloride | 2002 |
Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Female; Geriatric Assessment; Humans; Hyponatremia; Male; Middle Aged; Psychiatric Department, Hospital; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Victoria | 2002 |
Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Bupropion; Canada; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Treatment of psychotic depression associated with steroid therapy in Churg-Strauss syndrome.
Topics: Adrenal Cortex Hormones; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Churg-Strauss Syndrome; Cyclohexanols; Depression; Electroconvulsive Therapy; Female; Humans; Middle Aged; Paroxetine; Risperidone; Venlafaxine Hydrochloride | 2002 |
[Generalized anxiety disorders (GAD)--a neglected illness? Background und aims of the GAD-P study].
Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Diagnosis, Differential; Humans; Middle Aged; Prevalence; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2001 |
[Family physician's interventions and prescribing practice. Results of the GAD-P study].
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Barbiturates; Behavior Therapy; Cyclohexanols; Depression; Female; Humans; Hypnotics and Sedatives; Male; Physicians, Family; Phytotherapy; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
An organic psychosis due to a venlafaxine-propafenone interaction.
Topics: Aged; Bipolar Disorder; Cyclohexanols; Drug Interactions; Female; Humans; Propafenone; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2001 |
Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Convulsants; Cyclohexanols; Drug Interactions; Male; Pentylenetetrazole; Rats; Rats, Wistar; Seizures; Venlafaxine Hydrochloride | 2002 |
Disposition of venlafaxine enantiomers in rats with hepatic encephalopathy after chronic drug treatment.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Cyclohexanols; Disease Models, Animal; Hepatic Encephalopathy; Humans; Male; Portacaval Shunt, Surgical; Rats; Rats, Sprague-Dawley; Safety; Stereoisomerism; Venlafaxine Hydrochloride | 2002 |
Efficacy and safety of venlafaxine-ECT combination in treatment-resistant depression.
Topics: Aged; Anesthetics, Intravenous; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Electroconvulsive Therapy; Female; Heart Arrest; Heart Rate; Humans; Male; Middle Aged; Propofol; Retrospective Studies; Sodium Channels; Venlafaxine Hydrochloride | 2002 |
Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine.
Topics: Adult; Central Nervous System Stimulants; Cyclohexanols; Dextroamphetamine; Drug Interactions; Humans; Male; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2002 |
Venlafaxine and bilateral acute angle closure glaucoma.
Topics: Antipsychotic Agents; Chlorpromazine; Cyclohexanols; Drug Interactions; Drug Therapy, Combination; Female; Glaucoma, Angle-Closure; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2002 |
Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression.
Topics: Adult; Aged; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Retrospective Studies; Venlafaxine Hydrochloride | 2002 |
Prevalence of sexual dysfunction among newer antidepressants.
Topics: Adult; Antidepressive Agents; Attitude of Health Personnel; Attitude to Health; Cross-Sectional Studies; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Female; Humans; Logistic Models; Male; Physicians, Family; Prevalence; Primary Health Care; Prospective Studies; Research Design; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; United States; Venlafaxine Hydrochloride | 2002 |
Venlafaxine-associated vaginal bleeding.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Hemorrhage; Humans; Menstruation; Vaginal Diseases; Venlafaxine Hydrochloride | 2002 |
Gabapentin in complicated school refusal.
Topics: Acetates; Adolescent; Amines; Comorbidity; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxyzine; Male; Mental Disorders; Phobic Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Stability indicating LC method for the estimation of venlafaxine in pharmaceutical formulations.
Topics: Antidepressive Agents, Second-Generation; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cyclohexanols; Drug Stability; Venlafaxine Hydrochloride | 2002 |
Once daily sustained release tablets of venlafaxine, a novel antidepressant.
Topics: Antidepressive Agents; Area Under Curve; Chemistry, Pharmaceutical; Cyclohexanols; Delayed-Action Preparations; Humans; Methylcellulose; Polymers; Venlafaxine Hydrochloride | 2002 |
Treatment costs of venlafaxine and selective serotonin-reuptake inhibitors for depression and anxiety.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depressive Disorder; Drug Costs; Female; Health Care Costs; Humans; Longitudinal Studies; Male; Managed Care Programs; Middle Aged; Patient Compliance; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; United States; Venlafaxine Hydrochloride | 2002 |
Rapid onset of antidepressant activity with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Humans; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Inhibition by venlafaxine of the increase in norepinephrine output in rat prefrontal cortex elicited by acute stress or by the anxiogenic drug FG 7142.
Topics: Animals; Anxiety; Carbolines; Cyclohexanols; Dose-Response Relationship, Drug; Electroshock; Extracellular Space; GABA Agonists; Male; Microdialysis; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Venlafaxine Hydrochloride | 2002 |
Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats.
Topics: Acetic Acid; Administration, Intravesical; Adrenergic Uptake Inhibitors; Animals; Cats; Cyclohexanols; Duloxetine Hydrochloride; Electromyography; Female; Fluoxetine; Humans; Methiothepin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Thiophenes; Urethra; Urinary Bladder; Venlafaxine Hydrochloride | 2002 |
PHARMAC and availability of pharmaceuticals.
Topics: Bias; Cost-Benefit Analysis; Cyclohexanols; Drugs, Investigational; Humans; New Zealand; Pharmaceutical Services; Research Support as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2002 |
Effects on drug disposition, brain monoamines and behavior after chronic treatment with the antidepressant venlafaxine in rats with experimental hepatic encephalopathy.
Topics: Analysis of Variance; Animals; Behavior, Animal; Biogenic Monoamines; Brain; Cyclohexanols; Dialysis Solutions; Disease Models, Animal; Enzyme Inhibitors; Hepatic Encephalopathy; Male; Microdialysis; Motor Activity; Rats; Rats, Sprague-Dawley; Venlafaxine Hydrochloride | 2002 |
[Delirium during withdrawal of venlafaxine].
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delirium; Depression; Drug Administration Schedule; Half-Life; Humans; Male; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2002 |
Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Humans; Male; Middle Aged; Sex Factors; Smoking; Stereoisomerism; Venlafaxine Hydrochloride | 2002 |
Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?
Topics: Adult; Aged; Aging; Benzhydryl Compounds; Cresols; Cyclohexanols; Cytochrome P-450 CYP2D6; Debrisoquin; Desipramine; Encainide; Ethnicity; Genetic Variation; Humans; Hydroxylation; Infant; Infant, Newborn; Kidney Diseases; Kinetics; Liver Diseases; Metabolic Clearance Rate; Metoprolol; Phenylpropanolamine; Polymorphism, Genetic; Propafenone; Substrate Specificity; Tolterodine Tartrate; Venlafaxine Hydrochloride | 2002 |
Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxine.
Topics: Adenocarcinoma; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Phytogenic; Cyclohexanols; Female; Humans; Neurotoxicity Syndromes; Ovarian Neoplasms; Paclitaxel; Paresthesia; Sensation Disorders; Venlafaxine Hydrochloride | 2002 |
Treatment for hot flushes in women receiving tamoxifen.
Topics: Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Cyclohexanols; Female; Hot Flashes; Humans; Megestrol Acetate; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Venlafaxine Hydrochloride | 2002 |
Serotonin syndrome induced by amitriptyline, meperidine, and venlafaxine.
Topics: Adult; Amitriptyline; Analgesics; Antifungal Agents; Cyclohexanols; Drug Interactions; Female; Fluconazole; Humans; Meperidine; Serotonin Syndrome; Venlafaxine Hydrochloride | 2002 |
Interaction between ECT and venlafaxine.
Topics: Aged; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Atenolol; Combined Modality Therapy; Cyclohexanols; Depression; Electroconvulsive Therapy; Fatal Outcome; Female; Humans; Hypertension; Venlafaxine Hydrochloride | 2002 |
Venlafaxine in a patient with idiopathic leukopenia and mirtazapine-induced severe neutropenia.
Topics: Agranulocytosis; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depressive Disorder; Drug Hypersensitivity; Female; Humans; Leukopenia; Mianserin; Middle Aged; Mirtazapine; Neutropenia; Venlafaxine Hydrochloride | 2002 |
Treating hot flashes with drugs: an update.
Topics: Acetates; Amines; Anticonvulsants; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Clonidine; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Venlafaxine Hydrochloride | 2002 |
Women with PTSD: the psychodynamic aspects of psychopharmacologic and "hands-on" psychiatric management.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Carbamazepine; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Female; Humans; Oxcarbazepine; Psychotropic Drugs; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2002 |
Pharmacokinetically induced benzodiazepine withdrawal.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Interactions; Female; Humans; Middle Aged; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride | 2001 |
Fanconi and inappropriate secretion of antidiuretic hormone syndromes secondary to venlafaxine therapy.
Topics: Aged; Aged, 80 and over; Alcoholism; Cyclohexanols; Fanconi Anemia; Female; Humans; Inappropriate ADH Syndrome; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2002 |
Venlafaxine poisoning complicated by a late rise in creatine kinase: two case reports.
Topics: Adult; Antidepressive Agents, Second-Generation; Creatine Kinase; Cyclohexanols; Drug Overdose; Female; Humans; Rhabdomyolysis; Serotonin Syndrome; Venlafaxine Hydrochloride | 2002 |
Treatment of posttraumatic stress disorder with tiagabine.
Topics: Adult; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Male; Nipecotic Acids; Stress Disorders, Post-Traumatic; Tiagabine; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
The brain tells: early signs of depression recovery.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Prefrontal Cortex; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Venlafaxine Hydrochloride | 2002 |
A case of venlafaxine-induced inhibition of T-lymphocyte proliferation.
Topics: Cyclohexanols; Female; Humans; Lymphocyte Activation; Middle Aged; Obsessive-Compulsive Disorder; Recurrence; Selective Serotonin Reuptake Inhibitors; Sinusitis; T-Lymphocytes; Venlafaxine Hydrochloride | 2002 |
Venlafaxine and reversible blepharoedema.
Topics: Adult; Cyclohexanols; Edema; Eye Diseases; Female; Humans; Hyponatremia; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2002 |
Venlafaxine in the treatment of painful peripheral diabetic neuropathy in a uremic patient undergoing hemodialysis.
Topics: Adult; Analgesics; Cyclohexanols; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Humans; Pain; Uremia; Venlafaxine Hydrochloride | 2002 |
Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data.
Topics: Antidepressive Agents; Cyclohexanols; Drug Overdose; Humans; Risk Assessment; Risk Factors; Serotonin Agents; United Kingdom; Venlafaxine Hydrochloride | 2002 |
Hypokalemia with venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Electrolytes; Humans; Hypokalemia; Hyponatremia; Inappropriate ADH Syndrome; Magnesium Deficiency; Male; Middle Aged; Venlafaxine Hydrochloride | 2002 |
Alternative venlafaxine kinetics in overdose.
Topics: Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Cyclohexanols; Cytochrome P-450 CYP2D6; Diagnosis, Differential; Drug Overdose; Female; Humans; Hypnotics and Sedatives; Pyridines; Venlafaxine Hydrochloride; Zolpidem | 2002 |
Serotonin syndrome produced by a combination of venlafaxine and mirtazapine.
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Lorazepam; Mianserin; Mirtazapine; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2002 |
Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Brain-Derived Neurotrophic Factor; Cyclohexanols; Densitometry; Dose-Response Relationship, Drug; Hippocampus; Immunohistochemistry; Male; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Superoxide Dismutase; Venlafaxine Hydrochloride; Weight Gain | 2003 |
Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Space; Fluoxetine; Male; Microdialysis; Norepinephrine; Paroxetine; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Venlafaxine Hydrochloride | 2002 |
The neural substrates of affective processing in depressed patients treated with venlafaxine.
Topics: Adult; Affect; Amygdala; Brain Mapping; Cerebral Cortex; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Female; Follow-Up Studies; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Fentanyl-induced rigidity during emergence from general anesthesia potentiated by venlafexine.
Topics: Adult; Analgesics, Opioid; Anesthesia Recovery Period; Anesthesia, General; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Synergism; Female; Fentanyl; Humans; Muscle Rigidity; Naloxone; Narcotic Antagonists; Venlafaxine Hydrochloride | 2003 |
The effect of one-week treatment with venlafaxine on 35% CO2 hyperreactivity in patients with panic disorder: an open study.
Topics: Antidepressive Agents, Second-Generation; Carbon Dioxide; Cyclohexanols; Humans; Panic Disorder; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2003 |
Venlafaxine-induced galactorrhea.
Topics: Adult; Antidepressive Agents, Second-Generation; Buspirone; Cyclohexanols; Female; Galactorrhea; Humans; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 2003 |
Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans.
Topics: Administration, Oral; Adult; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Female; Genotype; Humans; Male; Phenotype; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Diffusion of new generation antidepressant treatment among elderly diagnosed with depression.
Topics: Age Factors; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depression; Diabetes Mellitus; Fee-for-Service Plans; Female; Health Status; Heart Diseases; Humans; Hypertension; Male; Medicare; Monoamine Oxidase Inhibitors; Multivariate Analysis; Racial Groups; Sample Size; Sampling Studies; Selective Serotonin Reuptake Inhibitors; Sex Factors; Socioeconomic Factors; Venlafaxine Hydrochloride | 2003 |
Serotonin syndrome induced by low-dose venlafaxine.
Topics: Adult; Cyclohexanols; Depressive Disorder; Female; Humans; Serotonin Syndrome; Venlafaxine Hydrochloride | 2003 |
Changes in regional cerebral blood flow with venlafaxine in the treatment of major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Brain; Cerebral Cortex; Cyclohexanols; Depressive Disorder; Female; Humans; Limbic System; Male; Middle Aged; Psychiatric Status Rating Scales; Regional Blood Flow; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
A case of venlafaxine abuse.
Topics: Adult; Chest Pain; Cyclohexanols; Humans; Male; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Venlafaxine Hydrochloride | 2003 |
Venlafaxine and increased aggression in a female with autism.
Topics: Adolescent; Aggression; Autistic Disorder; Cyclohexanols; Female; Humans; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Venlafaxine Hydrochloride | 2003 |
Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine.
Topics: Adult; Aged; Antipsychotic Agents; Butyrophenones; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Methylation; Middle Aged; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Venlafaxine Hydrochloride | 2003 |
Venlafaxine-induced delirium.
Topics: Cyclohexanols; Delirium; Depressive Disorder; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Erotomania induced by venlafaxine: a case study.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Delusions; Depressive Disorder; Female; Humans; Love; Venlafaxine Hydrochloride | 2003 |
Drug-induced pneumonitis and heart failure simultaneously associated with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Male; Middle Aged; Pneumonia; Venlafaxine Hydrochloride; Ventricular Dysfunction, Left | 2003 |
Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Cohort Studies; Cyclohexanols; Dothiepin; Female; Humans; Male; Middle Aged; Odds Ratio; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions.
Topics: Adverse Drug Reaction Reporting Systems; Bayes Theorem; Chemical and Drug Induced Liver Injury; Cyclohexanols; Databases, Factual; Humans; Neural Networks, Computer; Pancreatitis; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride; World Health Organization | 2003 |
Gabapentin and posttraumatic stress disorder.
Topics: Acetates; Adult; Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Cyclohexanecarboxylic Acids; Cyclohexanols; Depressive Disorder, Major; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2003 |
Venlafaxine: not yet first in the antidepressant class.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Humans; Remission Induction; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Serotonin syndrome after single doses of co-amoxiclav during treatment with venlafaxine.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Interactions; Drug Therapy, Combination; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2003 |
The antihyperalgesic effect of venlafaxine in diabetic rats does not involve the opioid system.
Topics: Analgesics; Animals; Cyclohexanols; Diabetes Complications; Dose-Response Relationship, Drug; Hyperalgesia; Male; Naloxone; Narcotic Antagonists; Pain Threshold; Pressure; Rats; Rats, Sprague-Dawley; Venlafaxine Hydrochloride; Vocalization, Animal | 2003 |
Shock-like sensations during venlafaxine withdrawal.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Sensation Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2003 |
The effects of venlafaxine on the subjective, reinforcing, and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans.
Topics: Adult; Affect; Behavior, Addictive; Cardiovascular System; Cocaine; Cyclohexanols; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Opioid-Related Disorders; Reinforcement, Psychology; Venlafaxine Hydrochloride | 2003 |
Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Desipramine; Drug Synergism; Extracellular Space; Fluoxetine; Glutamic Acid; Male; Microdialysis; Neurons; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sulfonamides; Synaptic Transmission; Thiophenes; Venlafaxine Hydrochloride | 2003 |
Randomized controlled trials in psychiatry. Part 1: methodology and critical evaluation.
Topics: Cyclohexanols; Depressive Disorder; Double-Blind Method; Humans; Patient Selection; Psychiatry; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
[Reversible and dose-related parkinsonism induced by venlafaxine].
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Humans; Male; Parkinson Disease, Secondary; Venlafaxine Hydrochloride | 2003 |
Investigation of epistasis between the serotonin transporter and norepinephrine transporter genes in anorexia nervosa.
Topics: Anorexia Nervosa; Carrier Proteins; Case-Control Studies; Chi-Square Distribution; Cyclohexanols; Epistasis, Genetic; Female; Humans; Linkage Disequilibrium; Male; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Biology; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Parents; Polymorphism, Genetic; Promoter Regions, Genetic; Risk; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Symporters; Venlafaxine Hydrochloride | 2003 |
Comparison of behavioural effects of venlafaxine and imipramine in rats.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Cyclohexanols; Imipramine; Male; Maze Learning; Memory, Short-Term; Motor Activity; Rats; Rats, Wistar; Swimming; Venlafaxine Hydrochloride | 2003 |
Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats.
Topics: alpha-Methyltyrosine; Analgesics; Animals; Antidepressive Agents; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Fenclonine; Male; Mononeuropathies; Motor Activity; Naloxone; Narcotic Antagonists; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Venlafaxine Hydrochloride; Vocalization, Animal | 2003 |
Venlafaxine for pathological crying after stroke.
Topics: Affective Symptoms; Aged; Crying; Cyclohexanols; Humans; Male; Selective Serotonin Reuptake Inhibitors; Stroke; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
A case report of paranoid delusion with venlafaxine use.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Delusions; Depressive Disorder; Humans; Male; Paranoid Disorders; Venlafaxine Hydrochloride | 2003 |
The antinociceptive effect of tramadol-venlafaxine combination on the paw withdrawal threshold in a rat model of neuropathic pain.
Topics: Analgesics; Animals; Cyclohexanols; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Male; Pain Threshold; Pressure; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Tramadol; Venlafaxine Hydrochloride | 2003 |
Protection against oxaliplatin acute neurosensory toxicity by venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Antineoplastic Agents; Colonic Neoplasms; Cyclohexanols; Humans; Male; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Venlafaxine Hydrochloride | 2003 |
Venlafaxine treatment of obsessive-compulsive disorder: case reports.
Topics: Adult; Cyclohexanols; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat.
Topics: Analgesics; Animals; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Phytogenic; Cyclohexanols; Disease Models, Animal; Hyperalgesia; Male; Neuralgia; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Vincristine | 2003 |
[Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Mania associated with venlafaxine discontinuation.
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depression; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2003 |
Infinite enantiomeric resolution of basic compounds using highly sulfated cyclodextrin as chiral selector in capillary electrophoresis.
Topics: Cyclodextrins; Cyclohexanols; Electrophoresis, Capillary; Fluoxetine; Mass Spectrometry; Methadone; Stereoisomerism; Tramadol; Venlafaxine Hydrochloride | 2003 |
Selective serotonin reuptake inhibitors combined with venlafaxine in depressed patients who had partial response to venlafaxine: four cases.
Topics: Adult; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Suggested guidelines for e-mail communication in psychiatric practice.
Topics: Adult; Borderline Personality Disorder; Combined Modality Therapy; Cyclohexanols; Electronic Mail; Female; Guidelines as Topic; Humans; Panic Disorder; Physician-Patient Relations; Practice Patterns, Physicians'; Privacy; Psychiatry; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Risperidone-responsive segmental dystonia and pallidal deep brain stimulation.
Topics: Aged; Antidepressive Agents; Combined Modality Therapy; Cyclohexanols; Depression; Dopamine Antagonists; Dystonic Disorders; Electric Stimulation Therapy; Globus Pallidus; Humans; Male; Parkinson Disease, Secondary; Risperidone; Severity of Illness Index; Venlafaxine Hydrochloride | 2003 |
Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug Interactions; Drug Therapy, Combination; Humans; Male; Obesity; Olanzapine; Pirenzepine; Risk Factors; Valproic Acid; Venlafaxine Hydrochloride | 2003 |
Effects of venlafaxine on extracellular 5-HT, dopamine and noradrenaline in the hippocampus and on peripheral hormone concentrations in the rat in vivo.
Topics: Adrenergic Uptake Inhibitors; Animals; Cyclohexanols; Extracellular Space; Hippocampus; Hormones; Injections, Intraperitoneal; Male; Microdialysis; Neurotransmitter Uptake Inhibitors; Norepinephrine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2003 |
Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.
Topics: Adult; Antidepressive Agents, Second-Generation; Antimanic Agents; Carbamazepine; Cyclohexanols; Depression, Postpartum; Female; Humans; Immunoglobulins, Intravenous; Stevens-Johnson Syndrome; Venlafaxine Hydrochloride | 2003 |
Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Dose-Response Relationship, Drug; Frontal Lobe; Male; Mice; Microdialysis; Norepinephrine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors; Venlafaxine Hydrochloride | 2003 |
[Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Venlafaxine Hydrochloride | 2003 |
Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption.
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Blood-Brain Barrier; Brain; Chromatography, High Pressure Liquid; Cyclohexanols; Doxepin; Drug Resistance, Multiple; Gene Expression; Injections, Subcutaneous; Kidney; Liver; Male; Mianserin; Mice; Mice, Knockout; Mirtazapine; Paroxetine; Point Mutation; Spleen; Venlafaxine Hydrochloride | 2003 |
Mirtazapine-induced hyponatraemia.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depression; Female; Humans; Hyponatremia; Mianserin; Mirtazapine; Venlafaxine Hydrochloride | 2003 |
Venlafaxine hydrochloride for the treatment of hot flashes.
Topics: Clinical Trials as Topic; Cyclohexanols; Female; Hot Flashes; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Dosage finding and outcome of venlafaxine treatment in psychiatric outpatients and inpatients: results of a drug utilization observation study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Drug Utilization; Female; Hospitalization; Humans; Male; Middle Aged; Observation; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride | 2003 |
Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
Topics: Adrenergic Uptake Inhibitors; alpha-Methyltyrosine; Animals; Biogenic Monoamines; Brain Chemistry; Carrier Proteins; Clomipramine; Cyclohexanols; Cyclopropanes; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Extracellular Space; In Vitro Techniques; Male; Microdialysis; Milnacipran; Norepinephrine; p-Chloroamphetamine; Prefrontal Cortex; Radioligand Assay; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Thiophenes; Venlafaxine Hydrochloride | 2003 |
Antidepressant drug treatment induces Arc gene expression in the rat brain.
Topics: Animals; Antidepressive Agents; Brain; Chlorpromazine; Cyclohexanols; Cytoskeletal Proteins; Desipramine; Gene Expression; Male; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Neuronal Plasticity; Paroxetine; Prosencephalon; Rats; Rats, Sprague-Dawley; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Synaptic Transmission; Tranylcypromine; Up-Regulation; Venlafaxine Hydrochloride | 2003 |
Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy.
Topics: Acute Disease; Benzhydryl Compounds; Carrier Proteins; Central Nervous System Stimulants; Child; Cyclohexanols; HLA Antigens; Humans; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Male; Modafinil; Narcolepsy; Neuropeptides; Orexins; Polysomnography; Prednisone; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Hypertensive crisis associated with venlafaxine.
Topics: Adult; Alcohol Deterrents; Alcoholism; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depression; Disulfiram; Drug Interactions; Humans; Hypertension; Venlafaxine Hydrochloride | 2003 |
ECT resistance and early relapse: two cases of subsequent response to venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Resistance; Electroconvulsive Therapy; Female; Humans; Middle Aged; Patient Care Planning; Recurrence; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Should children take antidepressants?
Topics: Adolescent; Affect; Antidepressive Agents; Child; Cyclohexanols; Humans; Paroxetine; Suicide; Venlafaxine Hydrochloride | 2003 |
Fatality related to a 30-g venlafaxine overdose.
Topics: Adult; Cyclohexanols; Drug Overdose; Fatal Outcome; Female; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Venlafaxine withdrawal in organic anxiety disorder.
Topics: Adult; Anxiety Disorders; Cyclohexanols; Female; Humans; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2003 |
Venlafaxine-induced depression of wind-up activity in mononeuropathic rats is potentiated by inhibition of brain 5-HT1A receptor expression in vivo.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Behavior, Animal; Body Temperature; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Drug Synergism; Fever; Hyperalgesia; Infusion Pumps, Implantable; Male; Oligonucleotides, Antisense; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Reflex; Regression, Psychology; Sciatic Neuropathy; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Time Factors; Venlafaxine Hydrochloride | 2004 |
Massive venlafaxine overdose resulted in a false positive Abbott AxSYM urine immunoassay for phencyclidine.
Topics: Adolescent; Cyclohexanols; Depression; Drug Overdose; False Positive Reactions; Female; Gas Chromatography-Mass Spectrometry; Humans; Immunoassay; Phencyclidine; Venlafaxine Hydrochloride | 2003 |
Acute and continuation treatment adequacy with venlafaxine extended release compared with fluoxetine.
Topics: California; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Low-dose venlafaxine-associated liver toxicity in chronic hepatitis.
Topics: Adult; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Cyclohexanols; Dose-Response Relationship, Drug; Female; Hepatitis, Chronic; Humans; Liver Function Tests; Venlafaxine Hydrochloride | 2004 |
Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Carrier Proteins; Citalopram; Cyclohexanols; Cyclopropanes; Duloxetine Hydrochloride; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Mental Disorders; Milnacipran; Nerve Tissue Proteins; Neurons; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Comparisons of psychotropic drug prescribing patterns in acute psychiatric wards across Europe.
Topics: Adult; Benzodiazepines; Biperiden; Chlorpromazine; Clozapine; Cyclohexanols; Diazepam; Drug Administration Schedule; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Europe; Female; Humans; Male; Mood Disorders; Olanzapine; Pharmacoepidemiology; Practice Patterns, Physicians'; Psychiatric Department, Hospital; Psychotropic Drugs; Schizophrenia; Time Factors; Venlafaxine Hydrochloride | 2004 |
[Antidepressive treatment and subcapsular splenic hematoma].
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Hematoma; Humans; Splenic Diseases; Venlafaxine Hydrochloride | 2003 |
Combined oral venlafaxine and intravenous clomipramine-A: successful temporary response in a patient with extremely refractory depression.
Topics: Administration, Oral; Adult; Clomipramine; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride | 2004 |
[An improved novel method of venlafaxine synthesis].
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Venlafaxine Hydrochloride | 2004 |
Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine.
Topics: Analgesics, Opioid; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pain; Polypharmacy; Serotonin Syndrome; Tramadol; Venlafaxine Hydrochloride | 2004 |
Is Effexor more effective for depression than an SSRI?
Topics: Cyclohexanols; Depression; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2004 |
Psychopharmacology news.
Topics: Adolescent; Child; Cyclohexanols; Delayed-Action Preparations; Humans; Pyridoxine; Selective Serotonin Reuptake Inhibitors; United Kingdom; United States; United States Food and Drug Administration; Venlafaxine Hydrochloride | 2003 |
Stimulatory effect of antidepressants on the production of IL-6.
Topics: 5-Hydroxytryptophan; Adult; Age Factors; Aging; Antidepressive Agents; Blood Cells; Cyclohexanols; Depressive Disorder; Drug Combinations; Female; Fluoxetine; Humans; Imipramine; In Vitro Techniques; Inflammation; Interleukin-6; Male; Middle Aged; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2004 |
Response to 'Wishful pharmaceutical thinking'.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Humans; Remission Induction; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Wishful pharmaceutical thinking.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Humans; Psychiatric Status Rating Scales; Research Design; Venlafaxine Hydrochloride | 2003 |
Update: A 75-year-old man with depression.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Male; Quality of Life; Venlafaxine Hydrochloride | 2004 |
SSRIs in IBS: sensing a dash of disappointment.
Topics: Antidepressive Agents; Cyclohexanols; Fluoxetine; Humans; Inflammatory Bowel Diseases; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Mechanisms for the inhibition of genital vascular responses by antidepressants in a female rabbit model.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Arginine; Blood Vessels; Citalopram; Cyclohexanols; Drug Interactions; Duloxetine Hydrochloride; Female; Nitric Oxide; Norepinephrine; Paroxetine; Phentolamine; Rabbits; Regional Blood Flow; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes; Vagina; Vasodilation; Venlafaxine Hydrochloride | 2004 |
Any value in venlafaxine study?
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Publication Bias; Venlafaxine Hydrochloride | 2004 |
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Doxepin; Drug Overdose; Drug Prescriptions; Emergency Service, Hospital; Female; Fluoxetine; Humans; Imipramine; Information Services; Male; Mianserin; Mirtazapine; Paroxetine; Patient Admission; Patient Readmission; Poison Control Centers; Retrospective Studies; Risk Assessment; Scotland; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Trazodone; Venlafaxine Hydrochloride | 2004 |
Comparative toxicity of citalopram and the newer antidepressants after overdose.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Drug Overdose; Female; Humans; Male; Mianserin; Mirtazapine; Piperazines; Poisoning; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride | 2004 |
The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Cyclohexanols; Cytoskeletal Proteins; Drug Administration Schedule; Gene Expression; Immediate-Early Proteins; Injections, Intraperitoneal; Male; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Pyramidal Cells; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors; Venlafaxine Hydrochloride | 2004 |
Effect of gabapentin derivates on mechanical allodynia-like behaviour in a rat model of chronic sciatic constriction injury.
Topics: Amines; Animals; Chronic Disease; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Gabapentin; gamma-Aminobutyric Acid; Memantine; Pain; Pain Threshold; Pregabalin; Prodrugs; Rats; Sciatic Neuropathy; Structure-Activity Relationship; Venlafaxine Hydrochloride | 2004 |
Value in venlafaxine study.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Humans; Periodicals as Topic; Venlafaxine Hydrochloride | 2004 |
Management of anorexia nervosa revisited: drug treatment suggestions are questionable.
Topics: Anorexia Nervosa; Antidepressive Agents; Cyclohexanols; Humans; Morpholines; Reboxetine; Venlafaxine Hydrochloride | 2004 |
Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
Topics: Adult; Benzylamines; Carbon Radioisotopes; Carrier Proteins; Citalopram; Corpus Striatum; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tomography, Emission-Computed; Venlafaxine Hydrochloride | 2004 |
Venlafaxine and SSRI remission data revisited.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Meta-Analysis as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2004 |
Serotonin syndrome due to co-administration of linezolid and venlafaxine.
Topics: Acetamides; Aged; Anti-Infective Agents; Cyclohexanols; Drug Interactions; Drug Resistance, Bacterial; Hip Prosthesis; Humans; Linezolid; Male; Oxazolidinones; Prosthesis-Related Infections; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2004 |
Blockade of supraspinal 5-HT1A receptors potentiates the inhibitory effect of venlafaxine on wind-up activity in mononeuropathic rats.
Topics: Animals; Cyclohexanols; Male; Nerve Fibers, Unmyelinated; Peripheral Nervous System Diseases; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Reflex; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Spinal Cord; Venlafaxine Hydrochloride | 2004 |
Alleviation of erythromelalgia with venlafaxine.
Topics: Administration, Oral; Analgesics; Capsules; Cyclohexanols; Drug Administration Schedule; Erythromelalgia; Female; Foot; Humans; Middle Aged; Venlafaxine Hydrochloride | 2004 |
Simple and an efficient method for the synthesis of 1-[2-dimethylamino-1-(4-methoxy-phenyl)-ethyl]-cyclohexanol hydrochloride: (+/-) venlafaxine racemic mixtures.
Topics: Cyclohexanols; Venlafaxine Hydrochloride | 2004 |
Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in mice.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanols; Dose-Response Relationship, Drug; Drug Interactions; Male; Mice; Narcotic Antagonists; Swimming; Venlafaxine Hydrochloride | 2004 |
Venlafaxine and sour date nut.
Topics: Adult; Anaphylaxis; Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Phytotherapy; Serotonin Syndrome; Venlafaxine Hydrochloride; Ziziphus | 2004 |
A case of social phobia and avoidant personality disorder with erectile dysfunction successfully treated with venlafaxine and add-on reboxetine.
Topics: Adult; Cyclohexanols; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Morpholines; Personality Disorders; Phobic Disorders; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2004 |
Venlafaxine withdrawal syndrome: report of seven cases in Trinidad.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Trinidad and Tobago; Venlafaxine Hydrochloride | 2004 |
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Topics: Acute Disease; Amines; Amitriptyline; Animals; Conscious Sedation; Cyclohexanecarboxylic Acids; Cyclohexanols; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Methyltyrosines; Milnacipran; Neuromuscular Junction; Norepinephrine; p-Chloroamphetamine; Pain; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Tolerability of high-dose venlafaxine in depressed patients.
Topics: Adult; Aged; Blood Pressure; Cyclohexanols; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Formularies as Topic; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; United Kingdom; Venlafaxine Hydrochloride | 2004 |
Recovery of hippocampal cell proliferation and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cell Proliferation; Cyclohexanols; Hippocampus; Male; Rats; Rats, Sprague-Dawley; Restraint, Physical; Stress, Physiological; Venlafaxine Hydrochloride | 2004 |
Venlafaxine-induced increase in urinary frequency in 3 women.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Humans; Polyuria; Urinary Incontinence; Urination Disorders; Venlafaxine Hydrochloride | 2004 |
Venlafaxine XR and chronic pelvic pain syndrome.
Topics: Adult; Chronic Disease; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Male; Pelvic Pain; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Very low dose quetiapine-induced galactorrhea in combination with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Depression; Dibenzothiazepines; Drug Synergism; Drug Therapy, Combination; Female; Galactorrhea; Humans; Prolactin; Quetiapine Fumarate; Venlafaxine Hydrochloride | 2004 |
Comment on: Serotonin syndrome due to co-administration of linezolid and venlafaxine.
Topics: Acetamides; Anti-Bacterial Agents; Cyclohexanols; Drug Synergism; Humans; Linezolid; Oxazolidinones; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2004 |
Withdrawal reactions associated with low-dose venlafaxine treatment in a patient with premenstrual dysphoric disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2004 |
Elevated defibrillation threshold with venlafaxine therapy.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Defibrillators, Implantable; Depressive Disorder, Major; Equipment Failure; Female; Heart Arrest; Humans; Venlafaxine Hydrochloride | 2004 |
Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.
Topics: Activities of Daily Living; Acute Disease; Ambulatory Care; Cost-Benefit Analysis; Cyclohexanols; Decision Support Techniques; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Costs; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus.
Topics: Adrenergic alpha-Antagonists; Animals; Biogenic Monoamines; Cyclohexanols; Dopamine; Drug Interactions; Hippocampus; Idazoxan; Male; Norepinephrine; Prazosin; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors; Venlafaxine Hydrochloride | 2004 |
Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Blepharoptosis; Body Temperature; Cyclohexanols; Desipramine; Fluvoxamine; Levorphanol; Male; Methadone; Mice; Morphine; Narcotics; Reserpine; Stereoisomerism; Time Factors; Tramadol; Venlafaxine Hydrochloride | 2004 |
Venlafaxine-associated hypomania in unipolar depression.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Humans; Male; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride | 2004 |
Atypical neuroleptic malignant syndrome caused by clozapine and venlafaxine: early brief treatment with dantrolene.
Topics: Adult; Clozapine; Cyclohexanols; Dantrolene; GABA Antagonists; Humans; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2004 |
Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.
Topics: Adrenergic Uptake Inhibitors; Analgesics, Opioid; Animals; Antidepressive Agents; Biogenic Monoamines; Conditioning, Operant; Cyclohexanols; Cyclopropanes; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Male; Milnacipran; Morphine; Morpholines; Naloxone; Narcotic Antagonists; Nomifensine; Rats; Rats, Wistar; Reboxetine; Receptors, Opioid, mu; Selective Serotonin Reuptake Inhibitors; Sodium Chloride; Tramadol; Venlafaxine Hydrochloride | 2004 |
[Vital functions at risk. Dealing with depressions rapidly and comprehensively].
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Cyclohexanols; Depressive Disorder; HIV Infections; Humans; Long-Term Care; Randomized Controlled Trials as Topic; Sick Role; Venlafaxine Hydrochloride | 2004 |
Lamotrigine therapy in treatment-resistant menstrually-related rapid cycling bipolar disorder: a case report.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Chronobiology Phenomena; Cyclohexanols; Drug Resistance; Female; Follicular Phase; Humans; Lamotrigine; Menstruation; Thyroxine; Triazines; Valproic Acid; Venlafaxine Hydrochloride | 2004 |
Buspirone to improve compliance in venlafaxine-induced movement disorder.
Topics: Antidepressive Agents, Second-Generation; Buspirone; Compliance; Cyclohexanols; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 2004 |
[Lethal diabetic ketoacidosis in a schizophrenic patient].
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Diabetic Ketoacidosis; Dibenzothiazepines; Fatal Outcome; Humans; Male; Quetiapine Fumarate; Schizophrenia, Paranoid; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Weight Gain | 2004 |
[Depression in Hashimoto's encephalopathy. Successful treatment of a severe depressive episode with a glucocorticoid as an add-on therapy].
Topics: Aged; Chemotherapy, Adjuvant; Cyclohexanols; Depressive Disorder, Major; Drug Combinations; Female; Glucocorticoids; Humans; Prednisolone; Severity of Illness Index; Thyroiditis, Autoimmune; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
A possible case of venlafaxine-induced Stevens-Johnson syndrome.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Exanthema; Female; Humans; Methylprednisolone; Selective Serotonin Reuptake Inhibitors; Stevens-Johnson Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Newer antidepressants in pregnancy: prospective outcome of a case series.
Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Mianserin; Mirtazapine; Piperazines; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Teratogens; Triazoles; Turkey; Venlafaxine Hydrochloride | 2004 |
Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine.
Topics: Cyclohexanols; Depressive Disorder; Emergency Medical Services; Humans; Male; Maprotiline; Middle Aged; Morpholines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2004 |
Trazodone addition for insomnia in venlafaxine-treated, depressed inpatients: a semi-naturalistic study.
Topics: Adult; Chi-Square Distribution; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Sleep Initiation and Maintenance Disorders; Statistics, Nonparametric; Trazodone; Venlafaxine Hydrochloride | 2005 |
Effects of venlafaxine on p90Rsk activity in rat C6-gliomas and brain.
Topics: Animals; Brain; Cell Line, Tumor; Cyclohexanols; Dose-Response Relationship, Drug; Glioma; Male; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 90-kDa; Venlafaxine Hydrochloride | 2004 |
Extended release of a novel antidepressant, venlafaxine, based on anionic polyamidoamine dendrimers and poly(ethylene glycol)-containing semi-interpenetrating networks.
Topics: Acrylamide; Anions; Antidepressive Agents; Cyclohexanols; Delayed-Action Preparations; Hydrogels; Magnetic Resonance Spectroscopy; Molecular Weight; Permeability; Polyamines; Polyethylene Glycols; Spectroscopy, Fourier Transform Infrared; Venlafaxine Hydrochloride | 2005 |
Effects of venlafaxine on ethanol withdrawal syndrome in rats.
Topics: Analysis of Variance; Animals; Cyclohexanols; Dose-Response Relationship, Drug; Ethanol; Male; Motor Activity; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stereotyped Behavior; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2004 |
Clarification to SSRI table.
Topics: Bupropion; Cyclohexanols; Dopamine Uptake Inhibitors; Humans; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Venlafaxine Hydrochloride | 2004 |
Multiple complications and withdrawal syndrome associated with quetiapine/venlafaxine intoxication.
Topics: Coma; Cyclohexanols; Diagnosis, Differential; Dibenzothiazepines; Drug Overdose; Electrocardiography; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Quetiapine Fumarate; Respiratory Insufficiency; Seizures; Serotonin Agents; Serotonin Syndrome; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2005 |
Reversible focal myositis in a patient taking venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Humans; Magnetic Resonance Imaging; Male; Myositis; Selective Serotonin Reuptake Inhibitors; Thigh; Venlafaxine Hydrochloride | 2004 |
Narcolepsy with cataplexy.
Topics: Adult; Cataplexy; Comorbidity; Cyclohexanols; Hallucinations; Humans; Male; Morpholines; Narcolepsy; Patient Education as Topic; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sodium Oxybate; Venlafaxine Hydrochloride | 2004 |
Complete relief of pain in acute painful diabetic neuropathy of rapid glycaemic control (insulin neuritis) with venlafaxine HCL.
Topics: Acute Disease; Analgesics; Blood Glucose; Cyclohexanols; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Male; Middle Aged; Pain; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
The effect of venlafaxine on behaviour, body weight and striatal monoamine levels on sleep-deprived female rats.
Topics: Animals; Body Weight; Corpus Striatum; Cyclohexanols; Female; Immobilization; Maze Learning; Memory; Motor Activity; Rats; Rats, Wistar; Sleep Deprivation; Venlafaxine Hydrochloride | 2004 |
Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects.
Topics: Adolescent; Adult; Aged; Alleles; Antidepressive Agents, Second-Generation; Carbamazepine; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2004 |
The response of synaptophysin and microtubule-associated protein 1 to restraint stress in rat hippocampus and its modulation by venlafaxine.
Topics: Animals; Antidepressive Agents, Second-Generation; Blotting, Western; Cyclohexanols; Hippocampus; Immunohistochemistry; Male; Microtubule-Associated Proteins; Rats; Rats, Sprague-Dawley; Restraint, Physical; Stress, Physiological; Synaptophysin; Venlafaxine Hydrochloride | 2004 |
The prevention of post-surgical neuralgia.
Topics: Analgesics; Celecoxib; Cyclohexanols; Cyclooxygenase Inhibitors; Double-Blind Method; Humans; Incidence; Neuralgia; Postoperative Complications; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides; Venlafaxine Hydrochloride | 2005 |
Quantification of venlafaxine and O-desmethylvenlafaxine in human serum using HPLC analysis.
Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cost-Benefit Analysis; Cyclohexanols; Desvenlafaxine Succinate; Humans; Linear Models; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Venlafaxine Hydrochloride | 2004 |
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Aryl Hydrocarbon Hydroxylases; Arylsulfotransferase; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclohexanols; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Enzyme Inhibitors; Estrogen Receptor Modulators; Female; Genotype; Humans; Middle Aged; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Time Factors; Venlafaxine Hydrochloride | 2005 |
Spontaneous orgasm started with venlafaxine and continued with citalopram.
Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Citalopram; Combined Modality Therapy; Cyclohexanols; Depression; Electroconvulsive Therapy; Female; Humans; Middle Aged; Orgasm; Patient Admission; Venlafaxine Hydrochloride | 2004 |
Venlafaxine-induced mania.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Humans; Male; Venlafaxine Hydrochloride | 2004 |
Venlafaxine induced hepatitis.
Topics: Adult; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury, Chronic; Cyclohexanols; Humans; Male; Risk Factors; Venlafaxine Hydrochloride | 2004 |
Combined antidepressant and hormone treatment is effective for chemotherapy-induced menopausal syndrome.
Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Contraceptives, Oral, Synthetic; Cyclohexanols; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Estrogens; Female; Follicle Stimulating Hormone; Humans; Lymphoma, B-Cell; Medroxyprogesterone; Menopause, Premature; Panic Disorder; Psychiatric Status Rating Scales; Severity of Illness Index; Venlafaxine Hydrochloride | 2005 |
Venlafaxine, serotonin syndrome, and differential diagnoses.
Topics: Adult; Antidepressive Agents, Second-Generation; Catatonia; Cyclohexanols; Diagnosis, Differential; Female; Humans; Neuroleptic Malignant Syndrome; Serotonin Syndrome; Venlafaxine Hydrochloride | 2005 |
Cost-effectiveness of venlafaxine XL compared with diazepam in the treatment of generalised anxiety disorder in the United Kingdom.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cost-Benefit Analysis; Cyclohexanols; Diazepam; Economics, Pharmaceutical; Humans; State Medicine; United Kingdom; Venlafaxine Hydrochloride | 2005 |
Bilateral acute angle closure caused by supraciliary effusions associated with venlafaxine intake.
Topics: Adult; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Anxiety; Ciliary Body; Cyclohexanols; Depression; Glaucoma, Angle-Closure; Gonioscopy; Humans; Iris; Male; Microscopy, Acoustic; Ocular Hypertension; Venlafaxine Hydrochloride | 2005 |
Medication-associated somnambulism.
Topics: Adolescent; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Hypnotics and Sedatives; Pyridines; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Somnambulism; Venlafaxine Hydrochloride; Zolpidem | 2005 |
Fatal cerebral edema after moderate valproic acid overdose.
Topics: Adult; Ammonia; Brain Edema; Cyclohexanols; Drug Overdose; Fatal Outcome; Humans; Male; Risperidone; Valproic Acid; Venlafaxine Hydrochloride | 2005 |
Increased libido with the combined use of venlafaxine and mirtazapine.
Topics: Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Libido; Mianserin; Middle Aged; Mirtazapine; Venlafaxine Hydrochloride | 2005 |
Capgras syndrome in the modern era: self misidentification on an ID picture.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Capgras Syndrome; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Olanzapine; Recurrence; Schizophrenia; Self Concept; Social Identification; Venlafaxine Hydrochloride; Visual Perception | 2005 |
A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium.
Topics: Antidepressive Agents, Second-Generation; Belgium; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Decision Support Techniques; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Costs; Humans; Models, Economic; Practice Patterns, Physicians'; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Cyclohexanols; Drug Interactions; Male; Nociceptors; Pain Measurement; Piperazines; Pressure; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Spinal Cord; Venlafaxine Hydrochloride | 2005 |
Effects of extract of Ginkgo biloba with venlafaxine on brain injury in a rat model of depression.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain Injuries; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Drugs, Chinese Herbal; Ginkgo biloba; Hippocampus; Male; Phytotherapy; Rats; Rats, Wistar; Venlafaxine Hydrochloride | 2005 |
Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients.
Topics: Adult; Aged; Bipolar Disorder; Blood Glucose; Brain; Brain Diseases, Metabolic; Cyclohexanols; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Drug Resistance; Female; Glucans; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lithium Carbonate; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Psychotic Disorders; Psychotropic Drugs; Reference Values; Risk Factors; Sorbitol; Statistics as Topic; Venlafaxine Hydrochloride | 2005 |
Antidepressant and memory affecting influence of estrogen and venlafaxine in ovariectomized rats.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Estrogens; Female; Maze Learning; Memory; Motor Activity; Ovariectomy; Rats; Rats, Wistar; Swimming; Venlafaxine Hydrochloride | 2005 |
Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress.
Topics: Animals; Antidepressive Agents, Tricyclic; Cerebral Cortex; Cyclohexanols; Electroshock; Extracellular Space; Fluvoxamine; Foot; Male; Mianserin; Microdialysis; Mirtazapine; Neurons; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress, Psychological; Venlafaxine Hydrochloride | 2005 |
Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Cyclohexanols; Electroshock; Hypnotics and Sedatives; Male; Mice; Motor Activity; Paroxetine; Punishment; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Receptors, GABA-A; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Stimulation, Chemical; Venlafaxine Hydrochloride | 2005 |
Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Epistaxis; Gastrointestinal Hemorrhage; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Cyclohexanols; Cytoskeletal Proteins; Drug Administration Schedule; Gene Expression; Immediate-Early Proteins; Injections, Intraperitoneal; Male; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Pyramidal Cells; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors; Venlafaxine Hydrochloride | 2004 |
Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cyclohexanols; Female; Fructose; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Peripheral Nervous System Diseases; Recovery of Function; Topiramate; Venlafaxine Hydrochloride | 2005 |
Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).
Topics: Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Citalopram; Cyclohexanols; Depression; Female; Fluoxetine; Humans; Male; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Venlafaxine Hydrochloride | 2005 |
Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Child; Citalopram; Cohort Studies; Cyclohexanols; Databases, Factual; Female; Fluoxetine; Hospitalization; Humans; Male; Middle Aged; Prevalence; Risk Factors; Sex Factors; Suicide, Attempted; Time Factors; United Kingdom; Venlafaxine Hydrochloride | 2005 |
A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Health Care Costs; Humans; Primary Health Care; Treatment Outcome; United Kingdom; Venlafaxine Hydrochloride | 2005 |
Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Narcolepsy; Polysomnography; Substance Withdrawal Syndrome; Treatment Failure; Venlafaxine Hydrochloride | 2005 |
The four-plates test-retest paradigm to discriminate anxiolytic effects.
Topics: Adrenergic Uptake Inhibitors; Amphetamines; Animals; Anti-Anxiety Agents; Anxiety; Atropine; Avoidance Learning; Behavior, Animal; Benzodiazepines; Cholinergic Agents; Cyclohexanols; Discrimination, Psychological; Dose-Response Relationship, Drug; Male; Mice; Paroxetine; Receptors, GABA-A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Venlafaxine Hydrochloride | 2005 |
Causal or casual?
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Drug Overdose; Fluoxetine; Humans; Risk Factors; Suicide, Attempted; Venlafaxine Hydrochloride | 2005 |
Adolescents' response to antidepressant treatment in a community mental health center.
Topics: Adolescent; Adolescent Psychiatry; Algorithms; Antidepressive Agents; Child; Child Psychiatry; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
The serotonin syndrome.
Topics: Aged; Androstanols; Combined Modality Therapy; Cyclohexanols; Humans; Hypnotics and Sedatives; Male; Monoamine Oxidase Inhibitors; Neuromuscular Nondepolarizing Agents; Propofol; Respiration, Artificial; Rocuronium; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Tranylcypromine; Venlafaxine Hydrochloride | 2005 |
Clinical experience with venlafaxine in the treatment of hot flushes in women with a history of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Cyclohexanols; Female; Follow-Up Studies; Hot Flashes; Humans; Middle Aged; Retrospective Studies; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Venlafaxine-associated interstitial pneumonitis.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Lung Diseases, Interstitial; Middle Aged; Venlafaxine Hydrochloride | 2005 |
Multimodal therapy of treatment resistant depression: a study and analysis.
Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Culture; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Female; Humans; Self Concept; Severity of Illness Index; Venlafaxine Hydrochloride | 2005 |
Olanzapine plus venlafaxine in treatment-resistant depression.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Humans; Olanzapine; Venlafaxine Hydrochloride | 2005 |
Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Mirtazapine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Solid Phase Microextraction; Venlafaxine Hydrochloride | 2005 |
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Serotonin syndrome:case report and current concepts.
Topics: Adolescent; Cyclohexanols; Drug Overdose; Female; Humans; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2005 |
Chronic administration of venlafaxine fails to attenuate 5-HT1A receptor function at the level of receptor-G protein interaction.
Topics: Animals; Brain; Cyclohexanols; Male; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, G-Protein-Coupled; Serotonin 5-HT1 Receptor Antagonists; Venlafaxine Hydrochloride | 2006 |
Metabolic ratios of psychotropics as indication of cytochrome P450 2D6/2C19 genotype.
Topics: Alleles; Amitriptyline; Aryl Hydrocarbon Hydroxylases; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Enzyme Activation; Gene Frequency; Genotype; Humans; Metabolic Clearance Rate; Mixed Function Oxygenases; Psychotropic Drugs; Risperidone; Venlafaxine Hydrochloride | 2005 |
Menopausal symptoms after cessation of hormone replacement therapy.
Topics: Administration, Topical; Aged; Attitude to Health; Chi-Square Distribution; Complementary Therapies; Cyclohexanols; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Middle Aged; Postmenopause; Prevalence; Retrospective Studies; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2006 |
alpha2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Citalopram; Clonidine; Cyclohexanols; Cyclopropanes; Dose-Response Relationship, Drug; Drug Antagonism; Guanabenz; Male; Mice; Milnacipran; Motor Activity; Paroxetine; Punishment; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric; Venlafaxine Hydrochloride | 2005 |
Quetiapine and venlafaxine synergically regulate heme oxygenase-2 protein expression in the hippocampus of stressed rats.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Cyclohexanols; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Heme Oxygenase (Decyclizing); Hippocampus; Male; Neurons; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Restraint, Physical; Stress, Physiological; Tissue Distribution; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Open-field behavioural alterations in liver-impaired and sham-operated rats after acute exposure to the antidepressant venlafaxine.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Body Weight; Brain; Cyclohexanols; Liver; Locomotion; Male; Organ Size; Portacaval Shunt, Surgical; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters.
Topics: Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Brain; Cyclohexanols; Desipramine; Male; Norepinephrine Plasma Membrane Transport Proteins; Paroxetine; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride | 2006 |
Severe rhabdomyolysis following venlafaxine overdose.
Topics: Adult; Antidepressive Agents, Second-Generation; Creatine Kinase; Cyclohexanols; Drug Overdose; Female; Humans; Rhabdomyolysis; Venlafaxine Hydrochloride | 2005 |
Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Estrogen Replacement Therapy; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sex Factors; Time Factors; Venlafaxine Hydrochloride | 2005 |
Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Creatine Kinase; Cyclohexanols; Delayed-Action Preparations; Drug Overdose; Female; Humans; Rhabdomyolysis; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2005 |
Serotonin transporter residual availability during long-term antidepressant therapy does not differentiate responder and nonresponder unipolar patients.
Topics: Adult; Aging; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Female; Humans; Image Processing, Computer-Assisted; Male; Mianserin; Middle Aged; Mirtazapine; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tomography, Emission-Computed, Single-Photon; Tropanes; Venlafaxine Hydrochloride | 2006 |
Detective work: reading fine print, insurers question studies of drugs; Kaiser's veteran sleuth scours medical-journal articles and sees marketing spin; doctors fear loss of choices.
Topics: Antidepressive Agents; Biomedical Research; California; Clinical Trials as Topic; Cost Control; Cyclohexanols; Deception; Drug Costs; Drug Industry; Duloxetine Hydrochloride; Formularies as Topic; Health Maintenance Organizations; Humans; Insurance, Pharmaceutical Services; Marketing of Health Services; Publishing; Research Design; Thiophenes; United States; Venlafaxine Hydrochloride | 2005 |
Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for simultaneous determination of venlafaxine and its active metabolite O-desmethyl venlafaxine in human plasma.
Topics: Antidepressive Agents, Second-Generation; Chromatography, Liquid; Citalopram; Cyclohexanols; Desvenlafaxine Succinate; Humans; Reference Standards; Spectrometry, Mass, Electrospray Ionization; Venlafaxine Hydrochloride | 2005 |
Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany.
Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Drug Costs; Drug Utilization; Germany; Health Care Surveys; Humans; Markov Chains; Models, Econometric; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Sertraline; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Discriminative stimulus properties of tianeptine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Caffeine; Central Nervous System Stimulants; Conditioning, Operant; Cyclohexanols; Discrimination Learning; Discrimination, Psychological; Fluoxetine; Male; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Thiazepines; Venlafaxine Hydrochloride | 2006 |
Moving beyond balance for a better antidepressant.
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Humans; Neurotransmitter Uptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2005 |
Fatal venlafaxine overdose with acinar zone 3 liver cell necrosis.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Overdose; Hepatocytes; Humans; Liver; Lung; Male; Multiple Organ Failure; Necrosis; Venlafaxine Hydrochloride | 2005 |
Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Cyclohexanols; Female; Follow-Up Studies; Humans; Male; Self-Injurious Behavior; Time Factors; Venlafaxine Hydrochloride | 2006 |
Venlafaxine and asthma.
Topics: Asthma; Cyclohexanols; Depressive Disorder, Major; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
The serotonin/noradrenaline reuptake inhibitor venlafaxine attenuates acquisition, but not maintenance, of intravenous self-administration of heroin in rats.
Topics: Animals; Behavior, Addictive; Behavior, Animal; Conditioning, Operant; Cyclohexanols; Feeding Behavior; Heroin; Heroin Dependence; Male; Rats; Rats, Long-Evans; Reinforcement Schedule; Selective Serotonin Reuptake Inhibitors; Self Administration; Substance Abuse, Intravenous; Venlafaxine Hydrochloride | 2005 |
Synthesis of new bioactive venlafaxine analogs: novel thiazolidin-4-ones as antimicrobials.
Topics: Anti-Bacterial Agents; Crystallography, X-Ray; Cyclohexanols; In Vitro Techniques; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Venlafaxine Hydrochloride | 2006 |
Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression--evolution of antidepressants and the role of the "neuro-immune" system.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Gene Expression Profiling; Humans; Lymphocytes; Male; Molecular Sequence Data; Neuroimmunomodulation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Venlafaxine Hydrochloride | 2005 |
Development and validation of a flow-injection assay for dissolution studies of the anti-depressant drug venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cyclohexanols; Flow Injection Analysis; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Solubility; Venlafaxine Hydrochloride | 2005 |
Assessment of Canadian provincial expenditures in depressed patients treated with venlafaxine XR versus SSRIs: the APEX Study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Canada; Cyclohexanols; Depression; Direct Service Costs; Female; Health Expenditures; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Optimization of the separation of some psychotropic drugs and their respective metabolites by liquid chromatography.
Topics: Acetonitriles; Buffers; Chromatography, High Pressure Liquid; Cyclohexanols; Haloperidol; Hydrogen-Ion Concentration; Methanol; Models, Theoretical; Psychotropic Drugs; Risperidone; Solvents; Time Factors; Venlafaxine Hydrochloride | 2006 |
Venlafaxine and the rapid development of anasarca.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Edema; Female; Humans; Vasomotor System; Venlafaxine Hydrochloride | 2006 |
Hepatitis associated with low-dose venlafaxine for postmenopausal vasomotor symptoms.
Topics: Chemical and Drug Induced Liver Injury; Cyclohexanols; Dose-Response Relationship, Drug; Female; Hot Flashes; Humans; Liver Function Tests; Middle Aged; Postmenopause; Venlafaxine Hydrochloride | 2006 |
Neuroleptic malignant syndrome after the use of venlafaxine in a patient with generalized anxiety disorder.
Topics: Aged; Anxiety Disorders; Cyclohexanols; Humans; Male; Neuroleptic Malignant Syndrome; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Interaction between venlafaxine and caffeine on antinociception in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Caffeine; Central Nervous System Stimulants; Cyclohexanols; Drug Interactions; Female; Hot Temperature; Injections, Intraperitoneal; Male; Mice; Pain Measurement; Reaction Time; Venlafaxine Hydrochloride | 2006 |
Role of the opioidergic system and nitric oxide in the analgesic effect of venlafaxine.
Topics: Analgesics; Animals; Cyclohexanols; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Male; Naloxone; Narcotic Antagonists; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Wistar; Receptors, Opioid; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Tension-type headache with aura.
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Bromazepam; Cyclohexanols; Fructose; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Tension-Type Headache; Topiramate; Venlafaxine Hydrochloride; Vision Disorders | 2006 |
Venlafaxine-associated serotonin syndrome and manic episode in a geriatric depressive patient.
Topics: Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Serotonin Syndrome; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2006 |
Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Topics: Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Hemorrhage; Humans; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
(R)-sila-venlafaxine: a selective noradrenaline reuptake inhibitor for the treatment of emesis.
Topics: Animals; Antiemetics; Crystallography, X-Ray; Cyclohexanols; Disease Models, Animal; Drug Evaluation, Preclinical; Ferrets; Humans; In Vitro Techniques; Male; Models, Molecular; Molecular Structure; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT3 Receptor Antagonists; Stereoisomerism; Structure-Activity Relationship; Venlafaxine Hydrochloride; Vomiting | 2006 |
The acutely psychotic patient--assessment and initial management.
Topics: Acute Disease; Adolescent; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Cyclohexanols; Female; Humans; Male; Physicians, Family; Piperazines; Practice Guidelines as Topic; Psychotic Disorders; Quinolones; Referral and Consultation; Risk Assessment; Venlafaxine Hydrochloride | 2006 |
Evaluation of antinociceptive and anti-inflammatory effects of venlafaxine in the rat.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Cyclohexanols; Disease Models, Animal; Edema; Female; Male; Mice; Mice, Inbred BALB C; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Venlafaxine Hydrochloride | 2005 |
The redistribution of selected psychiatric drugs in post-mortem cases.
Topics: Antipsychotic Agents; Cyclohexanols; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Gastrointestinal Contents; Humans; Liver; Postmortem Changes; Risperidone; Selective Serotonin Reuptake Inhibitors; Tissue Distribution; Venlafaxine Hydrochloride | 2006 |
Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.
Topics: Adult; Amitriptyline; Antidepressive Agents; Cerebral Cortex; Citalopram; Cyclohexanols; Electroencephalography; Epilepsy; Female; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Morpholines; Reboxetine; Venlafaxine Hydrochloride | 2006 |
Venlafaxine extended-release in patients older than 80 years with depressive syndrome.
Topics: Aged, 80 and over; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Female; Humans; Male; Primary Health Care; Prospective Studies; Remission Induction; Spain; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Estimation of symptom-free days in generalized anxiety disorder.
Topics: Adult; Anxiety Disorders; Chi-Square Distribution; Cyclohexanols; Double-Blind Method; Europe; Female; Humans; Male; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2006 |
QT interval prolongation associated with venlafaxine administration.
Topics: Cyclohexanols; Depression; Electrocardiography; Female; Heart Conduction System; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Treatment guidelines for mania.
Topics: Adult; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Cyclohexanols; Female; Humans; Patient Compliance; Venlafaxine Hydrochloride | 2006 |
Interference by venlafaxine ingestion in the detection of tramadol by liquid chromatography linked to tandem mass spectrometry for the screening of illicit drugs in human urine.
Topics: Antidepressive Agents, Second-Generation; Chromatography, Liquid; Cyclohexanols; Drug Interactions; False Positive Reactions; Humans; Narcotics; Opioid-Related Disorders; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection; Tramadol; Venlafaxine Hydrochloride | 2006 |
Anesthesiologist suicide with atracurium.
Topics: Anesthesiology; Atracurium; Central Nervous System Agents; Chromatography, Gas; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Forensic Medicine; Humans; Isoquinolines; Male; Middle Aged; Neuromuscular Depolarizing Agents; Opium; Suicide; Venlafaxine Hydrochloride | 2006 |
Repetitive transcranial magnetic stimulation (rTMS) in a patient suffering from comorbid depression and panic disorder following a myocardial infarction.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Citalopram; Clorazepate Dipotassium; Cyclohexanols; Depressive Disorder; Humans; Male; Middle Aged; Myocardial Infarction; Panic Disorder; Psychiatric Status Rating Scales; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride | 2006 |
Venlafaxine-associated psoriasiform palmoplantar keratoderma and subungual hyperkeratosis.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Eruptions; Humans; Keratoderma, Palmoplantar, Diffuse; Keratosis; Male; Middle Aged; Nail Diseases; Venlafaxine Hydrochloride | 2006 |
Induction of neuroserpin expression in rat frontal cortex after chronic antidepressant treatment and electroconvulsive treatment.
Topics: Animals; Antidepressive Agents; Cyclohexanols; Electroconvulsive Therapy; Expressed Sequence Tags; Fluoxetine; Frontal Lobe; Imipramine; Male; Neuropeptides; Neuroserpin; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Serpins; Sertraline; Venlafaxine Hydrochloride | 2006 |
CYP2D6 genotype and venlafaxine-XR concentrations in depressed elderly.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Creatinine; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Desvenlafaxine Succinate; Female; Genotype; Humans; Male; Venlafaxine Hydrochloride | 2006 |
Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus.
Topics: Animals; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Cell Proliferation; Chronic Disease; Cyclohexanols; Depressive Disorder; Dibenzothiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Hippocampus; Neuronal Plasticity; Neurons; Quetiapine Fumarate; Rats; Restraint, Physical; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Stem Cells; Stress, Psychological; Venlafaxine Hydrochloride | 2006 |
[Love, humor and psychosis in an atypical depression].
Topics: Antidepressive Agents; Antipsychotic Agents; Azabicyclo Compounds; Benzodiazepines; Clonazepam; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Love; Olanzapine; Piperazines; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Wit and Humor as Topic | 2005 |
[Cannabis dependence and social phobia].
Topics: Adult; Cyclohexanols; Drug Therapy, Combination; Humans; Male; Marijuana Abuse; Paroxetine; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2005 |
Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Cyclohexanols; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2006 |
[Not neglecting therapy of depression in the elderly].
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Somatoform Disorders; Venlafaxine Hydrochloride | 2006 |
The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine.
Topics: Animals; Antidepressive Agents, Second-Generation; Atmosphere Exposure Chambers; Behavior, Animal; Cyclohexanols; Depression; Female; Maze Learning; Memory; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Smoking; Swimming; Venlafaxine Hydrochloride | 2006 |
[Social anxiety disorders].
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Evidence-Based Medicine; Humans; Personality Disorders; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Narcolepsy-cataplexy associated with precocious puberty.
Topics: Aspartic Acid; Benzhydryl Compounds; Cataplexy; Child; Creatine; Cyclohexanols; Disorders of Excessive Somnolence; Female; Hallucinations; Health Education; Humans; Hypothalamus; Intracellular Signaling Peptides and Proteins; Male; Modafinil; Narcolepsy; Neuropeptides; Night Terrors; Obesity; Orexins; Polysomnography; Puberty, Precocious; Television; Venlafaxine Hydrochloride | 2006 |
Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: clinical intervention with donepezil and venlafaxine.
Topics: Aged; Antidepressive Agents, Second-Generation; Ataxia; Atrophy; Brain; Cyclohexanols; Dementia; Dominance, Cerebral; Donepezil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fragile X Mental Retardation Protein; Fragile X Syndrome; Genetic Carrier Screening; Humans; Image Processing, Computer-Assisted; Indans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Mood Disorders; Neurologic Examination; Neuropsychological Tests; Nootropic Agents; Piperidines; Tremor; Trinucleotide Repeats; Venlafaxine Hydrochloride | 2006 |
Modafinil-induced reversible hyperkinetic nondystonic movement disorder in a patient with major depressive disorder.
Topics: Aged; Antidepressive Agents, Second-Generation; Benzhydryl Compounds; Central Nervous System Stimulants; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperkinesis; Modafinil; Neurologic Examination; Venlafaxine Hydrochloride | 2006 |
Effects of venlafaxine and desipramine on heroin-induced conditioned place preference in the rat.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Association Learning; Choice Behavior; Conditioning, Classical; Cyclohexanols; Desipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Heroin Dependence; Injections, Intraperitoneal; Male; Premedication; Rats; Rats, Sprague-Dawley; Reward; Self Administration; Social Environment; Substance Abuse, Intravenous; Venlafaxine Hydrochloride | 2006 |
Can venlafaxine in breast milk attenuate the norepinephrine and serotonin reuptake neonatal withdrawal syndrome.
Topics: Breast Feeding; Cyclohexanols; Diagnosis, Differential; Female; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Pregnancy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Linezolid and serotonergic drug interactions: a retrospective survey.
Topics: Acetamides; Adult; Aged, 80 and over; Anti-Infective Agents; Cyclohexanols; Drug Interactions; Female; Humans; Incidence; Linezolid; Monoamine Oxidase Inhibitors; Oxazolidinones; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2006 |
Venlafaxine compromises the antinociceptive actions of gabapentin in rat models of neuropathic and persistent pain.
Topics: Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Cyclohexanols; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Kidney; Male; Neuralgia; Pain; Pain Measurement; Rats; Rats, Inbred BN; Venlafaxine Hydrochloride | 2006 |
Antidepressant withdrawal symptoms-telephone calls to a national medication helpline.
Topics: Antidepressive Agents; Cyclohexanols; Hotlines; Humans; Monoamine Oxidase Inhibitors; Paroxetine; Retrospective Studies; Substance Withdrawal Syndrome; Television; United Kingdom; Venlafaxine Hydrochloride | 2006 |
A case of recurrent hyponatremia induced by venlafaxine.
Topics: Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Female; Humans; Hyponatremia; Recurrence; Venlafaxine Hydrochloride | 2006 |
Enantioselective synthesis of beta-amino esters and its application to the synthesis of the enantiomers of the antidepressant Venlafaxine.
Topics: Amines; Amino Acids; Analgesics; Antidepressive Agents, Second-Generation; Catalysis; Cyclohexanols; Diazonium Compounds; Esters; Methylamines; Proline; Rhodium; Stereoisomerism; Venlafaxine Hydrochloride | 2006 |
Lithium and venlafaxine interaction: a case of serotonin syndrome.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Female; Humans; Lithium Carbonate; Serotonin Syndrome; Venlafaxine Hydrochloride | 2006 |
Acute adverse cutaneous reaction after the concomitant use of venlafaxine and orphenadrine citrate plus paracetamol in a depressed patient.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Drug Combinations; Drug Eruptions; Drug Interactions; Female; Humans; Middle Aged; Muscle Relaxants, Central; Orphenadrine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Volte-face on venlafaxine--reasons and reflections.
Topics: Animals; Antidepressive Agents, Second-Generation; Cardiovascular Physiological Phenomena; Cause of Death; Cyclohexanols; Drug Overdose; Drug Prescriptions; Guidelines as Topic; Heart Diseases; Humans; United Kingdom; Venlafaxine Hydrochloride | 2006 |
Less mood switching with venlafaxine?
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Drug Therapy, Combination; Humans; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
[Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Humans; Paroxetine; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Aripiprazole augmentation of venlafaxine in the treatment of psychogenic excoriation.
Topics: Antipsychotic Agents; Aripiprazole; Cyclohexanols; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Female; Humans; Middle Aged; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Skin; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Quetiapine augmentation in lactation: a series of case reports.
Topics: Adult; Antipsychotic Agents; Cyclohexanols; Dibenzothiazepines; Female; Humans; Infant; Infant Behavior; Lactation; Milk, Human; Paroxetine; Quetiapine Fumarate; Risk Assessment; Venlafaxine Hydrochloride | 2006 |
Venlafaxine-induced ecchymoses and impaired platelet aggregation.
Topics: Adenosine Triphosphate; Adult; Arachidonic Acid; Collagen; Cyclohexanols; Ecchymosis; Epinephrine; Female; Humans; Platelet Aggregation; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors; Venlafaxine Hydrochloride | 2006 |
Dose-dependent Venlafaxine-induced sinus tachycardia.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Female; Humans; Tachycardia, Sinus; Venlafaxine Hydrochloride | 2006 |
NICE guidelines on antidepressants.
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drug Overdose; Family Practice; Guideline Adherence; Humans; Practice Guidelines as Topic; Practice Patterns, Physicians'; Venlafaxine Hydrochloride | 2006 |
Neonatal seizures from in utero venlafaxine exposure.
Topics: Cyclohexanols; Female; Humans; Infant, Newborn; Male; New South Wales; Pregnancy; Seizures; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2006 |
Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
Topics: Adrenergic Uptake Inhibitors; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Chemistry; Carrageenan; Cyclohexanols; Desipramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Duloxetine Hydrochloride; Edema; Fluoxetine; Hot Temperature; Hyperalgesia; Male; Norepinephrine; Paroxetine; Pressure; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Thiophenes; Venlafaxine Hydrochloride | 2006 |
Venlafaxine for treatment of interferon alfa-induced depression.
Topics: Adult; Cyclohexanols; Depressive Disorder; Humans; Interferon-alpha; Male; Venlafaxine Hydrochloride | 2006 |
Is it possible to predict the long-term response to venlafaxine with the use of biological markers and psychophysiological methods?
Topics: Adult; Antidepressive Agents; Brain; Chronic Disease; Cyclohexanols; Depressive Disorder, Major; Dexamethasone; Dexfenfluramine; Dominance, Cerebral; Electrooculography; Electroretinography; Evoked Potentials, Visual; Female; Follow-Up Studies; Globus Pallidus; Humans; Hydrocortisone; Male; Middle Aged; Prognosis; Prolactin; Recurrence; Regional Blood Flow; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Prescribing of venlafaxine and dosulepin in primary care.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Dothiepin; Guidelines as Topic; Humans; Primary Health Care; Suicide; Venlafaxine Hydrochloride | 2006 |
Topiramate use in alprazolam addiction.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Female; Fructose; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders; Topiramate; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Using meta-regression in performing indirect-comparisons: comparing escitalopram with venlafaxine XR.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Databases as Topic; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Regression Analysis; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Pharmacokinetic/pharmacodynamic modelling of cardiac toxicity in venlafaxine overdose.
Topics: Cyclohexanols; Drug Overdose; Female; Heart Diseases; Humans; Middle Aged; Models, Biological; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Bezoar formation requiring endoscopic removal after intentional overdose of extended-release nifedipine.
Topics: Anticholesteremic Agents; Antidepressive Agents; Atorvastatin; Bezoars; Calcium Channel Blockers; Cyclohexanols; Delayed-Action Preparations; Drug Overdose; Endoscopy, Digestive System; Fatal Outcome; Female; Heptanoic Acids; Humans; Middle Aged; Nifedipine; Pyrroles; Radiography; Sertraline; Stomach; Venlafaxine Hydrochloride | 2006 |
Simultaneous stereoselective analysis of venlafaxine and O-desmethylvenlafaxine enantiomers in human plasma by HPLC-ESI/MS using a vancomycin chiral column.
Topics: Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Humans; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Vancomycin; Venlafaxine Hydrochloride | 2007 |
Digitalis intoxication induced by paroxetine co-administration.
Topics: Aged; Cardiovascular System; Citalopram; Cyclohexanols; Digoxin; Drug Interactions; Drug Overdose; Female; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cohort Studies; Cyclohexanols; Dothiepin; Fluoxetine; Humans; Incidence; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Suicide; Venlafaxine Hydrochloride | 2007 |
Venlafaxine (Effexor): concerns about increased risk of fatal outcomes in overdose.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Overdose; Humans; Risk; Venlafaxine Hydrochloride | 2007 |
Effects of antidepressant treatment on neural correlates of emotional and neutral declarative verbal memory in depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Emotions; Female; Fluoxetine; Frontal Lobe; Gyrus Cinguli; Humans; Male; Mental Recall; Middle Aged; Paired-Associate Learning; Personality Inventory; Positron-Emission Tomography; Semantics; Sertraline; Venlafaxine Hydrochloride; Wechsler Scales | 2007 |
Venlafaxine induces P-glycoprotein in human Caco-2 cells.
Topics: Antidepressive Agents, Second-Generation; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cyclohexanols; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Gene Expression; Humans; Multidrug Resistance-Associated Proteins; Polymerase Chain Reaction; Rifampin; Venlafaxine Hydrochloride | 2007 |
Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder; Female; Humans; Infant Behavior; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Male; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.
Topics: Aged; Antidepressive Agents; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Humans; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
High performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI) method for simultaneous determination of venlafaxine and its three metabolites in human plasma.
Topics: Antidepressive Agents, Second-Generation; Calibration; Chromatography, High Pressure Liquid; Cyclohexanols; Depression; Female; Humans; Male; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Venlafaxine Hydrochloride | 2007 |
Venlafaxine discontinuation syndrome and suicidal ideation: a case series.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Suicide, Attempted; Venlafaxine Hydrochloride | 2007 |
Cytotoxicity of different selective serotonin reuptake inhibitors (SSRIs) against cancer cells.
Topics: Animals; Antidepressive Agents; Benzimidazoles; Biological Transport; Cell Line, Tumor; Cyclohexanols; Fibroblasts; Humans; Ions; Mice; Necrosis; Neoplasms; Paroxetine; Propidium; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Liquid chromatography-mass spectrometry method for the determination of venlafaxine in human plasma and application to a pharmacokinetic study.
Topics: Adolescent; Adult; Area Under Curve; Chromatography, High Pressure Liquid; Chromatography, Liquid; Clozapine; Cyclohexanols; Drug Stability; Humans; Male; Plasma; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Venlafaxine Hydrochloride | 2007 |
STAR*D: what have we learned?
Topics: Ambulatory Care; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Follow-Up Studies; Humans; Lithium Compounds; Randomized Controlled Trials as Topic; Research Design; Secondary Prevention; Tranylcypromine; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Serotonin syndrome precipitated by the monoamine oxidase inhibitor linezolid.
Topics: Acetamides; Adult; Anti-Infective Agents; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Female; Humans; Linezolid; Monoamine Oxidase Inhibitors; Oxazolidinones; Serotonin Syndrome; Venlafaxine Hydrochloride | 2007 |
False positive phencyclidine results caused by venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Drug Interactions; False Positive Reactions; Female; Humans; Middle Aged; Phencyclidine; Phencyclidine Abuse; Psychotic Disorders; Substance Abuse Detection; Venlafaxine Hydrochloride | 2007 |
Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat.
Topics: Animals; Antidepressive Agents, Second-Generation; Antioxidants; Brain; Cerebral Cortex; Cyclohexanols; Depression; Disease Models, Animal; Housing, Animal; Lipid Peroxidation; Male; Medulla Oblongata; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Venlafaxine Hydrochloride; Water Deprivation | 2007 |
Venlafaxine for major depression.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Humans; Venlafaxine Hydrochloride | 2007 |
Acute heart failure associated with venlafaxine poisoning.
Topics: Adult; Cyclohexanols; Female; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Ventricular Dysfunction, Left | 2007 |
Mania after venlafaxine withdrawal in a patient with generalized anxiety disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Humans; Male; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2007 |
Alternate venlafaxine kinetics in overdose patients.
Topics: Cyclohexanols; Delayed-Action Preparations; Drug Overdose; Female; Gastric Lavage; Gastroscopy; Humans; Kinetics; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Validation and application of a stability-indicating HPLC method for the in vitro determination of gastric and intestinal stability of venlafaxine.
Topics: Animals; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cyclohexanols; Drug Stability; Gastrointestinal Tract; Hot Temperature; Hydrochloric Acid; Hydrogen-Ion Concentration; In Vitro Techniques; Intestinal Mucosa; Molecular Structure; Pancreatin; Pepsin A; Phosphates; Potassium Compounds; Reproducibility of Results; Sodium Hydroxide; Swine; Time Factors; Venlafaxine Hydrochloride; Water | 2007 |
Simultaneous separation and determination of process-related substances and degradation products of venlafaxine by reversed-phase HPLC.
Topics: Antidepressive Agents; Chromatography, High Pressure Liquid; Cyclohexanols; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Sensitivity and Specificity; Spectroscopy, Fourier Transform Infrared; Temperature; Venlafaxine Hydrochloride | 2006 |
Dopaminergic function in depressed patients with affective flattening or with impulsivity: [18F]fluoro-L-dopa positron emission tomography study with voxel-based analysis.
Topics: Adult; Affect; Biogenic Monoamines; Brain Stem; Caudate Nucleus; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Female; Fluorodeoxyglucose F18; Fluoxetine; Gyrus Cinguli; Hippocampus; Humans; Hypothalamus; Magnetic Resonance Imaging; Male; Nucleus Accumbens; Positron-Emission Tomography; Psychomotor Disorders; Putamen; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride | 2007 |
Venlafaxine ingestion is associated with rhabdomyolysis in adults: a case series.
Topics: Adult; Creatine Kinase; Cyclohexanols; Drug Overdose; Female; Humans; Male; Retrospective Studies; Rhabdomyolysis; Seizures; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Medical Audit; Mianserin; Middle Aged; Mirtazapine; Retrospective Studies; Venlafaxine Hydrochloride; Weight Gain | 2007 |
Onset of confusion in the context of late-life depression.
Topics: Aged; Confusion; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Memory Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Using striatal dopamine transporter single photon emission computed tomography imaging to rule out Dementia with Lewy Bodies in elderly patients with antipsychotic-induced parkinsonism.
Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Haloperidol; Humans; Lewy Body Disease; Neostriatum; Parkinson Disease, Secondary; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes; Venlafaxine Hydrochloride | 2007 |
Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Arginine; Behavior, Animal; Cyclic GMP; Cyclohexanols; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Immobility Response, Tonic; Male; Mice; Motor Activity; Nitric Oxide; Signal Transduction; Swimming; Venlafaxine Hydrochloride | 2007 |
Antidepressant response in the elderly.
Topics: Adult; Age Factors; Aged; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Treatment of narcolepsy with cataplexy.
Topics: Antidepressive Agents, Second-Generation; Cataplexy; Chemistry, Pharmaceutical; Cyclohexanols; Drug Administration Schedule; Humans; Narcolepsy; Venlafaxine Hydrochloride | 2007 |
STAR*D level IV methodology.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Research Design; Tranylcypromine; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Data safety monitoring boards and other study methodologies that address subject safety in "high-risk" therapeutic trials in youths.
Topics: Adolescent; Child; Clinical Trials as Topic; Clinical Trials Data Monitoring Committees; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Female; Human Experimentation; Humans; Male; Research Design; Risk Factors; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, alpha(2)-adrenergic, and 5-hydroxytryptamine(1A) receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Idazoxan; Locus Coeruleus; Male; Naloxone; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Adrenergic, alpha-2; Receptors, Opioid; Serotonin; Venlafaxine Hydrochloride | 2007 |
Was the exacerbation of PTSD symptoms after high doses of venlafaxine due to the noradrenergic mechanism? A case report.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Fluoxetine; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2007 |
Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model.
Topics: Animals; Anti-Inflammatory Agents; Astrocytes; Cells, Cultured; Coculture Techniques; Cyclohexanols; Enzyme-Linked Immunosorbent Assay; Interferon-gamma; Interleukin-10; Interleukin-6; Male; Membrane Potentials; Microglia; Phenotype; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Transforming Growth Factor beta; Venlafaxine Hydrochloride | 2008 |
Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors.
Topics: Aged; Cognition; Cyclohexanols; Eye Diseases; Female; Hallucinations; Humans; Selective Serotonin Reuptake Inhibitors; Syndrome; Treatment Outcome; Venlafaxine Hydrochloride; Vision Disorders | 2007 |
A Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Decision Support Techniques; Denmark; Depressive Disorder, Major; Drug Costs; Humans; Models, Economic; Practice Patterns, Physicians'; Primary Health Care; Remission Induction; Venlafaxine Hydrochloride | 2007 |
An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials.
Topics: Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Kava; Mianserin; Mirtazapine; Paroxetine; Psychometrics; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2007 |
Venlafaxine hyponatraemia: incidence, mechanism and management.
Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Incidence; Prospective Studies; Risk Factors; Sodium; Venlafaxine Hydrochloride | 2007 |
Employing atmospheric pressure photoionization in liquid chromatography/tandem mass spectrometry to minimize ion suppression and matrix effects for the quantification of venlafaxine and O-desmethylvenlafaxine.
Topics: Antidepressive Agents, Second-Generation; Biotransformation; Calibration; Chromatography, High Pressure Liquid; Chromatography, Liquid; Cyclohexanols; Desvenlafaxine Succinate; Flow Injection Analysis; Humans; Indicators and Reagents; Linear Models; Quality Control; Reference Standards; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Venlafaxine Hydrochloride | 2007 |
Venlafaxine and tardive blepharospasm: a case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Blepharospasm; Cyclohexanols; Dyskinesia, Drug-Induced; Humans; Male; Panic Disorder; Venlafaxine Hydrochloride | 2007 |
Non-pharmacological treatment of psychiatrists in addition to the prescribing of an antidepressant drug.
Topics: Antidepressive Agents, Second-Generation; Combined Modality Therapy; Counseling; Cyclohexanols; Depressive Disorder, Major; Drug Prescriptions; Female; Humans; Male; Middle Aged; Physicians; Psychiatry; Psychotherapy; Sex Factors; Venlafaxine Hydrochloride | 2007 |
Extended-release venlafaxine-induced alopecia.
Topics: Adult; Alopecia; Cyclohexanols; Female; Gluconates; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Carbazoles; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Ethylenediamines; Male; Mice; Motor Activity; Neuroprotective Agents; Pentazocine; Receptors, sigma; Sigma-1 Receptor; Swimming; Venlafaxine Hydrochloride | 2007 |
Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Child; Cyclohexanols; Depressive Disorder; Drug Labeling; Drug Prescriptions; Drug Utilization; Family Practice; Female; Humans; Imipramine; Male; Netherlands; Nocturnal Enuresis; Paroxetine; Practice Patterns, Physicians'; Selective Serotonin Reuptake Inhibitors; Tension-Type Headache; Time Factors; Venlafaxine Hydrochloride | 2007 |
Treatment of familial erythromelalgia with venlafaxine.
Topics: Adult; Cyclohexanols; Erythromelalgia; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection.
Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Humans; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Venlafaxine Hydrochloride | 2007 |
[Why measure drug metabolites?].
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Humans; Patient Compliance; Pharmaceutical Preparations; Pharmacogenetics; Risperidone; Venlafaxine Hydrochloride | 2007 |
Hyperprolactinemia and galactorrhea induced by serotonin and norepinephrine reuptake inhibiting antidepressants.
Topics: Adrenergic Uptake Inhibitors; Adult; Cyclohexanols; Duloxetine Hydrochloride; Dysthymic Disorder; Female; Galactorrhea; Humans; Hyperprolactinemia; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2007 |
Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Fluoxetine; Male; Mice; Motor Activity; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming; Venlafaxine Hydrochloride; Yohimbine | 2007 |
Severe hypoglycemia following venlafaxine intoxication: a case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidotes; Blood Glucose; Charcoal; Creatine Kinase; Critical Care; Cyclohexanols; Depressive Disorder; Glasgow Coma Scale; Humans; Hypnotics and Sedatives; Hypoglycemia; Male; Oxazepam; Respiration, Artificial; Stress Disorders, Post-Traumatic; Suicide, Attempted; Venlafaxine Hydrochloride | 2007 |
Using psychostimulants for treating residual symptoms in major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Benzhydryl Compounds; Central Nervous System Stimulants; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Modafinil; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2007 |
Photodistributed eruptive telangiectasia: an uncommon adverse drug reaction to venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Drug Eruptions; Female; Humans; Middle Aged; Photosensitivity Disorders; Selective Serotonin Reuptake Inhibitors; Telangiectasis; Venlafaxine Hydrochloride | 2007 |
Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.
Topics: Aged; Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Male; Nortriptyline; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2007 |
[Venlafaxine extended release and alcohol dependence].
Topics: Adult; Alcoholism; Cyclohexanols; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Prevalence; Selective Serotonin Reuptake Inhibitors; Spain; Venlafaxine Hydrochloride | 2007 |
Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.
Topics: Adrenergic Uptake Inhibitors; Animals; Bupropion; Circadian Rhythm; Cricetinae; Cyclohexanols; Dopamine Uptake Inhibitors; Light; Male; Mesocricetus; Morpholines; Motor Activity; Reboxetine; Running; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Cytochrome P450 2D6 genotype variation and venlafaxine dosage.
Topics: Adolescent; Adult; Alleles; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Depressive Disorder, Major; Dysthymic Disorder; Female; Genotype; Humans; Male; Middle Aged; Retrospective Studies; Treatment Failure; Venlafaxine Hydrochloride | 2007 |
Gastric bezoar following venlafaxine overdose.
Topics: Bezoars; Cerebral Infarction; Cyclohexanols; Delayed-Action Preparations; Drug Overdose; Female; Gastric Lavage; Gastroscopy; Humans; Middle Aged; Persistent Vegetative State; Seizures; Selective Serotonin Reuptake Inhibitors; Stomach; Venlafaxine Hydrochloride; Withholding Treatment | 2007 |
Venlafaxine-lithium toxicity: suitability for use in the elderly.
Topics: Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Female; Humans; Lithium Compounds; Risk; Serotonin Syndrome; Venlafaxine Hydrochloride | 2007 |
Successful duloxetine use to prevent venlafaxine withdrawal symptoms.
Topics: Adrenergic Uptake Inhibitors; Adult; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Neurotransmitter Uptake Inhibitors; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Thiophenes; Venlafaxine Hydrochloride | 2008 |
Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cyclohexanols; Dentate Gyrus; Fluoxetine; GAP-43 Protein; Hippocampus; Imipramine; Male; Neuronal Plasticity; Neurotransmitter Uptake Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Synaptophysin; Time Factors; Transcription, Genetic; Venlafaxine Hydrochloride | 2008 |
[Use of antidepressants among children and adolescents--did the warnings lead to fewer prescriptions?].
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Child; Cyclohexanols; Drug Prescriptions; Drug Utilization; Female; Fluoxetine; Humans; Male; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Sertraline versus venlafaxine XR in major depressive disorder.
Topics: Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2007 |
Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
Topics: Adrenergic Uptake Inhibitors; Animals; Citalopram; Cyclohexanols; Dopamine; Dopamine Uptake Inhibitors; Male; Methylphenidate; Microdialysis; Norepinephrine; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2007 |
[Palinopsia following discontinuation of venlafaxine].
Topics: Adult; Afterimage; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Perceptual Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride; Visual Perception | 2008 |
Venlafaxine to treat severe hypotension.
Topics: Cyclohexanols; Humans; Hypotension; Male; Middle Aged; Venlafaxine Hydrochloride | 2007 |
Delivery outcome in relation to maternal use of some recently introduced antidepressants.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adrenergic Uptake Inhibitors; Antidepressive Agents; Birth Weight; Cyclohexanols; Databases, Factual; Delivery, Obstetric; Female; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Mianserin; Mirtazapine; Morpholines; Pregnancy; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Reboxetine; Registries; Selective Serotonin Reuptake Inhibitors; Smoking; Sweden; Venlafaxine Hydrochloride | 2007 |
Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Cyclohexanols; Dibenzothiazepines; Female; Humans; Postpartum Period; Pregnancy; Pregnancy Outcome; Pregnancy Trimesters; Quetiapine Fumarate; Sleep Wake Disorders; Trazodone; Venlafaxine Hydrochloride | 2007 |
[Symptomatic secondary hyponatraemia due to combined treatment anticonvulsant and antidepressant: risk of sudden death in epilepsy?].
Topics: Adult; Anticonvulsants; Antidepressive Agents; Carbamazepine; Cyclohexanols; Death, Sudden; Drug Interactions; Epilepsy; Female; Humans; Hyponatremia; Lamotrigine; Risk Factors; Triazines; Venlafaxine Hydrochloride | 2007 |
Gingival bleeding due to venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Gingival Hemorrhage; Humans; Male; Risk Factors; Venlafaxine Hydrochloride | 2008 |
Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Patient Satisfaction; Psychiatric Status Rating Scales; Retrospective Studies; Self-Assessment; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
A case series of increased libido and spontaneous orgasm associated with venlafaxine treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Humans; Libido; Orgasm; Venlafaxine Hydrochloride | 2008 |
[Hypertrichosis as a possible adverse reaction to selective amine-reuptake inhibitor antidepressants].
Topics: Adult; Cyclohexanols; Female; Humans; Hypertrichosis; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
Experimental and computational morphology of three polymorphs of the free base of Venlafaxine: a comparison of morphology prediction methods.
Topics: Computer Simulation; Crystallization; Cyclohexanols; Monte Carlo Method; Venlafaxine Hydrochloride | 2008 |
Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanols; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Exploratory Behavior; Fluoxetine; Hindlimb Suspension; Male; Maze Learning; Mice; Motor Activity; Olfactory Bulb; Ondansetron; Paroxetine; Rats; Rats, Wistar; Serotonin 5-HT3 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists; Stress, Psychological; Venlafaxine Hydrochloride | 2008 |
Similar discontinuation symptoms for withdrawal from medium-dose paroxetine and venlafaxine after nine years in the same patient.
Topics: Adult; Cyclohexanols; Female; Humans; Marijuana Smoking; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2008 |
Hypotension caused by therapeutic doses of venlafaxine: case report and proposed pathophysiological mechanisms.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Hypotension; Polymorphism, Genetic; Receptors, Adrenergic, alpha-2; Venlafaxine Hydrochloride | 2008 |
Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Female; Genotype; Heterozygote; Humans; Male; Middle Aged; Retrospective Studies; Venlafaxine Hydrochloride | 2008 |
Heparin-immobilized pluronic/PVA composite microparticles for the sustained delivery of ionic drug.
Topics: Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Cyclohexanols; Delayed-Action Preparations; Heparin; Hydrogel, Polyethylene Glycol Dimethacrylate; Microspheres; Poloxamer; Polyvinyl Alcohol; Venlafaxine Hydrochloride | 2008 |
Venlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitation.
Topics: Aged, 80 and over; Cyclohexanols; Drug Interactions; Female; Hallucinations; Humans; Propafenone; Psychomotor Agitation; Venlafaxine Hydrochloride | 2008 |
Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine.
Topics: Adult; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Fluoxetine; Hospitalization; Humans; Interview, Psychological; Male; Mood Disorders; Patient Readmission; Prevalence; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder; Venlafaxine Hydrochloride | 2008 |
Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine.
Topics: Animals; Behavior, Animal; Brain Chemistry; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Extracellular Fluid; Frontal Lobe; Hindlimb Suspension; Immobility Response, Tonic; Male; Microdialysis; Norepinephrine; Normetanephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2008 |
Change in pain severity with open label venlafaxine use in patients with a depressive symptomatology: an observational study in primary care.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Chronic Disease; Comorbidity; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pain; Pain Measurement; Pain Threshold; Primary Health Care; Somatoform Disorders; Switzerland; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Combined antidepressants and CBT for panic disorder with agoraphobia.
Topics: Adult; Agoraphobia; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Female; Humans; Panic Disorder; Venlafaxine Hydrochloride | 2008 |
Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cohort Studies; Cyclohexanols; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Anxiety; Behavior, Animal; Cyclohexanols; Disease Models, Animal; Dopamine; Fatigue Syndrome, Chronic; Glutathione; Lipid Peroxidation; Male; Maze Learning; Memory; Mice; Motor Activity; Norepinephrine; Oxidative Stress; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2008 |
A fatal case of venlafaxine overdose.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Overdose; Fatal Outcome; Humans; Male; Venlafaxine Hydrochloride | 2008 |
Dose-related increase of intraocular pressure caused by venlafaxine use: case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Female; Humans; Intraocular Pressure; Venlafaxine Hydrochloride | 2008 |
A case of extreme paradoxical insomnia responding selectively to electroconvulsive therapy.
Topics: Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Dibenzothiazepines; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Middle Aged; Quetiapine Fumarate; Sick Role; Sleep Initiation and Maintenance Disorders; Suicide; Suicide Prevention; Venlafaxine Hydrochloride | 2008 |
Fatal cardiotoxicity induced by venlafaxine overdosage.
Topics: Adult; Cardiomyopathies; Chromatography, Gas; Cyclohexanols; Drug Overdose; Electrocardiography; Fatal Outcome; Female; Heart; Humans; Selective Serotonin Reuptake Inhibitors; Suicide; Venlafaxine Hydrochloride | 2008 |
Anticholinergic-type effects following a pediatric venlafaxine overdose.
Topics: Analgesics; Antidepressive Agents; Child; Cholinergic Antagonists; Cyclohexanols; Delayed-Action Preparations; Drug Overdose; Humans; Male; Medication Errors; Receptors, Cholinergic; Urinary Retention; Venlafaxine Hydrochloride | 2008 |
Similar effects of tramadol and venlafaxine in major depressive disorder.
Topics: Adult; Analgesics, Opioid; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Low Back Pain; Selective Serotonin Reuptake Inhibitors; Tramadol; Venlafaxine Hydrochloride | 2008 |
Recurrent herpes and post-traumatic stress disorder.
Topics: Accidents, Traffic; Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Herpes Labialis; Humans; Male; Recurrence; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2007 |
Liquid chromatography tandem mass spectrometry assay for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in human plasma and its application to a bioequivalence study.
Topics: Area Under Curve; Chromatography, Liquid; Cyclohexanols; Desvenlafaxine Succinate; Drug Stability; Humans; Sensitivity and Specificity; Tandem Mass Spectrometry; Therapeutic Equivalency; Venlafaxine Hydrochloride | 2008 |
Asystole during electroconvulsive therapy in an elderly woman treated concomitantly with venlafaxine.
Topics: Aged, 80 and over; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Heart Arrest; Humans; Venlafaxine Hydrochloride | 2008 |
Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analgesics; Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Male; Mice; Motor Activity; Pain Measurement; Piperazines; Pyridines; Reaction Time; Receptor, Serotonin, 5-HT1A; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming; Venlafaxine Hydrochloride | 2009 |
Venlafaxine: Successful treatment in impulsive disorders.
Topics: Adult; Antidepressive Agents, Second-Generation; Comorbidity; Compulsive Behavior; Cyclohexanols; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Venlafaxine Hydrochloride | 2008 |
[Velaxin (venlafaxine) in the treatment of anxious depression].
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depression; Female; Humans; Inpatients; Male; Middle Aged; Outpatients; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Heart failure worsening and exacerbation after venlafaxine and duloxetine therapy.
Topics: Adult; Aged; Cyclohexanols; Duloxetine Hydrochloride; Female; Heart Failure; Humans; Male; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Tachycardia; Thiophenes; Venlafaxine Hydrochloride; Ventricular Dysfunction, Left | 2008 |
Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder.
Topics: Adolescent; Adult; Cyclohexanols; Depressive Disorder, Major; Electroencephalography; Female; Humans; Male; Middle Aged; Personality Disorders; Predictive Value of Tests; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Theta Rhythm; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Selective publication of antidepressant trials.
Topics: Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Drug Industry; Evidence-Based Medicine; Humans; Publication Bias; Treatment Failure; Venlafaxine Hydrochloride | 2008 |
Duration of untreated illness as a predictor of treatment response and clinical course in generalized anxiety disorder.
Topics: Antidepressive Agents; Anxiety Disorders; Cyclohexanols; Demography; Diagnostic and Statistical Manual of Mental Disorders; Disease Progression; Female; Humans; Male; Middle Aged; Severity of Illness Index; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
[Microscopic colitis associated with celiac disease probably triggered by the administration of venlafaxine].
Topics: Aged; Antidepressive Agents, Second-Generation; Biopsy; Celiac Disease; Colitis, Microscopic; Colon; Colonoscopy; Cyclohexanols; Depressive Disorder; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
The review by Weinmann and colleagues.
Topics: Antidepressive Agents, Second-Generation; Bias; Cyclohexanols; Depressive Disorder, Major; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
A role for nuclear beta-catenin in SNRI antidepressant-induced hippocampal cell proliferation.
Topics: Animals; Antidepressive Agents; beta Catenin; Bromodeoxyuridine; Cell Nucleus; Cell Proliferation; Cyclohexanols; Dose-Response Relationship, Drug; Gene Expression Regulation; Hippocampus; Male; Microscopy, Electron; Models, Biological; Neurons; Rats; Rats, Wistar; Signal Transduction; Subcellular Fractions; Venlafaxine Hydrochloride | 2008 |
The influences of depression and venlafaxine use at therapeutic doses on atrial conduction.
Topics: Adult; Antidepressive Agents, Second-Generation; Atrial Function; Cyclohexanols; Depressive Disorder; Electrocardiography; Female; Heart Atria; Heart Conduction System; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2009 |
[Drug-induced pneumonitis in a patient treated with venlafaxine and propanolol].
Topics: 1-Propanol; Cyclohexanols; Drug Interactions; Female; Humans; Liver Cirrhosis; Middle Aged; Pneumonia; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
Semi-quantitative CYP2D6 gene doses in relation to metabolic ratios of psychotropics.
Topics: Adolescent; Adult; Aged; Alleles; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Cytochrome P-450 CYP2D6; Fluoxetine; Gene Dosage; Gene Frequency; Genotype; Humans; Middle Aged; Models, Genetic; Phenotype; Polymorphism, Genetic; Predictive Value of Tests; Psychotropic Drugs; Risperidone; Venlafaxine Hydrochloride; Young Adult | 2008 |
High-dose venlafaxine in delusional and severely depressed patients.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Delusions; Depressive Disorder; Female; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
[Correction of affective disorders in patients with cochlear-vestibular disturbances of vascular origin].
Topics: Adult; Aged; Analgesics; Antidepressive Agents, Second-Generation; Audiometry; Cochlear Diseases; Cyclohexanols; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mood Disorders; Psychometrics; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Venlafaxine Hydrochloride; Vestibular Diseases | 2008 |
Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs.
Topics: Antidepressive Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cyclohexanols; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Drug Stability; Drug Storage; Excipients; Fatty Alcohols; Kinetics; Methacrylates; Microscopy, Electron, Scanning; Polymers; Solubility; Tablets, Enteric-Coated; Temperature; Venlafaxine Hydrochloride; Waxes | 2008 |
Screening of venlafaxine hydrochloride for transdermal delivery: passive diffusion and iontophoresis.
Topics: Administration, Cutaneous; Animals; Cyclohexanols; Diffusion; Drug Evaluation, Preclinical; Iontophoresis; Skin Absorption; Solubility; Swine; Venlafaxine Hydrochloride | 2008 |
Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cohort Studies; Cyclohexanols; Databases, Factual; Depressive Disorder, Major; Drug Costs; Drug Utilization; Female; Health Care Costs; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma. Study of correlation between venlafaxine concentrations in both matrices.
Topics: Antidepressive Agents; Chromatography, Liquid; Cyclohexanols; Female; Humans; Male; Reproducibility of Results; Saliva; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Time Factors; Venlafaxine Hydrochloride | 2008 |
Do new-generation antidepressants work?
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Fluoxetine; Humans; Paroxetine; Piperazines; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2008 |
Wine and drug evaluations: lessons on making comparisons of noninferiority.
Topics: Anxiety Disorders; Cross-Cultural Comparison; Cyclohexanols; Depressive Disorder; Drug Approval; Duloxetine Hydrochloride; Europe; Humans; Placebo Effect; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; United States; United States Food and Drug Administration; Venlafaxine Hydrochloride; Wine | 2008 |
Establishing non-inferiority in treatment trials in psychiatry: guidelines from an Expert Consensus Meeting.
Topics: Antidepressive Agents; Anxiety Disorders; Consensus Development Conferences as Topic; Cyclohexanols; Duloxetine Hydrochloride; Evidence-Based Medicine; Humans; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2008 |
A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Cyclohexanols; Data Interpretation, Statistical; Delayed-Action Preparations; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2008 |
Adequacy of venlafaxine dose prescribing in major depression and hospital resources implications.
Topics: Administration, Oral; Adult; Aged; Antidepressive Agents, Second-Generation; Cohort Studies; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; England; Female; Hospital Costs; Humans; Length of Stay; Male; Middle Aged; Referral and Consultation; Retrospective Studies; Venlafaxine Hydrochloride | 2008 |
Venlafaxine dependence in a patient with a history of alcohol and amineptine misuse.
Topics: Alcohol Deterrents; Alcoholism; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dibenzocycloheptenes; Disulfiram; Humans; Male; Middle Aged; Prescription Drugs; Risk Factors; Substance-Related Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
A role of nitric oxide mechanism involved in the protective effects of venlafaxine in sleep deprivation.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Arginine; Behavior, Animal; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Lipid Peroxidation; Maze Learning; Methylene Blue; Mice; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Reaction Time; Sleep Deprivation; Venlafaxine Hydrochloride | 2008 |
Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.
Topics: Adrenergic Uptake Inhibitors; Animals; Antiemetics; Antineoplastic Agents; Apomorphine; Cisplatin; Cyclohexanols; Ferrets; Male; Morpholines; Reboxetine; Serotonin Antagonists; Venlafaxine Hydrochloride; Vomiting | 2008 |
Determination of venlafaxine in human plasma by high-performance liquid chromatography using cloud-point extraction and spectrofluorimetric detection.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Humans; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Venlafaxine Hydrochloride | 2008 |
Does venlafaxine maintenance therapy prevent depression recurrences or drug discontinuation reactions?
Topics: Cyclohexanols; Depressive Disorder, Major; Humans; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2008 |
Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources.
Topics: Adrenergic Uptake Inhibitors; Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Consumer Product Safety; Cyclohexanols; Databases as Topic; Duloxetine Hydrochloride; Humans; Liver; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Thiophenes; United States; United States Food and Drug Administration; Venlafaxine Hydrochloride | 2008 |
Identifying patients at risk of complete nonresponse in the outpatient treatment of depression.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Amitriptyline; Antidepressive Agents; Combined Modality Therapy; Cyclohexanols; Data Interpretation, Statistical; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Resistance; Female; Humans; Male; Middle Aged; Nortriptyline; Psychotherapy; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Severity of Illness Index; Venlafaxine Hydrochloride; Young Adult | 2008 |
[The place of escitalopram in the severe depressive episodes].
Topics: Age Factors; Citalopram; Cyclohexanols; Depressive Disorder, Major; Humans; Meta-Analysis as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
[A place for SSRIs in the treatment of severely depressed children and adolescents].
Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide; Venlafaxine Hydrochloride | 2008 |
Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Cyclohexanols; Cyclopropanes; Dopamine; Duloxetine Hydrochloride; Homovanillic Acid; Male; Milnacipran; Norepinephrine; Organ Specificity; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2009 |
Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanols; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Immobility Response, Tonic; Locomotion; Male; Mice; Receptors, Adrenergic, alpha-2; Risperidone; Swimming; Venlafaxine Hydrochloride; Yohimbine | 2008 |
Stimulus properties of venlafaxine in a conditioned taste aversion procedure.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Avoidance Learning; Conditioning, Psychological; Cyclohexanols; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Selective Serotonin Reuptake Inhibitors; Taste; Venlafaxine Hydrochloride | 2008 |
[Hypomania/mania induced by cessation of antidepressant drugs].
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2008 |
A case of venlafaxine-induced galactorrhea?
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Galactorrhea; Humans; Middle Aged; Phenytoin; Prolactin; Venlafaxine Hydrochloride | 2008 |
Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Mianserin; Middle Aged; Mirtazapine; Venlafaxine Hydrochloride | 2008 |
Reduction in the latency of action of antidepressants by 17 beta-estradiol in the forced swimming test.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Cyclohexanols; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Estrogens; Female; Fluoxetine; Injections, Subcutaneous; Motor Activity; Ovariectomy; Rats; Rats, Wistar; Reaction Time; Selective Serotonin Reuptake Inhibitors; Swimming; Venlafaxine Hydrochloride | 2008 |
Direct high-performance liquid chromatographic separation of the enantiomers of venlafaxine and 11 analogs using amylose-derived chiral stationary phases.
Topics: 2-Propanol; Amylose; Chromatography, High Pressure Liquid; Cyclohexanols; Ethanol; Hydrogen-Ion Concentration; Stereoisomerism; Venlafaxine Hydrochloride | 2009 |
[Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"].
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Mianserin; Mirtazapine; Venlafaxine Hydrochloride | 2008 |
The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: a pharmacoeconomic evaluation.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Decision Support Techniques; Depressive Disorder, Major; Economics, Pharmaceutical; Fluoxetine; Focus Groups; Humans; Models, Theoretical; Psychometrics; Selective Serotonin Reuptake Inhibitors; Thailand; Venlafaxine Hydrochloride | 2008 |
Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Inflammatory Agents; Antidepressive Agents; Benzazepines; Cyclohexanols; Dopamine Antagonists; Dose-Response Relationship, Drug; Estradiol; Haloperidol; Hindlimb Suspension; Male; Mice; Motor Activity; Progesterone; Receptors, Dopamine; Receptors, Serotonin; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sigma-1 Receptor; Sulpiride; Swimming; Venlafaxine Hydrochloride | 2008 |
The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines.
Topics: Animals; Antidepressive Agents, Second-Generation; Cell Survival; Cells, Cultured; Clone Cells; Cyclohexanols; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Female; Gliosis; Immunohistochemistry; Immunologic Factors; Lipopolysaccharides; Macrophages; Mice; Reverse Transcriptase Polymerase Chain Reaction; RNA; T-Lymphocytes; Venlafaxine Hydrochloride | 2009 |
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Cyclohexanols; Depression; Down-Regulation; Fenclonine; Male; Monoamine Oxidase Inhibitors; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Protein Synthesis Inhibitors; Protriptyline; Rats; Rats, Sprague-Dawley; Reboxetine; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Sertraline; Venlafaxine Hydrochloride | 2009 |
The solubility behaviour and thermodynamic relations of the three forms of Venlafaxine free base.
Topics: Antidepressive Agents; Calorimetry, Differential Scanning; Crystallization; Cyclohexanols; Drug Stability; Molecular Structure; Phase Transition; Solubility; Solvents; Temperature; Thermodynamics; Transition Temperature; Venlafaxine Hydrochloride; X-Ray Diffraction | 2009 |
Venlafaxine-induced excessive yawning.
Topics: Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Yawning; Young Adult | 2009 |
[Hypersensitivity pneumonitis due to venlafaxine].
Topics: Alveolitis, Extrinsic Allergic; Cyclohexanols; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2008 |
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.
Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Bupropion; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risk Factors; Sertraline; Statistics as Topic; Venlafaxine Hydrochloride; Young Adult | 2009 |
Predictive factors for generalized seizures after deliberate citalopram overdose.
Topics: Adult; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Drug Interactions; Drug Overdose; Emergency Medicine; Female; Humans; Male; Prognosis; Retrospective Studies; Seizures; Self-Injurious Behavior; Venlafaxine Hydrochloride; Young Adult | 2008 |
Recent NIMH clinical trials and implications for practice.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Mental Disorders; Methylphenidate; Multicenter Studies as Topic; National Institute of Mental Health (U.S.); Obsessive-Compulsive Disorder; Psychotropic Drugs; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2008 |
Invivo antioxidant status: a putative target of antidepressant action.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antioxidants; Body Weight; Cyclohexanols; Depressive Disorder; Fluvoxamine; Food Preferences; Imipramine; Lipid Peroxidation; Protein Carbonylation; Rats; Restraint, Physical; Stress, Psychological; Swimming; Taste; Venlafaxine Hydrochloride | 2009 |
Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amines; Animals; Anticonvulsants; Antidepressive Agents; Cyclohexanecarboxylic Acids; Cyclohexanols; Desipramine; Gabapentin; gamma-Aminobutyric Acid; Male; Mice; Mice, Transgenic; Morpholines; Pain; Pain Threshold; Propanolamines; Reboxetine; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-2; Sciatic Nerve; Venlafaxine Hydrochloride; Yohimbine | 2009 |
Is the antidepressant venlafaxine effective for the treatment of functional dyspepsia?
Topics: Cyclohexanols; Dyspepsia; Humans; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Venlafaxine induced-myoclonus in a patient with mixed dementia.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Dementia; Female; Humans; Myoclonus; Venlafaxine Hydrochloride | 2008 |
Death of a female cocaine user due to the serotonin syndrome following moclobemide-venlafaxine overdose.
Topics: Cocaine; Cocaine-Related Disorders; Cyclohexanols; Dopamine Uptake Inhibitors; Drug Overdose; Female; Forensic Toxicology; Hair; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride; Young Adult | 2009 |
Pharmacoeconomics of antidepressants in moderate-to-severe depressive disorder in Colombia.
Topics: Amitriptyline; Antidepressive Agents; Colombia; Convulsive Therapy; Cost-Benefit Analysis; Cyclohexanols; Decision Trees; Depressive Disorder; Developing Countries; Drug Costs; Female; Fluoxetine; Health Expenditures; Hospitalization; Humans; Male; Models, Theoretical; Monte Carlo Method; National Health Programs; Office Visits; Psychotherapy; Venlafaxine Hydrochloride | 2008 |
Case report: Effective treatment of Cotard's syndrome: quetiapine in combination with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Female; Hallucinations; Humans; Psychiatric Status Rating Scales; Quetiapine Fumarate; Schizophrenia, Paranoid; Syndrome; Venlafaxine Hydrochloride | 2009 |
Psychosis in the elderly.
Topics: Aged, 80 and over; Alzheimer Disease; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Combined Modality Therapy; Comorbidity; Cyclohexanols; Delirium; Depressive Disorder, Major; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Humans; Memantine; Nootropic Agents; Piperazines; Psychotherapy; Psychotic Disorders; Quinolones; Risk Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Automated determination of venlafaxine in human plasma by on-line SPE-LC-MS/MS. Application to a bioequivalence study.
Topics: Calibration; Cyclohexanols; Humans; Molecular Structure; Solid Phase Extraction; Tandem Mass Spectrometry; Venlafaxine Hydrochloride | 2009 |
Serotonin toxicity as a consequence of linezolid use in revision hip arthroplasty.
Topics: Acetamides; Administration, Oral; Analgesics; Anti-Infective Agents; Arthroplasty, Replacement, Hip; Contraindications; Cyclohexanols; Drug Interactions; Female; Humans; Linezolid; Middle Aged; Oxazolidinones; Postoperative Complications; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Syndrome; Venlafaxine Hydrochloride | 2008 |
Experience of the use of velaxin (venlafaxine) in anxious depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depression; Female; Humans; Inpatients; Male; Middle Aged; Outpatients; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Taurine transporter in lymphocytes of patients with major depression treated with venlafaxine plus psychotherapy.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cyclohexanols; Depressive Disorder, Major; Humans; Interleukin-2; Interleukin-4; Lymphocytes; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Venlafaxine Hydrochloride | 2009 |
Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder.
Topics: Adolescent; Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypnotics and Sedatives; Male; Middle Aged; Observer Variation; Personality Inventory; Psychometrics; Pyridines; Reproducibility of Results; Somatoform Disorders; Taiwan; Venlafaxine Hydrochloride; Young Adult; Zolpidem | 2009 |
Cost effectiveness of venlafaxine compared with generic fluoxetine or generic amitriptyline in major depressive disorder in the UK.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; Cyclohexanols; Decision Trees; Delphi Technique; Depressive Disorder, Major; Drug Costs; Drugs, Generic; Fluoxetine; Humans; Psychiatric Status Rating Scales; Quality-Adjusted Life Years; Treatment Outcome; United Kingdom; Venlafaxine Hydrochloride | 2009 |
Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone.
Topics: Adult; Antidepressive Agents, Second-Generation; Buspirone; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Severity of Illness Index; Sleep Bruxism; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Olanzapine; Personality Inventory; Psychometrics; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Big interest in heavy drugs.
Topics: Clinical Trials, Phase I as Topic; Cyclohexanols; Deuterium; Drug Industry; Female; Humans; Paroxetine; Patents as Topic; Pharmaceutical Preparations; Venlafaxine Hydrochloride | 2009 |
Regional origin and decrease of pain in patients with depressive symptoms under treatment with venlafaxine.
Topics: Acculturation; Adult; Analgesics; Antidepressive Agents, Second-Generation; Chronic Disease; Comorbidity; Culture; Cyclohexanols; Depression; Ethnicity; Europe; Europe, Eastern; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Physicians, Family; Psychophysiologic Disorders; Severity of Illness Index; Switzerland; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Venlafaxine-induced excessive yawning: a thermoregulatory connection.
Topics: Antidepressive Agents, Second-Generation; Body Temperature Regulation; Cyclohexanols; Humans; Venlafaxine Hydrochloride; Yawning | 2009 |
Dose-related hyperprolactinemia induced by venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Female; Humans; Hyperprolactinemia; Venlafaxine Hydrochloride | 2009 |
Major depression, antidepressant medication and the risk of obesity.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Body Mass Index; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Incidence; Male; Middle Aged; Obesity; Risk Factors; Venlafaxine Hydrochloride; Young Adult | 2009 |
Development of an in-capillary approach to nanoscale automated in vitro cytochromes p450 assays.
Topics: Autoanalysis; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme System; Dextromethorphan; Fluoxetine; Humans; Isoenzymes; Mass Spectrometry; Pharmaceutical Preparations; Quinidine; Recombinant Proteins; Solutions; Venlafaxine Hydrochloride | 2009 |
Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Body Mass Index; Case-Control Studies; Cyclohexanols; Depressive Disorder; Diabetes Mellitus; Female; Fluvoxamine; Humans; Incidence; Male; Middle Aged; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Time Factors; United Kingdom; Venlafaxine Hydrochloride | 2009 |
Teenaged, depressed, and treatment resistant: what predicts self-harm?
Topics: Adolescent; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Drug Resistance; Humans; Risk Assessment; Risk Factors; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Suicide, Attempted; Venlafaxine Hydrochloride | 2009 |
Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Denmark; Depressive Disorder, Major; Dothiepin; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Treatment with venlafaxine in six cases of children with narcolepsy and with cataplexy and hypnagogic hallucinations.
Topics: Cataplexy; Child; Cyclohexanols; Dose-Response Relationship, Drug; Female; Hallucinations; Humans; Male; Narcolepsy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
Dose-finding study of fluoxetine and venlafaxine for the treatment of self-injurious and stereotypic behavior in rhesus macaques (Macaca mulatta).
Topics: Administration, Oral; Animals; Behavior, Animal; Blood Platelets; Cyclohexanols; Dose-Response Relationship, Drug; Fluoxetine; Hydroxyindoleacetic Acid; Macaca mulatta; Male; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Serotonin; Stereotyped Behavior; Venlafaxine Hydrochloride | 2009 |
Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.
Topics: Adult; Alleles; Antidepressive Agents, Second-Generation; Base Sequence; Cyclohexanols; Cytochrome P-450 CYP2D6; Depression; DNA Mutational Analysis; Female; Gene Duplication; Genotype; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Reproducibility of Results; Sensitivity and Specificity; Sequence Analysis, DNA; Sequence Deletion; Venlafaxine Hydrochloride | 2009 |
Venlafaxine-induced complex visual hallucinations in a 17-year-old boy.
Topics: Adolescent; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Hallucinations; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
Optimal dosing of desvenlafaxine, new insights in gambling and anorexia, and caffeine-induced psychosis.
Topics: Adenosine; Anorexia; Antidepressive Agents, Second-Generation; Caffeine; Central Nervous System Stimulants; Cyclohexanols; Ethnicity; Gambling; Humans; Psychoses, Substance-Induced; Venlafaxine Hydrochloride | 2009 |
Antidepressant switching among adherent patients treated for depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug Administration Schedule; Humans; Mianserin; Middle Aged; Mirtazapine; Patient Compliance; Sertraline; Trazodone; Venlafaxine Hydrochloride; Young Adult | 2009 |
Nontricyclic antidepressants for neuropathic pain #187.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Duloxetine Hydrochloride; Humans; Neuralgia; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2009 |
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy.
Topics: Adolescent; Adult; Age of Onset; Aged; Algorithms; Antidepressive Agents; Anxiety Disorders; Bupropion; Child; Child Abuse, Sexual; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Life Change Events; Male; Mianserin; Middle Aged; Mirtazapine; Parenting; Risk Factors; Self Concept; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
[Venlafaxine-induced cholestatic hepatitis].
Topics: Adult; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Cyclohexanols; Humans; Male; Venlafaxine Hydrochloride | 2009 |
Fabrication of triple-layer matrix tablets of venlafaxine hydrochloride using xanthan gum.
Topics: Antidepressive Agents, Second-Generation; Chemistry, Pharmaceutical; Cyclohexanols; Delayed-Action Preparations; Polysaccharides, Bacterial; Solubility; Tablets; Venlafaxine Hydrochloride | 2009 |
Maternal use of venlafaxine near term: correlation between neonatal effects and plasma concentrations.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Gestational Age; Humans; Infant, Newborn; Plasma; Pregnancy; Statistics as Topic; Venlafaxine Hydrochloride | 2009 |
Venlafaxine treatment stimulates expression of brain-derived neurotrophic factor protein in frontal cortex and inhibits long-term potentiation in hippocampus.
Topics: Adrenergic Uptake Inhibitors; Animals; Brain-Derived Neurotrophic Factor; Cyclohexanols; Frontal Lobe; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
Borderline personality disorder: inpatient psychiatric nursing management.
Topics: Adult; Antidepressive Agents; Behavior Therapy; Borderline Personality Disorder; Combined Modality Therapy; Contracts; Cyclohexanols; Education; Female; Goals; Hospitalization; Humans; Interdisciplinary Communication; Milieu Therapy; Patient Care Team; Patient Discharge; Patient Education as Topic; Patient Readmission; Regression, Psychology; Trazodone; Venlafaxine Hydrochloride | 2009 |
[Results of a study of velaxin (venlafaxine) efficacy in patients with subacute and chronic spondylogenic dorsalgia].
Topics: Adult; Analgesics; Antidepressive Agents, Second-Generation; Chronic Disease; Cyclohexanols; Female; Humans; Low Back Pain; Male; Middle Aged; Pain Measurement; Patient Selection; Radiography; Selective Serotonin Reuptake Inhibitors; Spinal Diseases; Spinal Osteophytosis; Spondylitis; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding.
Topics: Aged; Analgesics; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Manitoba; Retrospective Studies; Risk Assessment; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
Comparative study on the gastroprotective potential of some antidepressants in indomethacin-induced ulcer in rats.
Topics: Animals; Anti-Ulcer Agents; Antidepressive Agents; Cyclohexanols; Famotidine; Indomethacin; Male; Rats; Rats, Inbred WF; Stomach Ulcer; Thiazepines; Trazodone; Venlafaxine Hydrochloride | 2009 |
Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland.
Topics: Cost-Benefit Analysis; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Duloxetine Hydrochloride; Health Care Costs; Humans; Mianserin; Mirtazapine; Prevalence; Quality of Life; Recurrence; Remission Induction; Scotland; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2010 |
Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Anxiety Disorders; Confidence Intervals; Cost-Benefit Analysis; Cyclohexanols; Delayed-Action Preparations; Economics, Pharmaceutical; gamma-Aminobutyric Acid; Humans; Models, Economic; Models, Statistical; Monte Carlo Method; Pregabalin; Psychiatric Status Rating Scales; Psychometrics; Quality-Adjusted Life Years; Spain; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Cognitive deterioration after venlafaxine overdose.
Topics: Cognition Disorders; Cyclohexanols; Drug Overdose; Female; Humans; Middle Aged; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Venlafaxine Hydrochloride | 2011 |
Rapid high-performance liquid chromatography-tandem mass spectrometry method for simultaneous measurement of venlafaxine and O-desmethylvenlafaxine in human plasma and its application in comparative bioavailability study.
Topics: Biological Availability; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Humans; Limit of Detection; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Tandem Mass Spectrometry; Venlafaxine Hydrochloride | 2009 |
Regarding "Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs".
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Humans; Meta-Analysis as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
A case of serotonin syndrome associated with methadone overdose.
Topics: Adult; Cyclohexanols; Drug Overdose; Humans; Male; Methadone; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline; Suicide, Attempted; Venlafaxine Hydrochloride | 2008 |
Electrocardiogram changes and arrhythmias in venlafaxine overdose.
Topics: Adult; Arrhythmias, Cardiac; Cyclohexanols; Drug Overdose; Electrocardiography; Female; Heart Conduction System; Humans; Long QT Syndrome; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine.
Topics: Adult; Clomipramine; Cyclohexanols; Delusions; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Humans; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2009 |
Venlafaxine metabolism as a marker of cytochrome P450 enzyme 2D6 metabolizer status.
Topics: Administration, Oral; Adolescent; Adrenergic Uptake Inhibitors; Adult; Biotransformation; Clinical Trials as Topic; Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Female; Genotype; Humans; Male; Middle Aged; Phenotype; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Substrate Specificity; Venlafaxine Hydrochloride; Young Adult | 2009 |
The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdose.
Topics: Adolescent; Adult; Aged; Area Under Curve; Charcoal; Cyclohexanols; Decontamination; Dose-Response Relationship, Drug; Drug Overdose; Female; Humans; Lower Gastrointestinal Tract; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Therapeutic Irrigation; Venlafaxine Hydrochloride; Young Adult | 2009 |
Venlafaxine in human breast milk and nursing infant plasma: determination of exposure.
Topics: Adult; Breast Feeding; Chromatography, High Pressure Liquid; Cyclohexanols; Delayed-Action Preparations; Desvenlafaxine Succinate; Female; Humans; Infant; Infant, Newborn; Lactation; Milk, Human; Neurotransmitter Uptake Inhibitors; Pregnancy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
Desvenlafaxine and venlafaxine exert minimal in vitro inhibition of human cytochrome P450 and P-glycoprotein activities.
Topics: Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Desvenlafaxine Succinate; Drug Interactions; Humans; In Vitro Techniques; Inhibitory Concentration 50; Microsomes, Liver; Venlafaxine Hydrochloride | 2009 |
[Delayed seizures after topiramate, venlafaxine and quetiapine overdose].
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Dibenzothiazepines; Drug Overdose; Fatal Outcome; Female; Fructose; Humans; Quetiapine Fumarate; Seizures; Time Factors; Topiramate; Venlafaxine Hydrochloride; Young Adult | 2010 |
TORDIA: unique opportunity to explore half-life theory.
Topics: Adolescent; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drug Resistance; Half-Life; Humans; Paroxetine; Randomized Controlled Trials as Topic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Suicide; Venlafaxine Hydrochloride | 2009 |
Development of a stir bar sorptive extraction based HPLC-FLD method for the quantification of serotonin reuptake inhibitors in plasma, urine and brain tissue samples.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Chromatography, High Pressure Liquid; Citalopram; Cyclohexanols; Fluorescence; Fluoxetine; Humans; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2010 |
To sweat or not to sweat? A hypothesis on the effects of venlafaxine and SSRIs.
Topics: Cyclohexanols; Humans; Models, Biological; Models, Theoretical; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sweat; Sympathetic Nervous System; Synaptic Transmission; Venlafaxine Hydrochloride | 2010 |
Venlafaxine versus SSRI therapy for major depression. Results of comparative efficacy trials.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?
Topics: Adrenergic Uptake Inhibitors; Adult; Age Factors; Antidepressive Agents; Climacteric; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Middle Aged; Morpholines; Personality Inventory; Reboxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Young Adult | 2009 |
Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Drug Administration Schedule; Drug Resistance; Female; Humans; Lithium; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2010 |
Cortisol metabolism in depressed patients and healthy controls.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cortisone; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Hydrocortisone; Mianserin; Middle Aged; Mirtazapine; Tetrahydrocortisol; Tetrahydrocortisone; Venlafaxine Hydrochloride; Young Adult | 2009 |
Venlafaxine-associated tinnitus.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Humans; Male; Middle Aged; Tinnitus; Venlafaxine Hydrochloride | 2009 |
[Venlafaxine-containing prolonged release: critical exchange?].
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Drug Approval; Drugs, Generic; Germany; Humans; Therapeutic Equivalency; Venlafaxine Hydrochloride | 2009 |
Brain creatine kinase activity is increased by chronic administration of paroxetine.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Corpus Striatum; Creatine Kinase, BB Form; Cyclohexanols; Hippocampus; Male; Nortriptyline; Paroxetine; Prefrontal Cortex; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
[Misuse of substances theoretically without abuse potential--case series].
Topics: Amitriptyline; Analgesics; Anti-Inflammatory Agents; Antidepressive Agents; Baclofen; Benzydamine; Cyclohexanols; Drug Overdose; Female; Humans; Imidazoles; Male; Muscle Relaxants, Central; Nasal Decongestants; Poisoning; Substance Abuse Detection; Thiazepines; Venlafaxine Hydrochloride | 2009 |
The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
Topics: Adolescent; Antidepressive Agents; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Female; Fluoxetine; Humans; Male; Multicenter Studies as Topic; Paroxetine; Personality Assessment; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide Prevention; Suicide, Attempted; Venlafaxine Hydrochloride | 2009 |
Nitric oxide mechanism in protective effect of imipramine and venlafaxine against acute immobilization stress-induced behavioral and biochemical alteration in mice.
Topics: Animals; Antidepressive Agents; Anxiety; Arginine; Behavior, Animal; Cyclohexanols; Drug Synergism; Imipramine; Immobilization; Mice; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Pain Measurement; Stress, Psychological; Venlafaxine Hydrochloride | 2009 |
Depressive effect of an antidepressant: therapeutic failure of venlafaxine in a case lacking CYP2D6 activity.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Depression; Female; Humans; Middle Aged; Models, Chemical; Polymorphism, Genetic; Risk; Venlafaxine Hydrochloride | 2009 |
Simultaneous determination of venlafaxine and its main active metabolite O-desmethyl venlafaxine in rat plasma by LC-MS/MS.
Topics: Animals; Blood Chemical Analysis; Calibration; Carbamazepine; Chromatography, Liquid; Cyclohexanols; Desvenlafaxine Succinate; Limit of Detection; Linear Models; Male; Rats; Rats, Sprague-Dawley; Reference Standards; Solid Phase Extraction; Solvents; Tandem Mass Spectrometry; Time Factors; Venlafaxine Hydrochloride | 2009 |
[Psycho- and pharmacotherapy of depressions. So you combine correctly].
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Behavior Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Dopamine Uptake Inhibitors; Duloxetine Hydrochloride; Humans; Mianserin; Middle Aged; Mirtazapine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2009 |
Development and validation of a stability-indicating LC method for the determination of venlafaxine in extended-release capsules and dissolution kinetic studies.
Topics: Capsules; Chromatography, High Pressure Liquid; Cyclohexanols; Delayed-Action Preparations; Kinetics; Solubility; Venlafaxine Hydrochloride | 2009 |
[Idiopathic intracranial hypertension and pregnancy. A report of two cases].
Topics: Acetazolamide; Adult; Brain; Cyclohexanols; Drug Overdose; Eye Diseases; Female; Fetal Growth Retardation; Gestational Age; Humans; Intracranial Hypertension; Labor, Induced; Magnetic Resonance Angiography; Oligohydramnios; Pregnancy; Pregnancy Complications; Spinal Puncture; Suicide, Attempted; Venlafaxine Hydrochloride | 2010 |
Neonatal hair analysis by liquid chromatography-high-resolution mass spectrometry to reveal gestational exposure to venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cyclohexanols; Drug Monitoring; Female; Hair; Humans; Infant; Infant, Newborn; Pregnancy; Reproducibility of Results; Retrospective Studies; Spectrometry, Mass, Electrospray Ionization; Twins, Monozygotic; Venlafaxine Hydrochloride | 2010 |
Menopausal symptoms following tamoxifen treatment for breast cancer.
Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Female; Hot Flashes; Humans; Menopause; Middle Aged; Relaxation Therapy; Tamoxifen; Venlafaxine Hydrochloride | 2008 |
Fulminant hepatic failure induced by venlafaxine and trazodone therapy: a case report.
Topics: Aspartate Aminotransferases; Bilirubin; Cyclohexanols; Depression; Factor V; Female; Humans; International Normalized Ratio; Jaundice; Liver Failure, Acute; Liver Transplantation; Middle Aged; Selective Serotonin Reuptake Inhibitors; Trazodone; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
A comparative study of non-fatal self-poisoning with antidepressants relative to prescribing in three centres in England.
Topics: Amitriptyline; Antidepressive Agents; Cross-Sectional Studies; Cyclohexanols; Dothiepin; England; Guideline Adherence; Humans; Odds Ratio; Poisoning; Practice Patterns, Physicians'; Recurrence; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2010 |
Advanced formulation design of venlafaxine hydrochloride coated and triple-layer tablets containing hypromellose.
Topics: Algorithms; Antidepressive Agents, Second-Generation; Biological Availability; Cellulose; Chemistry, Pharmaceutical; Cyclohexanols; Delayed-Action Preparations; Drug Stability; Ethanol; Excipients; Hypromellose Derivatives; Lactose; Methylcellulose; Models, Chemical; Models, Statistical; Stearic Acids; Tablets, Enteric-Coated; Venlafaxine Hydrochloride; Water | 2009 |
[Therapeutic effects of venlafaxine extended release for patients with depressive and anxiety disorders in the German outpatient setting - results of 2 observational studies including 8500 patients].
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Female; Germany; Humans; Male; Middle Aged; Outpatients; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Longitudinal changes of day-time and night-time gross motor activity in clinical responders and non-responders of major depression.
Topics: Actigraphy; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Circadian Rhythm; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Middle Aged; Motor Activity; Personality Inventory; Prognosis; Prospective Studies; Quetiapine Fumarate; Signal Processing, Computer-Assisted; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Neurotrophic factors in serum following ECT: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Bipolar Disorder; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nerve Growth Factors; Pilot Projects; Psychotherapy; Psychotropic Drugs; Recurrence; Reference Values; Venlafaxine Hydrochloride | 2009 |
Pro-inflammatory biomakers in depression: treatment with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Down-Regulation; Female; Humans; Inflammation Mediators; Male; Middle Aged; Personality Inventory; Reference Values; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
Tricyclic antidepressant toxicity treated with massive sodium bicarbonate.
Topics: Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Cyclohexanols; Desipramine; Drug Overdose; Electrocardiography; Female; Humans; Middle Aged; Sodium Bicarbonate; Venlafaxine Hydrochloride | 2009 |
Chiral HPLC analysis of venlafaxine metabolites in rat liver microsomal preparations after LPME extraction and application to an in vitro biotransformation study.
Topics: Animals; Antidepressive Agents; Biotransformation; Chemical Fractionation; Chromatography, High Pressure Liquid; Cyclohexanols; Male; Microsomes, Liver; Rats; Rats, Wistar; Venlafaxine Hydrochloride | 2010 |
[Evidence-based pharmacoanalytics of using venlafaxine in clinical medicine].
Topics: Antidepressive Agents, Second-Generation; Clinical Medicine; Cyclohexanols; Data Interpretation, Statistical; Evidence-Based Medicine; Humans; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2009 |
Chronic stress and antidepressant treatment have opposite effects on P-glycoprotein at the blood-brain barrier: an experimental PET study in rats.
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Cyclohexanols; Male; Models, Animal; Positron-Emission Tomography; Rats; Rats, Wistar; Stress, Psychological; Time Factors; Venlafaxine Hydrochloride; Verapamil | 2010 |
Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Arginine; Caffeine; Central Nervous System Stimulants; Chronic Disease; Cyclohexanols; Depressive Disorder; Disease Models, Animal; Enzyme Inhibitors; Male; Methylene Blue; Mice; Mice, Inbred Strains; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Random Allocation; Swimming; Venlafaxine Hydrochloride | 2010 |
Psychogenic movement disorder after a venlafaxine-induced dystonia.
Topics: Adult; Antiparkinson Agents; Biperiden; Cyclohexanols; Dystonia; Female; Humans; Movement Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2010 |
Agomelatine: new drug. Adverse effects and no proven efficacy.
Topics: Acetamides; Animals; Antidepressive Agents; Bias; Carcinogens; Clinical Trials as Topic; Cyclohexanols; Depression; Depressive Disorder; Double-Blind Method; Drug Approval; Europe; Fluoxetine; Humans; Hypnotics and Sedatives; Melatonin; Paroxetine; Psychiatric Status Rating Scales; Receptors, Melatonin; Recurrence; Selective Serotonin Reuptake Inhibitors; Suicide; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Changes in antidepressant metabolism in pregnancy evidenced by metabolic ratios in hair: a novel approach.
Topics: Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Female; Fluoxetine; Gas Chromatography-Mass Spectrometry; Hair; Humans; Postpartum Period; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Third; Sertraline; Venlafaxine Hydrochloride | 2010 |
Efficacy of tramadol in combination with doxepin or venlafaxine in inhibition of nociceptive process in the rat model of neuropathic pain: an isobolographic analysis.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Doxepin; Drug Interactions; Drug Therapy, Combination; Hyperalgesia; Male; Neuralgia; Pain Measurement; Rats; Rats, Wistar; Statistics as Topic; Tramadol; Venlafaxine Hydrochloride | 2009 |
Intralipid reverses coma associated with zopiclone and venlafaxine overdose.
Topics: Antidepressive Agents, Second-Generation; Azabicyclo Compounds; Coma; Cyclohexanols; Drug Overdose; Fat Emulsions, Intravenous; Humans; Hypnotics and Sedatives; Male; Middle Aged; Piperazines; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Anxiety Disorders; Blood Pressure; Clonidine; Cyclohexanols; Eye Movements; Female; Heart Rate; Human Growth Hormone; Humans; Hydrocortisone; Male; Middle Aged; Neuropsychological Tests; Norepinephrine; Receptors, Adrenergic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2011 |
Understanding outliers on the usual dose-response curve: venlafaxine as a way to phenotype patients in terms of their CYP 2D6 status and why it matters.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Genetic Variation; Genotype; Humans; Phenotype; Venlafaxine Hydrochloride | 2010 |
Involvement of potassium channels in the antidepressant-like effect of venlafaxine in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Male; Mice; Motor Activity; Potassium Channel Blockers; Potassium Channels; Venlafaxine Hydrochloride | 2010 |
[Discontinuation of antidepressant serotonergic antidepressant].
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2010 |
Dosing by side effect threshold: two cases of panic disorder responsive to low-dose venlafaxine.
Topics: Adult; Cyclohexanols; Female; Humans; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2010 |
Simultaneous quantification of venlafaxine and O-desmethylvenlafaxine in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.
Topics: Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Drug Stability; Ether; Humans; Linear Models; Male; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Venlafaxine Hydrochloride | 2010 |
Use of venlafaxine in the treatment of a canine narcolepsy-cataplexy case.
Topics: Animals; Cyclohexanols; Dog Diseases; Dogs; Female; Narcolepsy; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Case-Control Studies; Cyclohexanols; Death, Sudden, Cardiac; Depressive Disorder; Humans; Middle Aged; Odds Ratio; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Young Adult | 2010 |
Venlafaxine and cardiovascular toxicity.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Death, Sudden, Cardiac; Depressive Disorder; Drug Overdose; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2010 |
Cardiogenic shock associated with reversible dilated cardiomyopathy during therapy with regular doses of venlafaxine.
Topics: Cardiomyopathy, Dilated; Cyclohexanols; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Shock, Cardiogenic; Venlafaxine Hydrochloride | 2010 |
When is a "generic" medication not really a generic?
Topics: Bupropion; Cyclohexanols; Drug Costs; Drug Labeling; Drug Prescriptions; Drugs, Generic; Humans; Marketing of Health Services; Paroxetine; Patient Selection; Psychiatric Nursing; Psychotropic Drugs; Therapeutic Equivalency; United States; United States Food and Drug Administration; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; CA3 Region, Hippocampal; Cyclohexanols; Dentate Gyrus; Disease Models, Animal; Food Preferences; Hippocampus; Imipramine; In Situ Hybridization; Locomotion; Male; Maze Learning; Rats; Rats, Sprague-Dawley; RNA, Messenger; Saccharin; Stress, Psychological; Sweetening Agents; Swimming; Time Factors; Venlafaxine Hydrochloride | 2010 |
Deaths involving serotonergic drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Australia; Cause of Death; Citalopram; Cyclohexanols; Female; Fluoxetine; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Serotonin Agents; Sertraline; Tramadol; Venlafaxine Hydrochloride | 2010 |
Sensitive spectrofluorimetric method of analysis for venlafaxine in spiked rat plasma and formulations.
Topics: Animals; Chemistry, Pharmaceutical; Cyclohexanols; Linear Models; Rats; Reproducibility of Results; Spectrometry, Fluorescence; Time Factors; Venlafaxine Hydrochloride | 2010 |
Does night-time cortisol excretion normalize in the long-term course of depression?
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Circadian Rhythm; Cyclohexanols; Depressive Disorder; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mianserin; Middle Aged; Mirtazapine; Pituitary-Adrenal System; Time Factors; Venlafaxine Hydrochloride | 2010 |
Combining antidepressant medications: a good idea?
Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Fluoxetine; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2010 |
[Depressive symptoms in a case of "posterior cortical atrophy"].
Topics: Affect; Antidepressive Agents, Second-Generation; Atrophy; Brain Diseases; Cerebral Cortex; Cognition Disorders; Cyclohexanols; Depressive Disorder; Electroencephalography; Evoked Potentials; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Venlafaxine Hydrochloride | 2010 |
Selective serotonin reuptake inhibitors and the risk of cataracts: a nested case-control study.
Topics: Aged; Case-Control Studies; Cataract; Cataract Extraction; Cyclohexanols; Female; Fluvoxamine; Humans; Male; Paroxetine; Pharmacoepidemiology; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2010 |
Comparative study of the stability of venlafaxine hydrochloride sustained-release pellets prepared by double-polymer coatings and hot-melt subcoating combined with Eudragit(®) NE30D outercoating.
Topics: Chemistry, Pharmaceutical; Cyclohexanols; Delayed-Action Preparations; Drug Compounding; Drug Stability; Drug Storage; Excipients; Hot Temperature; Methacrylates; Microscopy, Electron, Scanning; Polymers; Solubility; Venlafaxine Hydrochloride | 2011 |
[Risperidone intoxication in a patient with a genetic predisposition as "poor [non]metabolizer"].
Topics: Adult; Antipsychotic Agents; Chromosomes, Human, Pair 22; Cyclohexanols; Cytochrome P-450 CYP2D6; Delusions; DNA Mutational Analysis; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Exons; Female; Genetic Carrier Screening; Humans; Inactivation, Metabolic; Introns; Metabolic Clearance Rate; Psychotic Disorders; Risperidone; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2010 |
A comparison of venlafaxine and SSRIs in deliberate self-poisoning.
Topics: Adult; Cohort Studies; Cyclohexanols; Drug Overdose; Electrocardiography; Emergency Medical Services; Female; Humans; Intention; Long QT Syndrome; Male; Poison Control Centers; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Healthcare expenditure in severely depressed patients treated with escitalopram, generic SSRIs or venlafaxine in the UK.
Topics: Adolescent; Adult; Aged; Citalopram; Cyclohexanols; Depression; Drugs, Generic; Female; Health Care Costs; Humans; Male; Middle Aged; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; United Kingdom; Venlafaxine Hydrochloride; Young Adult | 2010 |
The venlafaxine "heart revenge:" a short report.
Topics: Adult; Antidepressive Agents, Second-Generation; Coronary Angiography; Creatine Kinase; Cyclohexanols; Depression; Drug Overdose; Electrocardiography; Fatal Outcome; Female; Humans; Myocardial Infarction; Oxygen; Suicide, Attempted; Troponin I; Venlafaxine Hydrochloride | 2010 |
Management of depression in the presence of pain symptoms.
Topics: Antidepressive Agents; Brain; Chronic Disease; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Mind-Body Relations, Metaphysical; Norepinephrine; Pain; Psychotherapy; Serotonin; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Conventional and complementary therapies: a tale of two research standards?
Topics: Acupuncture Therapy; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Complementary Therapies; Cyclohexanols; Deoxycytidine; Dietary Supplements; Evidence-Based Medicine; Gemcitabine; Hot Flashes; Humans; Neoplasms; Peptide Hydrolases; Risk Assessment; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Evaluation of Krebs cycle enzymes in the brain of rats after chronic administration of antidepressants.
Topics: Animals; Antidepressive Agents; Brain; Citrate (si)-Synthase; Citric Acid Cycle; Cyclohexanols; Male; Nortriptyline; Paroxetine; Rats; Rats, Wistar; Succinate Dehydrogenase; Venlafaxine Hydrochloride | 2010 |
Lack of preparation, physical health after childbirth, and early postpartum depressive symptoms.
Topics: Adult; Belladonna Alkaloids; Cyclohexanols; Depression, Postpartum; Drug Combinations; Ergotamines; Female; Health Knowledge, Attitudes, Practice; Health Status; Humans; Isoflavones; Maternal Welfare; Multivariate Analysis; New York City; Patient Education as Topic; Phenobarbital; Pregnancy; Pregnancy Outcome; Venlafaxine Hydrochloride; Women's Health; Young Adult | 2010 |
Correction of venlafaxine- and duloxetine-induced transaminase elevations with desvenlafaxine in a patient with Gilbert's syndrome.
Topics: Adult; Aminoacyltransferases; Antidepressive Agents; Cyclohexanols; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Gilbert Disease; Humans; Male; Thiophenes; Venlafaxine Hydrochloride | 2010 |
Physician speciality and pain reduction in patients with depressive symptoms under treatment with venlafaxine.
Topics: Adult; Aged; Analgesics; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Depressive Disorder; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Pain Perception; Physicians; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Fatal venlafaxine poisonings are associated with a high prevalence of drug interactions.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Databases, Factual; Desvenlafaxine Succinate; Drug Interactions; Female; Forensic Pathology; Gas Chromatography-Mass Spectrometry; Genotype; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2011 |
Stereoselective determination of venlafaxine and its three demethylated metabolites in human plasma and whole blood by liquid chromatography with electrospray tandem mass spectrometric detection and solid phase extraction.
Topics: Chromatography, Liquid; Cyclohexanols; Desvenlafaxine Succinate; Drug Stability; Humans; Selective Serotonin Reuptake Inhibitors; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Venlafaxine Hydrochloride | 2010 |
Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor Venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Drug Overdose; Echocardiography; Female; Humans; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Takotsubo Cardiomyopathy; Venlafaxine Hydrochloride | 2010 |
Teaching case: menopausal migraine.
Topics: Amines; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Fructose; Gabapentin; gamma-Aminobutyric Acid; Gonadal Steroid Hormones; Herbal Medicine; Hot Flashes; Humans; Menstrual Cycle; Menstruation Disturbances; Middle Aged; Migraine Disorders; Postmenopause; Topiramate; Venlafaxine Hydrochloride | 2010 |
Manic episode following a combined treatment of repetitive transcranial magnetic stimulation and venlafaxine.
Topics: Bipolar Disorder; China; Cyclohexanols; Follow-Up Studies; Humans; Male; Mental Disorders; Middle Aged; Transcranial Magnetic Stimulation; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Blood-brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoprotein.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Cyclohexanols; Male; Mice; Mice, Knockout; Selective Serotonin Reuptake Inhibitors; Stereoisomerism; Venlafaxine Hydrochloride | 2010 |
Outliers on the dose-response curve: how to minimize this problem using therapeutic drug monitoring, an underutilized tool in psychiatry.
Topics: Antidepressive Agents, Second-Generation; Biotransformation; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance; Humans; Mental Disorders; Metabolic Clearance Rate; Pharmacogenetics; Phenotype; Psychotropic Drugs; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Amines; Anti-Anxiety Agents; Breast Neoplasms; Clonidine; Cyclohexanecarboxylic Acids; Cyclohexanols; Fatigue; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Libido; Menopause; Middle Aged; Patient Care Team; Patient Education as Topic; Patient Satisfaction; Patient-Centered Care; Practice Guidelines as Topic; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Sweating; Sympatholytics; Venlafaxine Hydrochloride; Vitamin E; Vitamins | 2010 |
Use of antidepressants during pregnancy and the risk of spontaneous abortion.
Topics: Abortion, Spontaneous; Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Case-Control Studies; Confidence Intervals; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gestational Age; Humans; Middle Aged; Odds Ratio; Paroxetine; Pregnancy; Pregnancy Complications; Quebec; Registries; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Young Adult | 2010 |
[Headaches of tension and psychogenic headaches: assessment of the treatment with venlafaxine].
Topics: Analgesics; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Headache; Humans; Male; Pain Measurement; Stress, Psychological; Tension-Type Headache; Venlafaxine Hydrochloride | 2010 |
Enantiomeric analysis of drugs of abuse in wastewater by chiral liquid chromatography coupled with tandem mass spectrometry.
Topics: Amphetamines; Chromatography, Liquid; Cyclohexanols; Illicit Drugs; Linear Models; Propanolamines; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Stereoisomerism; Tandem Mass Spectrometry; Venlafaxine Hydrochloride; Waste Products; Water Pollutants, Chemical | 2010 |
Multifactorial QT interval prolongation.
Topics: Alcoholism; Amiodarone; Antipsychotic Agents; Arrhythmias, Cardiac; Biomarkers; Citalopram; Cyclohexanols; Dibenzothiazepines; Diuretics; Domperidone; Dopamine Antagonists; Electrocardiography; Female; Humans; Hydrochlorothiazide; Hypokalemia; Magnesium; Middle Aged; Polypharmacy; Quetiapine Fumarate; Risk Factors; Selective Serotonin Reuptake Inhibitors; Torsades de Pointes; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Effect of venlafaxine on bone loss associated with ligature-induced periodontitis in Wistar rats.
Topics: Alveolar Bone Loss; Animals; Cyclohexanols; Gingiva; Immunohistochemistry; Ligation; Malondialdehyde; Nitric Oxide Synthase Type II; Periodontitis; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2010 |
Electroconvulsive therapy for lycanthropy and Cotard syndrome: a case report.
Topics: Adult; Anesthesia; Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Delusions; Depressive Disorder; Electroconvulsive Therapy; Electroencephalography; Female; Humans; Swine; Venlafaxine Hydrochloride | 2010 |
An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Comorbidity; Cyclohexanols; Depressive Disorder; England; Fluoxetine; Guideline Adherence; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Practice Patterns, Physicians'; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder; England; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Suicide risk and choice of antidepressant.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder; England; Female; Humans; Male; Practice Patterns, Physicians'; Risk Assessment; Secondary Prevention; Sex Factors; Suicide; Suicide Prevention; Suicide, Attempted; Venlafaxine Hydrochloride | 2010 |
Venlafaxine - quetiapine combination in the treatment of complicated clinical picture of enduring personality changes following PTSD in comorbidity with psychotic depression.
Topics: Affective Disorders, Psychotic; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Combat Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Personality Disorders; Quetiapine Fumarate; Secondary Prevention; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride; Veterans | 2010 |
Effects of long-term treatment with fluoxetine and venlafaxine on rat isolated vas deferens.
Topics: Adenosine Triphosphate; Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Electric Stimulation; Fluoxetine; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Norepinephrine; Potassium Chloride; Rats; Rats, Wistar; Serotonin; Time Factors; Vas Deferens; Venlafaxine Hydrochloride | 2010 |
Editorial: venlafaxine for functional chest pain: hope or hype?
Topics: Adult; Chest Pain; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Esophageal Diseases; Esophageal pH Monitoring; Female; Humans; Male; Manometry; Randomized Controlled Trials as Topic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sex Factors; Venlafaxine Hydrochloride | 2010 |
Effect of venlafaxine and nicotine on the level of neurotransmitters and their metabolites in rat brains.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Dopamine; Female; Ganglionic Stimulants; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Microdialysis; Neurotransmitter Agents; Nicotine; Norepinephrine; Rats; Rats, Wistar; Serotonin; Venlafaxine Hydrochloride | 2010 |
Protective effect of desipramine, venlafaxine and trazodone against experimental animal model of transient global ischemia: possible involvement of NO-cGMP pathway.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Arginine; Brain; Catalase; Cyclic GMP; Cyclohexanols; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Electron Transport Chain Complex Proteins; Enzyme Inhibitors; Glutathione; Ischemic Attack, Transient; Lipid Peroxidation; Mice; Models, Biological; Nitric Oxide; Signal Transduction; Trazodone; Venlafaxine Hydrochloride | 2010 |
Treatment of psychotic depression in the elderly compared with nonpsychotic depression.
Topics: Affective Disorders, Psychotic; Aged; Antidepressive Agents; Antipsychotic Agents; Cyclohexanols; Depressive Disorder, Major; Follow-Up Studies; Humans; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Clinically relevant pharmacokinetic interaction between venlafaxine and bupropion: a case series.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2010 |
Chronic effects of venlafaxine on synaptophysin and neuronal cell adhesion molecule in the hippocampus of cerebral ischemic mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain Ischemia; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hippocampus; Male; Mice; Neural Cell Adhesion Molecule L1; Neuronal Plasticity; Selective Serotonin Reuptake Inhibitors; Synaptophysin; Time Factors; Venlafaxine Hydrochloride | 2010 |
Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.
Topics: Adult; Alleles; Asian People; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Female; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride | 2010 |
[A painful weaning].
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2010 |
Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Decision Support Techniques; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Markov Chains; Outcome Assessment, Health Care; Quality-Adjusted Life Years; Recurrence; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sweden; Thiophenes; Venlafaxine Hydrochloride | 2010 |
Antidepressant-like effect of venlafaxine is abolished in μ-opioid receptor-knockout mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Opioid, mu; Swimming; Venlafaxine Hydrochloride | 2010 |
A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Data Collection; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Fatigue; Fluvoxamine; Humans; Internet; Lethargy; Mianserin; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Stages; Thiophenes; Venlafaxine Hydrochloride | 2011 |
Trends in the consumption of antidepressants in Castilla y León (Spain). Association between suicide rates and antidepressant drug consumption.
Topics: Antidepressive Agents; Cyclohexanols; Databases, Factual; Drug Costs; Humans; Lithium Compounds; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Spain; Suicide; Venlafaxine Hydrochloride | 2010 |
Neonatal seizures on EEG after in utero exposure to venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Electroencephalography; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Pregnancy; Prenatal Exposure Delayed Effects; Risk Factors; Seizures; Venlafaxine Hydrochloride | 2010 |
Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats.
Topics: Acceleration; Amitriptyline; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Brain Injuries; Bupropion; Citalopram; Cyclohexanols; Exploratory Behavior; Fear; Male; Neuronal Plasticity; Neurotransmitter Uptake Inhibitors; Norepinephrine; Rats; Rats, Wistar; Reflex, Startle; Serotonin; Social Behavior; Venlafaxine Hydrochloride | 2010 |
Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Delivery Systems; Female; Fluoxetine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2011 |
Venlafaxine-associated serotonin syndrome causing severe rhabdomyolysis and acute renal failure in a patient with idiopathic Parkinson disease.
Topics: Acute Kidney Injury; Adult; Cyclohexanols; Humans; Male; Parkinson Disease; Rhabdomyolysis; Serotonin Syndrome; Venlafaxine Hydrochloride | 2010 |
Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine.
Topics: Aged; Ataxia; Cyclohexanols; Drug Therapy, Combination; Female; Follow-Up Studies; Fragile X Mental Retardation Protein; Fragile X Syndrome; Humans; Memantine; Tremor; Venlafaxine Hydrochloride | 2010 |
The bipolar spectrum: do we need a single algorithm for affective disorders?
Topics: Algorithms; Antidepressive Agents; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Humans; Practice Guidelines as Topic; Primary Health Care; Referral and Consultation; Risk Factors; Venlafaxine Hydrochloride | 2010 |
Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats.
Topics: Action Potentials; Adenylyl Cyclases; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Benzamides; Brain; Bridged Bicyclo Compounds, Heterocyclic; CA1 Region, Hippocampal; Cyclohexanols; Drug Interactions; Male; Morpholines; Pyramidal Cells; Radioligand Assay; Rats; Rats, Wistar; Reboxetine; Receptors, Serotonin, 5-HT4; Signal Transduction; Venlafaxine Hydrochloride | 2010 |
Gambling on acamprosate: a case report.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents, Second-Generation; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Female; Follow-Up Studies; Gambling; Humans; Middle Aged; Taurine; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Pediatric emergency medicine: legal briefs.
Topics: Accidents, Traffic; Adolescent; Adult; Airway Obstruction; Aorta, Abdominal; Arterial Occlusive Diseases; Brain Concussion; Brain Damage, Chronic; Cardiomyopathy, Hypertrophic, Familial; Child; Clindamycin; Clostridium Infections; Crohn Disease; Cyclohexanols; Death, Sudden, Cardiac; Dehydration; Diagnostic Errors; Emergencies; Emergency Medical Services; Fatal Outcome; Female; Football; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Infant, Newborn; Infectious Mononucleosis; Informed Consent; Male; Malpractice; Megacolon, Toxic; Multiple Organ Failure; Retropharyngeal Abscess; Splenic Rupture; Suicide; Thrombosis; Triage; Venlafaxine Hydrochloride | 2010 |
In vivo, in vitro evaluation of linseed mucilage based buccal mucoadhesive microspheres of venlafaxine.
Topics: Adhesiveness; Adhesives; Administration, Buccal; Administration, Oral; Animals; Biological Availability; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Cyclohexanols; Drug Delivery Systems; Drug Stability; Flax; Liver; Microscopy, Electron, Scanning; Microspheres; Particle Size; Plant Extracts; Rabbits; Sheep; Spectroscopy, Fourier Transform Infrared; Venlafaxine Hydrochloride; X-Ray Diffraction | 2011 |
Association between antidepressant use during pregnancy and infants born small for gestational age.
Topics: Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Canada; Case-Control Studies; Confounding Factors, Epidemiologic; Cyclohexanols; Depression; Female; Humans; Infant, Newborn; Infant, Small for Gestational Age; Middle Aged; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Second; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2010 |
Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder, Major; Drug Combinations; Drug Costs; Female; Health Care Costs; Health Resources; Humans; Male; Retrospective Studies; Spain; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2010 |
Late-onset galactorrhea and menometrorrhagia with venlafaxine use in a migraine patient.
Topics: Adult; Cyclohexanols; Female; Galactorrhea; Humans; Menorrhagia; Migraine Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2010 |
Was Cipriani right? Audits to compare discharge rates and suicidality between antidepressant monotherapies used in a British community mental health team.
Topics: Antidepressive Agents; Citalopram; Community Mental Health Services; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Medical Audit; Mianserin; Mirtazapine; Outcome Assessment, Health Care; Patient Discharge; Sertraline; Suicidal Ideation; Suicide; Suicide Prevention; Treatment Outcome; United Kingdom; Venlafaxine Hydrochloride | 2010 |
Lipid therapy for serotonin syndrome after intoxication with venlafaxine, lamotrigine and diazepam.
Topics: Adult; Combined Modality Therapy; Cyclohexanols; Diazepam; Emulsions; Fat Emulsions, Intravenous; Female; Humans; Lamotrigine; Lipids; Muscle Rigidity; Reflex, Abnormal; Renal Dialysis; Serotonin Syndrome; Suicide, Attempted; Triazines; Venlafaxine Hydrochloride | 2011 |
Venlafaxine associated urinary symptoms.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Humans; Male; Middle Aged; Urination Disorders; Venlafaxine Hydrochloride | 2010 |
Rapid HPLC method for the simultaneous monitoring of duloxetine, venlaflaxine, fluoxetine and paroxetine in biofluids.
Topics: Chromatography, High Pressure Liquid; Cyclohexanols; Duloxetine Hydrochloride; Fluoxetine; Humans; Limit of Detection; Paroxetine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Thiophenes; Venlafaxine Hydrochloride | 2009 |
The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanols; Depression; Disease Models, Animal; Imipramine; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nitric Oxide; Swimming; Venlafaxine Hydrochloride | 2011 |
Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxine.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Aryl Hydrocarbon Hydroxylases; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Female; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Young Adult | 2011 |
Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children.
Topics: Adjuvants, Anesthesia; Adolescent; Age Distribution; Age of Onset; Antidepressive Agents, Second-Generation; Benzhydryl Compounds; Central Nervous System Stimulants; Child; Cyclohexanols; Drosophila Proteins; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Modafinil; Narcolepsy; Nerve Tissue Proteins; Nuclear Proteins; Overweight; Polysomnography; Puberty; Retrospective Studies; Sodium Oxybate; Streptococcal Infections; Surveys and Questionnaires; Transcription Factors; United States; Venlafaxine Hydrochloride; Weight Gain | 2010 |
A case of venlafaxine-induced bruxism alleviated by duloxetine substitution.
Topics: Aged; Antidepressive Agents; Bruxism; Cyclohexanols; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Thiophenes; Venlafaxine Hydrochloride | 2011 |
Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Severity of Illness Index; Venlafaxine Hydrochloride | 2010 |
Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry.
Topics: Antidepressive Agents; Antipsychotic Agents; Chemical Precipitation; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Dibenzothiazepines; Humans; Methanol; Mianserin; Mirtazapine; Piperazines; Quetiapine Fumarate; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Thiazoles; Venlafaxine Hydrochloride; Zinc Sulfate | 2011 |
Bioequivalence of venlafaxine modified-release capsule revisited with an innovative approach using experimental and predictive models.
Topics: Adolescent; Adult; Algorithms; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Cyclohexanols; Data Interpretation, Statistical; Decision Trees; Delayed-Action Preparations; Humans; Limit of Detection; Models, Theoretical; Stereoisomerism; Tandem Mass Spectrometry; Therapeutic Equivalency; Venlafaxine Hydrochloride | 2011 |
Evaluation of a QT nomogram for risk assessment after antidepressant overdose.
Topics: Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Drug Overdose; Electrocardiography; Female; Heart Rate; Humans; Long QT Syndrome; Male; Mianserin; Mirtazapine; Nomograms; Retrospective Studies; Risk Assessment; Torsades de Pointes; Venlafaxine Hydrochloride | 2010 |
Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine.
Topics: Acetamides; Animals; Antidepressive Agents; Brain; Brain-Derived Neurotrophic Factor; Cyclohexanols; Cytosol; Fibroblast Growth Factor 2; Gene Expression Regulation; Neuronal Plasticity; Rats; Rats, Sprague-Dawley; Synaptosomes; Time Factors; Venlafaxine Hydrochloride | 2011 |
[Clinical features of headache of tension type and principles of treatment].
Topics: Adult; Aged; Analgesics; Clonidine; Cyclohexanols; Female; Humans; Male; Masticatory Muscles; Middle Aged; Pain Threshold; Surveys and Questionnaires; Tension-Type Headache; Venlafaxine Hydrochloride; Young Adult | 2010 |
[New approaches to the treatment of chronic daily headache].
Topics: Adult; Aminopyridines; Analgesics; Attention Deficit Disorder with Hyperactivity; Constipation; Cyclohexanols; Diarrhea; Female; Headache Disorders; Humans; Male; Nausea; Pain Threshold; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Effects on enantiomeric drug disposition and open-field behavior after chronic treatment with venlafaxine in the P-glycoprotein knockout mice model.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cyclohexanols; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Mice; Mice, Knockout; Motor Activity; Stereoisomerism; Time Factors; Venlafaxine Hydrochloride | 2011 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
Functional gastrointestinal disorders: Venlafaxine is a potential therapy for functional chest pain.
Topics: Chest Pain; Cyclohexanols; Humans; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Behavior, Animal; Biogenic Amines; Brain; Cyclohexanols; Depression; Disease Models, Animal; Hindlimb Suspension; Hypnotics and Sedatives; Isoquinolines; Male; Mice; Motor Activity; Neurotransmitter Agents; Pentobarbital; Reserpine; Sleep; Swimming; Venlafaxine Hydrochloride | 2011 |
Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Drug Costs; Duloxetine Hydrochloride; Female; Health Care Costs; Humans; Male; Middle Aged; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
The effect of decontamination procedures on the pharmacodynamics of venlafaxine in overdose.
Topics: Adult; Antidotes; Bayes Theorem; Biological Availability; Charcoal; Cohort Studies; Cyclohexanols; Decontamination; Dose-Response Relationship, Drug; Drug Overdose; Female; Humans; Logistic Models; Male; Metabolic Clearance Rate; Seizures; Selective Serotonin Reuptake Inhibitors; Therapeutic Irrigation; Time Factors; Venlafaxine Hydrochloride | 2011 |
Venlafaxine modulates depression-induced behaviour and the expression of Bax mRNA and Bcl-xl mRNA in both hippocampus and myocardium.
Topics: Animals; bcl-2-Associated X Protein; bcl-X Protein; Cyclohexanols; Depression; Gene Expression Regulation; Hippocampus; Male; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stress, Psychological; Venlafaxine Hydrochloride | 2011 |
[Patch testing increases the likelihood of recognizing lamotrigine as a cause of drug-induced rash].
Topics: Antidepressive Agents; Antimanic Agents; Cyclohexanols; Depressive Disorder; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Lamotrigine; Middle Aged; Patch Tests; Triazines; Venlafaxine Hydrochloride | 2011 |
Development and validation of a HPLC-MS/MS method for the determination of venlafaxine enantiomers and application to a pharmacokinetic study in healthy Chinese volunteers.
Topics: Adult; Antidepressive Agents, Second-Generation; Area Under Curve; China; Chromatography, High Pressure Liquid; Cyclohexanols; Drug Stability; Humans; Male; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism; Tandem Mass Spectrometry; Vancomycin; Venlafaxine Hydrochloride; Young Adult | 2011 |
Paliperidone augmentation for treatment-resistant depression: a case report.
Topics: Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Female; Humans; Isoxazoles; Middle Aged; Paliperidone Palmitate; Pyrimidines; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Acute eosinophilic pneumonia after venlafaxine overdose.
Topics: Acute Disease; Adult; Cyclohexanols; Drug Overdose; Humans; Male; Pulmonary Eosinophilia; Venlafaxine Hydrochloride | 2011 |
Venlafaxine pharmacobezoar causing intestinal ischemia requiring emergent hemicolectomy.
Topics: Abdominal Pain; Adult; Bezoars; Colectomy; Cyclohexanols; Depressive Disorder, Major; Edema; Emergency Medical Services; Female; Humans; Ileocecal Valve; Intestinal Obstruction; Laparotomy; Necrosis; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Tachycardia; Venlafaxine Hydrochloride | 2011 |
The psychoactive effects of antidepressants and their association with suicidality.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Emotions; Female; Fluoxetine; Humans; Internet; Male; Middle Aged; Prevalence; Suicidal Ideation; Venlafaxine Hydrochloride; Young Adult | 2011 |
[Acute lethal poisoning with venlafaxine].
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Drug Overdose; Fatal Outcome; Female; Humans; Middle Aged; Suicide; Venlafaxine Hydrochloride | 2010 |
IFN-gamma reduction by tricyclic antidepressants.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cytokines; Depressive Disorder; Desipramine; Desvenlafaxine Succinate; Female; Humans; Imipramine; In Vitro Techniques; Interferon-gamma; Male; Nortriptyline; Venlafaxine Hydrochloride | 2010 |
Venlafaxine-induced delirium.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delirium; Humans; Male; Middle Aged; Venlafaxine Hydrochloride | 2011 |
Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Blood-Brain Barrier; Brain; Caco-2 Cells; Cell Membrane Permeability; Cells, Cultured; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Interactions; Endothelial Cells; Enzyme Inhibitors; Fluorescent Dyes; Humans; Intestinal Absorption; Neoplasm Proteins; Rhodamine 123; Rifampin; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2011 |
Dermatitis artefacta--a long way from the first clinical symptoms to diagnosis.
Topics: Antidepressive Agents, Second-Generation; Cicatrix; Combined Modality Therapy; Cyclohexanols; Dermatologic Agents; Diagnosis, Differential; Facial Dermatoses; Factitious Disorders; Humans; Male; Middle Aged; Patient Admission; Referral and Consultation; Self-Injurious Behavior; Silver Nitrate; Skin; Skin Ulcer; Venlafaxine Hydrochloride | 2011 |
Venlafaxine withdrawal syndrome.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Ischemic Attack, Transient; Retreatment; Stroke; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2011 |
Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clomipramine; Cyclohexanols; Depressive Disorder; Female; Genetic Association Studies; Humans; Male; Middle Aged; Paroxetine; Piperazines; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT1B; Severity of Illness Index; Suicidal Ideation; Tacrolimus Binding Proteins; Triazoles; Venlafaxine Hydrochloride; Young Adult | 2011 |
Balance control improves following replacement of paroxetine with venlafaxine and levodopa in a case of microvascular dementia.
Topics: Aged, 80 and over; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Cyclohexanols; Dementia, Vascular; Diagnosis, Computer-Assisted; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Microvessels; Paroxetine; Postural Balance; Venlafaxine Hydrochloride | 2011 |
Severe mania complicating treatment of narcolepsy with cataplexy.
Topics: Antidepressive Agents, Second-Generation; Benzhydryl Compounds; Bipolar Disorder; Central Nervous System Stimulants; Cyclohexanols; Drug Therapy, Combination; Humans; Male; Modafinil; Narcolepsy; Venlafaxine Hydrochloride; Young Adult | 2011 |
Hippocampal CA3 calcineurin activity participates in depressive-like behavior in rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bridged Bicyclo Compounds; CA3 Region, Hippocampal; Calcineurin; Calcineurin Inhibitors; Cyclohexanols; Cyclosporine; Depression; Haloperidol; Male; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Stress, Psychological; Venlafaxine Hydrochloride | 2011 |
Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows.
Topics: Animals; Antidepressive Agents; Brain; Bupropion; Cyclohexanols; Cyprinidae; Endocrine Disruptors; Female; Fluoxetine; Male; Reproduction; Sertraline; Testis; Venlafaxine Hydrochloride; Vitellogenins; Water Pollutants, Chemical | 2011 |
Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Anticoagulants; Antidepressive Agents; Blood Coagulation; Cohort Studies; Cyclohexanols; Drug Interactions; Fluvoxamine; Hemorrhage; Humans; Middle Aged; Proportional Hazards Models; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2011 |
Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases.
Topics: Adolescent; Adult; Algorithms; Antidepressive Agents; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dosage Forms; Duloxetine Hydrochloride; Female; Humans; Male; Medication Adherence; Middle Aged; Pain; Retrospective Studies; Somatoform Disorders; Thiophenes; Venlafaxine Hydrochloride; Young Adult | 2011 |
Antidepressant use during pregnancy. FPIN’s clinical inquiries.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Evidence-Based Medicine; Female; Fluoxetine; Humans; Odds Ratio; Paroxetine; Physicians, Family; Pregnancy; Pregnancy Complications; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2011 |
Venlafaxine inhibits the development and differentiation of dendritic cells through the regulation of P-glycoprotein.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cyclohexanols; Dendritic Cells; Down-Regulation; Interferon-gamma; Interleukins; Lipopolysaccharides; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; T-Lymphocytes; Up-Regulation; Venlafaxine Hydrochloride | 2011 |
Serum brain-derived neurotrophic factor and glucocorticoid receptor levels in lymphocytes as markers of antidepressant response in major depressive patients: a pilot study.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; CREB-Binding Protein; Cyclohexanols; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; Hydrocortisone; Lymphocytes; Male; Middle Aged; Pilot Projects; Receptors, Glucocorticoid; Time Factors; Venlafaxine Hydrochloride | 2011 |
Poly(lactic acid)-coated mesoporous silica nanosphere for controlled release of venlafaxine.
Topics: Coated Materials, Biocompatible; Cyclohexanols; Delayed-Action Preparations; Lactic Acid; Molecular Structure; Nanoparticles; Particle Size; Polyesters; Polymers; Porosity; Silicon Dioxide; Surface Properties; Venlafaxine Hydrochloride | 2011 |
Determination of venlafaxine in post-mortem whole blood by HS-SPME and GC-NPD.
Topics: Antidepressive Agents, Second-Generation; Chromatography, Gas; Cyclohexanols; Esophagus; Female; Forensic Toxicology; Gastrointestinal Contents; Humans; Limit of Detection; Middle Aged; Nitrogen; Phosphorus; Solid Phase Microextraction; Stomach; Venlafaxine Hydrochloride | 2012 |
Drugs and pheochromocytoma--don't be fooled by every elevated metanephrine.
Topics: Adrenal Gland Neoplasms; Biomarkers, Tumor; Cyclohexanols; Female; Humans; Metanephrine; Middle Aged; Mutation; Normetanephrine; Pheochromocytoma; Selective Serotonin Reuptake Inhibitors; Succinate Dehydrogenase; Venlafaxine Hydrochloride | 2011 |
Electroconvulsive therapy in older adults.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Retreatment; Venlafaxine Hydrochloride | 2011 |
Repetitive transcranial magnetic stimulation or venlafaxine-induced mania?
Topics: Bipolar Disorder; Cyclohexanols; Humans; Male; Middle Aged; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride | 2011 |
Venlafaxine and excessive yawning: is there any link?
Topics: Adult; Anxiety Disorders; Cyclohexanols; Humans; Male; Venlafaxine Hydrochloride; Yawning | 2011 |
Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems.
Topics: Animals; Behavior, Animal; Brain; Carbamazepine; Cyclohexanols; Cyprinidae; Female; Fluoxetine; Gene Expression Profiling; Gene Expression Regulation; Male; Oligonucleotide Array Sequence Analysis; Psychotropic Drugs; Reverse Transcriptase Polymerase Chain Reaction; Venlafaxine Hydrochloride | 2012 |
Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biomarkers; Body Weight; Chronic Disease; Cyclohexanols; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Food Preferences; Gas Chromatography-Mass Spectrometry; Male; Metabolomics; Motor Activity; Principal Component Analysis; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Stress, Psychological; Venlafaxine Hydrochloride | 2011 |
Venlafaxine or a second SSRI: Switching after treatment failure with an SSRI among depressed inpatients: a retrospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Chronic Disease; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Inpatients; Israel; Male; Medical Records Systems, Computerized; Middle Aged; Psychiatric Status Rating Scales; Receptors, Adrenergic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2011 |
Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine, and venlafaxine in Korean patients with major depressive disorder.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Cyclohexanols; Data Interpretation, Statistical; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Hyponatremia; Male; Mianserin; Middle Aged; Mirtazapine; Republic of Korea; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sodium; Venlafaxine Hydrochloride; Young Adult | 2011 |
Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.
Topics: Animals; Antidepressive Agents, Second-Generation; Cerebral Cortex; Cyclohexanols; Gene Expression Regulation; Hippocampus; Humans; Male; Nerve Tissue Proteins; Neuronal Plasticity; Norepinephrine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Serotonin; Time Factors; Venlafaxine Hydrochloride | 2012 |
Venlafaxine in somatopsychic and autopsychic depersonalization.
Topics: Agoraphobia; Cyclohexanols; Depersonalization; Depressive Disorder; Humans; Male; Obsessive Behavior; Panic Disorder; Paroxetine; Retreatment; Selective Serotonin Reuptake Inhibitors; Trimipramine; Venlafaxine Hydrochloride; Young Adult | 2011 |
Effects of venlafaxine and escitalopram treatments on NMDA receptors in the rat depression model.
Topics: Animals; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depression; Disease Models, Animal; Hippocampus; Male; Random Allocation; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Venlafaxine Hydrochloride | 2011 |
Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response.
Topics: Action Potentials; Animals; Antidepressive Agents, Second-Generation; Anxiety; Brain; Corticosterone; Cyclohexanols; Depression; Disease Models, Animal; Female; Hippocampus; Limbic System; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Imaging; Norepinephrine; Organic Cation Transport Proteins; Organic Cation Transporter 2; Radioligand Assay; Serotonin; Venlafaxine Hydrochloride | 2012 |
Stress-induced anhedonia is associated with an increase in Alzheimer's disease-related markers.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Anhedonia; Animals; Antidepressive Agents, Second-Generation; Aspartic Acid Endopeptidases; Biomarkers; Cognition; Corticosterone; Cyclohexanols; Hippocampus; Male; MAP Kinase Signaling System; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Self Administration; Stress, Psychological; Sucrose; Synaptophysin; tau Proteins; Venlafaxine Hydrochloride; Vesicular Transport Proteins | 2012 |
A simple HPLC method for the simultaneous determination of venlafaxine and its major metabolite O-desmethylvenlafaxine in human serum.
Topics: Antidepressive Agents; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Humans; Solid Phase Extraction; Venlafaxine Hydrochloride | 2011 |
Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice.
Topics: Animals; Antidepressive Agents; Cyclohexanols; Depression; DNA Damage; Hippocampus; Male; Mice; Oxidative Stress; Random Allocation; Stress, Psychological; Venlafaxine Hydrochloride | 2011 |
Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood.
Topics: Antidepressive Agents, Second-Generation; Chromatography, Liquid; Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Forensic Toxicology; Genotype; Humans; Stereoisomerism; Tandem Mass Spectrometry; Venlafaxine Hydrochloride | 2012 |
[Approximate entropy of the placebo effect in clinical trials of newer antidepressants].
Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Depression; Fluoxetine; Humans; Paroxetine; Placebo Effect; Placebos; Severity of Illness Index; Venlafaxine Hydrochloride | 2010 |
Paroxysmal cervical myoclonus.
Topics: Adult; Antidepressive Agents, Second-Generation; Chorea; Cyclohexanols; Electromyography; Humans; Male; Myoclonus; Neck; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2011 |
Association analysis between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and treatment response to venlafaxine XR in generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Anxiety Disorders; Brain-Derived Neurotrophic Factor; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Female; Genetic Variation; Genotype; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; White People; Young Adult | 2011 |
Proinflammatory and "resiliency" proteins in the CSF of patients with major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-1; Interleukin-6; Male; Middle Aged; Neuropeptide Y; Severity of Illness Index; Tumor Necrosis Factor-alpha; Up-Regulation; Venlafaxine Hydrochloride | 2012 |
Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?
Topics: Adult; Bias; Bupropion; Buspirone; Cluster Analysis; Cyclohexanols; Depressive Disorder; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Occurrence and removal of lidocaine, tramadol, venlafaxine, and their metabolites in German wastewater treatment plants.
Topics: Absorption; Analgesics, Opioid; Anesthetics, Local; Antidepressive Agents, Second-Generation; Cyclohexanols; Desvenlafaxine Succinate; Gas Chromatography-Mass Spectrometry; Germany; Lidocaine; Limit of Detection; Sewage; Solid Phase Extraction; Solubility; Sonication; Tramadol; Venlafaxine Hydrochloride; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Pollution, Chemical | 2012 |
Nonestrogenic management of hot flashes.
Topics: Breast Neoplasms; Clonidine; Cyclohexanols; Female; Hot Flashes; Humans; Venlafaxine Hydrochloride | 2011 |
Early syphilitic meningoencephalitis masquerading as postclimacteric endogenous depression--a unique dermatologic presentation.
Topics: Anti-Bacterial Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Humans; Meningoencephalitis; Middle Aged; Penicillin G; Postmenopause; Skin; Syphilis; Venlafaxine Hydrochloride | 2011 |
Effect of acutely and chronically administered venlafaxine on the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock model.
Topics: Animals; Anticonvulsants; Avoidance Learning; Behavior, Animal; Brain; Cyclohexanols; Drug Administration Schedule; Drug Interactions; Electroshock; Male; Mice; Models, Animal; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2011 |
Long lasting phantosmia treated with venlafaxine.
Topics: Cyclohexanols; Female; Humans; Middle Aged; Olfaction Disorders; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
[Effect of venlafaxine on cognitive function and hippocampal brain-derived neurotrophic factor expression in rats with post-stroke depression].
Topics: Animals; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Disease Models, Animal; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Rats; Rats, Sprague-Dawley; Stroke; Venlafaxine Hydrochloride | 2011 |
[Serotonin syndrome in the course of drug-poisoning--case presentation].
Topics: Alcoholic Intoxication; Alkaloids; Azocines; Bradycardia; Cyclohexanols; Depressive Disorder; Electrocardiography; Female; Humans; Mianserin; Middle Aged; Moclobemide; Myoclonus; Quinolizines; Respiratory Insufficiency; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Suicide, Attempted; Venlafaxine Hydrochloride | 2011 |
[Cardiogenic shock after venlafaxine poisoning].
Topics: Adult; Anticonvulsants; Cardiotonic Agents; Cyclohexanols; Diuretics; Dobutamine; Electrocardiography; Female; Furosemide; Humans; Hypotension; Isosorbide Dinitrate; Respiration, Artificial; Seizures; Selective Serotonin Reuptake Inhibitors; Shock, Cardiogenic; Suicide, Attempted; Vasodilator Agents; Venlafaxine Hydrochloride | 2011 |
Summer is the best time for Treatment of Resistant Depression in Adolescents (TORDIA): the importance of school in medication trials.
Topics: Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder, Treatment-Resistant; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2011 |
Venlafaxine and atenolol disrupt epinephrine-stimulated glucose production in rainbow trout hepatocytes.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Atenolol; Cyclohexanols; Epinephrine; Glucose; Hepatocytes; Hydrocortisone; Oncorhynchus mykiss; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2012 |
Severe acute cardiomyopathy associated with venlafaxine overdose and possible role of CYP2D6 and CYP2C19 polymorphisms.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Cardiomyopathies; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Drug Overdose; Female; Gene Deletion; Half-Life; Heart Failure; Humans; Milrinone; Norepinephrine; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2011 |
Venlafaxin-associated post-ictal asystole during electroconvulsive therapy.
Topics: Aged, 80 and over; Bipolar Disorder; Contraindications; Cyclohexanols; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Heart Arrest; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
Species comparison of in vivo P-glycoprotein-mediated brain efflux using mdr1a-deficient rats and mice.
Topics: Animals; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Citalopram; Cyclohexanols; Gene Knockout Techniques; Genotype; Mice; Piperazines; Quinolones; Rats; Risperidone; Species Specificity; Venlafaxine Hydrochloride | 2012 |
Time to discontinuation among the three second-generation antidepressants in a naturalistic outpatient setting of depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Female; Humans; Korea; Male; Medication Adherence; Mianserin; Middle Aged; Mirtazapine; Outpatients; Paroxetine; Retrospective Studies; Venlafaxine Hydrochloride | 2011 |
The effects of antidepressants and pilocarpine on rat parotid glands: an immunohistochemical study.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Calcium-Binding Proteins; Calponins; Cell Proliferation; Cyclohexanols; Epithelial Cells; Fluoxetine; Male; Microfilament Proteins; Muscarinic Agonists; Parotid Gland; Pilocarpine; Proliferating Cell Nuclear Antigen; Random Allocation; Rats; Rats, Wistar; Time Factors; Venlafaxine Hydrochloride | 2011 |
Tapentadol increases levels of noradrenaline in the rat spinal cord as measured by in vivo microdialysis.
Topics: Analgesics, Opioid; Animals; Area Under Curve; Chromatography, High Pressure Liquid; Cyclohexanols; Male; Microdialysis; Morphine; Norepinephrine; Phenols; Rats; Rats, Wistar; Receptors, Opioid, mu; ROC Curve; Spinal Cord; Tandem Mass Spectrometry; Tapentadol; Venlafaxine Hydrochloride | 2012 |
Treatment with duloxetine in adults and the incidence of cardiovascular events.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cardiovascular Diseases; Case-Control Studies; Cause of Death; Cohort Studies; Cross-Sectional Studies; Cyclohexanols; Depressive Disorder; Duloxetine Hydrochloride; Electrocardiography; Female; Follow-Up Studies; Humans; Insurance Claim Review; Male; Propensity Score; Risk Factors; Selective Serotonin Reuptake Inhibitors; Thiophenes; United States; Venlafaxine Hydrochloride; Young Adult | 2012 |
Cress seed mucilage based buccal mucoadhesive gel of venlafaxine: in vivo, in vitro evaluation.
Topics: Cyclohexanols; Gels; In Vitro Techniques; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Viscosity | 2012 |
Enantiomeric profiling of chiral drugs in wastewater and receiving waters.
Topics: Amphetamines; Atenolol; Chromatography, Liquid; Cyclohexanols; Ephedrine; Illicit Drugs; Molecular Conformation; Molecular Structure; Tandem Mass Spectrometry; Venlafaxine Hydrochloride; Waste Disposal, Fluid; Water Pollutants, Chemical | 2012 |
Treatment of night eating syndrome with topiramate: dawn of a new day.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Circadian Rhythm; Cyclohexanols; Drug Therapy, Combination; Feeding and Eating Disorders; Feeding Behavior; Female; Fructose; Humans; Middle Aged; Sleep Initiation and Maintenance Disorders; Topiramate; Venlafaxine Hydrochloride | 2012 |
The effect of a P123 template in mesopores of mesocellular foam on the controlled-release of venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Drug Carriers; Gastric Juice; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanospheres; Poloxamer; Powder Diffraction; Silicon Dioxide; Spectrometry, Fluorescence; Venlafaxine Hydrochloride; X-Ray Diffraction | 2012 |
Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus.
Topics: Age Factors; Animals; Antidepressive Agents, Second-Generation; Corticosterone; Cyclohexanols; Depression; Excitatory Amino Acid Transporter 1; Female; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Glutamic Acid; Hippocampus; Male; Maternal Deprivation; Nerve Net; Neurons; Rats; Venlafaxine Hydrochloride | 2012 |
The analysis of binary longitudinal data with time-dependent covariates.
Topics: Antidepressive Agents, Second-Generation; Computer Simulation; Cyclohexanols; Data Interpretation, Statistical; Depression; Humans; Likelihood Functions; Lithium; Logistic Models; Longitudinal Studies; Regression Analysis; Venlafaxine Hydrochloride | 2012 |
A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia.
Topics: Adrenergic Uptake Inhibitors; Animals; Cells, Cultured; Cyclohexanols; Lipopolysaccharides; Mice; Microglia; Nitric Oxide; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2012 |
Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
Topics: Administration, Oral; Animals; Antidepressive Agents, Second-Generation; Biological Availability; Calorimetry, Differential Scanning; Capsules; Cellulose; Chemistry, Pharmaceutical; Cyclohexanols; Delayed-Action Preparations; Dogs; Drug Compounding; Excipients; Hydrogen-Ion Concentration; Intestinal Absorption; Male; Methacrylates; Microscopy, Electron, Scanning; Particle Size; Polymers; Solubility; Surface Properties; Technology, Pharmaceutical; Venlafaxine Hydrochloride | 2012 |
Occurrence of Tako-Tsubo cardiomyopathy in association with ingestion of serotonin/noradrenaline reuptake inhibitors.
Topics: Adult; Aged; Aged, 80 and over; Cyclohexanols; Desvenlafaxine Succinate; Drug Overdose; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Normetanephrine; Peptide Fragments; Selective Serotonin Reuptake Inhibitors; Takotsubo Cardiomyopathy; Venlafaxine Hydrochloride | 2012 |
Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery.
Topics: Aged; Aged, 80 and over; Australia; Coronary Artery Bypass; Coronary Artery Disease; Cyclohexanols; Depression; Duloxetine Hydrochloride; Female; Follow-Up Studies; Hospital Mortality; Humans; Kidney Diseases; Male; Middle Aged; Postoperative Hemorrhage; Proportional Hazards Models; Renal Dialysis; Respiration, Artificial; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2012 |
Questions raised by the failure of a trial of short-term psychodynamic therapy versus pharmacotherapy for major depressive disorder.
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Drug Approval; Female; Humans; Male; Psychotherapy, Brief; Randomized Controlled Trials as Topic; Sertraline; United States Food and Drug Administration; Venlafaxine Hydrochloride | 2012 |
Optimized light therapy for non-seasonal major depressive disorder: effects of timing and season.
Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Phototherapy; Seasons; Time Factors; Venlafaxine Hydrochloride | 2012 |
Attenuating the persistence of fear memory storage using a single dose of antidepressant.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Avoidance Learning; Brain-Derived Neurotrophic Factor; Conditioning, Classical; Cyclohexanols; Fear; Hippocalcin; Male; Memory; Mice; Mice, Knockout; Piperidines; Rats; Rats, Wistar; Reaction Time; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin Antagonists; Time Factors; Venlafaxine Hydrochloride | 2013 |
Venlafaxine facilitates between-session extinction and prevents reinstatement of auditory-cue conditioned fear.
Topics: Acoustic Stimulation; Animals; Antidepressive Agents, Second-Generation; Anxiety Disorders; Conditioning, Psychological; Cues; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Extinction, Psychological; Fear; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Time Factors; Venlafaxine Hydrochloride | 2012 |
Antidepressant-like effect of the ethanolic extract from Suanzaorenhehuan Formula in mice models of depression.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Chemical Fractionation; Cyclohexanols; Depression; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Ethanol; Hippocampus; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase; Motor Activity; Norepinephrine; Phytotherapy; Plants, Medicinal; Prefrontal Cortex; Serotonin; Solvents; Time Factors; Venlafaxine Hydrochloride | 2012 |
Hypoglycaemia: a little known effect of Venlafaxine overdose.
Topics: Adult; Alprazolam; Analgesics; Anti-Anxiety Agents; Cyclohexanols; Depression; Drug Overdose; Drug Therapy, Combination; Female; Gastrointestinal Agents; Half-Life; Humans; Hypoglycemia; Octreotide; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
Anxiolytic-like actions of reboxetine, venlafaxine and endurance swimming in stressed male rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Cyclohexanols; Male; Morpholines; Motor Activity; Physical Conditioning, Animal; Rats; Rats, Wistar; Reboxetine; Restraint, Physical; Stress, Physiological; Stress, Psychological; Swimming; Venlafaxine Hydrochloride | 2012 |
Anti-depressant effects of Xiaoyaosan on rat model of chronic unpredictable mild stress: a plasma metabonomics study based on NMR spectroscopy.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biomarkers; Chronic Disease; Cyclohexanols; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Fluoxetine; Magnetic Resonance Spectroscopy; Male; Metabolomics; Motor Activity; Multivariate Analysis; Rats; Rats, Sprague-Dawley; Stress, Psychological; Sucrose; Venlafaxine Hydrochloride | 2012 |
A case of primary progressive aphasia associated with depression.
Topics: Animal Assisted Therapy; Aphasia, Primary Progressive; Cyclohexanols; Depressive Disorder; Exercise Therapy; Female; Humans; Middle Aged; Psychotherapy, Group; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
The effect of age, sex, smoking and co-medication on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditions.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Desvenlafaxine Succinate; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Retrospective Studies; Sex Characteristics; Smoking; Venlafaxine Hydrochloride | 2012 |
Field and laboratory studies of the fate and enantiomeric enrichment of venlafaxine and O-desmethylvenlafaxine under aerobic and anaerobic conditions.
Topics: Aerobiosis; Biodegradation, Environmental; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Laboratories; Oxidation-Reduction; Sewage; Stereoisomerism; Tandem Mass Spectrometry; Venlafaxine Hydrochloride; Waste Disposal, Fluid; Water Pollutants, Chemical | 2012 |
Impact of wastewater treatment plant discharge of lidocaine, tramadol, venlafaxine and their metabolites on the quality of surface waters and groundwater.
Topics: Cyclohexanols; Desvenlafaxine Succinate; Environmental Monitoring; Groundwater; Lidocaine; Rivers; Tramadol; Venlafaxine Hydrochloride; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Pollution, Chemical | 2012 |
Does aripiprazole protect from serotonin syndrome?
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Tremor; Venlafaxine Hydrochloride; Young Adult | 2012 |
Differential effects of fluoxetine and venlafaxine on memory recognition: possible mechanisms of action.
Topics: Animals; Brain; Cyclohexanols; Fluoxetine; Gene Expression; Male; MAP Kinase Signaling System; Mice; Nitric Oxide Synthase Type I; Receptor, trkB; Receptors, AMPA; Recognition, Psychology; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride | 2012 |
Saving lives: can we predict and prevent adolescent suicide?
Topics: Anhedonia; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
Joy returns last: anhedonia and treatment resistance in depressed adolescents.
Topics: Anhedonia; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
Comparison of monoamine reuptake inhibitors for the immobility time and serotonin levels in the hippocampus and plasma of sub-chronically forced swim stressed rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Cyclohexanols; Fluoxetine; Hippocampus; Imipramine; Immobilization; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress, Psychological; Swimming; Venlafaxine Hydrochloride | 2012 |
Endpoints of drug discovery for menopausal vasomotor symptoms: interpretation of data from a proxy of disease.
Topics: Acetamides; Amines; Animals; Body Temperature Regulation; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Diurnal Enuresis; Drug Discovery; Estradiol; Female; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Hypnotics and Sedatives; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Skin Temperature; Venlafaxine Hydrochloride | 2012 |
Glad about SAD (PD).
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Parkinson Disease; Paroxetine; Venlafaxine Hydrochloride | 2012 |
[The state of nociceptive and antinociceptive brain systems in patients with the pain form of diabetic polyneuropathy].
Topics: Adult; Aged; Anticonvulsants; Antidepressive Agents; Brain; Carbamazepine; Cyclohexanols; Diabetic Neuropathies; Female; Humans; Male; Middle Aged; Neuralgia; Nociceptive Pain; Nociceptors; Pain Measurement; Pain Threshold; Venlafaxine Hydrochloride | 2011 |
Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex.
Topics: Animals; Antidepressive Agents; Bupropion; Cyclohexanols; Dopamine; Extracellular Space; Frontal Lobe; Male; Microdialysis; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin; Venlafaxine Hydrochloride | 2012 |
A simple HPLC method for the simultaneous determination of two selective serotonin reuptake inhibitors and two serotonin-norepinephrine reuptake inhibitors in hair, nail clippings, and cerebrospinal fluid.
Topics: Adrenergic Uptake Inhibitors; Biological Transport; Cerebrospinal Fluid; Chromatography, High Pressure Liquid; Cyclohexanols; Duloxetine Hydrochloride; Fluoxetine; Hair; Humans; Nails; Norepinephrine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride | 2012 |
Long-lasting effects of chronic rTMS to treat chronic rodent model of depression.
Topics: Adrenocorticotropic Hormone; Anhedonia; Animals; Antidepressive Agents, Second-Generation; Antimetabolites; Blotting, Western; Body Weight; Brain; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cyclohexanols; Depression; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Food Preferences; Hydrocortisone; Male; MAP Kinase Signaling System; Motor Activity; Neurogenesis; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Swimming; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride | 2012 |
The effects of serotonin/norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats.
Topics: Amitriptyline; Analgesia; Analgesics; Animals; Cyclohexanols; Dihydroergotamine; Drug Tolerance; Male; Morphine; Pain Measurement; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 2012 |
Fatal agranulocytosis associated with psychotropic medication use.
Topics: Adult; Agranulocytosis; Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Blood Cell Count; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Fatal Outcome; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lamotrigine; Mianserin; Mirtazapine; Multiple Organ Failure; Neutropenia; Orbital Cellulitis; Psychotic Disorders; Psychotropic Drugs; Quetiapine Fumarate; Recombinant Proteins; Shock, Septic; Triazines; Venlafaxine Hydrochloride | 2012 |
Bioavailability of pharmaceuticals in waters close to wastewater treatment plants: use of fish bile for exposure assessment.
Topics: Animals; Anti-Inflammatory Agents; Bile; Biological Availability; Carbamazepine; Chromatography, Liquid; Citalopram; Cyclohexanols; Diclofenac; Finland; Ibuprofen; Liver; Male; Naproxen; Oncorhynchus mykiss; Plasma; Venlafaxine Hydrochloride; Wastewater; Water Pollutants, Chemical | 2012 |
[A case of venlafaxine-induced syndrome of inappropriate ADH secretion (SIADH) - treatment with tolvaptan].
Topics: Aged; Antidepressive Agents, Second-Generation; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Epilepsy, Generalized; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan; Venlafaxine Hydrochloride | 2012 |
5-HT2A receptor -1438 G/A polymorphism and serotonergic antidepressant-induced sexual dysfunction in male patients with major depressive disorder: a prospective exploratory study.
Topics: Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Humans; Male; Middle Aged; Prospective Studies; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Venlafaxine Hydrochloride; Young Adult | 2012 |
Implication of free cholesterol in LC-MS response enhancement.
Topics: Animals; Cholesterol; Chromatography, Liquid; Cyclohexanols; Humans; Ketoconazole; Liquid-Liquid Extraction; Pharmaceutical Preparations; Plasma; Rats; Solid Phase Extraction; Tandem Mass Spectrometry; Triazoles; Tryptamines; Venlafaxine Hydrochloride | 2012 |
Effects of amitriptyline, fluoxetine, tranylcypromine and venlafaxine on rat vascular smooth muscle in vitro--the role of the endothelium.
Topics: Amitriptyline; Animals; Antidepressive Agents; Aorta, Abdominal; Aorta, Thoracic; Cyclic AMP; Cyclic GMP; Cyclohexanols; Dinoprost; Endothelium, Vascular; Fluoxetine; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Nitric Oxide; Phenylephrine; Potassium Channel Blockers; Potassium Chloride; Rats; Rats, Inbred Lew; Selective Serotonin Reuptake Inhibitors; Tranylcypromine; Venlafaxine Hydrochloride | 2012 |
Psychoactive pharmaceuticals induce fish gene expression profiles associated with human idiopathic autism.
Topics: Animals; Autistic Disorder; Carbamazepine; Cell Adhesion Molecules; Cyclohexanols; Cyprinidae; Fluoxetine; Gene Expression Profiling; Gene Expression Regulation; Humans; Microarray Analysis; Nerve Tissue Proteins; Psychotropic Drugs; Receptors, Immunologic; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2012 |
Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Cyclohexanols; Depression; Depressive Disorder; Disease Models, Animal; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Risk Factors; RNA, Messenger; Social Behavior; Stress, Psychological; Thiazepines; Venlafaxine Hydrochloride; Vesicular Glutamate Transport Protein 1 | 2012 |
Evaluation of venlafaxine on glucose homeostasis and oxidative stress in diabetic mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Blood Glucose; Brain; Cyclohexanols; Diabetes Mellitus, Experimental; Glutathione; Homeostasis; Male; Mice; Motor Activity; Oxidative Stress; Streptozocin; Swimming; Thiobarbituric Acid Reactive Substances; Venlafaxine Hydrochloride | 2012 |
A venlafaxine and mirtazapine-induced serotonin syndrome confirmed by de- and re-challenge.
Topics: Aged, 80 and over; Cyclohexanols; Drug Therapy, Combination; Female; Humans; Mianserin; Mirtazapine; Serotonin Syndrome; Venlafaxine Hydrochloride | 2012 |
Duodenal calcium transporter mRNA expression in stressed male rats treated with diazepam, fluoxetine, reboxetine, or venlafaxine.
Topics: Animals; Calcium; Calcium Channels; Cyclohexanols; Diazepam; Duodenum; Fluoxetine; Gene Expression Regulation; Ion Transport; Male; Morpholines; Rats; Reboxetine; Restraint, Physical; RNA, Messenger; Venlafaxine Hydrochloride | 2012 |
Evaluation of hydrophilic, hydrophobic and waxy matrix excipients for sustained release tablets of venlafaxine hydrochloride.
Topics: Antidepressive Agents, Second-Generation; Chemistry, Pharmaceutical; Cyclohexanols; Delayed-Action Preparations; Excipients; Hydrophobic and Hydrophilic Interactions; Models, Theoretical; Solubility; Tablets; Venlafaxine Hydrochloride | 2013 |
Platelet count alterations associated with escitalopram, venlafaxine and bupropion in depressive patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Platelets; Bupropion; Citalopram; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Platelet Count; Retrospective Studies; Venlafaxine Hydrochloride | 2012 |
Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment.
Topics: Adult; Antidepressive Agents; Case-Control Studies; Corticotropin-Releasing Hormone; Cyclohexanols; Depressive Disorder, Major; Female; Glutamic Acid; Glutamine; Humans; Male; Middle Aged; Suicidal Ideation; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Chronic serotonin-norepinephrine reuptake transporter inhibition modifies basal respiratory output in adult mouse in vitro and in vivo.
Topics: Animals; Cyclohexanols; Electromyography; Male; Mice; Mice, Inbred C57BL; Phrenic Nerve; Respiration; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway.
Topics: Animals; Antidepressive Agents, Second-Generation; Calcineurin Inhibitors; Cyclohexanols; Cyclosporine; Depression; Disease Models, Animal; Immunosuppressive Agents; Male; Microinjections; Phosphorylation; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sucrose; Tacrolimus; TOR Serine-Threonine Kinases; Venlafaxine Hydrochloride | 2013 |
Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels.
Topics: Animals; Antidepressive Agents; Astrocytes; Carbamazepine; Cells, Cultured; Cerebral Cortex; Citalopram; Cyclohexanols; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Glycolipids; Histone-Lysine N-Methyltransferase; Imipramine; Indoles; Maleimides; Mice; Nerve Tissue Proteins; Neural Stem Cells; Neurons; Paroxetine; Protein Interaction Mapping; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Venlafaxine Hydrochloride | 2012 |
An indirect comparison of the efficacy and safety of desvenlafaxine and venlafaxine using placebo as the common comparator.
Topics: Adult; Aged; Antidepressive Agents; Australia; Bayes Theorem; Cyclohexanols; Databases, Factual; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Nausea; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
Plasma exchange in the management of a case of hypertriglyceridaemic pancreatitis triggered by venlafaxine.
Topics: Adult; Cyclohexanols; Depression; Diagnosis, Differential; Fluid Therapy; Humans; Hypertriglyceridemia; Male; Pancreatitis, Acute Necrotizing; Plasma Exchange; Selective Serotonin Reuptake Inhibitors; Tomography, X-Ray Computed; Venlafaxine Hydrochloride | 2012 |
Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
Topics: Adult; Antidepressive Agents; Citalopram; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Models, Economic; Quality of Life; Sertraline; Thailand; Venlafaxine Hydrochloride | 2012 |
Influence of sildenafil on the antidepressant activity of bupropion and venlafaxine in the forced swim test in mice.
Topics: Animals; Antidepressive Agents; Bupropion; Chromatography, High Pressure Liquid; Cyclohexanols; Locomotion; Male; Mice; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Swimming; Venlafaxine Hydrochloride | 2012 |
Bilateral pallidal necrosis and cardiac toxicity in a patient with venlafaxine and bupropion overdose.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Drug Overdose; Female; Globus Pallidus; Heart; Humans; Magnetic Resonance Imaging; Necrosis; Venlafaxine Hydrochloride | 2012 |
An investigation of the antidepressant action of xiaoyaosan in rats using ultra performance liquid chromatography-mass spectrometry combined with metabonomics.
Topics: Animals; Antidepressive Agents; Benzoates; Biomarkers; Bridged-Ring Compounds; Catechin; Chalcone; Chromatography, Liquid; Citric Acid; Citric Acid Cycle; Coumaric Acids; Creatine Kinase; Creatinine; Cyclohexanols; Drugs, Chinese Herbal; Flavanones; Fluoxetine; Gallic Acid; Gastrointestinal Tract; Glucosides; Glycine; Hippurates; Ketoglutaric Acids; Kynurenic Acid; Male; Mass Spectrometry; Metabolic Networks and Pathways; Metabolomics; Microbiota; Monoterpenes; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Stress, Psychological; Tryptophan; Tyrosine; Venlafaxine Hydrochloride | 2013 |
The challenge of treating (and supervising) patients with borderline pathology in a residents' clinic.
Topics: Adult; Antidepressive Agents, Second-Generation; Borderline Personality Disorder; Countertransference; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Hypnotics and Sedatives; Internship and Residency; Prescription Drug Misuse; Psychiatry; Psychotherapy; Pyridines; Self-Injurious Behavior; Transference, Psychology; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult; Zolpidem | 2012 |
Venlafaxine causing akathisia: a case report.
Topics: Aged; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Humans; Male; Venlafaxine Hydrochloride | 2012 |
Venlafaxine augmentation with lithium leading to serotonin syndrome.
Topics: Aged; Cyclohexanols; Depression; Drug Synergism; Humans; Lithium Chloride; Male; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2012 |
Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Humans; Intention; Male; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Personality Inventory; Primary Health Care; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Sertraline; Suicidal Ideation; Suicide, Attempted; Thinking; Venlafaxine Hydrochloride | 2012 |
In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Blood Coagulation; Blood Platelets; Citalopram; Cyclohexanols; Female; Fibrinogen; Humans; Male; Middle Aged; Morpholines; Norepinephrine; Platelet Adhesiveness; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Venlafaxine Hydrochloride; Young Adult | 2012 |
SERT and NET occupancy by venlafaxine and milnacipran in nonhuman primates: a PET study.
Topics: Animals; Brain; Cyclohexanols; Cyclopropanes; Dose-Response Relationship, Drug; Female; Macaca fascicularis; Milnacipran; Norepinephrine Plasma Membrane Transport Proteins; Positron-Emission Tomography; Protein Binding; Radioligand Assay; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride | 2013 |
Venlafaxine and risk of upper gastrointestinal bleeding in elderly depression.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Gastrointestinal Hemorrhage; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
Venlafaxine ingestion in a 4-year-old girl.
Topics: Antidepressive Agents, Second-Generation; Basal Ganglia Diseases; Child, Preschool; Cyclohexanols; Drug Overdose; Female; Humans; Venlafaxine Hydrochloride | 2012 |
Prenatal exposure to antidepressants: how safe are they?
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Child Behavior Disorders; Cyclohexanols; Depressive Disorder; Female; Humans; Intelligence; Male; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents, Second-Generation; Case-Control Studies; Child Behavior Disorders; Child, Preschool; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Infant; Infant, Newborn; Intelligence; Longitudinal Studies; Male; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Prospective Studies; Reference Values; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sex Factors; Venlafaxine Hydrochloride; Wechsler Scales | 2012 |
Investigating the roles of different monoamine transmitters and impulse control using the 5-choice serial reaction time task.
Topics: Acetamides; Adrenergic alpha-2 Receptor Antagonists; Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Choice Behavior; Cyclobutanes; Cyclohexanols; Fluoxetine; Hypnotics and Sedatives; Idazoxan; Impulsive Behavior; Male; Norepinephrine; Paroxetine; Rats; Reaction Time; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2013 |
Preliminary data suggest that venlafaxine environmental concentrations could be toxic to plants.
Topics: Antidepressive Agents; Biomarkers; Chlorophyll; Cyclohexanols; Dose-Response Relationship, Drug; Polystichum; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2013 |
Chiral signature of venlafaxine as a marker of biological attenuation processes.
Topics: Antidepressive Agents; Biodegradation, Environmental; Biomarkers; Cyclohexanols; Environmental Monitoring; France; Photochemical Processes; Rivers; Stereoisomerism; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2013 |
Degradation of lidocaine, tramadol, venlafaxine and the metabolites O-desmethyltramadol and O-desmethylvenlafaxine in surface waters.
Topics: Cyclohexanols; Desvenlafaxine Succinate; Hydrogen-Ion Concentration; Lidocaine; Models, Chemical; Photochemical Processes; Rivers; Sunlight; Tramadol; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2013 |
Optimization of thermosensitive chitosan hydrogels for the sustained delivery of venlafaxine hydrochloride.
Topics: Animals; Chitosan; Cyclohexanols; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Female; Glycerophosphates; Hydrogels; Male; Models, Theoretical; Rabbits; Selective Serotonin Reuptake Inhibitors; Temperature; Time Factors; Venlafaxine Hydrochloride | 2013 |
Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa.
Topics: Adhesiveness; Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; In Vitro Techniques; Nasal Mucosa; Permeability; Sheep; Venlafaxine Hydrochloride | 2013 |
Liquid chromatography tandem mass spectrometry method for the simultaneous stereoselective determination of venlafaxine and its major metabolite, O-desmethylvenlafaxine, in human plasma.
Topics: Acetates; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Drug Stability; Humans; Hydrogen-Ion Concentration; Least-Squares Analysis; Male; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Tandem Mass Spectrometry; Temperature; Venlafaxine Hydrochloride | 2013 |
Venlafaxine and neuropathic pain.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Cyclohexanols; Diabetes Mellitus, Experimental; Hyperalgesia; Male; Naloxone; Narcotic Antagonists; Neuralgia; p-Chloroamphetamine; Pain Threshold; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Venlafaxine Hydrochloride; Yohimbine | 2013 |
ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression.
Topics: Adult; Alleles; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Genotype; Heterozygote; Humans; Male; Polymorphism, Single Nucleotide; Predictive Value of Tests; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride | 2012 |
Venlafaxine and quetiapine bezoars.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bezoars; Cyclohexanols; Delayed-Action Preparations; Dibenzothiazepines; Humans; Intestines; Prescription Drug Misuse; Quetiapine Fumarate; Time Factors; Venlafaxine Hydrochloride | 2012 |
Venlafaxine: preeclampsia and eclampsia.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Eclampsia; Female; Humans; Patient Safety; Pre-Eclampsia; Pregnancy; Risk Assessment; Risk Factors; Venlafaxine Hydrochloride | 2012 |
Thermoreversible nasal in situ gel of venlafaxine hydrochloride: formulation, characterization, and pharmacodynamic evaluation.
Topics: Administration, Intranasal; Animals; Antidepressive Agents, Second-Generation; Chemistry, Pharmaceutical; Cyclohexanols; Gels; Hydrogen-Ion Concentration; Mice; Polymers; Rats; Temperature; Venlafaxine Hydrochloride; Viscosity | 2013 |
Modification of morphine analgesia by venlafaxine in diabetic neuropathic pain model.
Topics: Analgesics, Opioid; Animals; Cyclohexanols; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Morphine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Streptozocin; Venlafaxine Hydrochloride | 2012 |
Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007.
Topics: Abnormalities, Drug-Induced; Adult; Anencephaly; Antidepressive Agents, Second-Generation; Aortic Coarctation; Cleft Palate; Cyclohexanols; Female; Gastroschisis; Heart Septal Defects, Atrial; Humans; Maternal Exposure; Odds Ratio; Pregnancy; United States; Venlafaxine Hydrochloride | 2013 |
A case of high-dose venlafaxine-related psychosis.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Humans; Male; Middle Aged; Psychoses, Substance-Induced; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2013 |
Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Australia; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Humans; Hypericum; Markov Chains; Middle Aged; Models, Economic; Phytotherapy; Plant Preparations; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
The spectrum of acute heart failure after venlafaxine overdose.
Topics: Acute Disease; Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Death, Sudden, Cardiac; Delayed-Action Preparations; Electrocardiography; Epilepsy, Tonic-Clonic; Fatal Outcome; Female; Heart Failure; Humans; Hypoxia; Long QT Syndrome; Middle Aged; Respiration, Artificial; Serotonin Syndrome; Shock, Cardiogenic; Stroke Volume; Suicide, Attempted; Venlafaxine Hydrochloride; Ventricular Function, Left | 2013 |
Effects of early maternal separation on biobehavioral and neuropathological markers of Alzheimer's disease in adult male rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Aspartic Acid Endopeptidases; Brain-Derived Neurotrophic Factor; Cell Death; Cell Line, Tumor; Cell Proliferation; Cognition Disorders; Cyclohexanols; Disease Models, Animal; Disks Large Homolog 4 Protein; Female; Gene Expression Regulation; Hippocampus; Humans; Intracellular Signaling Peptides and Proteins; Male; Maternal Deprivation; Membrane Proteins; Mitogen-Activated Protein Kinase 8; Peptide Fragments; Pregnancy; Rats; Rats, Wistar; Recognition, Psychology; Synaptophysin; tau Proteins; Venlafaxine Hydrochloride | 2013 |
Mechanism of synergistic interactions and its influence on drug release from extended release matrices manufactured using binary mixtures of polyethylene oxide and sodium carboxymethylcellulose.
Topics: Calorimetry; Calorimetry, Differential Scanning; Carboxymethylcellulose Sodium; Chemistry, Pharmaceutical; Chlorpheniramine; Cyclohexanols; Drug Synergism; Photoelectron Spectroscopy; Polyethylene Glycols; Propranolol; Tablets; Time Factors; Venlafaxine Hydrochloride; Verapamil | 2013 |
Differences in clinician understanding and management of early menopause after breast cancer.
Topics: Anxiety; Australia; Breast Neoplasms; Cross-Sectional Studies; Cyclohexanols; Depression; Endocrinology; Exercise; Female; Follicle Stimulating Hormone; General Practitioners; General Surgery; Gynecology; Hot Flashes; Humans; Life Style; Medical Oncology; Menopause, Premature; Practice Patterns, Physicians'; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2013 |
Biochemical mechanism studies of venlafaxine by metabonomic method in rat model of depression.
Topics: Animals; Antidepressive Agents, Second-Generation; Biogenic Monoamines; Brain; Cyclohexanols; Depression; Disease Models, Animal; Male; Metabolomics; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Venlafaxine Hydrochloride | 2013 |
A poor metabolizer of both CYP2C19 and CYP2D6 identified by mechanistic pharmacokinetic simulation in a fatal drug poisoning case involving venlafaxine.
Topics: Adult; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Central Nervous System Depressants; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Ethanol; Forensic Toxicology; Gene Deletion; Gene Duplication; Genotype; Humans; Male; Oxycodone; Polymorphism, Single Nucleotide; Venlafaxine Hydrochloride | 2013 |
Preparation of sustained-release dosage form of Venlafaxine HCl using liquisolid technique.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Excipients; Polysorbates; Powders; Solubility; Venlafaxine Hydrochloride | 2014 |
Biotransformation pathways of biocides and pharmaceuticals in freshwater crustaceans based on structure elucidation of metabolites using high resolution mass spectrometry.
Topics: Animals; Biotransformation; Crustacea; Cyclohexanols; Disinfectants; Mass Spectrometry; Metabolic Networks and Pathways; Oxidation-Reduction; Pharmaceutical Preparations; Tramadol; Triazines; Venlafaxine Hydrochloride | 2013 |
Concomitant use of tramadol and venlafaxine - evaluation of antidepressant-like activity and other behavioral effects in rats.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Cyclohexanols; Drug Administration Schedule; Drug Interactions; Drug Tolerance; Injections, Intraperitoneal; Male; Motor Activity; Psychomotor Performance; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Swimming; Time Factors; Tramadol; Venlafaxine Hydrochloride | 2012 |
Depersonalization and derealization syndrome: report on a case study and pharmacological management.
Topics: Adult; Cyclohexanols; Depersonalization; Female; Humans; Lamotrigine; Selective Serotonin Reuptake Inhibitors; Syndrome; Treatment Outcome; Triazines; Venlafaxine Hydrochloride | 2012 |
Venlafaxine-related akathisia side-effects and management in a depressed patient.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Humans; Male; Venlafaxine Hydrochloride | 2013 |
Psychomotor depressive symptoms may differentially respond to venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Prospective Studies; Psychomotor Agitation; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Augmentation of venlafaxine with bupropion: risks associated with a triple monoamine reuptake inhibition approach to partially responsive depression.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder, Major; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Humans; Male; Middle Aged; Risk Factors; Treatment Failure; Venlafaxine Hydrochloride | 2013 |
Hollow-fiber liquid-phase microextraction and chiral LC-MS/MS analysis of venlafaxine and its metabolites in plasma.
Topics: 1-Octanol; Antidepressive Agents, Second-Generation; Calibration; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Humans; Hydrogen-Ion Concentration; Liquid Phase Microextraction; Stereoisomerism; Tandem Mass Spectrometry; Venlafaxine Hydrochloride | 2013 |
The role of Akt/FoxO3a in the protective effect of venlafaxine against corticosterone-induced cell death in PC12 cells.
Topics: Animals; Antidepressive Agents, Second-Generation; Blotting, Western; Cell Death; Corticosterone; Cyclohexanols; Disease Models, Animal; Forkhead Box Protein O3; Forkhead Transcription Factors; PC12 Cells; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Venlafaxine Hydrochloride | 2013 |
Simultaneous quantitation of venlafaxine and its main metabolite, O-desmethylvenlafaxine, in human saliva by HPLC.
Topics: Antidepressive Agents; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Female; Humans; Male; Saliva; Sensitivity and Specificity; Venlafaxine Hydrochloride | 2013 |
Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxiety.
Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Cerebral Cortex; Cyclohexanols; Cyclopropanes; Depression; Dopamine; Duloxetine Hydrochloride; Humans; Male; Mice; Milnacipran; Motor Activity; Neurotransmitter Transport Proteins; Norepinephrine; Rats; Serotonin; Synaptosomes; Thiophenes; Venlafaxine Hydrochloride | 2013 |
Efficacy of venlafaxine extended-release monotherapy for first-episode depression with painful physical symptoms.
Topics: Adult; Antidepressive Agents, Second-Generation; Cohort Studies; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Prospective Studies; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autopsy; Case-Control Studies; Citalopram; Cyclohexanols; Drug Overdose; Female; Forensic Genetics; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Sweden; Venlafaxine Hydrochloride | 2013 |
Increased alcohol consumption in rats after subchronic antidepressant treatment.
Topics: Alcohol Drinking; Alcohols; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Addictive; Body Weight; Conditioning, Operant; Cyclohexanols; Disease Models, Animal; Fluoxetine; Male; Motor Activity; Rats; Rats, Wistar; Self Administration; Time Factors; Venlafaxine Hydrochloride | 2013 |
Oromucosal delivery of venlafaxine by linseed mucilage based gel: in vitro and in vivo evaluation in rabbits.
Topics: Adhesives; Administration, Buccal; Administration, Oral; Animals; Cross-Over Studies; Cyclohexanols; Drug Delivery Systems; Drug Evaluation, Preclinical; Flax; Gels; Mouth Mucosa; Rabbits; Seeds; Sheep; Venlafaxine Hydrochloride | 2013 |
Region-specific regulation of 5-HT1B receptors in the rat brain by chronic venlafaxine treatment.
Topics: Animals; Antidepressive Agents; Brain; Cyclohexanols; Hypothalamus; Male; Protein Binding; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Venlafaxine Hydrochloride | 2013 |
Severe tremor after cotrimoxazole-induced elevation of venlafaxine serum concentrations in a patient with major depressive disorder.
Topics: Anti-Infective Agents; Aryl Hydrocarbon Hydroxylases; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Drug Interactions; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tremor; Trimethoprim, Sulfamethoxazole Drug Combination; Venlafaxine Hydrochloride | 2013 |
The combined treatment of venlafaxine and quetiapine for treatment-resistant depression: a clinical study.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cohort Studies; Cyclohexanols; Depression; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quetiapine Fumarate; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Venlafaxine-associated hyponatremia presenting with catatonia.
Topics: Antidepressive Agents, Second-Generation; Catatonia; Cyclohexanols; Female; Humans; Hypertension; Hyponatremia; Middle Aged; Venlafaxine Hydrochloride | 2013 |
Beneficial effects of fluoxetine, reboxetine, venlafaxine, and voluntary running exercise in stressed male rats with anxiety- and depression-like behaviors.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Cyclohexanols; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Male; Maze Learning; Morpholines; Physical Conditioning, Animal; Rats; Rats, Wistar; Reboxetine; Restraint, Physical; Running; Stress, Psychological; Sucrose; Swimming; Venlafaxine Hydrochloride | 2013 |
Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exploratory Behavior; Male; Methylphenidate; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Receptors, Adrenergic, alpha-2; Time Factors; Venlafaxine Hydrochloride | 2013 |
Changes in the utilization of venlafaxine after the introduction of generics in Sweden.
Topics: Antidepressive Agents, Second-Generation; Confidence Intervals; Cyclohexanols; Depression; Drug Prescriptions; Drugs, Generic; Humans; Sweden; Venlafaxine Hydrochloride | 2013 |
Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network.
Topics: Biomedical Research; Citalopram; Cyclohexanols; Dietary Supplements; Double-Blind Method; Estradiol; Estrogens; Exercise Therapy; Fatty Acids, Omega-3; Female; Hot Flashes; Humans; Menopause; Outcome Assessment, Health Care; Patient Selection; Placebos; Quality Control; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Statistics as Topic; Sweating; Time Factors; Venlafaxine Hydrochloride; Yoga | 2014 |
Dose-related paresthesias with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Male; Paresthesia; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2013 |
Treating wastewater from a pharmaceutical formulation facility by biological process and ozone.
Topics: Biodegradation, Environmental; Biological Oxygen Demand Analysis; Carbamazepine; Chemical Phenomena; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cyclohexanols; Hydrogen-Ion Concentration; Hydroxyl Radical; Industrial Waste; Mass Spectrometry; Ozone; Pharmaceutical Preparations; Ultraviolet Rays; Venlafaxine Hydrochloride; Waste Disposal, Fluid; Wastewater; Water Purification | 2013 |
The reversible cerebral vasoconstriction syndrome in association with venlafaxine and methenamine.
Topics: Cerebral Arteries; Cyclohexanols; Drug Therapy, Combination; Female; Headache Disorders, Primary; Humans; Magnetic Resonance Imaging; Methenamine; Middle Aged; Tomography, X-Ray Computed; Vasoconstriction; Venlafaxine Hydrochloride | 2013 |
Different serum BDNF levels in depression: results from BDNF studies in FYR Macedonia and Bulgaria.
Topics: Adult; Aged; Brain-Derived Neurotrophic Factor; Bulgaria; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Republic of North Macedonia; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Neuropsychological functioning in young subjects with generalized anxiety disorder with and without pharmacotherapy.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Attention; Case-Control Studies; Citalopram; Cyclohexanols; Executive Function; Female; Humans; Male; Memory; Neuropsychological Tests; Venlafaxine Hydrochloride | 2013 |
Novel CYP2D6 and CYP2C19 variants identified in a patient with adverse reactions towards venlafaxine monotherapy and dual therapy with nortriptyline and fluoxetine.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Base Sequence; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Haplotypes; Humans; Molecular Sequence Data; Nortriptyline; Polymorphism, Genetic; Sequence Analysis, DNA; Venlafaxine Hydrochloride; Young Adult | 2013 |
Lyme disease or a complication of delusional parasitosis?
Topics: Adult; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delusional Parasitosis; Diagnosis, Differential; Female; Humans; Lyme Disease; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Status cataplecticus precipitated by abrupt withdrawal of venlafaxine.
Topics: Aged; Cataplexy; Cyclohexanols; Electroencephalography; Female; Humans; Hypertension; Narcolepsy; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2013 |
Case report: quetiapine and refractory hypotension during general anesthesia in the operating room.
Topics: Adult; Anesthesia, General; Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Blood Pressure; Carbon Dioxide; Cardiac Surgical Procedures; Cyclohexanols; Dibenzothiazepines; Electronic Health Records; Ephedrine; Female; Humans; Hypotension; Intraoperative Complications; Lamotrigine; Obesity, Morbid; Operating Rooms; Oxygen; Phenylephrine; Quetiapine Fumarate; Triazines; Vasoconstrictor Agents; Vasopressins; Venlafaxine Hydrochloride | 2013 |
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes.
Topics: Acetamides; Analysis of Variance; Animals; Antidepressive Agents; Calcium Ionophores; Cyclohexanols; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Ionomycin; Male; Potassium Chloride; Rats; Rats, Sprague-Dawley; SNARE Proteins; Synaptosomes; Syntaxin 1; Venlafaxine Hydrochloride | 2013 |
Effect of diclofenac and antidepressants on the inflammatory response in astrocyte cell culture.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Astrocytes; Cells, Cultured; Cyclohexanols; Diclofenac; Enzyme-Linked Immunosorbent Assay; Fluvoxamine; Interleukin-10; Lipopolysaccharides; Mice; Pyridoxine; Selective Serotonin Reuptake Inhibitors; Sertraline; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2013 |
Effect of venlafaxine and desvenlafaxine on drug efflux protein expression and biodistribution in vivo.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Availability; Biological Transport; Brain; Cyclohexanols; Desvenlafaxine Succinate; Drug Interactions; Intestinal Absorption; Intestinal Mucosa; Liver; Male; Mice; Mice, Knockout; Tissue Distribution; Topotecan; Up-Regulation; Venlafaxine Hydrochloride | 2013 |
Neonatal seizures with reversible EEG changes after antenatal venlafaxine exposure.
Topics: Adult; Cyclohexanols; Electroencephalography; Female; Humans; Infant, Newborn; Maternal Exposure; Pregnancy; Seizures; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2013 |
Local control for identifying subgroups of interest in observational research: persistence of treatment for major depressive disorder.
Topics: Adolescent; Adult; Age Factors; Caregivers; Cluster Analysis; Cyclohexanols; Data Mining; Decision Making; Delayed-Action Preparations; Depressive Disorder, Major; Drug Costs; Duloxetine Hydrochloride; Female; Health Education; Humans; Insurance Claim Reporting; Male; Middle Aged; Observational Studies as Topic; Outcome and Process Assessment, Health Care; Statistics as Topic; Statistics, Nonparametric; Thiophenes; Venlafaxine Hydrochloride; Young Adult | 2013 |
Use of electroconvulsive therapy in an adolescent with systemic lupus erythematosus for management of depression.
Topics: Adolescent; Alkylating Agents; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Cyclophosphamide; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Lupus Erythematosus, Systemic; Olanzapine; Prednisolone; Venlafaxine Hydrochloride | 2013 |
Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Asian People; Citalopram; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Prospective Studies; Serotonin Plasma Membrane Transport Proteins; Single-Blind Method; Time Factors; Venlafaxine Hydrochloride; White People; Young Adult | 2013 |
Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study.
Topics: Abortion, Spontaneous; Adult; Antidepressive Agents; Cyclohexanols; Depression; Duloxetine Hydrochloride; Female; Humans; Maternal-Fetal Exchange; Mianserin; Mirtazapine; Pregnancy; Risk; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride; Young Adult | 2013 |
Shaking head means "no".
Topics: Cyclohexanols; Humans; Male; Middle Aged; Myoclonus; Neck Muscles; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Serotonin Syndrome; Sumatriptan; Venlafaxine Hydrochloride | 2013 |
Interaction of different antidepressants with acute and chronic methadone in mice, and possible clinical implications.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Citalopram; Clomipramine; Cyclohexanols; Desipramine; Drug Interactions; Fluvoxamine; Male; Methadone; Mice; Mice, Inbred ICR; Morpholines; Nociception; Pain Threshold; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2014 |
Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults.
Topics: Aged; Bone Resorption; Cyclohexanols; Depressive Disorder, Major; Female; Genetic Variation; Humans; Male; Middle Aged; Osteogenesis; Receptor, Serotonin, 5-HT1B; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride | 2014 |
Gender differences in CMS and the effects of antidepressant venlafaxine in rats.
Topics: Anhedonia; Animals; Antidepressive Agents, Second-Generation; Body Weight; Corticosterone; Cyclohexanols; Female; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Restraint, Physical; Sex Characteristics; Stress, Psychological; Tacrolimus Binding Proteins; Venlafaxine Hydrochloride | 2013 |
[Antidepressant treatment associated hyponatremia -- case report].
Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Critical Care; Cyclohexanols; Depression; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Humans; Hyponatremia; Male; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Sodium; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Restless legs syndrome associated with the combined use of quetiapine and venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Dibenzothiazepines; Drug Substitution; Drug Therapy, Combination; Female; Humans; Middle Aged; Olanzapine; Quetiapine Fumarate; Restless Legs Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
[Development of (hypo)mania during discontinuation of venlafaxine in two patients with bipolar disorder].
Topics: Bipolar Disorder; Cyclohexanols; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
When depression doesn't lead with depression.
Topics: Anger; Bipolar Disorder; Cyclohexanols; Depression; Depressive Disorder, Major; Emotions; Female; Fluoxetine; Humans; Irritable Mood; Male; Mood Disorders; Prefrontal Cortex; Venlafaxine Hydrochloride | 2013 |
[Taperingstrips for paroxetine and venlafaxine].
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Feasibility Studies; Humans; Paroxetine; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2013 |
Solid-state evaluation and polymorphic quantification of venlafaxine hydrochloride raw materials using the Rietveld method.
Topics: Antidepressive Agents; Calorimetry, Differential Scanning; Cyclohexanols; Drug Industry; Humans; Magnetic Resonance Spectroscopy; Scattering, Small Angle; Venlafaxine Hydrochloride; X-Ray Diffraction | 2013 |
Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression.
Topics: Administration, Intranasal; Alginates; Animals; Antidepressive Agents; Brain; Cyclohexanols; Depression; Disease Models, Animal; Female; Glucuronic Acid; Hexuronic Acids; Male; Motor Activity; Nanoparticles; Nasal Mucosa; Pharmacokinetics; Rats; Rats, Wistar; Swimming; Time Factors; Venlafaxine Hydrochloride | 2014 |
High impact child abuse may predict risk of elevated suicidality during antidepressant initiation.
Topics: Adult; Adult Survivors of Child Abuse; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Risk Factors; Suicidal Ideation; Suicide, Attempted; Venlafaxine Hydrochloride | 2013 |
Molecular modeling and spectroscopic studies on the interaction of the chiral drug venlafaxine hydrochloride with bovine serum albumin.
Topics: Absorption, Physicochemical; Algorithms; Animals; Binding Sites; Cattle; Circular Dichroism; Cyclohexanols; Kinetics; Ligands; Models, Molecular; Molecular Docking Simulation; Reproducibility of Results; Serum Albumin, Bovine; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Thermodynamics; Venlafaxine Hydrochloride | 2014 |
Occurrence of venlafaxine residues and its metabolites in marine mussels at trace levels: development of analytical method and a monitoring program.
Topics: Animals; Biotransformation; Bivalvia; Chromatography, Liquid; Cyclohexanols; Humans; Mass Spectrometry; Mediterranean Sea; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2014 |
Venlafaxine abuse in a patient with schizophrenia and prior history of substance dependence: a case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Drug-Seeking Behavior; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders; Venlafaxine Hydrochloride | 2013 |
Treatment of cataplexy in a three-year-old using venlafaxine.
Topics: Cataplexy; Child, Preschool; Cyclohexanols; Follow-Up Studies; Humans; Male; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
The comparison of brand-name and generic formulations of venlafaxine: a therapeutic drug monitoring analysis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Desvenlafaxine Succinate; Drug Monitoring; Drugs, Generic; Female; Humans; Male; Middle Aged; Serum; Sex Characteristics; Smoking; Venlafaxine Hydrochloride; Young Adult | 2014 |
Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine: analysis of therapeutic drug monitoring data under naturalistic conditions.
Topics: Adult; Aged; Antidepressive Agents; Biotransformation; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Doxepin; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; GABA Agents; Germany; Histamine Antagonists; Hospitals, University; Humans; Male; Middle Aged; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Valproic Acid; Venlafaxine Hydrochloride | 2014 |
Treatment in nonresponsive patients with social anxiety: back to the future with benzodiazepines.
Topics: Anti-Anxiety Agents; Clonazepam; Cyclohexanols; Female; Humans; Male; Phobic Disorders; Sertraline; Venlafaxine Hydrochloride | 2014 |
Effect of plasticiser type on the hot melt extrusion of venlafaxine hydrochloride.
Topics: Chemistry, Pharmaceutical; Citric Acid; Crystallization; Cyclohexanols; Drug Carriers; Drug Compounding; Esterification; Freezing; Hot Temperature; Humans; Plasticizers; Polyethylene Glycols; Polymethacrylic Acids; Stress, Mechanical; Venlafaxine Hydrochloride | 2014 |
Acute bilateral parotitis occurring during venlafaxine titration in an adolescent female with major depression.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Parotitis; Pregnancy; Venlafaxine Hydrochloride; Young Adult | 2014 |
Effects of the antidepressant venlafaxine on fish brain serotonin and predation behavior.
Topics: Animals; Behavior, Animal; Brain; Brain Chemistry; Cyclohexanols; Cyprinidae; Drug Stability; Predatory Behavior; Serotonin; Venlafaxine Hydrochloride; Water; Water Pollutants, Chemical | 2014 |
Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS/MS.
Topics: Antidepressive Agents; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Dried Blood Spot Testing; Drug Monitoring; Humans; Sensitivity and Specificity; Tandem Mass Spectrometry; Venlafaxine Hydrochloride | 2014 |
Distribution of venlafaxine, O-desmethylvenlafaxine, and O-desmethylvenlafaxine to venlafaxine ratio in postmortem human brain tissue.
Topics: Adult; Brain Chemistry; Chromatography, Liquid; Cyclohexanols; Desvenlafaxine Succinate; Female; Humans; Male; Middle Aged; Postmortem Changes; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2014 |
Pendular nystagmus associated with venlafaxine overdose: a forme fruste of the serotonin syndrome?
Topics: Cyclohexanols; Drug Overdose; Female; Humans; Middle Aged; Nystagmus, Pathologic; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2014 |
Case report of a 24-year-old man with resolution of treatment-resistant major depressive disorder and comorbid PTSD using rTMS.
Topics: Antidepressive Agents, Second-Generation; Combat Disorders; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Diagnostic and Statistical Manual of Mental Disorders; Humans; Male; Military Personnel; Stress Disorders, Post-Traumatic; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride; Young Adult | 2014 |
Lack of influence of rs4680 (COMT) and rs6276 (DRD2) on diagnosis and clinical outcomes in patients with major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Catechol O-Methyltransferase; Cyclohexanols; Depressive Disorder, Major; Epistasis, Genetic; Female; Humans; Male; Middle Aged; Paroxetine; Receptors, Dopamine D2; Republic of Korea; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Effects of acute and chronic administration of venlafaxine and desipramine on extracellular monoamine levels in the mouse prefrontal cortex and striatum.
Topics: Animals; Biogenic Monoamines; Corpus Striatum; Cyclohexanols; Desipramine; Extracellular Fluid; Male; Mice; Mice, Inbred ICR; Prefrontal Cortex; Venlafaxine Hydrochloride | 2014 |
Response to antidepressant medications in late-life depression across the spectrum of cognitive functioning.
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Citalopram; Cognitive Dysfunction; Cyclohexanols; Dementia; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2014 |
Retention modeling and method development in hydrophilic interaction chromatography.
Topics: Algorithms; Carbohydrates; Chromatography, Liquid; Cyclohexanols; Hydrophobic and Hydrophilic Interactions; Models, Chemical; Pteridines; Temperature; Tramadol; Venlafaxine Hydrochloride | 2014 |
Venlafaxine protects methylglyoxal-induced apoptosis in the cultured human brain microvascular endothelial cells.
Topics: Antidepressive Agents; Apoptosis; Brain; Cell Line; Cyclohexanols; Endothelial Cells; Humans; JNK Mitogen-Activated Protein Kinases; Microvessels; Neuroprotective Agents; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyruvaldehyde; Venlafaxine Hydrochloride | 2014 |
An observational study of Venlafaxine and CYP2D6 in clinical practice.
Topics: Adult; Aged; Cyclohexanols; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Phenotype; Practice Patterns, Physicians'; Venlafaxine Hydrochloride | 2014 |
Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
Topics: Aged; Antidepressive Agents; Anxiety; Cyclohexanols; Datasets as Topic; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Paroxetine; Predictive Value of Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Severity of Illness Index; Venlafaxine Hydrochloride | 2014 |
[Social phobia].
Topics: Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Cyclohexanols; Evidence-Based Medicine; Humans; Phobic Disorders; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Plasma levels and cerebrospinal fluid penetration of venlafaxine in a patient with a nonfatal overdose during a suicide attempt.
Topics: Adult; Cyclohexanols; Drug Monitoring; Drug Overdose; Female; Humans; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Venlafaxine Hydrochloride | 2014 |
Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation.
Topics: Administration, Intranasal; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Brain; Chitosan; Cyclohexanols; Drug Compounding; Female; In Vitro Techniques; Male; Motor Activity; Nanoparticles; Nasal Mucosa; Rats, Wistar; Venlafaxine Hydrochloride | 2012 |
Myoclonic seizures in a preterm baby: is this a presentation of venlafaxine withdrawal?
Topics: Antidepressive Agents; Cyclohexanols; Electroencephalography; Female; Humans; Infant, Newborn; Infant, Premature; Magnetic Resonance Imaging; Maternal Exposure; Phenobarbital; Phenytoin; Pregnancy; Seizures; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2014 |
Antidepressants that inhibit both serotonin and norepinephrine reuptake impair long-term potentiation in hippocampus.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cyclohexanols; Fluoxetine; Hippocampus; Imipramine; Long-Term Potentiation; Male; Maprotiline; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Venlafaxine Hydrochloride | 2014 |
A note on implementation of decaying product correlation structures for quasi-least squares.
Topics: Algorithms; Antidepressive Agents; Biostatistics; Bipolar Disorder; Clinical Trials as Topic; Cyclohexanols; Humans; Least-Squares Analysis; Lithium Compounds; Longitudinal Studies; Models, Statistical; Venlafaxine Hydrochloride | 2014 |
Seizures after single-agent overdose with pharmaceutical drugs: analysis of cases reported to a poison center.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Child; Child, Preschool; Citalopram; Cyclohexanols; Drug Overdose; Female; Humans; Infant; Male; Mefenamic Acid; Middle Aged; Poison Control Centers; Retrospective Studies; Seizures; Switzerland; Trimipramine; Venlafaxine Hydrochloride; Young Adult | 2014 |
Fatal methylene blue associated serotonin toxicity.
Topics: Aged; Cyclohexanols; Drug Interactions; Enzyme Inhibitors; Fatal Outcome; Female; Humans; Hyperparathyroidism; Methylene Blue; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2014 |
Impact of age on serum concentrations of venlafaxine and escitalopram in different CYP2D6 and CYP2C19 genotype subgroups.
Topics: Adult; Aged; Aged, 80 and over; Aging; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Young Adult | 2014 |
Antinociceptive effects of venlafaxine in a rat model of peripheral neuropathy: role of alpha2-adrenergic receptors.
Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Animals; Behavior, Animal; Cyclohexanols; Hyperalgesia; Male; Neuralgia; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Venlafaxine Hydrochloride; Yohimbine | 2014 |
Long-standing depression and anxiety in a Korean woman.
Topics: Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Republic of Korea; Venlafaxine Hydrochloride | 2014 |
Analgesic effects of antidepressants alone and after their local co-administration with morphine in a rat model of neuropathic pain.
Topics: Amitriptyline; Analgesics; Animals; Antidepressive Agents; Cyclohexanols; Disease Models, Animal; Doxepin; Hyperalgesia; Male; Morphine; Neuralgia; Pain Measurement; Pain Threshold; Rats; Sciatic Nerve; Venlafaxine Hydrochloride | 2014 |
Adverse cardiac events in older patients receiving venlafaxine: a population-based study.
Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cohort Studies; Comorbidity; Cyclohexanols; Drug Interactions; Female; Heart Failure; Humans; Hypertension; Male; Myocardial Infarction; Ontario; Retrospective Studies; Risk Factors; Sertraline; Tachycardia; Venlafaxine Hydrochloride | 2014 |
Serotonin and sudden death: differential effects of serotonergic drugs on seizure-induced respiratory arrest in DBA/1 mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Cyclohexanols; Cyproheptadine; Death, Sudden; Dose-Response Relationship, Drug; Epilepsy, Reflex; Female; Heart Arrest; Male; Mice; Mice, Inbred DBA; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Antagonists; Venlafaxine Hydrochloride | 2014 |
Serotonin toxicity in a CYP2D6 poor metabolizer, initially diagnosed as a drug-resistant major depression.
Topics: Cyclohexanols; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Depressive Disorder, Treatment-Resistant; Genotype; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2014 |
Distribution of venlafaxine and O-desmethylvenlafaxine in a fatal case.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Desvenlafaxine Succinate; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Male; Suicide; Tissue Distribution; Venlafaxine Hydrochloride | 2014 |
Venlafaxine in treatment resistant obsessive-compulsive disorder.
Topics: Adolescent; Adult; Cyclohexanols; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2014 |
Venlafaxine and O-desmethylvenlafaxine concentrations in plasma and cerebrospinal fluid.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Desvenlafaxine Succinate; Female; Humans; Male; Middle Aged; Venlafaxine Hydrochloride | 2015 |
Venlafaxine inhibits apoptosis of hippocampal neurons by up-regulating brain-derived neurotrophic factor in a rat depression model.
Topics: Animals; Antidepressive Agents, Second-Generation; Apoptosis; Behavior, Animal; Blotting, Western; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Disease Models, Animal; Hippocampus; Immunohistochemistry; In Situ Nick-End Labeling; Male; Microscopy, Electron, Transmission; Neurons; Rats; Rats, Sprague-Dawley; Up-Regulation; Venlafaxine Hydrochloride | 2014 |
β-Cyclodextrin/thermosensitive containing polymer brushes grafted onto magnetite nano-particles for extraction and determination of venlafaxine in biological and pharmaceutical samples.
Topics: Acrylamides; Adsorption; Allylamine; beta-Cyclodextrins; Cyclohexanols; Feasibility Studies; Humans; Hydrogen-Ion Concentration; Magnetite Nanoparticles; Organosilicon Compounds; Polymers; Selective Serotonin Reuptake Inhibitors; Silanes; Temperature; Time Factors; Venlafaxine Hydrochloride | 2014 |
Magnetized silane-coupling agent KH-570 based solid-phase extraction followed by gas chromatography-flame ionization detection to determine venlafaxine in human hair and aqueous environmental samples.
Topics: Antidepressive Agents, Second-Generation; Chromatography, Gas; Cyclohexanols; Flame Ionization; Hair; Humans; Methacrylates; Reproducibility of Results; Silanes; Solid Phase Extraction; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2015 |
The impacts of migraine and anxiety disorders on painful physical symptoms among patients with major depressive disorder.
Topics: Adolescent; Adult; Aged; Analgesics; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Disease Management; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain; Pain Measurement; Symptom Assessment; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2014 |
Hypoglycemia in venlafaxine overdose: a hypothesis of increased glucose uptake.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Glucose; C-Peptide; Cyclohexanols; Drug Overdose; Female; Glucose; Humans; Hypoglycemia; Insulin; Venlafaxine Hydrochloride | 2015 |
Assessment of in-utero venlafaxine induced, ROS-mediated, apoptotic neurodegeneration in fetal neocortex and neurobehavioral sequelae in rat offspring.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Apoptosis; bcl-2-Associated X Protein; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Exploratory Behavior; Female; Male; Microscopy, Electron; Neocortex; Nerve Degeneration; Pregnancy; Proto-Oncogene Proteins c-bcl-2; Pyelectasis; Rats; Reactive Oxygen Species; Venlafaxine Hydrochloride | 2015 |
The influence of microglia activation on the efficacy of amitriptyline, doxepin, milnacipran, venlafaxine and fluoxetine in a rat model of neuropathic pain.
Topics: Amitriptyline; Animals; Antidepressive Agents; Calcium-Binding Proteins; Cyclohexanols; Cyclopropanes; Doxepin; Fluoxetine; Ganglia, Spinal; Hyperalgesia; Male; Microfilament Proteins; Microglia; Milnacipran; Neuralgia; Rats, Wistar; Sciatic Nerve; Spinal Cord; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
Occurrence of venlafaxine, other antidepressants and selected metabolites in the Rhine catchment in the face of climate change.
Topics: Antidepressive Agents; Climate Change; Cyclohexanols; Environmental Monitoring; Germany; Humans; Rivers; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Wastewater; Water Pollutants, Chemical | 2015 |
Coupling of solid phase microextraction with electrospray ionization ion mobility spectrometry and direct analysis of venlafaxine in human urine and plasma.
Topics: Adult; Animals; Blood Chemical Analysis; Cyclohexanols; Humans; Hydrogen-Ion Concentration; Male; Rats; Reproducibility of Results; Salts; Solid Phase Microextraction; Spectrometry, Mass, Electrospray Ionization; Temperature; Time Factors; Urinalysis; Venlafaxine Hydrochloride | 2015 |
The antidepressants venlafaxine ("Effexor") and fluoxetine ("Prozac") produce different effects on locomotion in two species of marine snail, the oyster drill (Urosalpinx cinerea) and the starsnail (Lithopoma americanum).
Topics: Animals; Antidepressive Agents; Cyclohexanols; Fluoxetine; Locomotion; Snails; Species Specificity; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2015 |
First MEPS/HPLC assay for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in human plasma.
Topics: Calibration; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Humans; Limit of Detection; Reference Standards; Reproducibility of Results; Spectrometry, Fluorescence; Venlafaxine Hydrochloride | 2014 |
SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese population.
Topics: Adult; Asian People; Cyclohexanols; Depressive Disorder, Major; Female; Genetic Testing; Humans; Male; Middle Aged; Norepinephrine Plasma Membrane Transport Proteins; Polymorphism, Single Nucleotide; Regression Analysis; Remission Induction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
Drug-, dose- and sex-dependent effects of chronic fluoxetine, reboxetine and venlafaxine on open-field behavior and spatial memory in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Cyclohexanols; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Fluoxetine; Locomotion; Male; Maze Learning; Memory, Short-Term; Morpholines; Motor Activity; Rats; Rats, Inbred Strains; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sex Factors; Spatial Memory; Time Factors; Venlafaxine Hydrochloride | 2015 |
Organocatalytic enantioselective Michael addition of cyclic hemiacetals to nitroolefins: a facile access to chiral substituted 5- and 6-membered cyclic ethers.
Topics: Acetals; Alkenes; Antidepressive Agents; Catalysis; Cyclohexanols; Drug Design; Ethers; Ethers, Cyclic; Furans; Kinetics; Lactones; Models, Chemical; Pyrans; Stereoisomerism; Venlafaxine Hydrochloride | 2015 |
Differential co-expression and regulation analyses reveal different mechanisms underlying major depressive disorder and subsyndromal symptomatic depression.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Biomarkers; Case-Control Studies; Cyclohexanols; Depression; Depressive Disorder, Major; Female; Gene Regulatory Networks; Humans; Leukocytes, Mononuclear; Male; Microarray Analysis; Venlafaxine Hydrochloride | 2015 |
Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
Topics: Adult; Cohort Studies; Contraindications; Cyclohexanols; Depressive Disorder; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Logistic Models; Odds Ratio; Population Surveillance; Pregnancy; Pregnancy Complications; Scandinavian and Nordic Countries; Selective Serotonin Reuptake Inhibitors; Siblings; Venlafaxine Hydrochloride | 2015 |
[Venlafaxine in the treatment of moderate and severe depressions: the ways to increase treatment efficacy].
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression.
Topics: Adult; Affect; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2016 |
Venlafaxine inhibits apoptosis of hippocampal neurons by up-regulating brain-derived neurotrophic factor in a rat depression model.
Topics: Animals; Apoptosis; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Hippocampus; Male; Neurons; Nitric Oxide; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Signal Transduction; Up-Regulation; Venlafaxine Hydrochloride; Weight Gain | 2014 |
Psychoactive pharmaceuticals as environmental contaminants may disrupt highly inter-connected nodes in an Autism-associated protein-protein interaction network.
Topics: Animals; Anticonvulsants; Antidepressive Agents, Second-Generation; Autistic Disorder; Brain; Carbamazepine; Cyclohexanols; Cyprinidae; Environmental Pollutants; Female; Gene Regulatory Networks; Humans; Maternal Exposure; Nerve Tissue Proteins; Protein Interaction Maps; Valproic Acid; Venlafaxine Hydrochloride | 2015 |
The influence of caffeine on the activity of moclobemide, venlafaxine, bupropion and milnacipran in the forced swim test in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Bupropion; Caffeine; Cyclohexanols; Cyclopropanes; Drug Evaluation, Preclinical; Drug Interactions; Male; Mice; Milnacipran; Moclobemide; Motor Activity; Swimming; Venlafaxine Hydrochloride | 2015 |
[Optimization of the efficacy and safety of antidepressant therapy in patients of a geriatric psychiatric unit].
Topics: Acetamides; Acetylcarnitine; Aged; Antidepressive Agents; Apathy; Cyclohexanols; Depressive Disorder; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
Risperidone and Venlafaxine Metabolic Ratios Strongly Predict a CYP2D6 Poor Metabolizing Genotype.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Child; Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Female; Genotype; Humans; Male; Middle Aged; Paliperidone Palmitate; Predictive Value of Tests; Retrospective Studies; Risperidone; Sensitivity and Specificity; Venlafaxine Hydrochloride; Young Adult | 2016 |
Selective solid-phase extraction using molecularly imprinted polymers for analysis of venlafaxine, O-desmethylvenlafaxine, and N-desmethylvenlafaxine in plasma samples by liquid chromatography-tandem mass spectrometry.
Topics: Acrylates; Antidepressive Agents; Chromatography, High Pressure Liquid; Cyclohexanols; Depression; Desvenlafaxine Succinate; Humans; Methacrylates; Microscopy, Electron, Scanning; Molecular Imprinting; Nitriles; Polymerization; Polymers; Solid Phase Extraction; Spectroscopy, Fourier Transform Infrared; Tandem Mass Spectrometry; Toluene; Venlafaxine Hydrochloride | 2016 |
Venlafaxine exerts antidepressant effects possibly by activating MAPK-ERK1/2 and P13K-AKT pathways in the hippocampus.
Topics: Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Hippocampus; Male; MAP Kinase Signaling System; Metabolomics; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Norepinephrine; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2017 |
Antidepressant polypharmacy and the potential of pharmacokinetic interactions: Doxepin but not mirtazapine causes clinically relevant changes in venlafaxine metabolism.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Databases, Factual; Desvenlafaxine Succinate; Doxepin; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Polypharmacy; Venlafaxine Hydrochloride | 2018 |
DETERMINATION OF VENLAFAXINE, VILAZODONE AND THEIR MAIN ACTIVE METABOLITES IN HUMAN SERUM BY HPLC-DAD AND HPLC-MS.
Topics: Antidepressive Agents; Biotransformation; Calibration; Chromatography, High Pressure Liquid; Cyclohexanols; Humans; Limit of Detection; Reference Standards; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Venlafaxine Hydrochloride; Vilazodone Hydrochloride | 2017 |
Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients.
Topics: Aged; Alleles; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Drug Monitoring; Female; Genotype; Humans; Male; Middle Aged; Norway; Retrospective Studies; Venlafaxine Hydrochloride | 2019 |
A Case of Serotonin Syndrome Caused by the Concomitant Utilization of Methylene Blue and Venlafaxine in an Oncological Patient.
Topics: Cyclohexanols; Humans; Methylene Blue; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2020 |
Comparison of venlafaxine alone versus venlafaxine plus late partial sleep deprivation therapy combination for major depressive disorder.
Topics: Circadian Rhythm; Cyclohexanols; Depressive Disorder, Major; Humans; Psychiatric Status Rating Scales; Sleep Deprivation; Treatment Outcome; Venlafaxine Hydrochloride | 2021 |
Venlafaxine and desvenlafaxine to be included in the surface water Watch List.
Topics: Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Water | 2021 |
Discontinuation Syndrome of Extended-Release Venlafaxine during the COVID-19 Epidemic.
Topics: Antidepressive Agents, Second-Generation; COVID-19; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Epidemics; Humans; SARS-CoV-2; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2021 |
Delayed cardiotoxicity in venlafaxine and quetiapine overdose.
Topics: Antipsychotic Agents; Cardiotoxicity; Cyclohexanols; Dibenzothiazepines; Drug Overdose; Humans; Quetiapine Fumarate; Venlafaxine Hydrochloride | 2021 |
Venlafaxine and O-desmethylvenlafaxine serum levels are positively associated with antidepressant response in elder depressed out-patients.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Desvenlafaxine Succinate; Drug Monitoring; Humans; Outpatients; Venlafaxine Hydrochloride | 2022 |
Serotonin Syndrome Induced by a Single Dose of Venlafaxine and Magnesium Valproate.
Topics: Cyclohexanols; Humans; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Syndrome; Valproic Acid; Venlafaxine Hydrochloride | 2021 |
Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder.
Topics: Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Cyclohexanols; Depressive Disorder, Major; Humans; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Tyramine; Venlafaxine Hydrochloride | 2022 |
Multiple-reaction monitoring (MRM) LC-MS/MS quantitation of venlafaxine and its O-desmethyl metabolite for a preclinical pharmacokinetic study in rabbits.
Topics: Animals; Chromatography, Liquid; Cyclohexanols; Rabbits; Reproducibility of Results; Tandem Mass Spectrometry; Venlafaxine Hydrochloride | 2022 |